Moss genes from physcomitrella patens encoding proteins involved in the synthesis of carbohydrates

ABSTRACT

Isolated nucleic acid molecules, designated CMRP nucleic acid molecules, which encode novel CMRPs from  Physcomitrella patens  are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CMRP nucleic acid molecules, and host cells and organisms into which the expression vectors have been introduced. The invention still further provides isolated CMRPs, mutated CMRPs, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from transformed cells based on genetic engineering of CMRP genes in this organism.

BACKGROUND OF THE INVENTION

[0001] Certain products and by-products of naturally-occurring metabolic processes in cells have utility in a wide array of industries, including the food, feed, cosmetics, and pharmaceutical industries. These molecules, collectively termed ‘fine chemicals’, include carbohydrates, cofactors and enzymes.

[0002] Their production is most conveniently performed through the large-scale culture of microorganisms developed to produce and secrete large quantities of one or more desired molecules. One particularly useful organism for this purpose is Corynebacterium glutamicum, a gram positive, nonpathogenic bacterium.

[0003] Further particularly useful organisms for this purpose are Escherichia coli, Acetobacter xylinum and Chlorella. Through strain selection, a number of mutant strains of the respective microorganisms have been developed which produce an array of desirable compounds. However, selection of strains improved for the production of a particular molecule is a time-consuming and difficult process.

[0004] Alternatively the production of fine chemicals can be most conveniently performed via the large scale production of plants developed to produce one of aforementioned fine chemicals. Particularly well suited plants for this purpose are carbohydrate storing plants containing high amounts of carbohydrates like potato, maize, barley, wheat, rye, sugar cane, sugar beet, cotton, flax, poplar. But also other crop plants containing carbohydrates are well suited as mentioned in the detailed description of this invention. Through conventional breeding, a number of mutant plants have been developed which produce an array of desirable carbohydrates, cofactors and enzymes. However, selection of new plant cultivars improved for the production of a particular molecule is a time-consuming and difficult process or even impossible if the compound does not naturally occur in the respective plant as in the case of sugars like trehalose or raffinose.

SUMMARY OF THE INVENTION

[0005] This invention provides novel nucleic acid molecules which may be used to modify carbohydrates, cofactors and enzymes in microorganims and plants, especially and most preferred to produce carbohydrates like starch, cell wall polysaccharids and soluble sugars. Microorganisms like Escherichia coli and Corynebacterium, fungi, green algae like Chlorella and plants are commonly used in industry for the large-scale production of a variety of fine chemicals.

[0006] Given the availability of cloning vectors for use in Corynebacterium glutamicum, such as those disclosed in Sinskey et al., U.S. Pat. No. 4,649,119, and techniques for genetic manipulation of C. glutamicum and the related Brevibacterium species (e.g., lactofermentum) (Yoshihama et al, J. Bacteriol. 162: 591-597 (1985); Katsumata et al., J. Bacteriol. 159: 306-311 (1984); and Santamaria et al., J. Gen. Microbiol. 130: 2237-2246 (1984)), the nucleic acid molecules of the invention may be utilized in the genetic engineering of this organism to make it a better or more efficient producer of one or more fine chemicals. This improved production or efficiency of production of a fine chemical may be due to a direct effect of manipulation of a gene of the invention, or it may be due to an indirect effect of such manipulation.

[0007] Given the availability of cloning vectors and techniques of genetic manipulation of bacteria such as Acetobacter xylinum described in Hall et al., Plasmid 28: 194-200 (1992) and references therein the nucleic acid molecules of the invention may be utilized in the genetic engineering of this organism to make it a better or more efficient producer or efficiency of production of a fine chemical may be due to a direct effect of manipulation of a gene of the invention, or it may be due to an indirect effect of such manipulation.

[0008] Given the availability of cloning vectors and techniques for genetic manipulation of algae such as Chlorella described in El-Sheekh, Biologia Plantarum 42: 209-216 (1999) as well as in Chow and Tung, Plant Cell Reports 18: 778-780 (1999) and references therein the nucleic acid molecules of the invention may be utilized in the genetic engineering of this organism to make it a better or more efficient producer of one or more fine chemicals. This improved production or efficiency of production of a fine chemical may be due to a direct effect of manipulation of a gene of the invention, or it may be due to an indirect effect of such manipulation.

[0009] Mosses as well as some algae and higher plants produce considerable amounts of starch, different cell wall polysaccharides and soluble sugars like sucrose, trehalose and raffinose. Therefore nucleic acid molecules originating from a moss like Physcomitrella patens are suitable to modify the carbohydrate production system in a host, especially in microorganisms and plants. Furthermore nucleic acids from the moss Physcomitrella patens can be used to identify those DNA sequences and enzymes in other species which are useful to modify the biosynthesis of starch, cell wall polysaccharides and soluble sugars. Nucleic acid molecules from Physcomitrella are of special interest for the functional analysis of genes since directed gene knock-out by homologous recombination is established for this moss as described in Hofmann et al., Molecular and General Genetics 261: 92-99 (1999) as well as in Girke et al., Plant Journal 15: 39-48 (1998).

[0010] The moss Physcomitrella patens represents one member of the mosses. It is related to other mosses such as Ceratodon purpureus which is capable to grow in the absense of light. Mosses like Ceratodon and Physcomitrella share a high degree of homology on the DNA sequence and polypeptide level allowing the use of heterologous screening of DNA molecules with probes evolving from other mosses or organisms, thus enabling the derivation of a consensus sequence suitable for heterologous screening or functional annotation and prediction of gene functions in third species. The ability to identify such functions can therefore have significant relevance, e.g. prediction of substrate specificity of enzymes. Further, these nucleic acid molecules may serve as reference points for the mapping of moss genomes, or of genomes of related organisms.

[0011] These novel nucleic acid molecules encode proteins, referred to herein as Carbohydrate Metabolism Related Proteins_(CMRPs). These CMRPs are capable of, for example, performing a function involved in the metabolism (e.g., the biosynthesis or degradation) of compounds necessary for carbohydrate biosynthesis or of influencing the structural properties of the carbohydrate, or of assisting in the transmembrane transport of one or more carbohydrate compounds or its metabolits either into or out of the cell. Given the availability of cloning vectors for use in plants and plant transformation, such as those published in and cited therein: Plant Molecular Biology and Biotechnology (CRC Press, Boca Raton, Fla.), chapter 6/7, S.71-119 (1993); F. F. White, Vectors for Gene Transfer in Higher Plants; in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds.: Kung und R. Wu, Academic Press, 1993, 15-38; B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds.: Kung und R. Wu, Academic Press (1993), 128-143; Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991), 205-225)) the nucleic acid molecules of the invention may be utilized in the genetic engineering of a wide variety of plants to make it a better or more efficient producer of one or more fine chemicals. This improved production or efficiency of production of a fine chemical may be due to a direct effect of manipulation of a gene of the invention, or it may be due to an indirect effect of such manipulation.

[0012] There are a number of mechanisms by which the alteration of an CMRP of the invention may directly affect the yield, production, and/or efficiency of production of a fine chemical from a carbohydrate storing plant due to such an altered protein. The nucleic acid and protein molecules of the invention may directly improve the production or efficiency of production of one or more desired fine chemicals from Corynebacterium glutamicum, other microorganisms and plants. Using recombinant genetic techniques well known in the art, one or more of the biosynthetic or degradative enzymes of the invention for amino acids, vitamins, cofactors, nutraceuticals, nucleotides or nucleosides may be manipulated such that its function is modulated. For example, a biosynthetic enzyme may be improved in efficiency, or its allosteric control region destroyed such that feedback inhibition of production of the compound is prevented. Similarly, a degradative enzyme may be deleted or modified by substitution, deletion, or addition such that its degradative activity is lessened for the desired compound without impairing the viability of the cell. In each case, the overall yield or rate of production of the desired fine chemical may be increased.

[0013] It is also possible that such alterations in the protein and nucleotide molecules of the invention may improve the production of other fine chemicals besides the amino acids, vitamins, cofactors, nutraceuticals, nucleotide and nucleosides through indirect mechanisms. Metabolism of any one compound is necessarily interwined with other biosynthetic and degradative pathways within the cell, and necessary cofactors, intermediates, or substrates in one pathway are likely supplied or limited by another such pathway. Therefore, by modulating the activity of one or more of the proteins of the invention, the production or efficiency of activity of another fine chemical biosynthetic or degradative pathway may be impacted. For example, amino acids serve as the structural units of all proteins, yet may be present intracellularly in levels which are limiting for protein synthesis; therefore, by increasing the efficiency of production or the yields of one or more amino acids within the cell, proteins, such as biosynthetic or degradative proteins, may be more readily synthesized. Likewise, an alteration in a metabolic pathway enzyme such that a particular side reaction becomes more or less favored may result in the over- or under-production of one or more compounds which are utilized as intermediates or substrates for the production of a desired fine chemical.

[0014] Those CMRPs involved in the transport of fine chemical molecules from the cell may be increased in number or activity such that greater quantities of these compounds are allocated to different plant cell compartments or the cell exterior space from which they are more readily recovered and partitioned into the biosynthetic flux or deposited. Similarly, those CMRPs involved in the import of nutrients necessary for the biosynthesis of one or more fine chemicals (e.g., sugar phosphates and nucleotide sugars) may be increased in number or activity such that these precursors, cofactors, or intermediate compounds are increased in concentration within the cell or within the storing compartments. Further, carbohydrates themselves are desirable fine chemicals; by optimizing the activity or increasing the number of one or more CMRPs of the invention which participate in the biosynthesis of these compounds, or by impairing the activity of one or more CMRPs which are involved in the degradation of these compounds, it may be possible to increase the yield, production, and/or efficiency of production of carbohydrates from plants or microorganisms. Further, the invention pertains to an isolated nucleic acid molecule which encodes an CMRP or an isolated CMRP polypepetide involved in assisting in transmembrane transport.

[0015] The mutagenesis of one or more CMRPs of the invention may also result in CMRPs having altered activities which indirectly impact the production of one or more desired fine chemicals from plants. For example, CMRPs of the invention involved in the export of waste products may be increased in number or activity such that the normal metabolic wastes of the cell (possibly increased in quantity due to the overproduction of the desired fine chemical) are efficiently exported before they are able to damage nucleotides and proteins within the cell (which would decrease the viability of the cell) or to interfere with fine chemical biosynthetic pathways (which would decrease the yield, production, or efficiency of production of the desired fine chemical). Further, the relatively large intracellular quantities of the desired fine chemical may in itself be toxic to the cell or may interfere with enzyme feedback mechanisms such as allosteric regulation, so by increasing the activity or number of transporters able to export this compound from the compartment, one may increase the viability of seed cells, in turn leading to a greater number of cells in the culture producing the desired fine chemical. The CMRPs of the invention may also be manipulated such that the relative amounts of different carbohydrates molecules are produced. This may have a profound effect on the carbohydrate composition and structure. E.g. a manipulation of starch metabolism results in a structurally altered starch as described in Lloyd et al., 1999, Planta 209: 230-238 and in Lloyd et al., 1999, Biochemical J. 338: 515-521. Also the manipulation of cell wall biosynthesis leads to altered carbohydrate composition as described in Keller et al., 1999, The Plant J. 19: 131-141, or in an altered structure and physical property of the cell wall as described in Taylor et al., 1999, Plant Cell 11: 769-779. Changes in starch structure can influence its physical properties and also its digestibility. Changes in the cell wall structure can impact the integrity of the cell as well as the stability of plant organs and whole plants. This can in turn influence other characteristics like tolerance towards abiotic and biotic stress conditions.

[0016] The invention provides novel nucleic acid molecules which encode proteins, referred to herein as CMRPs, which are capable of, for example, participating in the metabolism of compounds necessary for the construction of carbohydrates. Nucleic acid molecules encoding an CMRP are referred to herein as CMRP nucleic acid molecules. In a preferred embodiment, the CMRP participates in the metabolism of compounds necessary for the construction of carbohydrates in plants. Examples of such proteins include those encoded by the genes set forth in Table 1.

[0017] As biotic and abiotic stress tolerance is a general trait wished to be inherited into a wide variety of plants like maize, wheat, rye, oat, triticale, rice, barley, soybean, peanut, cotton, flax, rapeseed and canola, manihot, pepper, sunflower and tagetes, solanaceaous plants like potato, tobacco, eggplant, and tomato, Vicia species, pea, alfalfa, bushy plants (coffee, cacao, tea), Salix species, trees (poplar, elm) and perennial grasses and forage crops, these crops plants are also preferred target plants for a genetic engineering as one futher embodiment of the present invention.

[0018] Accordingly, one aspect of the invention pertains to isolated nucleic acid molecules (e.g. cDNAs) comprising a nucleotide sequence encoding an CMRP or biologically active portions thereof, as well as nucleic acid fragments suitable as primers or hybridization probes for the detection or amplification of CMRP-encoding nucleic acid (e.g., DNA or mRNA). In another embodiment, the isolated nucleic acid molecule is at least 15 nucleotides in length and hybridizes under stringent conditions to a nucleic acid molecule comprising a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers). Preferably, the isolated nucleic acid molecule corresponds to a naturally-occurring nucleic acid molecule. More preferably, the isolated nucleic acid encodes a naturally-occurring Physcomitrella patens CMRP, or a biologically active portion thereof. In particularly preferred embodiments, the isolated nucleic acid molecule comprises one of the nucleotide sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) or the coding region or a complement thereof of one of these nucleotide sequences. In other particularly preferred embodiments, the isolated nucleic acid molecule of the invention comprises a nucleotide sequence which hybridizes to or is at least about 50%, preferably at least about 60%, more preferably at least about 70%, 80% or 90%, and even more preferably at least about 95%, 96%, 97%, 98%, 99% or more homologous to a nucleotide sequence set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), or a portion thereof In other preferred embodiments, the isolated nucleic acid molecule encodes one of the amino acid sequences set forth in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). The preferred CMRPs of the present invention also preferably possess at least one of the CMRP activities described herein.

[0019] In another embodiment, the isolated nucleic acid molecule encodes a protein or portion thereof wherein the protein or portion thereof includes an amino acid sequence which is sufficiently homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers), e.g., sufficiently homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) such that the protein or portion thereof maintains an CMRP activity. Preferably, the protein or portion thereof encoded by the nucleic acid molecule maintains the ability to participate in the metabolism of compounds necessary for the construction of carbohydrates of plants. In one embodiment, the protein encoded by the nucleic acid molecule is at least about 50%, preferably at least about 60%, and more preferably at least about 70%, 80%, or 90% and most preferably at least about 95%, 96%, 97%, 98%, or 99% or more homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) (e.g., an entire amino acid sequence selected from those sequences set forth in Appendix B). In another preferred embodiment, the protein is a full length Physcomitrella patens protein which is substantially homologous to an entire amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) (encoded by an open reading frame shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers)).

[0020] In another preferred embodiment, the isolated nucleic acid molecule is derived from Physcomitrella patens and encodes a protein (e.g., an CMRP fusion protein) which includes a biologically active domain which is at least about 50% or more homologous to one of the amino acid sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) and is able to participate in the metabolism of compounds necessary for the construction of carbohydrates, or has one or more of the activities set forth in Table 1, and which also includes heterologous nucleic acid sequences encoding a heterologous polypeptide or regulatory regions.

[0021] Another aspect of the invention pertains to a CMRP whose amino acid sequence can be modulated with the help of art-known computer simulation programms resulting in an polypeptide with e.g. improved activity or altered regulation (molecular modelling). On the basis of this artificially generated polypeptide sequences, a corresponding nucleic acid molecule coding for such a modulated polypeptide can be synthesized in-vitro using the specific codon-usage of the desired host cell, e.g. of microorganisms, mosses, algae, ciliates, fungi or plants. In a preferred embodiment, even these artificial nucleic acid molecules coding for improved CMRPs are within the scope of this invention.

[0022] Another aspect of the invention pertains to vectors, e.g., recombinant expression vectors, containing the nucleic acid molecules of the invention, and host cells into which such vectors have been introduced, especially microorganims, plant cells, plant tissue, organs or whole plants. In one embodiment, such a host cell is a cell capable of storing fine chemical compounds in order to isolate the desired compound from harvested material. The compound or the CMRP can then be isolated from the medium or the host cell, which in plants are cells containing and storing fine chemical compounds, most preferably cells of storage tissues like tubers, roots or seeds. Preferred are also cells like phloem fibres and cotton fibres.

[0023] Yet another aspect of the invention pertains to a genetically altered Physcomitrella patens plant in which an CMRP gene has been introduced or altered. In one embodiment, the genome of the Physcomitrella patens plant has been altered by introduction of a nucleic acid molecule of the invention encoding wild-type or mutated CMRP sequence as a transgene. In another embodiment, an endogenous CMRP gene within the genome of the Physcomitrella patens plant has been altered, e.g., functionally disrupted, by homologous recombination with an altered CMRP gene. In a preferred embodiment, the plant organism belongs to the genus Physcomitrella or Ceratodon, with Physcomitrella being particularly preferred. In a preferred embodiment, the Physcomitrella patens plant is also utilized for the production of a desired compound, such as carbohydrates, with starch, cell wall carbohydrates, sucrose, trehalose and raffinose being particularly preferred.

[0024] Hence in another preferred embodiment, the moss Physcomitrella patens can be used to show the function of a moss gene using homologous recombination based on the nucleic acids described in this invention.

[0025] Still another aspect of the invention pertains to an isolated CMRP or a portion, e.g., a biologically active portion, thereof. In a preferred embodiment, the isolated CMRP or portion thereof can participate in the metabolism of compounds necessary for the construction of carbohydrates in a microorganism or a plant cell, or in the transport of sugar metabolites across its membranes. In another preferred embodiment, the isolated CMRP or portion thereof is sufficiently homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) such that the protein or portion thereof maintains the ability to participate in the metabolism of compounds necessary for the construction of carbohydrates in microorganisms or plant cells.

[0026] The invention also provides an isolated preparation of an CMRP. In preferred embodiments, the CMRP comprises an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). In another preferred embodiment, the invention pertains to an isolated full length protein which is substantially homologous to an entire amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) (encoded by an open reading frame set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers)). In yet another embodiment, the protein is at least about 50%, preferably at least about 60%, and more preferably at least about 70%, 80%, or 90%, and most preferably at least about 95%, 96%, 97%, 98%, or 99% or more homologous to an entire amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). In other embodiments, the isolated CMRP comprises an amino acid sequence which is at least about 50% or more homologous to one of the amino acid sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) and is able to participate in the metabolism of compounds necessary for the construction of carbohydrates in a microorganism or a plant cell, or has one or more of the activities set forth in Table 1.

[0027] Alternatively, the isolated CMRP can comprise an amino acid sequence which is encoded by a nucleotide sequence which hybridizes, e.g., hybridizes under stringent conditions, or is at least about 50%, preferably at least about 60%, more preferably at least about 70%, 80%, or 90%, and even more preferably at least about 95%, 96%, 97%, 98,%, or 99% or more homologous, to a nucleotide sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). It is also preferred that the preferred forms of CMRPs also have one or more of the CMRP activities described herein.

[0028] The CMRP polypeptide, or a biologically active portion thereof, can be operatively linked to a non-CMRP polypeptide to form a fusion protein. In preferred embodiments, this fusion protein has an activity which differs from that of the CMRP alone. In other preferred embodiments, this fusion protein participates in the metabolism of compounds necessary for the synthesis of carbohydrates, cofactors and enzymes and structural proteins in microorganisms or plants, or in the transport of sugar metabolites across the membranes of plants. In particularly preferred embodiments, integration of this fusion protein into a host cell modulates production of a desired compound from the cell. Further the instant invention pertains to an antibody specifically binding to an CMRP polypeptide mentioned before or to a portion thereof

[0029] Another aspect of the invention pertains to a test kit comprising a nucleic acid molecule encoding a CMRP protein, a portion and/or a complement of this nucleid acid molecule used as probe or primer for identifying and/or cloning further nucleic acid molecules involved in the synthesis of amino acids, vitamis, cofactors, nucloetides and/or nucleosides or assisting in transmembrane transport in other cell types or organisms. In another embodiment the test kit comprises a CMRP-antibody for identifying and/or purifying further CMRP molecules or fragments thereof in other cell types or organisms.

[0030] Another aspect of the invention pertains to a method for producing a fine chemical. This method involves either the culturing of a suitable microorganism or culturing plant cells tissues, organs or whole plants containing a vector directing the expression of an CMRP nucleic acid molecule of the invention, such that a fine chemical is produced. In a preferred embodiment, this method further includes the step of obtaining a cell containing such a vector, in which a cell is transformed with a vector directing the expression of an CMRP nucleic acid. In another preferred embodiment, this method further includes the step of recovering the fine chemical from the culture. In a particularly preferred embodiment, the cell is from the genus Escherichia, Corynebacterium, fungi, from carbohydrate storing plants or from fibre plants.

[0031] Another aspect of the invention pertains to a method for producing a fine chemical which involves the culturing of a suitable host cell whose genomic DNA has been altered by the inclusion of an CMRP nucleic acid molecule of the invention. Further, the invention pertains to a method for producing a fine chemical which involves the culturing of a suitable host cell whose membrane has been altered by the inclusion of an CMRP of the invention.

[0032] Another aspect of the invention pertains to methods for modulating production of a molecule from a microorganism. Such methods include contacting the cell with an agent which modulates CMRP activity or CMRP nucleic acid expression such that a cell associated activity is altered relative to this same activity in the absence of the agent. In a preferred embodiment, the cell is modulated for one or more metabolic pathways for carbohydrates, cofactors, enzymes or structural proteins or is modulated for the transport of sugar metabolites across such membranes, such that the yields or rate of production of a desired fine chemical by this microorganism is improved. The agent which modulates CMRP activity can be an agent which stimulates CMRP activity or CMRP nucleic acid expression. Examples of agents which stimulate CMRP activity or CMRP nucleic acid expression include small molecules, active CMRPs, and nucleic acids encoding CMRPs that have been introduced into the cell. Examples of agents which inhibit CMRP activity or expression include small molecules and antisense CMRP nucleic acid molecules.

[0033] Another aspect of the invention pertains to methods for modulating yields of a desired compound from a cell, involving the introduction of a wild-type or mutant CMRP gene into a cell, either maintained on a separate plasmid or integrated into the genome of the host cell. If integrated into the genome, such integration can be random, or it can take place by recombination such that the native gene is replaced by the introduced copy, causing the production of the desired compound from the cell to be modulated or by using a gene in trans such as the gene is functionally linked to a functional expression unit containing at least a sequence facilitating the expression of a gene and a sequence facilitating the polyadenylation of a functionally transcribed gene.

[0034] In a preferred embodiment, said yields are modified. In another preferred embodiment, said desired chemical is increased while unwanted disturbing compounds can be decreased. In a particularly preferred embodiment, said desired fine chemical is carbohydrate, cofactor, enzyme or structural protein. In especially preferred embodiments, said chemicals are starch, cell wall polysaccharides and soluble sugars.

[0035] Another aspect of the invention pertains to the fine chemicals produced by a method described before and the use of the fine chemical or a polypeptide of the invention for the production of another fine chemical.

DETAILED DESCRIPTION OF THE INVENTION

[0036] The present invention provides CMRP nucleic acid and protein molecules which are involved in the metabolism of carbohydrates, cofactors, enzymes and structural proteins in the moss Physcomitrella patens. The molecules of the invention may be utilized in the modulation of production of fine chemicals from microorganisms, such as Corynebacterium, fungi, algae and plants like maize, wheat, rye, oat, triticale, rice, barley, soybean, sugar cane, sugar beet, cotton, flax, poplar, Brassica species like rapeseed, canola and turnip rape, pepper, sunflower and tagetes, solanaceaous plants like potato, tobacco, eggplant, and tomato, Vicia species, pea, manihot, alfalfa, bushy plants (coffee, cacao, tea), Salix species, trees (poplar, elm) and perennial grasses and forage crops either directly (e.g., where overexpression or optimization of a carbohydrate biosynthesis protein has a direct impact on the yield, production, and/or efficiency of production of the carbohydrate from modified organisms), or may have an indirect impact which nonetheless results in an increase of yield, production, and/or efficiency of production of the desired compound or decrease of undesired compounds (e.g., where modulation of the metabolism of carbohydrates, cofactors, enzymes or structural proteins results in alterations in the yield, production, and/or efficiency of production or the composition of desired compounds within the cells, which in turn may impact the production of one or more fine chemicals). Aspects of the invention are further explicated below.

[0037] Fine Chemicals

[0038] The term ‘fine chemical’ is art-recognized and includes molecules produced by an organism which have applications in various industries, such as, but not limited to, pharmaceutical, agriculture, and cosmetics industries. Such compounds include carbohydrates, cofactors, enzymes, structural proteins (as described e.g. in Kuninaka, A. (1996) and nucleotides and related compounds, p. 561-612, in Biotechnology vol. 6, Rehim et al., eds. VCH: Weinheim, and references contained therein), carbohydrates (e.g., starch, amylopectine, amylose, cellulose, hemicelluloses, pectins, sucrose, trehalose, raffinose) Encyclopedia of Industrial Chemistry, vol. A27; Chemicals by Fermentation, Noyes Data Corporation, ISBN: 0818805086 and references therein. The metabolism and uses of certain of these fine chemicals are further explicated below.

[0039] Carbohydrates

[0040] Carbohydrates can be divided into polymeric carbohydrates like starch, fructans and cell wall polysaccharides (cellulose, hemicelluloses and pectins) on the one hand and soluble mono- and oligosaccharides on the other hand.

[0041] Polysaccharides like starch serve as an energy reserve, either as transitory starch that is built up within the leaves during the day and is degraded during the night, or as reserve starch, that is deposited in storage organs like tubers, roots and seeds. More than 20 million tons of starch are isolated each year to serve for a wide range of industrial applications, such as the coating of textiles and paper, or as a thickening of gelling agent in the food industry (see Lillford, P. J. and Morrison, A, in ‘Starch—Structure and Functionality’, p. 1-8, edited by Frazier, P. J., Donald, A. M., Richmond, Cambridge: The Royal Society of Chemistry, 1997). Starch is constituted of 20-30% of the essentially linear polymer amylose in which the glucose is polymerized via alpha-1,4-glycosidic linkages. 70-80% of the starch is accounted for by amylopectin, which has a higher molecular weight than amylose and is much more frequently branched (via alpha-1,6-glycosidic linkages). These branchpoints are arranged in clusters, allowing the formation of alpha-helices and resulting in a semi-crystalline amylopectin phase (reviewed in Smith, A. M., Denyer, K., Martin, C. (1997) Annu. Rev. Plant Physiol. Plant Mol. Biol. 48: 67-87). Furthermore the glucose moieties of amylopectin can be phosphorylated at the C-3 or C-6 position, with an especially high phosphate content in the starch of tuberous plant species like potato (see Jane, J., Kasemsuwan, T., Chen, J. F., Juliano, B. O. (1996) Cereal Foods World 41: 827-832).

[0042] Cell wall polysaccharides fulfill structural, protective and growth regulating functions within the lifecycle of a plant cell and the whole plant. The cell wall contains different classes of polysaccharides. Cellulose, which consists of beta-1,4-linked glucose units, forms semi-crystalline microfibrills that imparts mechanical strength to the cell and represents the world's most abundant biopolymer, being an important raw material for the fibre and paper industry. The cellulose microfibrills are embedded in a matrix of hemicellulose and pectic polysaccharides. Hemicelluloses have a carbohydrate backbone structurally similar to celluose and are cross-linked to cellulose microfibrills via strong hydrogen-bond interactions. Xyloglucan is the predominant hemicellulose in the primary cell wall of most dicotyledonous plants. It consists of linear beta-1,4-glucan chains that contain xylosyl units. Hemicelluloses of monocotyledonous plants contain little xyloglucans and pectins, but high amounts of xylans and mixed-linked glucans (short blocks of beta-1,4-inked glucose molecules connected via beta-1,3-glycosidic bonds). Pectins are highly negatively charged polysaccharides, mainly consisting of polygalacturonic acid and rhamnogalacturonan I. They appear to form a three-dimensional network that is interwined with the cellulose-xyloglucan network. In addition to polysaccharides, plant cell walls contain structural proteins like hydroxyproline-rich glycoproteins (e.g. extensins) and enzymes (e.g. expansins and various glucan hydrolases) that are essential for cell expansion and fruit ripening by loosening the cellulose-hemicellulose connections. A model of the plant cell wall structure is reviewed in Carpita, N. C. and Gibeaut, D. M. (1993) The Plant J. 3: 1-30 and in Rose, J. K. C. and Bennett, A. B. (1999) Trends in Plant Science 4: 176-183.

[0043] Soluble mono- and oligosaccharides contain a wide variety of sugars that serve either as metabolites or as transport and storage forms of carbohydrates. Many monosaccharides are metabolites of the primary metabolism that are further converted to polysaccharides (such as glucose, fructose, fucose, ribose, xylose, xyluluse, galactose etc.) or other fine chemicals like amino acids by the formation of sugar phosphates and nucleotide sugars. Regulation and interaction of different pathways of the primary metabolism is reviewed in Siedow, J. N. and Stitt, M. (1998) Current Opinion in Plant Biology 1: 197-200. There are several reviews to date summarizing the efforts to modify carbohydrate metabolism and partitioning via soluble sugars and sugar phosphates (see including references therein: Sonnewald et al. 1994, Plant, Cell and Environment, 17:1-10; Frommer & Sonnewald 1995, J. Experim. Botany, Vol 46, 287:587-607). The disaccharide sucrose is the major transport form of carbohydrates in plants. In some species like sugar cane and sugar beet, however, sucrose is also the storage form. The cleavage of sucrose is crucial for development, growth and carbon partitioning in plants and is thus highly regulated (reviewed in Sturm, A. and Tang, G. -Q. (1999) Trends in Plant Science 4: 401-407). In some members of the Cucurbitaceae the trisaccharide raffinose serves as an alternative transport form of carbohydrates. Moreover, raffinose plays an important role in desiccation tolerance as described in Brenac, P., Smith, M. E., Obendorf, R. L. (1997) Planta 203: 222-228. Raffinose has many applications, e.g. in organ transplantation and preservation (reviewed in Southard, J. H. and Belzer, F. O. (1995) Annual Review of Medicine 46: 235-247). The disaccharide trehalose is composed of two glucose moieties. Its role in plants is not fully clarified, however, it is discussed to be a regulatory component in the control of glycolytic flux and in a variety of stress survival strategies (see Goddijn O. J. M. and van Dun, K. (1999) Trends in Plants Science 4: 315-319).

[0044] Starch

[0045] Starch metabolism is mainly localized in the plastids of plant cells. A prerequisite for efficient starch metabolism is therefore the transport of sugar phosphates from the cytosol into the plastids (reviewed in Pozueta-Romero, J. Perata, P. and Akazawa, T. (1999) Critical Reviews in Plant Sciences 18: 489-525). In photosynthetic tissues the phosphateltriose phosphate translocator plays a crucial role in the partitioning of photosynthetic assimilates (Flügge, U. I. (1999) Annual Review Plant Physiol. Plant Mol. Biol. 50: 27-45). Plastids of heterotrophic tissues contain ATP/ADP translocators (e.g. Neuhaus, H. E., Henrichs, G. and Scheibe, R. (1993) Plant Physiol. 101: 573-578) and are able to import glucose-1-phosphate and glucose-6-phosphate (e.g. Neuhaus, H. E., Batz, O., Thom, E. and Scheibe, R. (1993) Biochem. S. 196: 395-401). ADP-glucose is also imported into amyloplasts via a specific translocator (Shannon, J. C., Pien, F. -M., Cao, H. and Liu, K. -C. (1998) Plant Physiol. 117: 1235-1252). The initial step in starch biosynthesis within the plastids is the conversion of glucose-1-phosphate to ADP-glucose by ADP-glucose-pyrophosphorylase. ADP-glucose then serves as a substrate for starch synthases. These catalyze the chain elongation by transferring the glucose moiety from ADP-glucose to alpha-1,4-glucans. At least four different starch synthases are known. The different isoforms contribute in various degree to the incorporation of glucose into starch. One isoform, the granule bound starch synthase, is responsible for the synthesis of amylose. Starch from waxy mutants lacking granule bound starch synthase (known from maize, rice and potato) are essentially amylose free (see e.g. Hovenkamp-Hermelink et al. (1987) Theor. Appl. Genet. 75: 217-221). In the mutants dull1 in maize and rugosus5 in pea, other starch synthases are affected, leading to reduced starch yield and altered amylopectin structure (see Gao, M. et al. (1998) Plant Cell 10: 399-412 and Craig, J. et al. (1998) Plant Cell 10: 413-426). At least two branching enzyme isoforms are responsible for the introduction of branchpoints, i.e. for the production of amylopectin (see Martin, C. and Smith, A. M. (1995) Plant Cell 7:971-985 and literature cited therein). Debranching enzymes, originally known to be involved in starch breakdown (see below) are also involved in starch biosynthesis by ‘trimming’ highly branched glucans to amylopectin. This was shown by the analysis of sugary-1 mutants of rice that accumulate highly branched glucans and are reduced in the activity of both debranching enzymes (see Nakamura, Y. et al. (1999) Plant Physiol. 121: 399-409 and Smith, A. M. (1999) Current Opinion in Plant Biology 2: 223-229).

[0046] The mechanism and the function of starch phosphorylation is not yet fully understood. In potato, however, a granule bound protein was shown to be involved in starch phosphorylation (see Lorberth, R., Ritte, G., Willmitzer, L. and Kossmann, J. (1998) Nature Biotechnol. 16: 473-477). Antisense plants with strongly reduced expression levels of the corresponding gene produced essentially unphosphorylated starch and showed a so-called ‘starch excess phenotype’, i.e. the unphosphorylated starch was not amenable to the starch degrading enzyme system of the plant. Starch biosynthesis is reviewed in Smith, A. M. (1999) Current Opinion in Plant Biology 2: 223-229 and in Heyer, A. G., Lloyd, J. R., Kossmann, J. (1999) Current Opinion in Biotechnology 10: 169-174.

[0047] The hydrolytic starch degrading enzymes include alpha- and beta-amylases that hydrolyse alpha-1,4-linkages of starch. Several amylase-isoenzymes are present in plants, some of them being localized in the plastid, some outside of it. The function of extraplastidial isoenzymes is still unclear. Debranching enzymes hydrolyse the alpha-1,6-linkages of amylopectin. There are two classes of debranching enzymes in plants: isoamylase and pullulanase (r-enzyme), differing with respect to their substrate specificties and protein heterogeneity. The so-called disproportionating enzyme (d-enzyme) transfers short side chains within the starch molecule, thus producing longer glucan chains, that can be hydrolysed by amylases and debranching enzymes (Kakefuda, G. and Duke, S. H. (1989) Plant Physiol. 91: 136-143). Maltooligosaccharides and maltose are hydrolysed by alpha-gucosidase (maltase), producing glucose which is again phosphorylated by hexokinase. The resuling glucose-6-phosphate is part of the hexose phosphate pool that is part of various metabolic pathways. In the phosphorolytic starch degradation inorganic phosphate, instead of water, serves as a glucosyl-acceptor. In a reversible reaction, starch phosphorylase cleaves glucose from the non-reducing end of a glucan chain and transfers it to inorganic phosphate, thus producing glucose-1-phosphate. Several isoforms of starch phosphorylase are described in Duwenig, E., Steup, M., Willmitzer, L., Kossmann, J. (1999) Plant J. 12: 323-333 with the cytosolic form being involved in potato tuber sprouting and flower formation.

[0048] The biosynthesis of starch is a highly regulated pathway, e.g. ADP-glucose-pyrophosphorylase is an allosteric enzyme effected by various metabolites. Moreover, indirect evidence of protein-protein-interaction of starch biosynthetic enzymes exist, as the parallel antisense-inhibition of two or more starch biosynthetic enzymes often leads to dramatic effects on starch structure (see e.g. Lloyd, J. R., Landschuitze, V., Kossmann, J. (1999) Biochem. J. 338: 515-521).

[0049] The heterologous expression of starch biosynthetic enzymes may not only alter the amount of starch produced by a transformed organism, but may have a significant effect on the starch quality (e.g. amylose content, chains length distribution, physical properties, phosphate content, digestability). Moreover, a functional gene analysis (e.g. directed gene knock-out in the moss Physcomitrella patens) will give important informations about the function of various isoenzymes and thus far poorly characterized enzymes of starch metabolism.

[0050] Cell wall carbohydrates

[0051] The biosynthesis of semi-cristalline cellulose microfibrills starts with the enzyme sucrose synthase that cleaves sucrose into fructose and UDP-glucose. The latter is the substrate for the plasmalemma bound multienzyme complex of cellulose synthase which forms the so-called rosette complexes. The catalytic subunit of cellulose synthase, CelA, a transmembrane protein, was cloned from several plant species including cotton, poplar and Arabidopsis. Several CelA isoforms with tissue- and development specific expression are described (see Delmer, D. P. (1999) Annual Review Plant Physiol. Plant Mol. Biol. 50: 245-276). Although CelA belongs to a multigene family, the disruption of a single isoform (rsw1) results in the disassembly of rosette complexes, a dramatic reduction of the cellulose content and the accumulation of non-crystalline beta-1,4-glucans in the cell wall (Arioli, T. et al. (1998) Science 279: 717-720). Arabidopsis irx3 mutants show a severe deficiency in secondary cell wall cellulose deposition which leads to collapsed xylem cells. A close interaction between a membrane associated sucrose synthase and cellulose synthase was shown by Nakai, T. et al. (1999) Proc. Natl. Acad. Sci. U.S.A. 96: 14-18 who showed that cellulose biosynthesis in Acetobacter xylinurm is enhanced by the overexpression of sucrose synthase. Moreover several lines of evidence exist for a protein-protein interaction between sucrose synthase and cellulose synthase (Delmer, D. P. and Amor, Y. (1995) Plant Cell 7: 987-1000). All components of the cellulose synthase complex are characterized in Acetobacter and Agrobacterium (see e.g. Mattysse, A. G., White, S. and Lightfoot, R. (1995) J. Bacteriol. 177: 1069-1075). In plants, a membrane associated endo-beta-D-glucanase is discussed to be part of the cellulose synthase complex (Brummell, D. A., Catala, C., Lashbrook C. C., Bennett, A. B. (1997) Proc. Natl. Acad. Sci. U.S.A. 94: 4794-4799).

[0052] The biosynthesis of non-cellulosic cell wall polysaccharides can be devided into four stages: (i) Formation of activated monosaccharides via nucleotide sugar interconversion pathways. (ii) Translocation of these precursors from the cytosol into the lumen of the endomembrane system. (iii) synthesis of polysaccharides from the nucleotide sugars. (iv) Modification of the polysaccharides in the apoplastic space.

[0053] The enzymes involved in the nucleotide sugar interconversion pathway are described in detail by Feingold, D. S. and Barber, G. A. (1990) Nucleotide sugars. In: Dey, P. M. (ed.) Methods in Plant Biochemistry, vol. 2. Carbohydrates. Academic Press, London, pp. 39-78. Several plant genes involved in the nucleotide sugar interconversion have been described, e.g. UDP-D-glucose dehydrogenase (Tenhaken, R. and Thulke, O. (1996) Plant Physiol. 112: 1127-1134), UDP-D-glucose 4-epimerase (Dörrmann, P. and Benning, C. (1996) Arch. Biochem. Biophys. 327: 27-34), GDP-D-mannose 4,6-dehydratase (Bonin, C. P. et al. (1997) Proc. Natl. Acad. Sci. U.S.A. 94: 2085-2090) and GDP-D-mannose pyrophosphorylase (Keller, R., Springer, F., Renz, A. and Kossmann, J. (1999) Plant J. 19: 131-141 and Conklin, P. L. et al. (1999) Proc. Natl. Acad. Sci. U.S.A. 96: 4198-4203), with GDP-D-mannose 4,6-dehydratase and GDP-D-mannose pyrophosphorylase corresponding to known mutations in Arabidopsis (mur1 and vtc1, respectively). Besides murk, ten more, independent Arabidopsis mutants are known showing an altered cell wall monosaccharide composition (Reiter, W. D., Chapple, C. and Somerville, C. R. (1997) Plant J. 12: 335-345). Manipulation of genes involved in nucleotide sugar interconversions is of considerable interest, because they act at an early step in cell wall synthesis, and may therefore serve as important regulators. Moreover, nucleotide sugars are not only involved in cell wall biosynthesis, but also in pathways like protein glycosylation and vitamin c biosynthesis. E.g. Arabidopsis mur1 mutants do not only have reduced fucose contents in cell wall polysaccharides, but also show reduced fucose levels in N-linked glycans of glycoproteins (Rayon, C. et al. (1999) Plant Physiol. 119: 725-734). Transgenic potato plants with reduced GDP-D-mannose pyrophosphorylase activity do not only show reduced cell wall mannose contents, but also significantly reduced ascorbate levels, leading to a severe damage of the aerial part of the plants (Keller, R. et al. (1999) Plant J. 19: 131-141). These data imply, that genetic manipulation of the nucleotide interconversion pathway is a promising target in plant biotechnology.

[0054] The translocation of nucleotide sugar into the lumen of the endomembrane system is not well understood in plants. In biochemical studies it was shown that e.g. UDP-glucose and UDP-galacturonic acid are transported into the Golgi apparatus (Nunoz, P., Norambuena, L. and Orellana, A. (1996) Plant Physiol. 112: 1585-1594 and Orellana, A., Mohnen, D. (1999) Analyt. Biochem. 272: 224-231, respectively). Several nucleotide sugar transporters are known from animals and yeast (reviewed in Kawakita, M. et al. (1998) J. Biochem. 123: 777-785). Thus, it should be possible to isolate plant homologs in the near future.

[0055] Non-cellulosic polysaccharides are synthesized from nucleotide sugar precursors by glycosyltransferases that are localized in the Golgi apparatus (for xylosyl- and glucuronyltransferases see e.g. Baydoun, E. A. -H. and Brett, C. T. (1997) J. Exp. Bot. 48: 1209-1214). The so-called cellulose synthase-like (Csl) genes, that form a multigene family of about 17 members, are discussed to code for glycosyltransferases, e.g. xyloglucan synthases (Cutler, S. and Somerville, C. (1997) Current Biology 7: R108-R111). Csl genes could be characterized by functional genomic approaches like gene disruption and heterologous gene expression. The correct targeting of a foreign glycosyltransferase gene into the plant golgi apparatus was shown by Wee, E. G. T., Sherrier, D. J., Prime, T. A. and Dupree, P. (1998) Plant Cell 10: 1759-1768.

[0056] Different glycosyltransferases involved in pectin biosynthesis are biochemically characterised, e.g. galacturonosyltransferases (see Doong, R. L. et al. (1998) Plant J. 13: 363-374). Others are reviewed in Gibeaut, D. M. and Carpita, N. C. (1994) FASEB J. 8: 904-915. Plant enzymes involved in pectin degradation, e.g. pectin methylesterase, polygalacturonases and pectate lyases are biochemically and genetically characterised. Pectin degradation plays an important role in fruit ripening (reviewed in Hadfield, K. A. and Bennett, A. B. (1997) Cell Death and Differentiation 4: 662-670) and cell adhesion (see e.g. Rhee, S. Y. and Somerville, C. R. (1998) Plant J. 15: 79-88). The manipulation of pectin degradation was applied for the production of plants with delayed senescence or modified pectins (reviewed in Tucker, G. A., Simons, H. and Errington, N. (1999) Biotech. Genet. Engin. Rev. 16: 293-308).

[0057] The modification of cell wall polysaccharides in the apoplastic space involves a variety of enzymes as well as structural proteins. Xyloglucan endotransglycosylases have been cloned from various plants and are proposed to catalyse the intramolecular cleavage of xyloglucans and transfer the newly generated, potentially reducing end, to another xyloglucan chain. They form a multigene family and are involved in cell elongation and differentiation as well as in fruit ripening (reviewed in Campbell, P. and Braam, J. (1999) Trends in Plant Sci. 4: 361-366). Expansins and endoglucanases, together with xyloglucan endotransglycosyltases, play important roles during cell wall growth (reviewed in Cosgrove, D. J. (1999) Annual Review Plant Physiol. Plant Mol. Biol. 50: 391-417 and McQueen-Mason, S. J., Rochange, F. (1999) Plant Biology 1: 19-25).

[0058] Extensin is certainly the best studied plant cell wall structural protein. It forms a multigene family, with different isoforms localized in different cell wall types and connected to different components of the cell wall. The function of extensins is not yet clear, however, some isoforms play a significant role in development, wound healing, and plant defense (reviewed in Cassab, G. I. (1998) Annu. Rev. Plant Physiol. Plant Mol. Biol. 49: 281-309).

[0059] Soluble sugars

[0060] The synthesis of soluble sugars starts with the assimilation of carbon in the reductive pentose phosphate cycle (Calvin-Benson Cycle) localized in the plastids. For reference about Calvin-Benson Cycle see e.g. Woodrow, I. E. and Berry, J. A. (1988) Ann. Rev. Plant Physiol. Plant Mol. Biol. 39: 533-594. It has to be dated that many of the sugar metabolism pathways are linked and interconnected. For review and description of such cycles suchas the tricarbonic acid cycle, glycolysis and respiration see in: Plant Physiology, Biochemistry and Molecular Biology, eds.: Dennis & Turpin; Longman Scientific & Technical, Longman House, Burnt Mill, Harlow UK, 2^(nd) edition: the whole book.

[0061] C4-plants utilize a distinctive feature to increase the CO2 concentration in the plastids: the maltate/pyruvate shuttle system (see e.g. Furbank, R. T., Taylor, W. C. (1995) Plant Cell 7: 797-807; Schnarrenberger (1997) Curr. Genet. 32: 1-18). Genetic manipulation of enzymes of the Calvin-Benson as well as of the tricarboxylic acid cycle may be used to increase productivity of the photosynthetic machinery.

[0062] The intermediate of the Calvin-Benson Cycle fructose-1,6-bisphosphate is dephosphorylated to fructose-6-phosphate by the enzyme fructose-1,6-bisphosphate phosphatase (FBPase). Antisense inhibition of FBPase activity in potato plants leads to a dramatic reduction of the photosynthetic capacity resulting in altered metabolite levels (Kossmann, J. et al. (1992) Planta 188: 7-12). Fructose-6-phosphate is then converted into glucose-6-phosphate by phosphoglucose isomerase (hexose isomerase) and finally to glucose-1-phosphate by phosphoglucomutase (see Fridlyand, L. E., Scheibe, R. (1999), Biosystems 51: 79-93). Glucose-phosphate is utilized for starch synthesis or is transported into the cytosol via glucose-phosphate translocators.

[0063] Starch degradation results in the formation of hexose phosphates and glucose. While glucose can be exported into the cytosol via a glucose translocator (Herold et al 1981, Plant Physiol., 67:85-88; Trethewey & apRees, 1994, Biochem J. 301:449-454), hexose phosphates are converted to triose phosphates and exported into the cytosol via the triose phosphate translocator. Here glucose can be metabolized to pyruvate via the glycolytic pathway or can be converted to di- and oligosaccharides, mainly sucrose. Sucrose is the major form in which carbohydrates are translocated form source tissue to sink organs (described e.g. in Heldt, H. W. (1996) Pflanzenbiochemie, Spektrum Akademischer Verlag, Heidelberg).

[0064] The first step of sucrose biosynthesis is the formation of UDP-glucose by the enzyme UDP-glucose pyrophosphorylase (also named glucose-1-phosphate uridylyltransferase) reaction. Sucrose-6-phosphate is formed in an irreversible translocation of the glucose residue to fructose-6-phospate by the sucrose-phosphate synthase (or UDP-glucose-fructosephosphate glucosyltransferase). Sucrose is formed in the irreversible sucrose phosphate phosphorylase reaction.

[0065] Fructose-1,6-bisphosphate is synthesized in the fructose-bisphosphate-aldolase reaction from triosephosphate mainly dihydroxyacetone-phosphate. Dihydroxyacetonephosphate is translocated from plastids into the cytosol via an exchange reaction of the triosephosphate-translocator, transporting inorganic phosphate into the plastids. Fructose-1,6-phosphate is dephosphorylated into fructose-6-phosphate. Fructose-6-phosphate can be converted into glucose-6-phosphate by the hexosephosphate isomerase (or phosphogluco mutase) reversible reaction or it can be utilized for sucrose synthesis as described above.

[0066] The sucrose biosynthesis pathway is highly regulated. The first committed step is the fructose-1,6-bisphosphatase reaction. This enzyme controls the flux of triosephosphate, used in the Calvin-Benson Cycle, into sucrose. An important regulator of this reaction is fructose-2,6-bisphosphate that differs from fructose-1,6-phosphate just in the position of one phosphate group. To control triosephosphate flux into sucrose synthesis, fructose-2,6-bisphosphate inhibits the synthesis of fructose-6-phosphate when the triosephosphate concentration is low (for review see: Okar D A, Lange A J. (1999) Biofactors 10: 1-14).

[0067] Another regulatory step of the sucrose synthesis is the sucrose phosphate synthase reaction. Two regulatory mechanisms are active: first the enzyme is activated by glucose-6-phosphate and inhibited by phosphate. Secondly the enzyme is phosphorylated and thereby inhibited by the sucrose-phosphate-synthase kinase and dephosphorylated by the sucrose-phosphate-synthase (further details are described by: Huber et al. (1994) International Reviews of Cytology 149: 47-98).

[0068] Sucrose is degraded in sink tissue where sucrose is utilized as an energy source or for the formation of cell walls. Cleavage of the o-glycosidic bond of sucrose is catalyzed in plants by two enzymes with entirely different properties: different isoforms of invertases and sucrose synthases. Invertases are hydrolases which cleave sucrose into fructose and glucose, whereas the sucrose synthase is a glycosyl transferase, which converts sucrose into UDP-glucose and fructose in the presence of UDP.

[0069] Another disaccharide found in plants is trehalose. Because trehalose is a stabilizing agent, it can be utilized to confer dessication and cold tolerance to plants (Hohnstöm et al. (1996) Nature 379: 683-684; Romero et al. (1997) Planta 201: 293-297). The synthesis of trehalose is very similar to that of sucrose.

[0070] Trehalose-6-phosphate is formed from UDP-glucose and glucose-6-phosphate by the enzyme trehalose-6-phosphate synthase Trehalose-phosphate phosphatase than forms trehalose (Goddijn O. J. M. and van Dun, K. (1999) Trends in Plant Science 4: 315-319). Trehalose is cleaved into two glucose molecules by the enzyme alpha,alpha-Trehalase. Beside sucrose and trehalose, raffinose, stachyose and verbascose as well as sugar-alcohol's are important transport-forms of carbohydrates (Zimmermann et al (1975) Encyclopedia of Plant Physiology, Vol I, Süringer Verlag Heidelberg: pp. 480-503). Raffinose is synthesized by the enzymes galactiol synthase and raffinose synthase. Raffinose and stachyose synthetic enzymes have been described from several plants (see e.g. Peterbauer, T. and Richter, A. (1998) Plant Physiol. 117: 165-172.

[0071] Elements and Methods of the Invention

[0072] The present invention is based, at least in part, on the discovery of novel molecules, referred to herein as CMRP nucleic acid and protein molecules, which control the construction of carbohydrates in Physcomitrella patens and Ceratodon purpureus. In one embodiment, the CMRP molecules participate in the metabolism of compounds necessary for the construction of carbohydrates in microorganisms and plants. In a preferred embodiment, the activity of the CMRP molecules of the present invention to regulate carbohydrate production has an impact on the production of a desired fine chemical by this organism. In a particularly preferred embodiment, the CMRP molecules of the invention are modulated in activity, such that the microorganisms or plants metabolic pathways which the CMRPs of the invention regulate are modulated in yield, production, and/or efficiency of production and the transport of compounds through the membranes is altered in efficiency, which either directly or indirectly modulates the yield, production, and/or efficiency of production of a desired fine chemical by microorganisms and plants.

[0073] The language, CMRP or CMRP polypeptide includes proteins which participate in the metabolism of compounds necessary for the construction of carbohydrate in microorganisms and plants. Examples of CMRPs include those encoded by the CMRP genes set forth in Table 1 and Appendix A (SEQ ID NO:1 to SEQ ID NO:177. odd integers). The terms CMRP gene or CMRP nucleic acid sequence include nucleic acid sequences encoding an CMRP, which consist of a coding region and also corresponding untranslated 5′ and 3′ sequence regions. Examples of CMRP genes include those set forth in Table 1. The terms production or productivity are art-recognized and include the concentration of the fermentation product (for example, the desired fine chemical) formed within a given time and a given fermentation volume (e.g., kg product per hour per liter). The term efficiency of production includes the time required for a particular level of production to be achieved (for example, how long it takes for the cell to attain a particular rate of output of a fine chemical). The term yield or product/carbon yield is art-recognized and includes the efficiency of the conversion of the carbon source into the product (i.e., fine chemical). This is generally written as, for example, kg product per kg carbon source. By increasing the yield or production of the compound, the quantity of recovered molecules, or of useful recovered molecules of that compound in a given amount of culture over a given amount of time is increased. The terms biosynthesis or a biosynthetic pathway are art-recognized and include the synthesis of a compound, preferably an organic compound, by a cell from intermediate compounds in what may be a multistep and highly regulated process. The terms degradation or a degradation pathway are art-recognized and include the breakdown of a compound, preferably an organic compound, by a cell to degradation products (generally speaking, smaller or less complex molecules) in what may be a multistep and highly regulated process. The language metabolism is art-recognized and includes the totality of the biochemical reactions that take place in an organism. The metabolism of a particular compound, then, (e.g., the metabolism of a carbohydrate) comprises the overall biosynthetic, modification, and degradation pathways in the cell related to this compound.

[0074] In another embodiment, the CMRP molecules of the invention are capable of modulating the production of a desired molecule, such as a fine chemical, in a microorganisms and plants. There are a number of mechanisms by which the alteration of an CMRP of the invention may directly affect the yield, production, and/or efficiency of production of a fine chemical from a microorganisms or plant strain incorporating such an altered protein. Those CMRPs involved in the transport of fine chemical molecules within or from the cell may be increased in number or activity such that greater quantities of these compounds are transported across mebranes, from which they are more readily recovered and interconverted. Similarly, those CMRPs involved in the import of nutrients necessary for the biosynthesis of one or more fine chemicals may be increased in number or activity such that these precursor, cofactor, or intermediate compounds are increased in concentration within a desired cell. Further, carbohydrates themselves are desirable fine chemicals; by optimizing the activity or increasing the number of one or more CMRPs of the invention which participate in the biosynthesis of these compounds, or by impairing the activity of one or more CMRPs which are involved in the degradation of these compounds, it may be possible to increase the yield, production, and/or efficiency of production of carbohydrates from microorganisms or plants.

[0075] The mutagenesis of one or more CMRP genes of the invention may also result in CMRPs having altered activities which indirectly impact the production of one or more desired fine chemicals from microorganisms and plants. For example, CMRPs of the invention involved in the export of waste products may be increased in number or activity such that the normal metabolic wastes of the cell (possibly increased in quantity due to the overproduction of the desired fine chemical) are efficiently exported before they are able to damage nucleotides and proteins within the cell (which would decrease the viability of the cell) or to interfere with fine chemical biosynthetic pathways (which would decrease the yield, production, or efficiency of production of the desired fine chemical). Further, the relatively large intracellular quantities of the desired fine chemical may in itself be toxic to the cell, so by increasing the activity or number of transporters able to export this compound from the cell, one may increase the viability of the cell in culture, in turn leading to a greater number of cells in the culture producing the desired fine chemical. The CMRPs of the invention may also be manipulated such that the relative amounts of different carbohydrate molecules are produced. This may have a profound effect on the sugar composition of the polysaccharides of the cell (e.g. starch and cell wall polysaccharides). Since each type of polysaccharide has different physical properties, an alteration in the sugar composition or in the chain length of a polysaccharide may significantly alter its physical properties. In the case of cell wall polysaccharides this can impact the stability and flexibility of the cell wall which in turn may result in altered growth and yield as well as in altered tolerance towards salt, drought, heat, cold, pathogens like bacteria and fungi. An altered tolerance towards drought can also be expected by altering the content of oligosaccharides like trehalose and raffinose in plants. Modulating plant carbohydrates therefore can have a profound effect on the plants fitness to survive under aforementioned stress parameters. This can happen either via the changed content, composition and structure of carbohydrates (e.g. see Arioli, T. et al. (1998) Science 279: 717-720 and Reiter, W. -D. (1998) Trends in Plants Sciene 3: 27-32) or via an altered carbohydrate partitioning (reviewed in Siedow, J. N. and Stitt, M. (1998) Current Opinion in Plant Biology 1: 197-200 and in Sturm, A. and Tang, G. -Q. (1999) Trends in Plant Science 4: 401-407).

[0076] The isolated nucleic acid sequences of the invention are contained within the genome of a Physcomitrella patens strain available through the moss collection of the University of Hamburg. The nucleotide sequence of the isolated Physcomitrella patens CMRP cDNAs and the predicted amino acid sequences of the Physcomitrella patens CMRPs are shown in Appendices A and B, respectively.

[0077] The present invention also pertains to proteins which have an amino acid sequence which is substantially homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). As used herein, a protein which has an amino acid sequence which is substantially homologous to a selected amino acid sequence is least about 50% homologous to the selected amino acid sequence, e.g., the entire selected amino acid sequence. A protein which has an amino acid sequence which is substantially homologous to a selected amino acid sequence can also be at least about 50-60%, preferably at least about 60-70%, and more preferably at least about 70-80%, 80-90%, or 90-95%, and most preferably at least about 96%, 97%, 98%, 99% or more homologous to the selected amino acid sequence.

[0078] The CMRP or a biologically active portion or fragment thereof of the invention can participate in the metabolism of compounds necessary for the construction of carbohydrates in microorganisms or plants, or in the transport of sugar metabolites across these membranes, or have one or more of the activities set forth in Table 1.

[0079] Various aspects of the invention are described in further detail in the following subsections:

[0080] A. Isolated Nucleic Acid Molecules

[0081] One aspect of the invention pertains to isolated nucleic acid molecules that encode CMRP polypeptides or biologically active portions thereof, as well as nucleic acid fragments sufficient for use as hybridization probes or primers for the identification or amplification of CMRP-encoding nucleic acid (e.g., CMRP DNA). As used herein, the term “nucleic acid molecule” is intended to include DNA molecules (e.g., cDNA or genomic DNA) and RNA molecules (e.g., mRNA) and analogs of the DNA or RNA generated using nucleotide analogs. This term also encompasses untranslated sequence located at both the 3′ and 5′ ends of the coding region of the gene: at least about 100 nucleotides of sequence upstream from the 5′ end of the coding region and at least about 20 nucleotides of sequence downstream from the 3′ end of the coding region of the gene. The nucleic acid molecule can be single-stranded or double-stranded, but preferably is double-stranded DNA. An “isolated” nucleic acid molecule is one which is separated from other nucleic acid molecules which are present in the natural source of the nucleic acid. Preferably, an “isolated” nucleic acid is free of sequences which naturally flank the nucleic acid (i.e., sequences located at the 5′ and 3′ ends of the nucleic acid) in the genomic DNA of the organism from which the nucleic acid is derived. For example, in various embodiments, the isolated CMRP nucleic acid molecule can contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleotide sequences which naturally flank the nucleic acid molecule in genomic DNA of the cell from which the nucleic acid is derived (e.g., a Physcomitrella patens cell). Moreover, an “isolated” nucleic acid molecule, such as a cDNA molecule, can be substantially free of other cellular material, or culture medium when produced by recombinant techniques, or chemical precursors or other chemicals when chemically synthesized.

[0082] A nucleic acid molecule of the present invention, e.g., a nucleic acid molecule having a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), or a portion thereof, can be isolated using standard molecular biology techniques and the sequence information provided herein. For example, a P. patens CMRP cDNA can be isolated from a P. patens library using all or portion of one of the sequences of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) as a hybridization probe and standard hybridization techniques (e.g., as described in Sambrook et al., Molecular Cloning: A Laboratory Manual. 2nd, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989). Moreover, a nucleic acid molecule encompassing all or a portion of one of the sequences of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) can be isolated by the polymerase chain reaction using oligonucleotide primers designed based upon this sequence (e.g., a nucleic acid molecule encompassing all or a portion of one of the sequences of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) can be isolated by the polymerase chain reaction using oligonucleotide primers designed based upon this same sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers)). For example, mRNA can be isolated from plant cells (e.g., by the guanidinium-thiocyanate extraction procedure of Chirgwin et al. (1979) Biochemistry 18: 5294-5299) and cDNA can be prepared using reverse transcriptase (e.g., Moloney MLV reverse transcriptase, available from Gibco/BRL, Bethesda, Md.; or AMV reverse transcriptase, available from Seikagaku America, Inc., St. Petersburg, Fla.). Synthetic oligonucleotide primers for polymerase chain reaction amplification can be designed based upon one of the nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers). A nucleic acid of the invention can be amplified using cDNA or, alternatively, genomic DNA, as a template and appropriate oligonucleotide primers according to standard PCR amplification techniques. The nucleic acid so amplified can be cloned into an appropriate vector and characterized by DNA sequence analysis. Furthermore, oligonucleotides corresponding to an CMRP nucleotide sequence can be prepared by standard synthetic techniques, e.g., using an automated DNA synthesizer.

[0083] In a preferred embodiment, an isolated nucleic acid molecule of the invention comprises one of the nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers). The sequences of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) correspond to the Physcomitrella patens CMRP cDNAs of the invention. This cDNA comprises sequences encoding CMRPs (i.e., the “coding region”, indicated in each sequence in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers)), as well as 5′ untranslated sequences and 3′ untranslated sequences. Alternatively, the nucleic acid molecule can comprise only the coding region of any of the sequences in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) or can contain whole genomic fragments isolated from genomic DNA.

[0084] For the purposes of this application, it will be understood that each of the sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) has an identifying entry number. Each of these sequences comprises up to three parts: a 5′ upstream region, a coding region, and a downstream region. Each of these three regions is identified by the same entry number designation to eliminate confusion. The recitation of one of the sequences in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), then, refers to any of the sequences in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), which may be distinguished by their differing entry number designations. The coding region of each of these sequences is translated into a corresponding amino acid sequence, which is set forth in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). The sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) are identified by the same entry numbers designations as Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), such that they can be readily correlated. For example, the amino acid sequence in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) designated 19_ck 1_d01fwd (SEQ ID NO:56) is a translation of the coding region of the nucleotide sequence of nucleic acid molecule 19_ck 1_d01fwd (SEQ ID NO:55). Table 1 gives the function and utility of the respective clones as 19_ck 1_d01fwd is identified as a cytosolic phosphoglucomutase.

[0085] In another preferred embodiment, an isolated nucleic acid molecule of the invention comprises a nucleic acid molecule which is a complement of one of the nucleotide sequences shown in Appendix A (SEQ I) NO:1 to SEQ ID NO:177, odd integers), or a portion thereof A nucleic acid molecule which is complementary to one of the nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) is one which is sufficiently complementary to one of the nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) such that it can hybridize to one of the nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), thereby forming a stable duplex.

[0086] In still another preferred embodiment, an isolated nucleic acid molecule of the invention comprises a nucleotide sequence which is at least about 50-60%, preferably at least about 60-70%, more preferably at least about 70-80%, 80-90%, or 90-95%, and even more preferably at least about 95%, 96%, 97%, 98%, 99% or more homologous to a nucleotide sequence shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), or a portion thereof. In an additional preferred embodiment, an isolated nucleic acid molecule of the invention comprises a nucleotide sequence which hybridizes, e.g., hybridizes under stringent conditions, to one of the nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), or a portion thereof

[0087] Moreover, the nucleic acid molecule of the invention can comprise only a portion of the coding region of one of the sequences in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), for example a fragment which can be used as a probe or primer or a fragment encoding a biologically active portion of an CMRP. The nucleotide sequences determined from the cloning of the CMRP genes from P. patens allows for the generation of probes and primers designed for use in identifying and/or cloning CMRP homologues in other cell types and organisms, as well as CMRP homologues from other mosses or related species. The probe/primer typically comprises substantially purified oligonucleotide. The oligonucleotide typically comprises a region of nucleotide sequence that hybridizes under stringent conditions to at least about 12, preferably about 25, more preferably about 40, 50 or 75 consecutive nucleotides of a sense strand of one of the sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), an anti-sense sequence of one of the sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), or naturally occurring mutants thereof. Primers based on a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) can be used in PCR reactions to clone CMRP homologues. Probes based on the CMRP nucleotide sequences can be used to detect transcripts or genomic sequences encoding the same or homologous proteins. In preferred embodiments, the probe further comprises a label group attached thereto, e.g. the label group can be a radioisotope, a fluorescent compound, an enzyme, or an enzyme co-factor. Such probes can be used as a part of a genomic marker test kit for identifying cells which misexpress an CMRP, such as by measuring a level of an CMRP-encoding nucleic acid in a sample of cells, e.g., detecting CMRP mRNA levels or determining whether a genomic CMRP gene has been mutated or deleted.

[0088] In one embodiment, the nucleic acid molecule of the invention encodes a protein or portion thereof which includes an amino acid sequence which is sufficiently homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) such that the protein or portion thereof maintains the ability to participate in the metabolism of compounds necessary for the construction of carbohydrates in microorganisms or plants. As used herein, the language “sufficiently homologous” refers to proteins or portions thereof which have amino acid sequences which include a minimum number of identical or equivalent (e.g., an amino acid residue which has a similar side chain as an amino acid residue in one of the sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers)) amino acid residues to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) such that the protein or portion thereof is able to participate in the metabolism of compounds necessary for the construction of carbohydrates in microorganisms or plants, or in the transport of sugar metabolites across membranes. Protein members of such membrane component metabolic pathways or membrane transport systems, as described herein, may play a role in the production and secretion of one or more fine chemicals. Examples of such activities are also described herein. Thus, the function of an CMRP contributes either directly or indirectly to the yield, production, and/or efficiency of production of one or more fine chemicals. Examples of CMRP activities are set forth in Table 1.

[0089] In another embodiment, the protein is at least about 50-60%, preferably at least about 60-70%, and more preferably at least about 70-80%, 80-90%, 90-95%, and most preferably at least about 96%, 97%, 98%, 99% or more homologous to an entire amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers).

[0090] Portions of proteins encoded by the CMRP nucleic acid molecules of the invention are preferably biologically active portions of one of the CMRPs. As used herein, the term “biologically active portion of an CMRP” is intended to include a portion, e.g., a domain/motif, of an CMRP that participates in the metabolism of compounds necessary for the construction of carbohydrates in microorganisms or plants, or has an activity as set forth in Table 1. To determine whether an CMRP or a biologically active portion thereof can participate in the metabolism of compounds necessary for the construction of carbohydrates in microorganisms or plants, an assay of enzymatic activity may be performed. Such assay methods are well known to those skilled in the art, as detailed in Example 8 of the Exemplification.

[0091] Additional nucleic acid fragments encoding biologically active portions of an CMRP can be prepared by isolating a portion of one of the sequences in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers), expressing the encoded portion of the CMRP or peptide (e.g., by recombinant expression in vitro) and assessing the activity of the encoded portion of the CMRP or peptide.

[0092] The invention further encompasses nucleic acid molecules that differ from one of the nucleotide sequences shown in Appendix A (SEQ ID NO: I to SEQ ID NO:177, odd integers) (and portions thereof) due to degeneracy of the genetic code and thus encode the same CMRP as that encoded by the nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers). In another embodiment, an isolated nucleic acid molecule of the invention has a nucleotide sequence encoding a protein having an amino acid sequence shown in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). In a still further embodiment, the nucleic acid molecule of the invention encodes a full length Physcomitrella patens protein which is substantially homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) (encoded by an open reading frame shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers)).

[0093] In addition to the Physcomitrella patens CMRP nucleotide sequences shown in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), it will be appreciated by those skilled in the art that DNA sequence polymorphisms that lead to changes in the amino acid sequences of CMRPs may exist within a population (e.g., the Physcomitrella patens population). Such genetic polymorphism in the CMRP gene may exist among individuals within a population due to natural variation. As used herein, the terms “gene” and “recombinant gene” refer to nucleic acid molecules comprising an open reading frame encoding an CMRP, preferably a Physcomitrella patens CMRP. Such natural variations can typically result in 1-5% variance in the nucleotide sequence of the CMRP gene. Any and all such nucleotide variations and resulting amino acid polymorphisms in CMRP that are the result of natural variation and that do not alter the functional activity of CMRPs are intended to be within the scope of the invention.

[0094] Nucleic acid molecules corresponding to natural variants and non-Physcomitrella patens homologues of the Physcomitrella patens CMRP cDNA of the invention can be isolated based on their homology to Physcomitrella patens CMRP nucleic acid disclosed herein using the Physcomitrella patens cDNA, or a portion thereof, as a hybridization probe according to standard hybridization techniques under stringent hybridization conditions. Accordingly, in another embodiment, an isolated nucleic acid molecule of the invention is at least 15 nucleotides in length and hybridizes under stringent conditions to the nucleic acid molecule comprising a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers). In other embodiments, the nucleic acid is at least 30, 50, 100, 250 or more nucleotides in length. As used herein, the term “hybridizes under stringent conditions” is intended to describe conditions for hybridization and washing under which nucleotide sequences at least 60% homologous to each other typically remain hybridized to each other. Preferably, the conditions are such that sequences at least about 65%, more preferably at least about 70%, and even more preferably at least about 75% or more homologous to each other typically remain hybridized to each other. Such stringent conditions are known to those skilled in the art and can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6. A preferred, non-limiting example of stringent hybridization conditions are hybridization in 6×sodium chloride/sodium citrate (SSC) at about 45° C., followed by one or more washes in 0.2×SSC, 0.1% SDS at 50-65° C. Preferably, an isolated nucleic acid molecule of the invention that hybridizes under stringent conditions to a sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) corresponds to a naturally-occurring nucleic acid molecule. As used herein, a “naturally-occurring” nucleic acid molecule refers to an RNA or DNA molecule having a nucleotide sequence that occurs in nature (e.g., encodes a natural protein). In one embodiment, the nucleic acid encodes a natural Physcomitrella patens CMRP.

[0095] In addition to naturally-occurring variants of the CMRP sequence that may exist in the population, the skilled artisan will further appreciate that changes can be introduced by mutation into a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), thereby leading to changes in the amino acid sequence of the encoded CMRP, without altering the functional ability of the CMRP. For example, nucleotide substitutions leading to amino acid substitutions at “non-essential” amino acid residues can be made in a sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers). A “non-essential” amino acid residue is a residue that can be altered from the wild-type sequence of one of the CMRPs (Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers)) without altering the activity of said CMRP, whereas an “essential” amino acid residue is required for CMRP activity. Other amino acid residues, however, (e.g., those that are not conserved or only semi-conserved in the domain having CMRP activity) may not be essential for activity and thus are likely to be amenable to alteration without altering CMRP activity.

[0096] Accordingly, another aspect of the invention pertains to nucleic acid molecules encoding CMRPs that contain changes in amino acid residues that are not essential for CMRP activity. Such CMRPs differ in amino acid sequence from a sequence contained in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) yet retain at least one of the CMRP activities described herein. In one embodiment, the isolated nucleic acid molecule comprises a nucleotide sequence encoding a protein, wherein the protein comprises an amino acid sequence at least about 50% homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) and is capable of participation in the metabolism of compounds necessary for the construction of carbohydrates in P. patens, or has one or more activities set forth in Table 1. Preferably, the protein encoded by the nucleic acid molecule is at least about 50-60% homologous to one of the sequences in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers), more preferably at least about 60-70% homologous to one of the sequences in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers), even more preferably at least about 70-80%, 80-90%, 90-95% homologous to one of the sequences in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers), and most preferably at least about 96%, 97%, 98%, or 99% homologous to one of the sequences in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers).

[0097] To determine the percent homology of two amino acid sequences (e.g., one of the sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) and a mutant form thereof) or of two nucleic acids, the sequences are aligned for optimal comparison purposes (e.g., gaps can be introduced in the sequence of one protein or nucleic acid for optimal alignment with the other protein or nucleic acid). The amino acid residues or nucleotides at corresponding amino acid positions or nucleotide positions are then compared. When a position in one sequence (e.g., one of the sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers)) is occupied by the same amino acid residue or nucleotide as the corresponding position in the other sequence (e.g., a mutant form of the sequence selected from Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers)), then the molecules are homologous at that position (i.e., as used herein amino acid or nucleic acid “homology” is equivalent to amino acid or nucleic acid “identity”). The percent homology between the two sequences is a function of the number of identical positions shared by the sequences (i.e., % homology=numbers of identical positions/total numbers of positions×100).

[0098] An isolated nucleic acid molecule encoding an CMRP homologous to a protein sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) can be created by introducing one or more nucleotide substitutions, additions or deletions into a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) such that one or more amino acid substitutions, additions or deletions are introduced into the encoded protein. Mutations can be introduced into one of the sequences of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers) by standard techniques, such as site-directed mutagenesis and PCR-mediated mutagenesis. Preferably, conservative amino acid substitutions are made at one or more predicted non-essential amino acid residues. A “conservative amino acid substitution” is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art. These families include amino acids with basic side chains (e.g., lysine, arginine, histidine), acidic side chains (e.g., aspartic acid, glutamic acid), uncharged polar side chains (e.g., glycine, asparagine, glutamine, serine, threonine, tyrosine, cysteine), nonpolar side chains (e.g., alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), beta-branched side chains (e.g., threonine, valine, isoleucine) and aromatic side chains (e.g., tyrosine, phenylalanine, tryptophan, histidine). Thus, a predicted nonessential amino acid residue in an CMRP is preferably replaced with another amino acid residue from the same side chain family. Alternatively, in another embodiment, mutations can be introduced randomly along all or part of an CMRP coding sequence, such as by saturation mutagenesis, and the resultant mutants can be screened for an CMRP activity described herein to identify mutants that retain CMRP activity. Following mutagenesis of one of the sequences of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), the encoded protein can be expressed recombinantly and the activity of the protein can be determined using, for example, assays described herein (see Example 8 of the Exemplification).

[0099] In addition to the nucleic acid molecules encoding CMRPs described above, another aspect of the invention pertains to isolated nucleic acid molecules which are antisense thereto. An “antisense” nucleic acid comprises a nucleotide sequence which is complementary to a “sense” nucleic acid encoding a protein, e.g., complementary to the coding strand of a double-stranded cDNA molecule or complementary to an mRNA sequence. Accordingly, an antisense nucleic acid can hydrogen bond to a sense nucleic acid. The antisense nucleic acid can be complementary to an entire CMRP coding strand, or to only a portion thereof In one embodiment, an antisense nucleic acid molecule is antisense to a “coding region” of the coding strand of a nucleotide sequence encoding an CMRP. The term “coding region” refers to the region of the nucleotide sequence comprising codons which are translated into amino acid residues (e.g., the entire coding region of ,,,,, comprises nucleotides 1 to . . . ). In another embodiment, the antisense nucleic acid molecule is antisense to a “noncoding region” of the coding strand of a nucleotide sequence encoding CMRP. The term “noncoding region” refers to 5′ and 3′ sequences which flank the coding region that are not translated into amino acids (i.e., also referred to as 5′ and 3′ untranslated regions).

[0100] Given the coding strand sequences encoding CMRP disclosed herein (e.g., the sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers)), antisense nucleic acids of the invention can be designed according to the rules of Watson and Crick base pairing. The antisense nucleic acid molecule can be complementary to the entire coding region of CMRP mRNA, but more preferably is an oligonucleotide which is antisense to only a portion of the coding or noncoding region of CMRP mRNA. For example, the antisense oligonucleotide can be complementary to the region surrounding the translation start site of CMRP mRNA. An antisense oligonucleotide can be, for example, about 5, 10, 15, 20, 25, 30, 35, 40, 45 or 50 nucleotides in length. An antisense nucleic acid of the invention can be constructed using chemical synthesis and enzymatic ligation reactions using procedures known in the art. For example, an antisense nucleic acid (e.g., an antisense oligonucleotide) can be chemically synthesized using naturally occurring nucleotides or variously modified nucleotides designed to increase the biological stability of the molecules or to increase the physical stability of the duplex formed between the antisense and sense nucleic acids, e.g., phosphorothioate derivatives and acridine substituted nucleotides can be used. Examples of modified nucleotides which can be used to generate the antisense nucleic acid include 5-fluorouracil, 5-bromouracil, 5-chlorouracil, 5-iodouracil, hypoxanthine, xanthine, 4-acetylcytosine, 5-(carboxyhydroxylmethyl) uracil, 5-carboxymethylaminomethyl-2-thiouridine, 5-carboxymethylaminomethyluracil, dihydrouracil, beta-D-galactosylqueosine, inosine, N6-isopentenyladenine, 1-methylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-methyladenine, 2-methylguanine, 3-methylcytosine, 5-methylcytosine, N6-adenine, 7-methylguanine, 5-methylaminomethyluracil, 5-methoxyaminomethyl-2-thiouracil, beta-D-mannosylqueosine, 5′-methoxycarboxymethyluracil, 5-methoxyuracil, 2-methylthio-N6-isopentenyladenine, uracil-5-oxyacetic acid (v), wybutoxosine, pseudouracil, queosine, 2-thiocytosine, 5-methyl-2thiouracil, 2-thiouracil, 4-thiouracil, 5-methyluracil, uracil-5-oxyacetic acid methylester, uracil-5-oxyacetic acid (v), 5-methyl-2-thiouracil, 3-(3-amino-3-N-2-carboxypropyl) uracil, (acp3)w, and 2,6-diaminopurine. Alternatively, the antisense nucleic acid can be produced biologically using an expression vector into which a nucleic acid has been subcloned in an antisense orientation (i.e., RNA transcribed from the inserted nucleic acid will be of an antisense orientation to a target nucleic acid of interest, described further in the following subsection).

[0101] The antisense nucleic acid molecules of the invention are typically administered to a cell or generated in situ such that they hybridize with or bind to cellular mRNA and/or genomic DNA encoding an CMRP to thereby inhibit expression of the protein, e.g., by inhibiting transcription and/or translation. The hybridization can be by conventional nucleotide complementarity to form a stable duplex, or, for example, in the case of an antisense nucleic acid molecule which binds to DNA duplexes, through specific interactions in the major groove of the double helix. The antisense molecule can be modified such that it specifically binds to a receptor or an antigen expressed on a selected cell surface, e.g., by linking the antisense nucleic acid molecule to a peptide or an antibody which binds to a cell surface receptor or antigen. The antisense nucleic acid molecule can also be delivered to cells using the vectors described herein. To achieve sufficient intracellular concentrations of the antisense molecules, vector constructs in which the antisense nucleic acid molecule is placed under the control of a strong prokaryotic, viral, or eukaryotic including plant promoters are preferred.

[0102] In yet another embodiment, the antisense nucleic acid molecule of the invention is an α-anomeric nucleic acid molecule. An α-anomeric nucleic acid molecule forms specific double-stranded hybrids with complementary RNA in which, contrary to the usual β-units, the strands run parallel to each other (Gaultier et al. (1987) Nucleic Acids. Res. 15:6625-6641). The antisense nucleic acid molecule can also comprise a 2′-o-methylribonucleotide (Inoue et al. (1987) Nucleic Acids Res. 15:6131-6148) or a chimeric RNA-DNA analogue (Inoue et al. (1987) FEBS Lett. 215:327-330).

[0103] In still another embodiment, an antisense nucleic acid of the invention is a ribozyme. Ribozymes are catalytic RNA molecules with ribonuclease activity which are capable of cleaving a single-stranded nucleic acid, such as an mRNA, to which they have a complementary region. Thus, ribozymes (e.g., hammerhead ribozymes (described in Haselhoff and Gerlach (1988) Nature 334:585-591)) can be used to catalytically cleave CMRP mRNA transcripts to thereby inhibit translation of CMRP mRNA. A ribozyme having specificity for an CMRP-encoding nucleic acid can be designed based upon the nucleotide sequence of an CMRP cDNA disclosed herein (for example 19_ck 1_d01fwd (SEQ ID NO:55) in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers)) or on the basis of a heterologous sequence to be isolated according to methods taught in this invention. For example, a derivative of a Tetrahymena L-19 IVS RNA can be constructed in which the nucleotide sequence of the active site is complementary to the nucleotide sequence to be cleaved in an CMRP-encoding mRNA. See, e.g., Cech et al. U.S. Pat. No. 4,987,071 and Cech et al. U.S. Pat. No. 5,116,742. Alternatively, CMRP mRNA can be used to select a catalytic RNA having a specific ribonuclease activity from a pool of RNA molecules. See, e.g., Bartel, D. and Szostak, J. W. (1993) Science 261:1411-1418.

[0104] Alternatively, CMRP gene expression can be inhibited by targeting nucleotide sequences complementary to the regulatory region of an CMRP nucleotide sequence (e.g., an CMRP promoter and/or enhancers) to form triple helical structures that prevent transcription of an CMRP gene in target cells. See generally, Helene, C. (1991) Anticancer Drug Des. 6(6):569-84; Helene, C. et al. (1992) Ann. N. Y. Acad. Sci. 660:27-36; and Maher, L. J. (1992) Bioassays 14(12):807-15.

[0105] B. Recombinant Expression Vectors and Host Cells

[0106] Another aspect of the invention pertains to vectors, preferably expression vectors, containing a nucleic acid encoding an CMRP (or a portion thereof). As used herein, the term “vector” refers to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. One type of vector is a “plasmid”, which refers to a circular double stranded DNA loop into which additional DNA segments can be ligated. Another type of vector is a viral vector, wherein additional DNA segments can be ligated into the viral genome. Certain vectors are capable of autonomous replication in a host cell into which they are introduced (e.g., bacterial vectors having a bacterial origin of replication and episomal mammalian vectors). Other vectors (e.g., non-episomal mammalian vectors) are integrated into the genome of a host cell upon introduction into the host cell, and thereby are replicated along with the host genome. Moreover, certain vectors are capable of directing the expression of genes to which they are operatively linked. Such vectors are referred to herein as “expression vectors”. In general, expression vectors of utility in recombinant DNA techniques are often in the form of plasmids. In the present specification, “plasmid” and “vector” can be used interchangeably as the plasmid is the most commonly used form of vector. However, the invention is intended to include such other forms of expression vectors, such as viral vectors (e.g., replication defective retroviruses, adenoviruses and adeno-associated viruses), which serve equivalent functions.

[0107] The recombinant expression vectors of the invention comprise a nucleic acid of the invention in a form suitable for expression of the nucleic acid in a host cell, which means that the recombinant expression vectors include one or more regulatory sequences, selected on the basis of the host cells to be used for expression, which is operatively linked to the nucleic acid sequence to be expressed. Within a recombinant expression vector, “operably linked” is intended to mean that the nucleotide sequence of interest is linked to the regulatory sequence(s) in a manner which allows for expression of the nucleotide sequence are fused to each other so that both sequences fulfil the proposed function addicted to the sequence used. (e.g., in an in vitro transcription/translation system or in a host cell when the vector is introduced into the host cell). The term “regulatory sequence” is intended to include promoters, enhancers and other expression control elements (e.g., polyadenylation signals). Such regulatory sequences are described, for example, in Goeddel; Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, Calif. (1990) or see: Gruber and Crosby, in: Methods in Plant Molecular Biology and Biotechnolgy, CRC Press, Boca Raton, Fla., eds.:Glick and Thompson, Chapter 7, 89-108 including the references therein. Regulatory sequences include those which direct constitutive expression of a nucleotide sequence in many types of host cell and those which direct expression of the nucleotide sequence only in certain host cells or under certain conditions. It will be appreciated by those skilled in the art that the design of the expression vector can depend on such factors as the choice of the host cell to be transformed, the level of expression of protein desired, etc. The expression vectors of the invention can be introduced into host cells to thereby produce proteins or peptides, including fusion proteins or peptides, encoded by nucleic acids as described herein (e.g., CMRPs, mutant forms of CMRPs, fusion proteins, etc.).

[0108] The recombinant expression vectors of the invention can be designed for expression of CMRPs in prokaryotic or eukaryotic cells. For example, CMRP genes can be expressed in bacterial cells such as C. glutamicum, insect cells (using baculovirus expression vectors), yeast and other fungal cells (see Romanos, M. A. et al. (1992) Foreign gene expression in yeast: a review, Yeast 8: 423-488; van den Hondel, C. A. M. J. J. et al. (1991) Heterologous gene expression in filamentous fungi, in: More Gene Manipulations in Fungi, J. W. Bennet & L. L. Lasure, eds., p. 396-428: Academic Press: San Diego; and van den Hondel, C. A. M. J. J. & Punt, P. J. (1991) Gene transfer systems and vector development for filamentous fungi, in: Applied Molecular Genetics of Fungi, Peberdy, J. F. et al., eds., p. 1-28, Cambridge University Press: Cambridge), algae (Falciatore et al., 1999, Marine Biotechnology.1, 3:239-251), ciliates of the types: Holotrichia, Peritrichia, Spirotrichia, Suctoria, Tetrahymena, Paramecium, Colpidium, Glaucoma, Platyophrya, Potomacus, Pseudocohnilembus, Euplotes, Engelmaniella, and Stylonychia, especially of the genus Stylonychia lemnae with vectors following a transformation method as described in WO9801572 and multicellular plant cells (see Schmidt, R. and Willlmitzer, L. (1988), High efficiency Agrobacterium tumefaciens-mediated transformation of Arabidopsis thaliana leaf and cotyledon explants, Plant Cell Rep.: 583-586); Plant Molecular Biology and Biotechnology, C Press, Boca Raton, Fla., chapter 6/7, S.71-119 (1993); F. F. White, B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds.:Kung und R. Wu, Academic Press (1993), 128-43; Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991), 205-225 (and references cited therein) or mammalian cells. Suitable host cells are discussed further in Goeddel, Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, Calif. (1990). Alternatively, the recombinant expression vector can be transcribed and translated in vitro, for example using T7 promoter regulatory sequences and T7 polymerase.

[0109] Expression of proteins in prokaryotes is most often carried out with vectors containing constitutive or inducible promoters directing the expression of either fusion or non-fusion proteins. Fusion vectors add a number of amino acids to a protein encoded therein, usually to the amino terminus of the recombinant protein but also to the C-terminus or fused within suitable regions in the proteins. Such fusion vectors typically serve three purposes: 1) to increase expression of recombinant protein; 2) to increase the solubility of the recombinant protein; and 3) to aid in the purification of the recombinant protein by acting as a ligand in affinity purification. Often, in fusion expression vectors, a proteolytic cleavage site is introduced at the junction of the fusion moiety and the recombinant protein to enable separation of the recombinant protein from the fusion moiety subsequent to purification of the fusion protein. Such enzymes, and their cognate recognition sequences, include Factor Xa, thrombin and enterokinase.

[0110] Typical fusion expression vectors include pGEX (Pharmacia Biotech Inc; Smith, D. B. and Johnson, K. S. (1988) Gene 67:31-40), pMAL (New England Biolabs, Beverly, Mass.) and pRIT5 (Pharmacia, Piscataway, N.J.) which fuse glutathione S-transferase (GST), maltose E binding protein, or protein A, respectively, to the target recombinant protein. In one embodiment, the coding sequence of the CMRP is cloned into a pGEX expression vector to create a vector encoding a fusion protein comprising, from the N-terminus to the C-terminus, GST-thrombin cleavage site-X protein. The fusion protein can be purified by affinity chromatography using glutathione-agarose resin. Recombinant CMRP unfused to GST can be recovered by cleavage of the fusion protein with thrombin.

[0111] Examples of suitable inducible non-fusion E. coli expression vectors include pTrc (Amann et al., (1988) Gene 69:301-315) and pET lid (Studier et al., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, Calif. (1990) 60-89). Target gene expression from the pTrc vector relies on host RNA polymerase transcription from a hybrid trp-lac fusion promoter. Target gene expression from the pET 11d vector relies on transcription from a T7 gn10-lac fusion promoter mediated by a coexpressed viral RNA polymerase (T7 gn1). This viral polymerase is supplied by host strains BL21(DE3) or HMB174(DE3) from a resident λ prophage harboring a T7 gn1 gene under the transcriptional control of the lacUV 5 promoter.

[0112] One strategy to maximize recombinant protein expression is to express the protein in a host bacteria with an impaired capacity to proteolytically cleave the recombinant protein (Gottesman, S., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, Calif. (1990) 119-128). Another strategy is to alter the nucleic acid sequence of the nucleic acid to be inserted into an expression vector so that the individual codons for each amino acid are those preferentially utilized in the bacterium chosen for expression, such as C. glutamicum (Wada et al. (1992) Nucleic Acids Res. 20:2111-2118). Such alteration of nucleic acid sequences of the invention can be carried out by standard DNA synthesis techniques.

[0113] In another embodiment, the CMRP expression vector is a yeast expression vector. Examples of vectors for expression in yeast S. cerivisae include pYepSec1 (Baldari, et al., (1987) Embo J. 6:229-234), pMFa (Kuijan and Herskowitz, (1982) Cell 30:933-943), pJRY88 (Schultz et al., (1987) Gene 54:113-123), and pYES2 (Invitrogen Corporation, San Diego, Calif.). Vectors and methods for the construction of vectors appropriate for use in other fungi, such as the filamentous fungi, include those detailed in: van den Hondel, C. A. M. J. J. & Punt, P. J. (1991) “Gene transfer systems and vector development for filamentous fungi, in: Applied Molecular Genetics of Fungi, J. F. Peberdy, et al., eds., p. 1-28, Cambridge University Press: Cambridge.

[0114] Alternatively, the CMRPs of the invention can be expressed in insect cells using baculovirus expression vectors. Baculovirus vectors available for expression of proteins in cultured insect cells (e.g., Sf9 cells) include the pAc series (Smith et al. (1983) Mol. Cell Biol. 3:2156-2165) and the pVL series (Lucklow and Summers (1989) Virology 170:31-39).

[0115] In yet another embodiment, a nucleic acid of the invention is expressed in mammalian cells using a mammalian expression vector. Examples of mammalian expression vectors include pCDM8 (Seed, B. (1987) Nature 329:840) and pMT2PC (Kaufman et al. (1987) EMBO J. 6:187-195). When used in mammalian cells, the expression vector's control functions are often provided by viral regulatory elements. For example, commonly used promoters are derived from polyoma, Adenovirus 2, cytomegalovirus and Simnian Virus 40. For other suitable expression systems for both prokaryotic and eukaryotic cells see chapters 16 and 17 of Sambrook, J., Fritsh, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. 2nd, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989.

[0116] In another embodiment, the recombinant mammalian expression vector is capable of directing expression of the nucleic acid preferentially in a particular cell type (e.g., tissue-specific regulatory elements are used to express the nucleic acid). Tissue-specific regulatory elements are known in the art. Non-limiting examples of suitable tissue-specific promoters include the albumin promoter (liver-specific; Pinkert et al. (1987) Genes Dev. 1:268-277), lymphoid-specific promoters (Calame and Eaton (1988) Adv. Immunol. 43:235-275), in particular promoters of T cell receptors (Winoto and Baltimore (1989) EMBO J. 8:729-733) and immunoglobulins (Banerji et al. (1983) Cell 33:729-740; Queen and Baltimore (1983) Cell 33:741-748), neuron-specific promoters (e.g., the neurofilament promoter; Byrne and Ruddle (1989) PNAS 86:5473-5477), pancreas-specific promoters (Edlund et al. (1985) Science 230:912-916), and mammary gland-specific promoters (e.g., milk whey promoter; U.S. Pat. No. 4,873,316 and European Application Publication No. 264,166). Developmentally-regulated promoters are also encompassed, for example the murine hox promoters (Kessel and Gruss (1990) Science 249:374-379) and the fetoprotein promoter (Campes and Tilghman (1989) Genes Dev. 3:537-546).

[0117] In another embodiment, the CMRPs of the invention may be expressed in unicellular plant cells (such as algae) see Falciatore et al., 1999, Marine Biotechnology. 1 (3):239-251 and references therein and plant cells from higher plants (e.g., the spermatophytes, such as crop plants). Examples of plant expression vectors include those detailed in: Becker, D., Kemper, E., Schell, J. and Masterson, R. (1992) “New plant binary vectors with selectable markers located proximal to the left border”, Plant Mol. Biol. 20: 1195-1197; and Bevan, M. W. (1984) “Binary Agrobacterium vectors for plant transformation, Nucl. Acid Res. 12: 8711-8721; Vectors for Gene Transfer in Higher Plants; in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds.: Kung und R. Wu, Academic Press, 1993, S. 15-38.

[0118] A plant expression cassette preferably contains regulatory sequences capable to drive gene expression in plants cells and which are operably linked so that each sequence can fulfil its function such as termination of transcription such as polyadenylation signals. Preferred polyadenylation signals are those originating from Agrobacterium tumefaciens t-DNA such as the gene 3 known as octopine synthase of the Ti-plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984), 835 ff) or functional equivalents therof but also all other terminators functionally active in plants are suitable.

[0119] As plant gene expression is very often not limited on transcriptional levels a plant expression cassette preferably contains other operably linked sequences like translational enhancers such as the overdrive-sequence containing the 5′-untranlated leader sequence from tobacco mosaic virus enhancing the protein per RNA ratio (Gallie et al 1987, Nuel. Acids Research 15:8693-8711).

[0120] Plant gene expression has to be operably linked to an appropriate promoter conferring gene expression in a timely , cell or tissue specific manner. Preferrred are promoters driving constitutitive expression (Benfey et al., EMBO J. 8 (1989) 2195-2202) like those derived from plant viruses like the 35S CAMV (Franck et al., Cell 21(1980) 285-294), the 19S CaMV (see also U.S. Pat. No. 5,352,605 and WO8402913) or plant promoters like those from Rubisco small subunit described in U.S. Pat. No. 4,962,028.

[0121] Other preferred sequences for use operable linkage in plant gene expression cassettes are targeting-sequences necessary to direct the gene-product in its appropriate cell compartment (for review see Kermode, Crit. Rev. Plant Sci. 15, 4 (1996), 285-423 and references cited therin) such as the vacuole, the nucleus, all types of plastids like amyloplasts, chloroplasts, chromoplasts, the extracellular space, mitochondria, the endoplasmic reticulum, oil bodies, peroxisomes and other compartments of plant cells.

[0122] Plant gene expression can also be facilitated via a chemically inducible promoter (for rewiew see Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are especially suitable if gene expression is wanted to occur in a time specific manner. Examples for such promoters are a salicylic acid inducible promoter (WO 95/19443), a tetracycline inducible promoter (Gatz et al., (1992) Plant J. 2, 397-404) and an ethanol inducible promoter (WO 93/21334).

[0123] Also promoters responding to biotic or abiotic stress conditions are suitable promoters such as the pathogen inducible PRP 1-gene promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), the heat inducible hsp8o-promoter from tomato (U.S. Pat. No. 5,187,267), cold inducible alpha-amylase promoter from potato (WO9612814) or the wound-inducible pinII-promoter (EP375091).

[0124] Especially those promoters are preferred which confer gene expression in tissues and organs where lipid and oil biosynthesis occurs in seed cells such as cells of the endosperm and the developing embryo. Suitable promoters are the napin-gene promoter from rapeseed (U.S. Pat. No. 5,608,152), the USP-promoter from Vicia faba (Baeumlein et al., Mol Gen Genet, 1991, 225 (3):459-67), the oleosin-promoter from Arabidopsis (WO9845461), the phaseolin-promoter from Phaseolus vulgaris (U.S. Pat. No. 5,504,200), the Bce4-promoter from Brassica (WO9113980) or the legumin B4 promoter (LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2):233-9) as well as promoters conferring seed specific expression in monocot plants like maize, barley, wheat, rye, rice etc. Suitable promoters to note are the 1pt2 or 1pt1-gene promoter from barley (WO9515389 and WO9523230) or those desribed in WO9916890 (promoters from the barley hordein-gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat gliadin gene, wheat glutelin gene, the maize zein gene, the oat glutelin gene, the Sorghum kasirin-gene, the rye secalin gene).

[0125] Also especially suited are promoters that confer plastid-specific gene expression as plastids are the compartment where precursors and some end products of lipid biosynthesis are synthesized. Suitable promoters such as the viral RNA-polymerase promoter are described in WO9516783 and WO9706250 and the clpP-promoter from Arabidopsis described in WO9946394.

[0126] The invention farther provides a recombinant expression vector comprising a DNA molecule of the invention cloned into the expression vector in an antisense orientation. That is, the DNA molecule is operatively linked to a regulatory sequence in a manner which allows for expression (by transcription of the DNA molecule) of an RNA molecule which is antisense to CMRP mRNA. Regulatory sequences operatively linked to a nucleic acid cloned in the antisense orientation can be chosen which direct the continuous expression of the antisense RNA molecule in a variety of cell types, for instance viral promoters and/or enhancers, or regulatory sequences can be chosen which direct constitutive, tissue specific or cell type specific expression of antisense RNA. The antisense expression vector can be in the form of a recombinant plasmid, phagemid or attenuated virus in which antisense nucleic acids are produced under the control of a high efficiency regulatory region, the activity of which can be determined by the cell type into which the vector is introduced. For a discussion of the regulation of gene expression using antisense genes see Weintraub, H. et al., Antisense RNA as a molecular tool for genetic analysis, Reviews—Trends in Genetics, Vol. 1(1) 1986 and Mol et al., 1990, FEBS Letters 268:427-430.

[0127] Another aspect of the invention pertains to host cells into which a recombinant expression vector of the invention has been introduced. The terms “host cell” and “recombinant host cell” are used interchangeably herein. It is understood that such terms refer not only to the particular subject cell but to the progeny or potential progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein.

[0128] A host cell can be any prokaryotic or eukaryotic cell. For example, an CMRP can be expressed in bacterial cells such as C. glutamicum, insect cells, fungal cells or mammalian cells (such as Chinese hamster ovary cells (CHO) or COS cells), algae, ciliates, plant cells, fungi or other microorganims like C. glutamicum. Other suitable host cells are known to those skilled in the art.

[0129] Vector DNA can be introduced into prokaryotic or eukaryotic cells via conventional transformation or transfection techniques. As used herein, the terms “transformation” and “transfection”, conjugation and transduction are intended to refer to a variety of art-recognized techniques for introducing foreign nucleic acid (e.g., DNA) into a host cell, including calcium phosphate or calcium chloride co-precipitation, DEAE-dextran-mediated transfection, lipofection, natural competence, chemical-mediated transfer, or electroporation. Suitable methods for transforming or transfecting host cells including plant cells can be found in Sambrook, et al. (Molecular Cloning: A Laboratory Manual. 2nd, ed, Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989) and other laboratory manuals such as Methods in Molecular Biology, 1995, Vol. 44, Agrobacterium protocols, ed: Gartland and Davey, Humana Press, Totowa, N.J.

[0130] For stable transfection of mammalian cells, it is known that, depending upon the expression vector and transfection technique used, only a small fraction of cells may integrate the foreign DNA into their genome. In order to identify and select these integrants, a gene that encodes a selectable marker (e.g., resistance to antibiotics) is generally introduced into the host cells along with the gene of interest. Preferred selectable markers include those which confer resistance to drugs, such as G418, hygromycin and methotrexate or in plants that confer resistance towards a herbicide such as glyphosate or glufosinate. Nucleic acid encoding a selectable marker can be introduced into a host cell on the same vector as that encoding an CMRP or can be introduced on a separate vector. Cells stably transfected with the introduced nucleic acid can be identified by, for example, drug selection (e.g., cells that have incorporated the selectable marker gene will survive, while the other cells die).

[0131] To create a homologous recombinant microorganism, a vector is prepared which contains at least a portion of an CMRP gene into which a deletion, addition or substitution has been introduced to thereby alter, e.g., functionally disrupt, the CMRP gene. Preferably, this CMRP gene is a Physcomitrella patens CMRP gene, but it can be a homologue from a related plant or even from a mammalian, yeast, or insect source. In a preferred embodiment, the vector is designed such that, upon homologous recombination, the endogenous CMRP gene is functionally disrupted (i.e., no longer encodes a functional protein; also referred to as a knock-out vector). Alternatively, the vector can be designed such that, upon homologous recombination, the endogenous CMRP gene is mutated or otherwise altered but still encodes functional protein (e.g., the upstream regulatory region can be altered to thereby alter the expression of the endogenous CMRP). To create a point mutation via homologous recombination also DNA-RNA hybrids can be used known as chimeraplasty known from Cole-Strauss et al. 1999, Nucleic Acids Research 27(5):1323-1330 and Kmiec Gene therapy. 19999, American Scientist. 87(3):240-247.

[0132] Whereas in the homologous recombination vector, the altered portion of the CMRP gene is flanked at its 5′ and 3′ ends by additional nucleic acid of the CMRP gene to allow for homologous recombination to occur between the exogenous CMRP gene carried by the vector and an endogenous CMRP gene in a microorganism or plant. The additional flanking CMRP nucleic acid is of sufficient length for successful homologous recombination with the endogenous gene. Typically, several hundreds of basepairs up to kilobases of flanking DNA (both at the 5′ and 3′ ends) are included in the vector (see e.g., Thomas, K. R., and Capecchi, M. R. (1987) Cell 51: 503 for a description of homologous recombination vectors or Strepp et al., 1998, PNAS, 95 (8):4368-4373 for cDNA based recombination in Physcomitrella patens). The vector is introduced into a microorganism or plant cell (e.g., via polyethyleneglycol mediated DNA) and cells in which the introduced CMRP gene has homologously recombined with the endogenous CMRP gene are selected, using art-known techniques.

[0133] In another embodiment, recombinant microorganisms can be produced which contain selected systems which allow for regulated expression of the introduced gene. For example, inclusion of an CMRP gene on a vector placing it under control of the lac operon permits expression of the CMRP gene only in the presence of IPTG. Such regulatory systems are well known in the art.

[0134] A host cell of the invention, such as a prokaryotic or eukaryotic host cell in culture, can be used to produce (i.e., express) an CMRP. An alternate method can be applied in addition in plants by the direct transfer of DNA into developing flowers via electroporation or Agrobacterium medium gene transfer. Accordingly, the invention further provides methods for producing CMRPs using the host cells of the invention. In one embodiment, the method comprises culturing the host cell of invention (into which a recombinant expression vector encoding an CMRP has been introduced, or into which genome has been introduced a gene encoding a wild-type or altered CMRP) in a suitable medium until CMRP is produced. In another embodiment, the method further comprises isolating CMRPs from the medium or the host cell.

[0135] C. Isolated CMRPs

[0136] Another aspect of the invention pertains to isolated CMRPs, and biologically active portions thereof. An “isolated” or “purified” protein or biologically active portion thereof is substantially free of cellular material when produced by recombinant DNA techniques, or chemical precursors or other chemicals when chemically synthesized. The language “substantially free of cellular material” includes preparations of CMRP in which the protein is separated from cellular components of the cells in which it is naturally or recombinantly produced. In one embodiment, the language “substantially free of cellular material” includes preparations of CMRP having less than about 30% (by dry weight) of non-CMRP (also referred to herein as a “contaminating protein”), more preferably less than about 20% of non-CMRP, still more preferably less than about 10% of non-CMRP, and most preferably less than about 5% non-CMRP. When the CMRP or biologically active portion thereof is recombinantly produced, it is also preferably substantially free of culture medium, i.e., culture medium represents less than about 20%, more preferably less than about 10%, and most preferably less than about 5% of the volume of the protein preparation. The language “substantially free of chemical precursors or other chemicals” includes preparations of CMRP in which the protein is separated from chemical precursors or other chemicals which are involved in the synthesis of the protein. In one embodiment, the language “substantially free of chemical precursors or other chemicals” includes preparations of CMRP having less than about 30% (by dry weight) of chemical precursors or non-CMRP chemicals, more preferably less than about 20% chemical precursors or non-CMRP chemicals, still more preferably less than about 10% chemical precursors or non-CMRP chemicals, and most preferably less than about 5% chemical precursors or non-CMRP chemicals. In preferred embodiments, isolated proteins or biologically active portions thereof lack contaminating proteins from the same organism from which the CMRP is derived. Typically, such proteins are produced by recombinant expression of, for example, a Physcomitrella patens CMRP in other plants than Physcomitrella patens or microorganisms such as C. glutamicum or ciliates, algae or fungi.

[0137] An isolated CMRP or a portion thereof of the invention can participate in the metabolism of compounds necessary for the construction of carbohydrates in Physcomitrella patens, has one or more of the activities set forth in Table 1. In preferred embodiments, the protein or portion thereof comprises an amino acid sequence which is sufficiently homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) such that the protein or portion thereof maintains the ability participate in the metabolism of compounds necessary for the construction of carbohydrates in Physcomitrella patens. The portion of the protein is preferably a biologically active portion as described herein. In another preferred embodiment, an CMRP of the invention has an amino acid sequence shown in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). In yet another preferred embodiment, the CMRP has an amino acid sequence which is encoded by a nucleotide sequence which hybridizes, e.g., hybridizes under stringent conditions, to a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers). In still another preferred embodiment, the CMRP has an amino acid sequence which is encoded by a nucleotide sequence that is at least about 50-60%, preferably at least about 60-70%, more preferably at least about 70-80%, 80-90%, 90-95%, and even more preferably at least about 96%, 97%, 98%, 99% or more homologous to one of the amino acid sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers). The preferred CMRPs of the present invention also preferably possess at least one of the CMRP activities described herein. For example, a preferred CMRP of the present invention includes an amino acid sequence encoded by a nucleotide sequence which hybridizes, e.g., hybridizes under stringent conditions, to a nucleotide sequence of Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), and which can participate in the metabolism of compounds necessary for the construction of carbohydrates in Physcomitrella patens, or which has one or more of the activities set forth in Table 1.

[0138] In other embodiments, the CMRP is substantially homologous to an amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) and retains the functional activity of the protein of one of the sequences of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) yet differs in amino acid sequence due to natural variation or mutagenesis, as described in detail in subsection I above. Accordingly, in another embodiment, the CMRP is a protein which comprises an amino acid sequence which is at least about 50-60%, preferably at least about 60-70%, and more preferably at least about 70-80, 80-90, 90-95%, and most preferably at least about 96%, 97%, 98%, 99% or more homologous to an entire amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) and which has at least one of the CMRP activities described herein. In another embodiment, the invention pertains to a full Physcomitrella patens protein which is substantially homologous to an entire amino acid sequence of Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers).

[0139] Biologically active portions of an CMRP include peptides comprising amino acid sequences derived from the amino acid sequence of an CMRP, e.g., the an amino acid sequence shown in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers) or the amino acid sequence of a protein homologous to an CMRP, which include fewer amino acids than a full length CMRP or the full length protein which is homologous to an CMRP, and exhibit at least one activity of an CMRP. Typically, biologically active portions (peptides, e.g., peptides which are, for example, 5, 10, 15, 20, 30, 35, 36, 37, 38, 39, 40, 50, 100 or more amino acids in length) comprise a domain or motif with at least one activity of an CMRP. Moreover, other biologically active portions, in which other regions of the protein are deleted, can be prepared by recombinant techniques and evaluated for one or more of the activities described herein. Preferably, the biologically active portions of an CMRP include one or more selected domains/motifs or portions thereof having biological activity.

[0140] CMRPs are preferably produced by recombinant DNA techniques. For example, a nucleic acid molecule encoding the protein is cloned into an expression vector (as described above), the expression vector is introduced into a host cell (as described above) and the CMRP is expressed in the host cell. The CMRP can then be isolated from the cells by an appropriate purification scheme using standard protein purification techniques. Alternative to recombinant expression, an CMRP, polypeptide, or peptide can be synthesized chemically using standard peptide synthesis techniques. Moreover, native CMRP can be isolated from cells (e.g., endothelial cells), for example using an anti-CMRP antibody, which can be produced by standard techniques utilizing an CMRP or fragment thereof of this invention.

[0141] The invention also provides CMRP chimeric or fusion proteins. As used herein, an CMRP “chimeric protein” or “fusion protein” comprises an CMRP polypeptide operatively linked to a non-CMRP polypeptide. An “CMRP polypeptide” refers to a polypeptide having an amino acid sequence corresponding to an CMRP, whereas a “non-CMRP polypeptide” refers to a polypeptide having an amino acid sequence corresponding to a protein which is not substantially homologous to the CMRP, e.g., a protein which is different from the CMRP and which is derived from the same or a different organism. Within the fusion protein, the term “operatively linked” is intended to indicate that the CMRP polypeptide and the non-CMRP polypeptide are fused to each other so that both sequences fulfil the proposed function addicted to the sequence used. The non-CMRP polypeptide can be fused to the N-terminus or C-terminus of the CMRP polypeptide. For example, in one embodiment the fusion protein is a GST-CMRP fusion protein in which the CMRP sequences are fused to the C-terminus of the GST sequences. Such fusion proteins can facilitate the purification of recombinant CMRPs. In another embodiment, the fusion protein is an CMRP containing a heterologous signal sequence at its N-terminus. In certain host cells (e.g., mammalian host cells), expression and/or secretion of an CMRP can be increased through use of a heterologous signal sequence.

[0142] Preferably, an CMRP chimeric or fusion protein of the invention is produced by standard recombinant DNA techniques. For example, DNA fragments coding for the different polypeptide sequences are ligated together in-frame in accordance with conventional techniques, for example by employing blunt-ended or stagger-ended termini for ligation, restriction enzyme digestion to provide for appropriate termini, filing-in of cohesive ends as appropriate, alkaline phosphatase treatment to avoid undesirable joining, and enzymatic ligation. In another embodiment, the fusion gene can be synthesized by conventional techniques including automated DNA synthesizers. Alternatively, PCR amplification of gene fragments can be carried out using anchor primers which give rise to complementary overhangs between two consecutive gene fragments which can subsequently be annealed and reamplified to generate a chimeric gene sequence (see, for example, Current Protocols in Molecular Biology, eds. Ausubel et al. John Wiley & Sons: 1992). Moreover, many expression vectors are commercially available that already encode a fusion moiety (e.g., a GST polypeptide). An CMRP-encoding nucleic acid can be cloned into such an expression vector such that the fusion moiety is linked in-frame to the CMRP.

[0143] Homologues of the CMRP can be generated by mutagenesis, e.g., discrete point mutation or truncation of the CMRP. As used herein, the term “homologue” refers to a variant form of the CMRP which acts as an agonist or antagonist of the activity of the CMRP. An agonist of the CMRP can retain substantially the same, or a subset, of the biological activities of the CMRP. An antagonist of the CMRP can inhibit one or more of the activities of the naturally occurring form of the CMRP, by, for example, competitively binding to a downstream or upstream member of the cell membrane component metabolic cascade which includes the CMRP, or by binding to an CMRP which mediates transport of compounds across such membranes, thereby preventing translocation from taking place.

[0144] In an alternative embodiment, homologues of the CMRP can be identified by screening combinatorial libraries of mutants, e.g., truncation mutants, of the CMRP for CMRP agonist or antagonist activity. In one embodiment, a variegated library of CMRP variants is generated by combinatorial mutagenesis at the nucleic acid level and is encoded by a variegated gene library. A variegated library of CMRP variants can be produced by, for example, enzymatically ligating a mixture of synthetic oligonucleotides into gene sequences such that a degenerate set of potential CMRP sequences is expressible as individual polypeptides, or alternatively, as a set of larger fusion proteins (e.g., for phage display) containing the set of CMRP sequences therein. There are a variety of methods which can be used to produce libraries of potential CMRP homologues from a degenerate oligonucleotide sequence. Chemical synthesis of a degenerate gene sequence can be performed in an automatic DNA synthesizer, and the synthetic gene then ligated into an appropriate expression vector. Use of a degenerate set of genes allows for the provision, in one mixture, of all of the sequences encoding the desired set of potential CMRP sequences. Methods for synthesizing degenerate oligonucleotides are known in the art (see, e.g., Narang, S. A. (1983) Tetrahedron 39:3; Itakura et al. (1984) Annu. Rev. Biochem. 53:323; Itakura et al. (1984) Science 198:1056; Ike et al. (1983) Nucleic Acid Res. 11:477.

[0145] In addition, libraries of fragments of the CMRP coding can be used to generate a variegated population of CMRP fragments for screening and subsequent selection of homologues of an CMRP. In one embodiment, a library of coding sequence fragments can be generated by treating a double stranded PCR fragment of an CMRP coding sequence with a nuclease under conditions wherein nicking occurs only about once per molecule, denaturing the double stranded DNA, renaturing the DNA to form double stranded DNA which can include sense/antisense pairs from different nicked products, removing single stranded portions from reformed duplexes by treatment with S1 nuclease, and ligating the resulting fragment library into an expression vector. By this method, an expression library can be derived which encodes N-terminal, C-terminal and internal fragments of various sizes of the CMRP.

[0146] Several techniques are known in the art for screening gene products of combinatorial libraries made by point mutations or truncation, and for screening cDNA libraries for gene products having a selected property. Such techniques are adaptable for rapid screening of the gene libraries generated by the combinatorial mutagenesis of CMRP homologues. The most widely used techniques, which are amenable to high through-put analysis, for screening large gene libraries typically include cloning the gene library into replicable expression vectors, transforming appropriate cells with the resulting library of vectors, and expressing the combinatorial genes under conditions in which detection of a desired activity facilitates isolation of the vector encoding the gene whose product was detected. Recursive ensemble mutagenesis (REM), a new technique which enhances the frequency of functional mutants in the libraries, can be used in combination with the screening assays to identify CMRP homologues (Arkin and Yourvan (1992) PNAS 89:7811-7815; Delgrave et al. (1993) Protein Engineering 6(3):327-331).

[0147] In another embodiment, cell based assays can be exploited to analyze a variegated CMRP library, using methods well known in the art.

[0148] D. Uses and Methods of the Invention

[0149] The nucleic acid molecules, proteins, protein homologues, fusion proteins, primers, vectors, and host cells described herein can be used in one or more of the following methods: identification of Physcomitrella patens and related organisms; mapping of genomes of organisms related to Physcomitrella patens; identification and localization of Physcomitrella patens sequences of interest; evolutionary studies; determination of CMRP regions required for function; modulation of an CMRP activity; modulation of the metabolism of one or more carbohydrate components; modulation of the transmembrane transport of one or more compounds; and modulation of cellular production of a desired compound, such as a fine chemical.

[0150] The CMRP nucleic acid molecules of the invention have a variety of uses. First, they may be used to identify an organism as being Physcomitrella patens or a close relative thereof. Also, they may be used to identify the presence of Physcomitrella patens or a relative thereof in a mixed population of microorganisms. The invention provides the nucleic acid sequences of a number of Physcomitrella patens genes; by probing the extracted genomic DNA of a culture of a unique or mixed population of microorganisms under stringent conditions with a probe spanning a region of a Physcomitrella patens gene which is unique to this organism, one can ascertain whether this organism is present. Although Physcomitrella patens itself is not used for the commercial construction of carbohydrates, mosses are capable of synthesizing carbohydrates like monosaccharides, sucrose, trehalose, raffinose, starch, cellulose, hemicelluloses and pectins. Therefore DNA sequences related to CMRPs are especially suited to be used for carbohydrate production and modification in other organisms.

[0151] Further, the nucleic acid and protein molecules of the invention may serve as markers for specific regions of the genome. This has utility not only in the mapping of the genome, but also for functional studies of Physcomitrella patens proteins. For example, to identify the region of the genome to which a particular Physcomitrella patens DNA-binding protein binds, the Physcomitrella patens genome could be digested, and the fragments incubated with the DNA-binding protein. Those which bind the protein may be additionally probed with the nucleic acid molecules of the invention, preferably with readily detectable labels; binding of such a nucleic acid molecule to the genome fragment enables the localization of the fragment to the genome map of Physcomitrella patens, and, when performed multiple times with different enzymes, facilitates a rapid determination of the nucleic acid sequence to which the protein binds. Further, the nucleic acid molecules of the invention may be sufficiently homologous to the sequences of related species such that these nucleic acid molecules may serve as markers for the construction of a genomic map in related mosses, such as Physcomitrium piriforme or Ceratodon purpureus.

[0152] The CMRP nucleic acid molecules of the invention are also useful for evolutionary and protein structural studies. The metabolic and transport processes in which the molecules of the invention participate are utilized by a wide variety of prokaryotic and eukaryotic cells; by comparing the sequences of the nucleic acid molecules of the present invention to those encoding similar enzymes from other organisms, the evolutionary relatedness of the organisms can be assessed. Similarly, such a comparison permits an assessment of which regions of the sequence are conserved and which are not, which may aid in determining those regions of the protein which are essential for the functioning of the enzyme. This type of determination is of value for protein engineering studies and may give an indication of what the protein can tolerate in terms of mutagenesis without losing function.

[0153] Manipulation of the CMRP nucleic acid molecules of the invention may result in the production of CMRPs having functional differences from the wild-type CMRPs. These proteins may be improved in efficiency or activity, may be present in greater numbers in the cell than is usual, or may be decreased in efficiency or activity.

[0154] There are a number of mechanisms by which the alteration of an CMRP of the invention may directly affect the yield, production, and/or efficiency of production of a fine chemical incorporating such an altered protein. Recovery of fine chemical compounds from large-scale cultures of C. glutamicum, algae or fungi is significantly improved if the cell secrets the desired compounds, since such compounds may be readily purified from the culture medium (as opposed to extracted from the mass of cultured cells). In the case of plants expressing CMRPs increased transport can lead to improved partitioning within the plant tissue and organs. By either increasing the number or the activity of transporter molecules which export fine chemicals from the cell, it may be possible to increase the amount of the produced fine chemical which is present in the extracellular medium, thus permitting greater ease of harvesting and purification or in case of plants mor efficient partitioning. Conversely, in order to efficiently overproduce one or more fine chemicals, increased amounts of the cofactors, precursor molecules, and intermediate compounds for the appropriate biosynthetic pathways are required. Thereforee, by increasing the number and/or activity of transporter proteins involved in the import of nutrients, such as carbon sources (i.e., sugars), nitrogen sources (i.e., amino acids, ammonium salts), phosphate, and sulfur, it may be possible to improve the production of a fine chemical, due to the removal of any nutrient supply limitations on the biosynthetic process. Further, carbohydrates are themselves desirable fine chemicals, so by optimizing the activity or increasing the number of one or more CMRPs of the invention which participate in the biosynthesis of these compounds, or by impairing the activity of one or more CMRPs which are involved in the degradation of these compounds, it may be possible to increase the yield, production, and/or efficiency of production of carbohydrates in algae, plants, fungi or other microorganims like C. glutamicum.

[0155] The engineering of one or more CMRP genes of the invention may also result in CMRPs having altered activities which indirectly impact the production of one or more desired fine chemicals from algae, plants or fungi or other microorganims like C. glutamicum. For example, the normal biochemical processes of metabolism result in the production of a variety of waste products (e.g., hydrogen peroxide and other reactive oxygen species) which may actively interfere with these same metabolic processes (for example, peroxynitrite is known to nitrate tyrosine side chains, thereby inactivating some enzymes having tyrosine in the active site (Groves, J. T. (1999) Curr. Opin. Chem. Biol. 3(2): 226-235). While these waste products are typically excreted, cells utilized for large-scale fermentative production are optimized for the overproduction of one or more fine chemicals, and thus may produce more waste products than is typical for a wild-type cell. By optimizing the activity of one or more CMRPs of the invention which are involved in the export of waste molecules, it may be possible to improve the viability of the cell and to maintain efficient metabolic activity. Also, the presence of high intracellular levels of the desired fine chemical may actually be toxic to the cell, so by increasing the ability of the cell to secrete these compounds, one may improve the viability of the cell.

[0156] Further, the CMRPs of the invention may be manipulated such that the relative amounts of various carbohydrate molecules produced are altered. Especially in the case of polysaccharides this may have a profound effect on the stability and flexibility of the cell. Since each type of polysaccharide has different physical properties, and some polysaccharides are connected with each another, an alteration in the composition and of the chain length may significantly alter cell stability. By manipulating CMRPs involved in the production of carbohydrates such that the resulting carbohydrates has a sugar composition and physical property more amenable to the environmental conditions, a greater proportion of the cells should survive and multiply. Greater numbers of producing cells should translate into greater yields, production, or efficiency of production of the fine chemical from the culture.

[0157] The aforementioned mutagenesis strategies for CMRPs to result in increased yields of a fine chemical are not meant to be limiting; variations on these strategies will be readily apparent to one skilled in the art. Using such strategies, and incorporating the mechanisms disclosed herein, the nucleic acid and protein molecules of the invention may be utilized to generate algae, plants, fungi or other microorganims like C. glutamicum expressing mutated CMRP nucleic acid and protein molecules such that the yield, production, and/or efficiency of production of a desired compound is improved. This desired compound may be any natural product of algae, plants, fungi or C. glutamicum, which includes the final products of biosynthesis pathways and intermediates of naturally-occurring metabolic pathways, as well as molecules which do not naturally occur in the metabolism of said cells, but which are produced by a said cells of the invention.

[0158] This invention is further illustrated by the following examples which should not be construed as limiting. The contents of all references, patent applications, patents, and published patent applications cited throughout this application are hereby incorporated by reference.

EXAMPLIFICATION Example 1

[0159] General processes

[0160] a) General cloning processes:

[0161] Cloning processes such as, for example, restriction cleavages, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linkage of DNA fragments, transformation of Escherichia coli and yeast cells, growth of bacteria and sequence analysis of recombinant DNA were carried out as described in Sambrook et al. (1989) (Cold Spring Harbor Laboratory Press: ISBN 0-87969-309-6) or Kaiser, Michaelis and Mitchell (1994) ,Methods in Yeast Genetics” (Cold Spring Harbor Laboratory Press: ISBN 0-87969-451-3). Transformation and cultivation of bacteria such as Acetobacter xylimum and algae such as Chlorella are performed as described by Hall et al., Plasmid 28: 194-200 (1992) and El-Sheekh (1999) Biologia Plantarum 42: 209-216, respectively.

[0162] b)Chemicals:

[0163] The chemicals used were obtained, if not mentioned otherwise in the text, in p.a. quality from the companies Fluka (Neu-Ulm), Merck (Darmstadt), Roth (Karlsruhe), Serva (Heidelberg) and Sigma (Deisenhofen). Solutions were prepared using purified, pyrogen-free water, designated as H₂O in the following text, from a Milli-Q water system water purification plant (Millipore, Eschborn). Restriction endonucleases, DNA-modifying enzymes and molecular biology kits were obtained from the companies AGS (Heidelberg), Amersham (Braunschweig), Biometra (Gottingen), Boehringer Iannheim), Genomed (Bad Oeynnhausen), New England Biolabs (Schwalbach/Taunus), Novagen (Madison, Wis., USA), Perkin-Elmer (Weiterstadt), Pharmacia (Freiburg), Qiagen (Rilden) and Stratagene (Amsterdam, Netherlands). They were used, if not mentioned otherwise, according to the manufacturer's instructions.

[0164] c)Plant material

[0165] For this study, plants of the species Physcomitrella patens (Hedw.) B. S. G. from the collection of the genetic studies section of the University of Hamburg were used. They originate from the strain 16/14 collected by H. L. K. Whitehouse in Gransden Wood, Huntingdonshire (England), which was subcultured from a spore by Engel (1968, Am J Bot 55, 438-446). Proliferation of the plants was carried out by means of spores and by means of regeneration of the gametophytes. The protonema developed from the haploid spore as a chloroplast-rich chloronema and chloroplast-low caulonema, on which buds formed after approximately 12 days. These grew to give gametophores bearing antheridia and archegonia. After fertilization, the diploid sporophyte with a short seta and the spore capsule resulted, in which the meiospores mature.

[0166] d) Plant growth

[0167] Culturing was carried out in a climatic chamber at an air temperature of 25° C. and light intensity of 55 micromol s⁻¹ m⁻² (white light; Philips TL 65W/25 fluorescent tube) and a light/dark change of 16/8 hours. The moss was either modified in liquid culture using Knop medium according to Reski and Abel (1985, Planta 165, 354-358) or cultured on Knop solid medium using 1% oxoid agar (Unipath, Basingstoke, England).

[0168] The protonemas used for RNA and DNA isolation were cultured in aerated liquid cultures. The protonemas were comminuted every 9 days and transferred to fresh culture medium.

Example 2

[0169] Total DNA isolation from plants

[0170] The details for the isolation of total DNA relate to the working up of one grain fresh weight of plant material. CTAB buffer: 2% (w/v) N-cethyl-N,N,N-trimethylammonium bromide (CTAB); 100 mM Tris HCl pH 8.0; 1.4 M NaCl; 20 mM EDTA.

[0171] N-Laurylsarcosine buffer: 10% (w/v) N-laurylsarcosine; 100 MM Tris HCl pH 8.0; 20 mM EDTA.

[0172] The plant material was triturated under liquid nitrogen in a mortar to give a fine powder and transferred to 2 ml Eppendorf vessels. The frozen plant material was then covered with a layer of 1 ml of decomposition buffer (1 ml CTAB buffer, 100 ml of N-laurylsarcosine buffer, 20 ml of b-mercaptoethanol and 10 ml of proteinase K solution, 10 mg/ml) and incubated at 60° C. for one hour with continuous shaking. The homogenate obtained was distributed into two Eppendorf vessels (2 ml) and extracted twice by shaking with the same volume of chloroform/isoamyl alcohol (24:1). For phase separation, centrifugation was carried out at 8000×g and RT for 15 min in each case.

[0173] The DNA was then precipitated at −70° C. for 30 min using ice-cold isopropanol. The precipitated DNA was sedimented at 4° C. and 10,000 g for 30 min and resuspended in 180 ml of TE buffer (Sambrook et al., 1989, Cold Spring Harbor Laboratory Press: ISBN 0-87969-309-6). For further purification, the DNA was treated with NaCl (1.2 M final concentration) and precipitated again at −70° C. for 30 min using twice the volume of absolute ethanol. After a washing step with 70% ethanol, the DNA was dried and subsequently taken up in 50 ml of H₂O+RNAse A (50 mg/ml final concentration). The DNA was dissolved overnight at 4° C. and the RNAse digestion was subsequently carried out at 37° C. for 1 h. Storage of the DNA took place at 4° C.

Example 3

[0174] Isolation of total RNA and poly-(A)⁺ RNA from plants

[0175] For the investigation of transcripts, both total RNA and poly-(A)⁺ RNA were isolated. The total RNA was obtained from wild-type 9d old protonemata following the GTC-method (Reski et al. 1994, Mol. Gen. Genet., 244:352-359).

[0176] Isolation of poly(A)+RNA was isolated using Dyna Beads^(R) (Dynal, Oslo). Following the instructions of the manufacturers protocol.

[0177] After determination of the concentration of the RNA or of the poly(A)+RNA, the RNA was precipitated by addition of {fraction (1/10)} volumes of 3 M sodium acetate pH 4.6 and 2 volumes of ehanol and stored at −70° C.

Example 4

[0178] cDNA library construction

[0179] For cDNA library construction first strand synthesis was achieved using Murine Leukemia Virus reverse transcriptase (Roche, Mannheim, Germany) and olido-d(T)-primers, second strand synthesis by incubation with DNA polymerase I, Klenow enzyme and RNAseH digestion at 12° C. (2 h), 16° C. (1 h)) and 22° C. (1 h). The reaction was stopped by incubation at 65° C. (10 min) and subsequently transferred to ice. Double stranded DNA molecules were blunted by T4-DNA-polymerase (Roche, Mannheim) at 37° C. (30 min). Nucleotides were removed by phenol/chloroform extraction and Sephadex G50 spin columns. EcoRI adapters (Pharmacia, Freiburg, Germany) were ligated to the cDNA ends by T4-DNA-ligase (Roche, 12° C., overnight) and phosphorylated by incubation with polynucleotide kinase (Roche, 37° C., 30 min). This mixture was subjected to separation on a low melting agarose gel. DNA molecules larger than 300 basepairs were eluted from the gel, phenol extracted, concentrated on Elutip-D-columns (Schleicher and Schuell, Dassel, Germany) and were ligated to vector arms and packed into lambda ZAPII phages or lambda ZAP-Express phages using the Gigapack Gold Kit (Stratagene, Amsterdam, Netherlands) using material and following the instructions of the manufacturer.

Example 5

[0180] Identification of genes of interest

[0181] Gene sequences can be used to identify homologous or heterologous genes from cDNA or genomic libraries.

[0182] Homologous genes (e. g. full length cDNA clones) can be isolated via nucleic acid hybridization using for example cDNA libraries: Depended on the abundance of the gene of interest 100,000 up to 1,000,000 recombinant bacteriophages are plated and transferred to a nylon membrane. After denaturation with alkali, DNA is immobilized on the membrane by e. g. UV cross linking. Hybridization is carried out at high stringency conditions. In aqueous solution hybridization and washing is performed at an ionic strength of 1 M NaCl and a temperature of 68° C. Hybridization probes are generated by e. g. radioactive (³²P) nick transcription labeling (Amersham Ready Prime). Signals are detected by exposure to x-ray films.

[0183] Partially homologous or heterologous genes that are related but not identical can be identified analog to the above described procedure using low stringency hybridization and washing conditions. For aqueous hybridization the ionic strength is normally kept at 1 M NaCl while the temperature is progressively lowered from 68 to 42° C.

[0184] Isolation of gene sequences with homologies only in a distinct domain of (for example 20 aminoacids) can be carried out by using synthetic radioactively labeled oligonucleotide probes. Radioactively labeled oligonucleotides are prepared by phosphorylalation of the 5′-prime end of two complementary oligonucleotides with T4 polynucleotede kinase. The complementary oligonucleotides are annealed and ligated to form concatemers. The double stranded concatemers are than radiolabled by for example nick transcription. Hybridization is normally performed at low stringency conditions using high oligonucleotide concentrations.

[0185] Oligonucleotide hybridization solution:

[0186] 6×SSC

[0187] 0.01 M sodium phosphate

[0188] 1 mM EDTA (pH 8)

[0189] 0.5% SDS

[0190] 100 μg/ml denaturated salmon sperm DNA

[0191] 0.1% nonfat dried milk

[0192] During hybridization temperature is lowered stepwise to 5-10° C. below the estimated oligonucleotid Tm.

[0193] Further details are described by Sambrook, J. et al. (1989), “Molecular Cloning: A Laboratory Manual”, Cold Spring Harbor Laboratory Press or Ausubel, F. M. et al. (1994) “Current Protocols in Molecular Biology”, John Wiley & Sons.

Example 6

[0194] Identification of genes of interest by screening expression libraries with antibodies

[0195] cDNA sequences can be used to produce recombinant protein for example in E. coli (e. g. Qiagen QIAexpress pQE system). Recombinant proteins are than normally affinity purified via Ni—NTA affinity chromatoraphy (Qiagen). Recombinant proteins are than used to produce specific antibodies for example by using standard techniques for rabbit immunization. Antibodies are affinity purified using a Ni—NTA column saturated with the recombinant antigen as described by Gu et al., (1994)BioTechniques 17: 257-262. The antibody can than be used to screen expression cDNA libraries to identify homologous or heterologous genes via an immunological screening (Sambrook, J. et al. (1989), “Molecular Cloning: A Laboratory Manual”, Cold Spring Harbor Laboratory Press or Ausubel, F. M. et al. (1994) “Current Protocols in Molecular Biology”, John Wiley & Sons).

Example 7

[0196] Northern-hybridization

[0197] For RNA hybridization, 20 mg of total RNA or 1 mg of poly-(A)⁺ RNA were separated by gel electrophoresis in 1.25% strength agarose gels using formaldehyde as described in Amasino (1986, Anal. Biochem. 152, 304), transferred by capillary attraction using 10×SSC to positively charged nylon membranes (Hybond N+, Amersham, Braunschweig), immobilized by UV light and prehybridized for 3 hours at 68° C. using hybridization buffer (10% dextran sulfate w/v, 1 M NaCl, 1% SDS, 100 mg of herring sperm DNA). The labeling of the DNA probe with the “Highprime DNA labeling kit” (Roche, Mannheim, Germany) was carried out during the prehybridization using alpha-³²P dCTP (Amersham, Braunschweig, germany). Hybridization was carried out after addition of the labeled DNA probe in the same buffer at 68° C. overnight. The washing steps were carried out twice for 15 min using 2×SSC and twice for 30 min using 1×SSC, 1% SDS at 68° C. The exposure of the sealed-in filters was carried out at −70° C. for a period of 1 to 4 d.

Example 8

[0198] DNA Sequencing and Computational Functional Analysis

[0199] CDNA libraries libraries as described in Example 4 were used for DNA sequencing according to standard methods, in particular by the chain termination method using the ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Ehner, Weiterstadt, germany). Random Sequencing was carried out subsequent to preparative plasmid recovery from cDNA libraries via in vivo mass excision and retransformation of DH10B on agar plates (material and protocol details from Stratagene, Amsterdam, Netherlands. Plasmid DNA was prepared from overnight grown E. coli cultures grown in Luria-Broth medium containing ampicillin (see Sambrook et al. (1989) (Cold Spring Harbor Laboratory Press: ISBN 0-87969-309-6)) on a Qiagene DNA preparation robot (Qiagen, Hilden) according to the manufacturers protocols. Sequencing primers with the following nucleotide sequences were used: 5′-CAGGAAACAGCTATGACC-3′ (SEQ ID NO:179) 5′-CTAAAGGGAACAAAAGCTG-3′ (SEQ ID NO:180) 5′-TGTAAAACGACGGCCAGT-3′ (SEQ ID NO:181)

Example 9

[0200] Plasmids for plant transformation

[0201] For plant transformation binary vectors such as pBinAR can be used (Höfgen and Willmitzer (1990) Plant Science 66: 221-230). Construction of the binary vectors can be performed by ligation of the cDNA in sense or antisense orientation into the T-DNA. 5′ to the cDNA a plant promotor activates transcription of the cDNA. A polyadenylation sequence is located 3′ to the cDNA.

[0202] Tissue specific expression can be archived by using a tissue specific promotor. For example seed specific expression can be achived by cloning the napin or USP promotor 5′ to the cDNA. Also any other seed specific promotor element can be used. For constitutive expression within the whole plant the CaMV 35S promotor can be used. The expressed protein can be targeted to a cellular compartment using a signal peptide, for example for plastids, mitochondria or endoplasmatic reticulum (Kermode (1996) Crit. Rev. Plant Sci. 15: 285-423). The signal peptide is cloned 5′ in frame to the cDNA to achive subcellular localization of the fusion protein.

[0203] Nucleic acid molecules from Physomitrella patens are used for a direct gene knock-out by homologous recombination. Therefore Physcomitrella patens sequences are useful for functional genomic approaches. The technique is described by Strepp et al. (1998) Proc. Natl. Acad. Sci. USA 95: 4369-4373; Girke et al. (1998) Plant J. 15: 39-48; Hofmann et al. (1999) Molecular and General Genetics 261: 92-99.

Example 10

[0204] Transformation of Agrobacterium

[0205] Agrobacterium mediated plant transformation can be performed using for example the GV3101(pMP90) (Koncz and Schell (1986) Mol. Gen. Genet. 204: 383-396) or LBA4404 (Clontech) Agrobacterium tumefaciens strain. Transformation can be performed by standard transformation techniques (Deblaere et al. (1984) Nucl. Acids 13: 4777-4788).

Example 11

[0206] Plant transformation

[0207] Agrobacterium mediated plant transformation can be performed using standard transformation and regeneration techniques (Gelvin, S. B.; Schilperoort, R. A., “Plant Molecular Biology Manual”, 2nd Ed.—Dordrecht : Kluwer Academic Publ., 1995 and Glick, B. R., Thompson, J. E., “Methods in Plant Molecular Biology and Biotechnology”, Boca Raton: CRC Press, 1993.

[0208] For example, rapeseed can be transformed via cotyledon or hypocotyl transformation (Moloney et al.(1989) Plant Cell Report 8: 238-242; De Block et al. (1989) Plant Physiol. 91: 694-701). Use of antibiotica for Agrobacterium and plant selection depends on the binary vector and the agrobacterium strain used for transformation. Rapeseed selection is normally performed using kanamycin as selectable plant marker.

[0209] Agrobacterium mediated gene transfer to flax can be performed using for example a technique described by Mlynarova et al. (1994) Plant Cell Report 13: 282-285.

[0210] Transformation of soybean can be performed using for example a technique described in EP 0424 047, U.S. Pat. No. 322,783 (Pioneer Hi-Bred International) or in EP 0397 687, U.S. Pat. No. 5,376,543, U.S. Pat. No. 5,169,770 (University Toledo).

[0211] Plant transformation using particle bombardment, Polyethylene Glycol mediated DNA uptake or via the Silicon Carbide Fiber technique is for example described by Freeling and Walbot “The maize handbook” (1993) ISBN 3-540-97826-7, Springer Verlag New York).

Example 12

[0212] In vivo Mutagenesis

[0213] In vivo mutagenesis of microorganisms can be performed by passage of plasmid (or other vector) DNA through E. coli or other microorganisms (e.g. Bacillus spp. or yeasts such as Saccharomyces cerevisiae) which are impaired in their capabilities to maintain the integrity of their genetic information. Typical mutator strains have mutations in the genes for the DNA repair system (e.g., mutBLS, mutD, mutT, etc.; for reference, see Rupp, W. D. (1996) DNA repair mechanisms, in: Escherichia coli and Salmonella, p. 2277-2294, ASM: Washington.) Such strains are well known to those skilled in the art. The use of such strains is illustrated, for example, in Greener, A. and Callahan, M. (1994) Strategies 7: 32-34. Transfer of mutated DNA molecules into plants is preferably done after selection and testing in microorganisms. Transgenic plants are generated according to various examples within the exemplification of this document.

Example 13

[0214] DNA Transfer between Escherichia coli and Corynebacterium glutamicum

[0215] Several Corynebacterium and Brevibacterium species contain endogenous plasmids (as e.g., pHM1519 or pBL1) which replicate autonomously (for review see, e.g., Martin, J. F. et al. (1987) Biotechnology, 5:137-146). Shuttle vectors for Escherichia coli and Corynebacterium glutamicum can be readily constructed by using standard vectors for E. coli (Sambrook, J. et al. (1989), “Molecular Cloning: A Laboratory Manual”, Cold Spring Harbor Laboratory Press or Ausubel, F. M. et al. (1994) “Current Protocols in Molecular Biology”, John Wiley & Sons) to which a origin or replication for and a suitable marker from Corynebacterium glutamicum is added. Such origins of replication are preferably taken from endogenous plasmids isolated from Corynebacterium and Brevibacterium species. Of particular use as transformation markers for these species are genes for kanamycin resistance (such as those derived from the Tn5 or Tn903 transposons) or chloramphenicol (Winnacker, E. L. (1987) “From Genes to Clones—Introduction to Gene Technology, VCH, Weinheim). There are numerous examples in the literature of the construction of a wide variety of shuttle vectors which replicate in both E. coli and C. glutamicum, and which can be used for several purposes, including gene over-expression (for reference, see e.g., Yoshihama, M. et al. (1985) J. Bacteriol. 162:591-597, Martin J. F. et al. (1987) Biotechnology, 5:137-146 and Eikmanns, B. J. et al. (1991) Gene, 102:93-98). Using standard methods, it is possible to clone a gene of interest into one of the shuttle vectors described above and to introduce such a hybrid vectors into strains of Corynebacterium glutamicum. Transformation of C. glutamicum can be achieved by protoplast transformation (Kastsumata, R. et al. (1984) J. Bacteriol. 159306-311), electroporation (Liebl, E. et al. (1989) FEMS Microbiol. Letters, 53:399-303) and in cases where special vectors are used, also by conjugation (as described e.g. in Schäfer, A et al. (1990) J. Bacteriol. 172:1663-1666). It is also possible to transfer the shuttle vectors for C. glutamicum to E. coli by preparing plasmid DNA from C. glutamicum (using standard methods well-known in the art) and transforming it into E. coli. This transformation step can be performed using standard methods, but it is advantageous to use an Mcr-deficient E. coli strain, such as NM522 (Gough & Murray (1983) J. Mol. Biol. 166:1-19).

Example 14

[0216] Assessment of the recombinant gene product in a transformed organism

[0217] The activity of a recombinant gene product in the transformed host organism can be measured on the transcriptional or/and on the translational level. A useful method to analyse the level of transcription of the transformed gene (an indicator of the amount of mRNA available for translation to the gene product) is to perform a Northern blot (for reference see, for example, Ausubel et al. (1988) Current Protocols in Molecular Biology, Wiley: New York), in which a primer designed to bind to the gene of interest is labeled with a detectable tag (usually radioactive or chemiluminescent), such that when the total RNA of a culture of the organism is extracted, run on gel, transferred to a stable matrix and incubated with this probe, the binding and quantity of binding of the probe indicates the presence and also the quantity of MnRNA for this gene. This information is evidence of the degree of transcription of the transformed gene. Total cellular RNA can be prepared from cells, tissues or organs by several methods, all well-known in the art, such as that described in Bormann, E. R. et al. (1992) Mol. Microbiol. 6: 317-326.

[0218] To assess the presence or relative quantity of protein translated from this mRNA, standard techniques, such as a Western blot, may be employed (see, for example, Ausubel et al. (1988) Current Protocols in Molecular Biology, Wiley: New York). In this process, total cellular proteins are extracted, separated by gel electrophoresis, transferred to a matrix such as nitrocellulose, and incubated with a probe, such as an antibody, which specifically binds to the desired protein. This probe is generally tagged with a chemiluminescent or calorimetric label which may be readily detected. The presence and quantity of label observed indicates the presence and quantity of the desired mutant protein present in the cell.

Example 15

[0219] Growth of Genetically Modified Corynebacterium glutamicum—Media and Culture Conditions

[0220] Genetically modified Corynebacteria are cultured in synthetic or natural growth media. A number of different growth media for Corynebacteria are both well-known and readily available (Lieb et al. (1989) Appl. Microbiol. Biotechnol., 32:205-210; von der Osten et al. (1998) Biotechnology Letters, 11:11-16; Patent DE 4,120,867; Liebl (1992) “The Genus Corynebacterium, in: The Procaryotes, Volume II, Balows, A. et al., eds. Springer-Verlag). These media consist of one or more carbon sources, nitrogen sources, inorganic salts, vitamins and trace elements. Preferred carbon sources are sugars, such as mono-, di-, or polysaccharides. For example, glucose, fructose, mannose, galactose, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch or cellulose serve as very good carbon sources. It is also possible to supply sugar to the media via complex compounds such as molasses or other by-products from sugar refinement. It can also be advantageous to supply mixtures of different carbon sources. Other possible carbon sources are alcohols and organic acids, such as methanol, ethanol, acetic acid or lactic acid. Nitrogen sources are usually organic or inorganic nitrogen compounds, or materials which contain these compounds. Exemplary nitrogen sources include ammonia gas or ammonia salts, such as NH₄Cl or (NH₄)₂SO₄, NH₄OH, nitrates, urea, amino acids or complex nitrogen sources like corn steep liquor, soy bean flour, soy bean protein, yeast extract, meat extract and others.

[0221] Inorganic salt compounds which may be included in the media include the chloride-, phosphorous- or sulfate- salts of calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper and iron. Chelating compounds can be added to the medium to keep the metal ions in solution. Particularly useful chelating compounds include dihydroxyphenols, like catechol or protocatechuate, or organic acids, such as citric acid. It is typical for the media to also contain other growth factors, such as vitamins or growth promoters, examples of which include biotin, riboflavin, thiamin, folic acid, nicotinic acid, pantothenate and pyridoxin. Growth factors and salts frequently originate from complex media components such as yeast extract, molasses, corn steep liquor and others. The exact composition of the media compounds depends strongly on the immediate experiment and is individually decided for each specific case. Information about media optimization is available in the textbook “Applied Microbiol. Physiology, A Practical Approach (eds. P. M. Rhodes, P. F. Stanbury, IRL Press (1997) pp. 53-73, ISBN 0 19 963577 3). It is also possible to select growth media from commercial suppliers, like standard 1 (Merck) or BHI (grain heart infusion, DIFC) or others.

[0222] All medium components are sterilized, either by heat (20 minutes at 1.5 bar and 121° C.) or by sterile filtration. The components can either be sterilized together or, if necessary, separately. All media components can be present at the beginning of growth, or they can optionally be added continuously or batchwise.

[0223] Culture conditions are defined separately for each experiment. The temperature should be in a range between 15° C. and 45° C. The temperature can be kept constant or can be altered during the experiment. The pH of the medium should be in the range of 5 to 8.5, preferably around 7.0, and can be maintained by the addition of buffers to the media. An exemplary buffer for this purpose is a potassium phosphate buffer. Synthetic buffers such as MOPS, AEPES, ACES and others can alternatively or simultaneously be used. It is also possible to maintain a constant culture pH through the addition of NaOH or NH₄OH during growth. If complex medium components such as yeast extract are utilized, the necessity for additional buffers may be reduced, due to the fact that many complex compounds have high buffer capacities. If a fermentor is utilized for culturing the micro-organisms, the pH can also be controlled using gaseous ammonia.

[0224] The incubation time is usually in a range from several hours to several days. This time is selected in order to permit the maximal amount of product to accumulate in the broth. The disclosed growth experiments can be carried out in a variety of vessels, such as microtiter plates, glass tubes, glass flasks or glass or metal fermentors of different sizes. For screening a large number of clones, the microorganisms should be cultured in microtiter plates, glass tubes or shake flasks, either with or without baffles. Preferably 100 ml shake flasks are used, filled with 10% (by volume) of the required growth medium. The flasks should be shaken on a rotary shaker (amplitude 25 mm) using a speed-range of 100-300 rpm. Evaporation losses can be diminished by the maintenance of a humid atmosphere; alternatively, a mathematical correction for evaporation losses should be performed.

[0225] If genetically modified clones are tested, an unmodified control clone or a control clone containing the basic plasmid without any insert should also be tested. The medium is inoculated to an OD₆₀₀ of 0.5-1.5 using cells grown on agar plates, such as CM plates (10 g/l glucose, 2,5 g/l NaCl, 2 g/l urea, 10 g/l polypeptone, 5 g/l yeast extract, 5 g/l meat extract, 22 g/l NaCl, 2 g/l urea, 10 g/l polypeptone, 5 g/l yeast extract, 5 g/l meat extract, 22 g/l agar, pH 6.8 with 2M NaOH) that had been incubated at 30° C. Inoculation of the media is accomplished by either introduction of a saline suspension of C. glutamicum cells from CM plates or addition of a liquid preculture of this bacterium.

Example 16

[0226] In vitro Analysis of the Function of Physcomitrella Genes in Transgenic Organisms

[0227] The determination of activities and kinetic parameters of enzymes is well established in the art. Experiments to determine the activity of any given altered enzyme must be tailored to the specific activity of the wild-type enzyme, which is well within the ability of one skilled in the art. Overviews about enzymes in general, as well as specific details concerning structure, kinetics, principles, methods, applications and examples for the determination of many enzyme activities may be found, for example, in the following references: Dixon, M., and Webb, E. C., (1979) Enzymes. Longmans: London; Fersht, (1985) Enzyme Structure and Mechanism. Freeman: New York; Walsh, (1979) Enzymatic Reaction Mechanisms. Freeman: San Francisco; Price, N. C., Stevens, L. (1982) Fundamentals of Enzymology. Oxford Univ. Press: Oxford; Boyer, P. D., ed. (1983) The Enzymes, 3^(rd) ed. Academic Press: New York; Bisswanger, H., (1994) Enzymiinetik, 2^(nd) ed. VCH: Weinheim (ISBN 3527300325); Bergmeyer, H. U., Bergmeyer, J., Grall, M., eds. (1983-1986) Methods of Enzymatic Analysis, 3^(rd) ed., vol. I-XHI, Verlag Chemie: Weinheim; and Ullmann's Encyclopedia of Industrial Chemistry (1987) vol. A9, “Enzymes”. VCH: Weinheim, p. 352-363.

[0228] The activity of proteins which bind to DNA can be measured by several well-established methods, such as DNA band-shift assays (also called gel retardation assays; described in Mikami, K., Takase, H. and Iwabuchi, M. (1995) Gel mobility shift assay, in ‘Plant Molecular Biology Manual’, Second edition, Gelvin, S. B. and Schilperoort, R. A. (eds.), Kluwer Academic Publishers, section I1, pp. 1-14). The effect of such proteins on the expression of other molecules can be measured using reporter gene assays (such as that described in Kolmar, H. et al. (1995) EMBO J. 14: 3895-3904 and references cited therein). Reporter gene test systems are well known and established for applications in both pro- and eukaryotic cells, using enzymes such as beta-galactosidase, green fluorescent protein, and several others.

[0229] The determination of activity of membrane-transport proteins can be performed according to techniques such as those described in Gennis, R. B. (1989) “Pores, Channels and Transporters”, in Biomembranes, Molecular Structure and Function, Springer: Heidelberg, p. 85-137; 199-234; and 270-322.

Example 17

[0230] Analysis of Impact of Recombinant Proteins on the Production of the Desired Product

[0231] The effect of the genetic modification in higher plants, C. glutamicum, other bacteria, fungi or algae on production of a desired compound (such as carbohydrates) can be assessed by growing the modified microorganism or plant under suitable conditions (such as those described above) and analyzing the medium and/or the cellular component for increased production of the desired product (i.e., carbohydrates). Such analysis techniques are well known to one skilled in the art, and include spectroscopy, thin layer chromatography, staining methods of various kinds, enzymatic and microbiological methods, and analytical chromatography such as high performance liquid chromatography (see, for example, Ullman, Encyclopedia of Industrial Chemistry, vol. A2, p. 89-90 and p. 443-613, VCH: Weinheim (1985); Fallon, A. et al., (1987) “Applications of HPLC in Biochemistry” in: Laboratory Techniques in Biochemistry and Molecular Biology, vol. 17; Rehm et al. (1993) Biotechnology, vol. 3, Chapter III: “Product recovery and purification”, page 469-714, VCH: Weinheim; Belter, P. A. et al. (1988) Bioseparations: downstream processing for biotechnology, John Wiley and Sons; Kennedy, J. F. and Cabral, J. M. S. (1992) Recovery processes for biological materials, John Wiley and Sons; Shaeiwitz, J. A. and Henry, J. D. (1988) Biochemical separations, in: Ulmann's Encyclopedia of Industrial Chemistry, vol. B3, Chapter 11, page 1-27, VCH: Weinheim; and Dechow, F. J. (1989) Separation and purification techniques in biotechnology, Noyes Publications.)

[0232] In addition to the measurement of the final product of plant growth or fermentation, it is also possible to analyze other components of the metabolic pathways utilized for the production of the desired compound, such as intermediates and side-products, to determine the overall efficiency of production of the compound. Analysis methods include measurements of nutrient levels in the medium (e.g., sugars, hydrocarbons, nitrogen sources, phosphate, and other ions), measurements of biomass composition and growth, analysis of the production of common metabolites of biosynthetic pathways, and measurement of gasses produced during fermentation. Standard methods for these measurements are outlined in Applied Microbial Physiology, A Practical Approach, P. M. Rhodes and P. F. Stanbury, eds., IRL Press, p. 103-129; 131-163; and 165-192 (ISBN: 0199635773) and references cited therein.

[0233] One example for the analysis of final products and its constituents is the analysis of starch and starch compounds:

[0234] Starch is extracted from plant material e.g. as described by Zeeman, S. C., Northrop, F., Smith, A. M. and ap Rees, T. (1998) Plant J. 15: 357-365 or by Edwards, A., Marshall J., Sidebottom, D., Visser, R. G. F., Smith, A. M., Martin, C. (1995). This involves grinding up plant samples in a mechanical blender with 50 mM Tris-HCl (pH 7.0), 1 mM EDTA, 1 mM DTT, 10 mg 1-1 Na-metabisulfate before allowing the starch to sediment at 4° C. The starch is resuspended in buffer and filtered through two layers of Miracloth (Calbiochem, La Jolla, Calif., USA) before being centrifuged at 2000×g and 4° C. for 10 min. This step is repeated four more times. The starch is washed three times with cooled acetone (−20° C.) before being allowed to air dry, and is then stored at −20° C. before use. The amylose content of starch can be measured e.g. by a spectralphotometric method that is described in Hovenkamp-Hermelink J. H. M., De Vries, J. N., Adamse, P., Jacobsen, E., Witholt, B., Feenstra, W. J. (1988) Potato Research 31: 241-246. Amylopectin can be isolated from purified starch e.g. by selectively precipitating the amylose fraction using the chemical thymol, according to Tomlinson, K. L., Lloyd, J. R., Smith, A. M. (1997) Plant J. 11: 31-43. To study the constituent chains of the amylopectin, the purified amylopectin can be digested with Pseudomonas isoamylase as described in Lloyd, J. R., Springer, F., Buleon, A., Müller-Röber, B., Willmitzer, L. and Kossmann, J. (1999). Size exclusion HPLC can be used for the analysis of the amylose/amylopectin ratio. HPAEC is a preferred method for the determination of the amylopectin chain length (see Zeeman, S. C., Umemoto, T., Lue, W. -L., Pui, A. -Y., Martin, C., Smith, A. M. and Chen, J. (1998) Plant Cell 10: 1699-1711.

[0235] A protocol for the determination of starch contents and glucose-6-phosphate contents of the starch is described in Nielsen, T. H., Wischmann, B., Enevoldsen, K., Moller, B. L. (1994) Plant Physiol. 105: 111-117. The starch is digested to glucose either by using amyloglucosidase or by hydrolysis in 0.7 N HCl at 95° C. The glucose as well as the glucose-6-phosphate content can be determined via enzymatic assays.

[0236] Another example for the analysis of final products and its constituents is the analysis of cell wall carbohydrates:

[0237] Cellulose can be quantified e.g. as described by Updegraff, D. M. (1969) Analytical Biochem. 32: 420-424. This method involves the extraction of cellulose from organic material with acetic/nitric acid and the hydrolysis with concentrated sulfuric acid. The resulting glucose is then quantified via the spectralphotometrical anthron assay. Moreover cellulose microfibrills can be detected by staining with calcofluor white (see e.g. Haigler, C. H., Brown, R. M. Jr., Benziman, M. (1980) Science 210: 903-906. The monosaccharide composition of the matrix polysaccharides (i.e. hemicelluloses and pectins) can be analysed as described in Keller, R., Springer, F., Renz, A. and Kossmann, J. (1999). This method involves an phenol/acetic acid/chloroform extraction and the hydrolysis of non-cellulosic polysaccharides in 1 M TFA. The resulting monosaccharides can be separated by anion-exchange HPLC and are detected by pulsed amperometry after a post column derivatization step. Alternatively the monosaccharide composition can be analysed via gas-liquid chromatography of alditol acetates as described by Reiter, W. D., Chapple, C. C. S. and Somerville, C. R. (1993) Science 261: 1032-1035 or by other chromatographic methods.

[0238] Another suitable method for the analysis of cell wall carbohydrates is given by immunolocalisation using antibodies raised against specific cell wall compounds. E.g. JIM 5 and JIM 7 monoclonal antibodies can be used for the detection of unesterified and esterified pectins, respectively (see Dolan, L., Linstead, P. and Roberts, K. (1997) J. Exp. Bot. 308: 713-720, and Steele, N. M., McCann, M. C. and Roberts, K. (1997) Plant Physiol. 114: 373-381).

[0239] A method for the quantification of uronic acids in pectins is described e.g. in Blumenkrantz, N. and Asboe-Hansen, G. (1973) Anal. Biochem. 54: 484-489.

[0240] The impact of an altered cell wall polysaccharide composition on the mechanical properties of a plant can be analysed by testing the physical stability of stem segments as described in Turner, S. R. and Somerville, C. R. (1997) Plant Cell 9: 689-701.

[0241] Another example for the analysis of final products and its constituents is the analysis of soluble sugars:

[0242] Glucose, fructose and sucrose can be extracted with ethanol and measured using spectralphotometrical assays as described by Stitt, M., Lilley, McC., Gerhardt, R., Heldt, H. W. (1989) In: Methods in Enzymology Vol. 174, Fleischer, S., Fleischer, R. (eds.), Academic Press Ltd., London, UK, pp. 518-552). In the same reference protocols for the extraction and measurement of hexose-phosphates, fructose-1,6-bisphosphate and triose-phosphates are described. Sucrose can also be quantified by the anthron test as described in Geigenberger, P., Hajirezaei, M., Geiger, M., Deiting, U., Sonnewald, U. and Stitt, M. (1998) Planta 205: 428-437 and in the references therein.

[0243] The extraction and analysis of trehalose and its metabolite trehalose-6-phosphate from plant materails are described in Goddijn, O. J. M. et al. (1997) Plant Physiol. 113: 181-190 and in Drennan, P. M. et al. (1993) J. Plant Physiol. 142: 493-496.

[0244] The trisaccharide raffinose can be analysed by TLC, GC or other chromatographic methods as described in Muzquiz, M. Burbano, C., Pedrosa, M. M., Folkman, W. and Gulewicz, K. (1999) Industrial Crops and Products 9: 183-188 and references cited therein.

Example 18

[0245] Purification of the Desired Product from Transformed Organisms

[0246] Recovery of the desired product from plant materials or fungi, algae and bacteria like Acetobacter xylinum or C. glutamicum cells or supernatant of the above-described culture can be performed by various methods well known in the art. If the desired product is not secreted from the cells, the cells, can be harvested from the culture by low-speed centrifugation, the cells can be lysed by standard techniques, such as mechanical force or sonication. Organs of plants can be separated mechanically from other tissues or organs. Following homogenization, cellular debris is removed by centrifugation, and the supernatant fraction containing the soluble proteins is retained for further purification of the desired compound. If the product is secreted from desired cells, then the cells are removed from the culture by low-speed centrifugation, and the supernatant fraction is retained for further purification.

[0247] The supernatant fraction from either purification method is subjected to chromatography with a suitable resin, in which the desired molecule is either retained on a chromatography resin while many of the impurities in the sample are not, or where the impurities are retained by the resin while the sample is not. Such chromatography steps may be repeated as necessary, using the same or different chromatography resins. One skilled in the art would be well-versed in the selection of appropriate chromatography resins and in their most efficacious application for a particular molecule to be purified. The purified product may be concentrated by filtration or ultrafiltration, and stored at a temperature at which the stability of the product is maximized.

[0248] There are a wide array of purification methods known to the art and the preceding method of purification is not meant to be limiting. Such purification techniques are described, for example, in Bailey, J. E. & Ollis, D. F. Biochemical Engineering Fundamentals, McGraw-Hill: New York (1986).

[0249] The identity and purity of the isolated compounds may be assessed by techniques standard in the art. These include high-performance liquid chromatography (HPLC), spectroscopic methods, staining methods, thin layer chromatography, NIRS, enzymatic assay, or microbiologically. Such analysis methods are reviewed in: Patek et al. (1994) Appl. Environ. Microbiol. 60: 133-140; Malakhova et al. (1996) Biotekhnologiya 11: 27-32; and Schmidt et al. (1998) Bioprocess Engineer. 19: 67-70. Ulmann's Encyclopedia of Industrial Chemistry, (1996) vol. A27, VCH: Weinheim, p. 89-90, p. 521-540, p. 540-547, p. 559-566, 575-581 and p. 581-587; Michal, G. (1999) Biochemical Pathways: An Atlas of Biochemistry and Molecular Biology, John Wiley and Sons; Fallon, A. et al. (1987) Applications of BPLC in Biochemistry in: Laboratory Techniques in Biochemistry and Molecular Biology, vol. 17.

[0250] One example for the preparation of desired products from plants is the isolation of starch. Various wet-milling and other starch extraction techniques are described in the literature, depending on the crop plant and on the industrial application (e.g. see in Ellis, R. P. et al. (1998) Journal of the Science of Food and Agriculture 77: 289-311; Singh, S. K. et al. (1997) Cereal Chemistry 74 and references cited therin).

[0251] Equivalents

[0252] Those skilled in the art will recognize, or will be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are intended to be encompassed by the following claims.

[0253] Legends to the Figures:

[0254] Table 1: Enzymes involved in production of carbohydrates, the accession/entry number of the corresponding partial nucleic acid molecules, the entry number of longest clones corresponding to partial nucleic acid molecules and the position of open reading frame.

[0255] Appendix A: Nucleic acid sequences encoding for CMR (Carbohydrate Metabolism Related) polypeptides (SEQ ID NO:1 to SEQ ID NO:177, odd integers)

[0256] Appendix B: CMR polypeptide sequences (SEQ ID NO:2 to SEQ ID NO:178, even integers) TABLE 1 Start of open Stop of open Enzyme encoded Acc. no./Entry no. reading frame reading frame Hemicellulose metabolism UDP-glucose dehydrogenase 18_ck32_c09fwd 1-3 547-549 (SEQ ID NO: 1, SEQ ID NO:2) UDP-N-acetylglucosamine O-acyltransferase- 21_ppprot1_047_d02 1-3 544-546 like protein (SEQ ID NO: 3, SEQ ID NO: 4) GDP-D-mannose dehydratase 91_ppprot1_055_h04 2-4 161-163 (SEQ ID NO: 5, SEQ ID NO: 6) GDP-D-mannose dehydratase 51_ppprot1_056_a05 3-5 282-284 (SEQ ID NO: 7, SEQ ID NO: 8) GPD-D-mannose dehydratase 05_ppprot1_090_a03 1-3 139-141 (SEQ ID NO: 9, SEQ ID NO: 10) GDP-D-mannose dehydratase 15_ppprot1_080_c02 3-5 192-194 (SEQ ID NO: 11, SEQ ID NO: 12) GDP-D-mannose dehydratase 80_ppprot1_092_f10 1-3 316-318 (SEQ ID NO: 13, SEQ ID NO: 14) GDP-4-keto-6-deoxy-D-mannose 3,5- 20_ppprot1_064_d07 2-4 485-487 epimerase-4-reductase (SEQ ID NO: 15, SEQ ID NO: 16) Xyloglucan endotransglycosylase 41_ppprot_069_g03 2-4 338-340 (SEQ ID NO: 17, SEQ ID NO: 18) Xyloglucan endotransglycosylase 48_ck10_h09fwd 104-106 500-502 (SEQ ID NO: 19, SEQ ID NO: 20) Xyloglucan endotransglycosylase 18_ppprot1_055_c09 2-4 392-394 (SEQ ID NO: 21, SEQ ID NO: 22) Xyloglucan endotransglycosylase 90_ppprot1_056_g12 3-5 429-431 (SEQ ID NO: 23, SEQ ID NO: 24) Endoxyloglucan transferase 37_ppprot1_051_g01 237-239 618-620 (SEQ ID NO: 25, SEQ ID NO: 26) Endoxyloglucan transferase 35_mm14_f03rev 102-104 567-569 (SEQ ID NO: 27, SEQ ID NO: 28) Endoxyloglucan transferase 96_ppprot1_081_h12 1-3 430-432 (SEQ ID NO: 29, SEQ ID NO: 30) Beta-1,3-glucanase 96_ck7_h12fwd 2-4 515-517 (SEQ ID NO: 31, SEQ ID NO: 32) Beta-D-glucan exohydrolase 37_mm21_g01rev 3-5 513-515 (SEQ ID NO: 33, SEQ ID NO: 34) Pectine metabolism polygalacturonase 10_ppprot1_085_b08 1-3 238-240 (SEQ ID NO: 35, SEQ ID NO: 36) Cellulose metabolism Cellulose synthase catalytic subunit 16_mm6 2-4 494-496 (SEQ ID NO: 37, SEQ ID NO: 38) Cellulose synthase catalytic subunit 83_mm10_f06rev 3-5 477-479 (SEQ ID NO: 39, SEQ ID NO: 40) Cellulose synthase catalytic subunit 09_mm10_b02rev 1-3 343-345 (SEQ ID NO: 41, SEQ ID NO: 42) Beta-glucosidase 67_mm22_d04rev 3-5 519-521 (SEQ ID NO: 43, SEQ ID NO: 44) Sugar metabolism Trehalose-6-phosphate phosphatase 73_ck12_e04fwd 1-3 304-306 (SEQ ID NO: 45, SEQ ID NO: 46) Trehalose-6-phosphate synthase 63_ck23_c05fwd 1-3 517-519 (SEQ ID NO: 47, SEQ ID NO: 48) Trehalose-6-phosphate synthase 80_ck30_f10fwd 3-5 537-539 (SEQ ID NO: 49, SEQ ID NO: 50) Plastidic triosephosphate isomerase 46_ck2_h08fwd (SEQ 187-189 469-471 ID NO: 51, SEQ ID NO: 52) Plastidic triosephosphate isomerase 83_bd06_f06rev (SEQ 1-3 364-366 ID NO: 53, SEQ ID NO: 54) Cytosolic phosphoglucomutase 19_ck1_d01fwd (SEQ 1-3 331-333 ID NO: 55, SEQ ID NO: 56) Fructokinase 11_ck_19_b03 (SEQ 1-3 208-210 ID NO: 57, SEQ ID NO: 58) Hexokinase 56_ppprot1_061_b10 2-4 392-394 (SEQ ID NO: 59, SEQ ID NO: 60) UDP-glucose pyrophosphorylase 18_ppprot1_064_c09 1-3 346-348 (SEQ ID NO: 61, SEQ ID NO: 62) Sucrose synthase 76_ck27_e11fwd 2-4 494-496 (SEQ ID NO: 63, SEQ ID NO: 64) Invertase 71_ck18_d06fwd 1-3 373-375 (SEQ ID NO: 65, SEQ ID NO: 66) Invertase 94_ck14_h11fwd 1-3 295-297 (SEQ ID NO: 67, SEQ ID NO: 68) Sucrolytic enzyme 25_bd07_e01rev 3-5 279-281 (SEQ ID NO: 69, SEQ ID NO: 70) Sucrose phophate synthase 66_ppprot1_075_c12 1-3 412-414 (SEQ ID NO: 71, SEQ ID NO: 72) Glucose-6-phosphate isomerase 50_mm15_a10rev 1-3 574-576 (SEQ ID NO: 73, SEQ ID NO: 74) Phosphoenolpyruvate carboxylase 70_mm10_d11rev 3-5 474-476 (SEQ ID NO: 75, SEQ ID NO: 76) Pyruvate dehydrogenase 12_ck22_b09fwd 3-5 441-443 (SEQ ID NO: 77, SEQ ID NO: 78) Citrate synthetase 37_mm3_g01rev 88-90 486-489 (SEQ ID NO: 79, SEQ ID NO: 80) Ribokinase 70_ppprot1_069_d11 107-109 623-625 (SEQ ID NO: 81, SEQ ID NO: 82) Cytosolic pyruvate kinase 96_ck20_h12fwd 2-4 248-250 (SEQ ID NO: 83, SEQ ID NO: 84) Carboxyphosphoenolpyruvate mutase 88_mm13_g11rev 9-11 384-386 (SEQ ID NO: 85, SEQ ID NO: 86) Phosphoribulokinase 18_ck25_c09fwd 3-5 429-431 (SEQ ID NO: 87, SEQ ID NO: 88) 3-Phosphoglycerate dehydrogenase 83_ck30_f06fwd 2-4 518-520 (SEQ ID NO: 89, SEQ ID NO: 90) Cytosolic phosphoglycerate kinase 63_ck7_c05fwd 2-4 386-388 (SEQ ID NO: 91, SEQ ID NO: 92) Plastidial phosphoglycerate kinase 18_ck24_c09fwd 92-94 476-478 (SEQ ID NO: 93, SEQ ID NO: 94) Chloroplastic fructose bisphosphate 18_ck26_c09fwd 200-202 440-442 aldolase (SEQ ID NO: 95, SEQ ID NO: 96) Chloroplastic fructose bisphosphate 60_ppgam17_b12 75-77 402-404 aldolase (SEQ ID NO: 97, SEQ ID NO: 98) Plastidial SBPase 50_ck19_a10fwd 2-4 167-169 (SEQ ID NO: 99, SEQ ID NO: 100) Plastidial FBPase 35_ck11_f03fwd 65-67 572-574 (SEQ ID NO: 101, SEQ ID NO: 102) Fructose-6-phosphate 2-kinase/ 20_ppprot1_083_d07 3-5 243-245 fructose-2,6-bisphosphatase (SEQ ID NO: 103, SEQ ID NO: 104) 3-Deoxy-D-arabino-heptulosonate 7- 14_ck4_c07fwd 3-5 181-182 phosphate synthase (shkB) (SEQ ID NO: 105, SEQ ID NO: 106) 3-Deoxy-d-manno-octulosonic acid 8- 89_ck12_g06fwd 2-4 422-424 phosphate synthase (SEQ ID NO: 107, SEQ ID NO: 108) Ribulose-phosphate-3-epimerase 55_bd01_b04rev 76-78 340-342 (pentose-5-phosphate-3-epimerase) (SEQ ID NO: 109, SEQ ID NO: 110) Cytosolic glucose-6-phosphate 50_mm15_a10rev 1-3 574-576 isomerase (SEQ ID NO: 111, SEQ ID NO: 112) Ribose-5-P isomerase 86_ck23g_g10fwd 239-241 452-454 (SEQ ID NO: 113, SEQ ID NO: 114) Lysosomal alpha-mannosidase 22_ppgam15_d08 1-3 334-336 (SEQ ID NO: 115, SEQ ID NO: 116) Transporter Triosephosphate transporter 70_ck11_d11fwd 2-4 464-466 (SEQ ID NO: 117, SEQ ID NO: 118) ADP/ATP carrier protein 29_ck12_e03fwd 3-5 282-284 (SEQ ID NO: 119, SEQ ID NO: 120) Sucrose transporter 07_ppprot1_057_b01 3-5 159-161 (SEQ ID NO: 121, SEQ ID NO: 122) Sucrose transporter 25_ppprot1_057_e01 1-3 208-210 (SEQ ID NO: 123, SEQ ID NO: 124) Sugar transporter 48_ck24_h09fwd 1-3 517-519 (SEQ ID NO: 125, SEQ ID NO: 126) Starch catabolism Alpha-glucosidase 41_ppprot1_105_g03 1-3 463-465 (SEQ ID NO: 127, SEQ ID NO: 128) Alpha-glucosidase 44_ppprot1_075_h07 1-3 595-597 (SEQ ID NO: 129, SEQ ID NO: 130) Alpha-glucosidase 63_ppprot1_60 3-5 705-707 (SEQ ID NO: 131, SEQ ID NO: 132) Alpha-glucosidase 74_ck13_e10fwd 2-4 563-565 (SEQ ID NO: 133, SEQ ID NO: 134) Alpha-amylase 03_ppprot1_056_a02 1-3 316-318 (SEQ ID NO: 135, SEQ ID NO: 136) Alpha-amylase 50_ck1_a10fwd 2-4 599-601 (SEQ ID NO: 137, SEQ ID NO: 138) Beta-amylase 25_ppprot1_104_e01 2-4 548-550 (SEQ ID NO: 139, SEQ ID NO: 140) Starch anabolism ADP glucose pyrophosphorylase 53_ppprot1_074_a06 3-5 213-215 large subunit (SEQ ID NO: 141, SEQ ID NO: 142)

[0257] Additional clones; full length Function/Amino acid Clone entry no. Clone entry no. of Start of open Stop- metabolism of longest clone corresponding partial clone reading frame codon UDP-N-acetylglucosamine s_pp001047038r 21_ppprot1_047_d02 2-4 551-553 O-acyltransferase- (SEQ ID NO: 143, SEQ ID NO: 144) (SEQ ID NO: 3, SEQ ID NO: 4) like protein GDP-D-mannose c_pp030002055r 91_ppprot1_055_h04 224-226 1268-1270 dehydratase (SEQ ID NO: 145, SEQ ID NO: 146) (SEQ ID NO: 5, SEQ ID NO: 6) GDP-4-keto-6-deoxy- c_pp001064043r 20_ppprot1_064_d07 347-349 1274-1276 D-mannose 3,5- (SEQ ID NO: 147, SEQ ID NO: 148) (SEQ ID NO: 15, SEQ ID NO: 16) epimerase-4-reductase Endoxyloglucan c_pp032009028r 37_ppprot1_051_g01 322-324 919-921 transferase (SEQ ID NO: 149, SEQ ID NO: 150) (SEQ ID NO: 25, SEQ ID NO: 26) Endoxyloglucan c_pp004089354r 35_mm14_f03rev 268-270 1126-1128 transferase (SEQ ID NO: 151, SEQ ID NO: 152) (SEQ ID NO: 27, SEQ ID NO: 28) Cellulose synthase s_pp002010066r 83_mm10_f06rev 1-3 499-501 catalytic subunit (SEQ ID NO: 153, SEQ ID NO: 154) (SEQ ID NO: 39, SEQ ID NO: 40) Plastidic c_pp001002092f 46_ck2_h08fwd 187-189 1165-1167 triosephosphate isomerase (SEQ ID NO: 155, SEQ ID NO: 156) (SEQ ID NO: 51, SEQ ID NO: 52) Plastidic s_pp013006066r 83_bd06_f06rev 3-5 915-917 triosephosphate isomerase (SEQ ID NO: 157, SEQ ID NO: 158) (SEQ ID NO: 39, SEQ ID NO: 40) Fructokinase c_pp004048178r 11_ck_19_b03 2-4 776-778 (SEQ ID NO: 159, SEQ ID NO: 160) (SEQ ID NO: 57, SEQ ID NO: 58) Invertase c_pp001074086r 71_ck18_d06fwd 1-3 796-798 (SEQ ID NO: 161, SEQ ID NO: 162) (SEQ ID NO: 65, SEQ ID NO: 66) Sucrolytic enzyme c_pp004102322r 25_bd07_e01rev 482-484 1388-1390 (SEQ ID NO: 163, SEQ ID NO: 164) (SEQ ID NO: 69, SEQ ID NO: 70) Cytosolic c_pp004089380r 63_ck7_c05fwd 135-137 1557-1559 phosphoglycerate kinase (SEQ ID NO: 165, SEQ ID NO: 166) (SEQ ID NO: 91, SEQ ID NO: 92) Triosephosphate c_pp004044298r 70_ck11_d11fwd 81-83 1158-1160 transporter (SEQ ID NO: 167, SEQ ID NO: 168) (SEQ ID NO: 117, SEQ ID NO: 118) ADP/ATP carrier c_pp004075307r 29_ck12_e03fwd 82-84 1237-1239 protein (SEQ ID NO: 169, SEQ ID NO: 170) (SEQ ID NO: 119, SEQ ID NO: 120) Sugar transporter s_pp001024093f 48_ck24_h09fwd 1-3 1438-1440 (SEQ ID NO: 171, SEQ ID NO: 172) (SEQ ID NO: 125, SEQ ID NO: 126) Alpha-amylase c_pp010010057r 50_ck1_a10fwd 1-3 1288-1290 (SEQ ID NO: 173, SEQ ID NO: 174) (SEQ ID NO: 137, SEQ ID NO: 138) Beta-amylase c_pp004072377r 25_ppprot1_104_e01 168-170 1626-1628 (SEQ ID NO: 175, SEQ ID NO: 176) (SEQ ID NO: 139, SEQ ID NO: 140) ADP glucose pyro- c_pp001109095r 53_ppprot1_074_a06 736-738 2053-2055 phosphorylase large subunit (SEQ ID NO: 177, SEQ ID NO: 178) (SEQ ID NO: 141, SEQ ID NO: 142)

[0258]

1 181 1 550 DNA Physcomitrella patens CDS (1)..(549) 18_ck32_c09fwd 1 agc aag ccc agg att gcg gcc tgg aac agt gat gag ttg ccg att tat 48 Ser Lys Pro Arg Ile Ala Ala Trp Asn Ser Asp Glu Leu Pro Ile Tyr 1 5 10 15 gag ccg ggt ttg gac gat gtt gtg aag tcg tgc agg ggt aag aac ttg 96 Glu Pro Gly Leu Asp Asp Val Val Lys Ser Cys Arg Gly Lys Asn Leu 20 25 30 ttc ttc tcg acg gag gtt gag aag cac gtc gct gag gcg gac att gtg 144 Phe Phe Ser Thr Glu Val Glu Lys His Val Ala Glu Ala Asp Ile Val 35 40 45 ttc gtg tct gtg aac act cca acc aag acc cgg ggt ttg gga gct ggt 192 Phe Val Ser Val Asn Thr Pro Thr Lys Thr Arg Gly Leu Gly Ala Gly 50 55 60 aag gct gca gat ctg act tat tgg gaa agt gct gcg cgt atg att gct 240 Lys Ala Ala Asp Leu Thr Tyr Trp Glu Ser Ala Ala Arg Met Ile Ala 65 70 75 80 gat gtg tcg aag agc gat aag atc gtg gtt gag aag tct acc gtg ccg 288 Asp Val Ser Lys Ser Asp Lys Ile Val Val Glu Lys Ser Thr Val Pro 85 90 95 gtg aaa acc gca gag gcg atc gag aag atc ctg acg cat aac aac aag 336 Val Lys Thr Ala Glu Ala Ile Glu Lys Ile Leu Thr His Asn Asn Lys 100 105 110 ggg att aac ttt cag atc ttg tcg aac ccg gag ttt ttg gcc gag ggt 384 Gly Ile Asn Phe Gln Ile Leu Ser Asn Pro Glu Phe Leu Ala Glu Gly 115 120 125 acc gcc att gaa gac ttg gac aag ccc gat cgt gtg ctg atc ggt gga 432 Thr Ala Ile Glu Asp Leu Asp Lys Pro Asp Arg Val Leu Ile Gly Gly 130 135 140 cgc atg act ccg gag gga cag aaa gct gtg gct gct ttg aag ctg tgt 480 Arg Met Thr Pro Glu Gly Gln Lys Ala Val Ala Ala Leu Lys Leu Cys 145 150 155 160 acg cac act ggg tgc cag agg acc gca tta tta cta cca act tgt ggt 528 Thr His Thr Gly Cys Gln Arg Thr Ala Leu Leu Leu Pro Thr Cys Gly 165 170 175 ctg ctg act ctc caa gct cgc c 550 Leu Leu Thr Leu Gln Ala Arg 180 2 183 PRT Physcomitrella patens 2 Ser Lys Pro Arg Ile Ala Ala Trp Asn Ser Asp Glu Leu Pro Ile Tyr 1 5 10 15 Glu Pro Gly Leu Asp Asp Val Val Lys Ser Cys Arg Gly Lys Asn Leu 20 25 30 Phe Phe Ser Thr Glu Val Glu Lys His Val Ala Glu Ala Asp Ile Val 35 40 45 Phe Val Ser Val Asn Thr Pro Thr Lys Thr Arg Gly Leu Gly Ala Gly 50 55 60 Lys Ala Ala Asp Leu Thr Tyr Trp Glu Ser Ala Ala Arg Met Ile Ala 65 70 75 80 Asp Val Ser Lys Ser Asp Lys Ile Val Val Glu Lys Ser Thr Val Pro 85 90 95 Val Lys Thr Ala Glu Ala Ile Glu Lys Ile Leu Thr His Asn Asn Lys 100 105 110 Gly Ile Asn Phe Gln Ile Leu Ser Asn Pro Glu Phe Leu Ala Glu Gly 115 120 125 Thr Ala Ile Glu Asp Leu Asp Lys Pro Asp Arg Val Leu Ile Gly Gly 130 135 140 Arg Met Thr Pro Glu Gly Gln Lys Ala Val Ala Ala Leu Lys Leu Cys 145 150 155 160 Thr His Thr Gly Cys Gln Arg Thr Ala Leu Leu Leu Pro Thr Cys Gly 165 170 175 Leu Leu Thr Leu Gln Ala Arg 180 3 547 DNA Physcomitrella patens CDS (1)..(546) 21_ppprot1_047_d02 3 ggt ctg gaa aat cca cca gga gca cat tgt tgt ttg cct cac gta gaa 48 Gly Leu Glu Asn Pro Pro Gly Ala His Cys Cys Leu Pro His Val Glu 1 5 10 15 aat ctg ctg gac gct cgt agt ccc atg gcc gcc caa gta ttt ttc aat 96 Asn Leu Leu Asp Ala Arg Ser Pro Met Ala Ala Gln Val Phe Phe Asn 20 25 30 ggc agt ttg ctg gga ggc att agt tgc act tca aca ccc agt tca ctt 144 Gly Ser Leu Leu Gly Gly Ile Ser Cys Thr Ser Thr Pro Ser Ser Leu 35 40 45 tct gtg cct cga tct tcg ctg aca cta cct gtg cca act tcc ttg cgc 192 Ser Val Pro Arg Ser Ser Leu Thr Leu Pro Val Pro Thr Ser Leu Arg 50 55 60 aag agt ctt tac tct atg gta agc tgg aag gat ttg ctt tct agg cac 240 Lys Ser Leu Tyr Ser Met Val Ser Trp Lys Asp Leu Leu Ser Arg His 65 70 75 80 cgt tct ttt aag agg ggt atg agg tca agc gct tta gct gat tca gac 288 Arg Ser Phe Lys Arg Gly Met Arg Ser Ser Ala Leu Ala Asp Ser Asp 85 90 95 ttt tca gtg aag aaa gat gag atg caa acg caa agt atg ttt cca gct 336 Phe Ser Val Lys Lys Asp Glu Met Gln Thr Gln Ser Met Phe Pro Ala 100 105 110 gca aga cgt ggc aag gag aat gcg gtt tct acg acc act gtg aac gct 384 Ala Arg Arg Gly Lys Glu Asn Ala Val Ser Thr Thr Thr Val Asn Ala 115 120 125 aca agt gta ctt ccg gaa cgc aaa atc att cat gag aca gcg gta gtt 432 Thr Ser Val Leu Pro Glu Arg Lys Ile Ile His Glu Thr Ala Val Val 130 135 140 cat ccg gac gcc ttc ata ggt gag ggg gtt gtc atc agc gca ttt tgt 480 His Pro Asp Ala Phe Ile Gly Glu Gly Val Val Ile Ser Ala Phe Cys 145 150 155 160 aca gtg gga cct ggt gtt tca ata gga aat ggc tgc aag tta cat cct 528 Thr Val Gly Pro Gly Val Ser Ile Gly Asn Gly Cys Lys Leu His Pro 165 170 175 agt agt cac gtc tgt ggg a 547 Ser Ser His Val Cys Gly 180 4 182 PRT Physcomitrella patens 4 Gly Leu Glu Asn Pro Pro Gly Ala His Cys Cys Leu Pro His Val Glu 1 5 10 15 Asn Leu Leu Asp Ala Arg Ser Pro Met Ala Ala Gln Val Phe Phe Asn 20 25 30 Gly Ser Leu Leu Gly Gly Ile Ser Cys Thr Ser Thr Pro Ser Ser Leu 35 40 45 Ser Val Pro Arg Ser Ser Leu Thr Leu Pro Val Pro Thr Ser Leu Arg 50 55 60 Lys Ser Leu Tyr Ser Met Val Ser Trp Lys Asp Leu Leu Ser Arg His 65 70 75 80 Arg Ser Phe Lys Arg Gly Met Arg Ser Ser Ala Leu Ala Asp Ser Asp 85 90 95 Phe Ser Val Lys Lys Asp Glu Met Gln Thr Gln Ser Met Phe Pro Ala 100 105 110 Ala Arg Arg Gly Lys Glu Asn Ala Val Ser Thr Thr Thr Val Asn Ala 115 120 125 Thr Ser Val Leu Pro Glu Arg Lys Ile Ile His Glu Thr Ala Val Val 130 135 140 His Pro Asp Ala Phe Ile Gly Glu Gly Val Val Ile Ser Ala Phe Cys 145 150 155 160 Thr Val Gly Pro Gly Val Ser Ile Gly Asn Gly Cys Lys Leu His Pro 165 170 175 Ser Ser His Val Cys Gly 180 5 536 DNA Physcomitrella patens CDS (2)..(163) 91_ppprot1_055_h04 5 c att ctg cga ggc agt gcg cag aaa gcg aag gag gtg ctg gga tgg cag 49 Ile Leu Arg Gly Ser Ala Gln Lys Ala Lys Glu Val Leu Gly Trp Gln 1 5 10 15 cct aag gtg cag ttc aag cag ctg gtg gcg atg atg gtg gat ggt gat 97 Pro Lys Val Gln Phe Lys Gln Leu Val Ala Met Met Val Asp Gly Asp 20 25 30 ttg gag aag gcg aag cga gag aag gtg ctt gtg gat gct ggc ttc att 145 Leu Glu Lys Ala Lys Arg Glu Lys Val Leu Val Asp Ala Gly Phe Ile 35 40 45 gac tcg cac cag cag ccc tgaattttgg gcaccgaatg aatagtgtta 193 Asp Ser His Gln Gln Pro 50 ataattatat gaaacgaatg gatataatat gacaggcctt gcaatatatg gttaatatat 253 tgatacatag tgatatgtca acccgagagt acttcttcaa ttaggttata gccttagctt 313 tgccatgtaa ggcttacaat atattcttcg ctgccgcagt gcttagcaca caccaagtac 373 tagttccgag caattttagt gggttgttta ttcagcagaa tgcactgaca ccactcatct 433 agaatataag cccgcattcg ggtgcaaatc aatgctattc tctgatgagg acgattttgc 493 caacctgtgc accctccttc gaaatgaata ttcaatctta aaa 536 6 54 PRT Physcomitrella patens 6 Ile Leu Arg Gly Ser Ala Gln Lys Ala Lys Glu Val Leu Gly Trp Gln 1 5 10 15 Pro Lys Val Gln Phe Lys Gln Leu Val Ala Met Met Val Asp Gly Asp 20 25 30 Leu Glu Lys Ala Lys Arg Glu Lys Val Leu Val Asp Ala Gly Phe Ile 35 40 45 Asp Ser His Gln Gln Pro 50 7 658 DNA Physcomitrella patens CDS (3)..(284) 51_ppprot1_056_a05 7 tc gcg acg gag gat tcc cac act gtg gag gag ttt ctg gaa gag gca 47 Ala Thr Glu Asp Ser His Thr Val Glu Glu Phe Leu Glu Glu Ala 1 5 10 15 ttc agc tat gtt ggt ctg aac tgg aag gac cat gtc gag att gat ccc 95 Phe Ser Tyr Val Gly Leu Asn Trp Lys Asp His Val Glu Ile Asp Pro 20 25 30 aga tat ttc cgt cct tcg gag gtg gac aat ctg cga ggc agt gcg cag 143 Arg Tyr Phe Arg Pro Ser Glu Val Asp Asn Leu Arg Gly Ser Ala Gln 35 40 45 aaa gcg aag gag gtg ctg gga tgg cag cct aag gtg cag ttc aag cag 191 Lys Ala Lys Glu Val Leu Gly Trp Gln Pro Lys Val Gln Phe Lys Gln 50 55 60 ctg gtg gcg atg atg gtg gat ggt gat ttg gag aag gcg aag cga gag 239 Leu Val Ala Met Met Val Asp Gly Asp Leu Glu Lys Ala Lys Arg Glu 65 70 75 aag gtg ctt gtg gat gct ggc ttc att gac tcg cac cag cag ccc 284 Lys Val Leu Val Asp Ala Gly Phe Ile Asp Ser His Gln Gln Pro 80 85 90 tgaattttgg gcaccgaatg aatagtgtta ataattatat gaaacgaatg gatataatat 344 gacaggcctt gcaatatatg gttaatatat tgatacatag tgatatgtca acccgagagt 404 acttcttcaa ttaggttata gccttagctt tgccatgtaa ggcttacaat atattcttcg 464 ctgccgcagt gcttagcaca caccaagtac tagttccgag caattttagt gggttgttta 524 ttcagcagaa tgcactgaca ccactcatct agaatataag cccgcattcg ggtgcaaatc 584 aatgctattc tctgatgagg acgattttgc caacctgtgc accctccttc gaaatgaata 644 ttcaattctt aaaa 658 8 94 PRT Physcomitrella patens 8 Ala Thr Glu Asp Ser His Thr Val Glu Glu Phe Leu Glu Glu Ala Phe 1 5 10 15 Ser Tyr Val Gly Leu Asn Trp Lys Asp His Val Glu Ile Asp Pro Arg 20 25 30 Tyr Phe Arg Pro Ser Glu Val Asp Asn Leu Arg Gly Ser Ala Gln Lys 35 40 45 Ala Lys Glu Val Leu Gly Trp Gln Pro Lys Val Gln Phe Lys Gln Leu 50 55 60 Val Ala Met Met Val Asp Gly Asp Leu Glu Lys Ala Lys Arg Glu Lys 65 70 75 80 Val Leu Val Asp Ala Gly Phe Ile Asp Ser His Gln Gln Pro 85 90 9 437 DNA Physcomitrella patens CDS (1)..(141) 05_ppprot1_090_a03 9 agg ccc aga gag cgt ttg gtt tgc caa cca aaa gtc aac ttc aag cag 48 Arg Pro Arg Glu Arg Leu Val Cys Gln Pro Lys Val Asn Phe Lys Gln 1 5 10 15 ttg gtt gct atg atg gta gac ggt gat ttg gag aga gct aaa cgt gag 96 Leu Val Ala Met Met Val Asp Gly Asp Leu Glu Arg Ala Lys Arg Glu 20 25 30 aag gtt cta gtg gac aac ggt tat att gat tct cac caa cag cct 141 Lys Val Leu Val Asp Asn Gly Tyr Ile Asp Ser His Gln Gln Pro 35 40 45 tgaagcacat caatccactc ttcattccta tttttatacc atgagaagat gaaaaaatgt 201 gttctttaag tcccatgcat tcattggctc aaatgccgaa gatggtttaa cagacgaccg 261 gatatccaag caatcaatag gagagataga tcgttaaata tctagtatcg gtgccctgga 321 aattagttgg gatagtggaa taagctttct gcaaggccaa cagtgatcac tctttcagac 381 catacattta tggtgaatac cttgataatg ctaacattta ccacgaaaaa aaaaaa 437 10 47 PRT Physcomitrella patens 10 Arg Pro Arg Glu Arg Leu Val Cys Gln Pro Lys Val Asn Phe Lys Gln 1 5 10 15 Leu Val Ala Met Met Val Asp Gly Asp Leu Glu Arg Ala Lys Arg Glu 20 25 30 Lys Val Leu Val Asp Asn Gly Tyr Ile Asp Ser His Gln Gln Pro 35 40 45 11 522 DNA Physcomitrella patens CDS (3)..(194) 15_ppprotl_080_c02 11 at ttc act caa gaa caa tac cac cac gag atc agg aga tgt gat ata 47 Phe Thr Gln Glu Gln Tyr His His Glu Ile Arg Arg Cys Asp Ile 1 5 10 15 cac agc cag tta ctg aat gtt atc cga caa cag agc caa cag agg ttc 95 His Ser Gln Leu Leu Asn Val Ile Arg Gln Gln Ser Gln Gln Arg Phe 20 25 30 gtg gta aat gtt agc att atc aag gta ttc acc ata aat gta tgg tct 143 Val Val Asn Val Ser Ile Ile Lys Val Phe Thr Ile Asn Val Trp Ser 35 40 45 gaa aga gtg atc act gtt ggc ctt gca gaa agc tta ttc cac tat ccc 191 Glu Arg Val Ile Thr Val Gly Leu Ala Glu Ser Leu Phe His Tyr Pro 50 55 60 aac taatttccag ggcaccgata ctagatattt aacgatctat ctctcctatt 244 Asn gattgcttgg atatccggtc gtctgttaaa ccatcttcgg catttgagcc aatgaatgca 304 tgggacttaa agaacacatt ttttcatctt ctcatggtat aaaaatagga atgaagagtg 364 gattgatgtg cttcaaggct gttggtgaga atcaatataa ccgttgtcca ctagaacctt 424 ctcacgttta gctctctcca aatcaccgtc taccatcata gcaaccaact gcttgaagtt 484 gacttttggt tgcaaccaaa cgctctctgg ccttctgt 522 12 64 PRT Physcomitrella patens 12 Phe Thr Gln Glu Gln Tyr His His Glu Ile Arg Arg Cys Asp Ile His 1 5 10 15 Ser Gln Leu Leu Asn Val Ile Arg Gln Gln Ser Gln Gln Arg Phe Val 20 25 30 Val Asn Val Ser Ile Ile Lys Val Phe Thr Ile Asn Val Trp Ser Glu 35 40 45 Arg Val Ile Thr Val Gly Leu Ala Glu Ser Leu Phe His Tyr Pro Asn 50 55 60 13 614 DNA Physcomitrella patens CDS (1)..(318) 80_ppprot1_092_f10 13 atg ttg cag cag gag aag cca gat gat tat gtc ctt gct acc gag agt 48 Met Leu Gln Gln Glu Lys Pro Asp Asp Tyr Val Leu Ala Thr Glu Ser 1 5 10 15 tct tat act gtc gaa gag ttt ctt gag gaa gcc ttc ggt tac gtt ggt 96 Ser Tyr Thr Val Glu Glu Phe Leu Glu Glu Ala Phe Gly Tyr Val Gly 20 25 30 ctt aac tgg aga gat cat gtt gaa atc gat ccc agg tat ttc cgt cct 144 Leu Asn Trp Arg Asp His Val Glu Ile Asp Pro Arg Tyr Phe Arg Pro 35 40 45 tcc gaa gtg gat aat ttg aga ggt tca gca cag aag gcc aga gag cgt 192 Ser Glu Val Asp Asn Leu Arg Gly Ser Ala Gln Lys Ala Arg Glu Arg 50 55 60 ttg ggt tgg caa cca aaa gtc aac ttc aag cag ttg gtt gct atg atg 240 Leu Gly Trp Gln Pro Lys Val Asn Phe Lys Gln Leu Val Ala Met Met 65 70 75 80 gta gac ggt gat ttg gag aga gct aaa cgt gag aag gtt cta gtg gac 288 Val Asp Gly Asp Leu Glu Arg Ala Lys Arg Glu Lys Val Leu Val Asp 85 90 95 aac ggt tat att gat tct cac caa cag cct tgaagcacat caatccactc 338 Asn Gly Tyr Ile Asp Ser His Gln Gln Pro 100 105 ttcattccta tttttatacc atgagaagat gaaaaaatgt gttctttaag tcccatgcat 398 tcattggctc aaatgccgaa gatggtttaa cagacgaccg gatatccaag caatcaatag 458 gagagataga tcgttaaata tctagtatcg gtgccctgga aattagttgg gatagtggaa 518 taagctttct gcaaggcgaa cagtgatcac tctttcagac catacattta tggtgaatac 578 cttgataatg ctaacattta ccacgaaaaa aaaaaa 614 14 106 PRT Physcomitrella patens 14 Met Leu Gln Gln Glu Lys Pro Asp Asp Tyr Val Leu Ala Thr Glu Ser 1 5 10 15 Ser Tyr Thr Val Glu Glu Phe Leu Glu Glu Ala Phe Gly Tyr Val Gly 20 25 30 Leu Asn Trp Arg Asp His Val Glu Ile Asp Pro Arg Tyr Phe Arg Pro 35 40 45 Ser Glu Val Asp Asn Leu Arg Gly Ser Ala Gln Lys Ala Arg Glu Arg 50 55 60 Leu Gly Trp Gln Pro Lys Val Asn Phe Lys Gln Leu Val Ala Met Met 65 70 75 80 Val Asp Gly Asp Leu Glu Arg Ala Lys Arg Glu Lys Val Leu Val Asp 85 90 95 Asn Gly Tyr Ile Asp Ser His Gln Gln Pro 100 105 15 701 DNA Physcomitrella patens CDS (2)..(487) 20_ppprot1_064_d07 15 c cag gct tac agg ctg cag tat aat ttc gac gcc att tct gga atg ccg 49 Gln Ala Tyr Arg Leu Gln Tyr Asn Phe Asp Ala Ile Ser Gly Met Pro 1 5 10 15 aca aac ctc tac ggt ccc cac gac aat ttc cat ccc gag aac tcc cac 97 Thr Asn Leu Tyr Gly Pro His Asp Asn Phe His Pro Glu Asn Ser His 20 25 30 gtc ttg cca gcc ttg atc aga cgc ttt cac gag gct aag gtg aac ggc 145 Val Leu Pro Ala Leu Ile Arg Arg Phe His Glu Ala Lys Val Asn Gly 35 40 45 gct aag gaa gtg gtt gtg tgg gga tca ggt tcc cca ttc cgt gag ttt 193 Ala Lys Glu Val Val Val Trp Gly Ser Gly Ser Pro Phe Arg Glu Phe 50 55 60 ctt cac gtg gac gac ttg gca gag gca aca gta ttt ctg ctg cag aat 241 Leu His Val Asp Asp Leu Ala Glu Ala Thr Val Phe Leu Leu Gln Asn 65 70 75 80 tac tcc gcg cat gag cat gtc aac atg ggc agt ggc tct gag gtc tca 289 Tyr Ser Ala His Glu His Val Asn Met Gly Ser Gly Ser Glu Val Ser 85 90 95 atc aag gaa ctc gcc gaa atg gtg aag gaa gtg gtt gga ttt cag ggg 337 Ile Lys Glu Leu Ala Glu Met Val Lys Glu Val Val Gly Phe Gln Gly 100 105 110 cag ctg aca tgg gat act tct aag cct gat gga act cca cga aag ctc 385 Gln Leu Thr Trp Asp Thr Ser Lys Pro Asp Gly Thr Pro Arg Lys Leu 115 120 125 atc gat agc agc aaa ctt gcc aac atg ggg tgg caa gcg aga att ccc 433 Ile Asp Ser Ser Lys Leu Ala Asn Met Gly Trp Gln Ala Arg Ile Pro 130 135 140 ctc aag gaa gga ttg gca gag act tac aaa tgg tac tgt gag aac tac 481 Leu Lys Glu Gly Leu Ala Glu Thr Tyr Lys Trp Tyr Cys Glu Asn Tyr 145 150 155 160 aat gtc taggctattt tattcggatc aaccttgaag cacctgtttt tgaattctta 537 Asn Val ctacgataga taaattcaag cggtggctat gtgaagcagt ggtagctttg caggatactg 597 acctcgagga tatttatcac aattcattgc ctgtttagtg ggtactgcaa ccttgtattg 657 tgaggctgtc atggcaattt tctttctagc atgctgactt taaa 701 16 162 PRT Physcomitrella patens 16 Gln Ala Tyr Arg Leu Gln Tyr Asn Phe Asp Ala Ile Ser Gly Met Pro 1 5 10 15 Thr Asn Leu Tyr Gly Pro His Asp Asn Phe His Pro Glu Asn Ser His 20 25 30 Val Leu Pro Ala Leu Ile Arg Arg Phe His Glu Ala Lys Val Asn Gly 35 40 45 Ala Lys Glu Val Val Val Trp Gly Ser Gly Ser Pro Phe Arg Glu Phe 50 55 60 Leu His Val Asp Asp Leu Ala Glu Ala Thr Val Phe Leu Leu Gln Asn 65 70 75 80 Tyr Ser Ala His Glu His Val Asn Met Gly Ser Gly Ser Glu Val Ser 85 90 95 Ile Lys Glu Leu Ala Glu Met Val Lys Glu Val Val Gly Phe Gln Gly 100 105 110 Gln Leu Thr Trp Asp Thr Ser Lys Pro Asp Gly Thr Pro Arg Lys Leu 115 120 125 Ile Asp Ser Ser Lys Leu Ala Asn Met Gly Trp Gln Ala Arg Ile Pro 130 135 140 Leu Lys Glu Gly Leu Ala Glu Thr Tyr Lys Trp Tyr Cys Glu Asn Tyr 145 150 155 160 Asn Val 17 670 DNA Physcomitrella patens CDS (2)..(340) 41_ppprot1_069_g03 17 a ggg aca ggg att gta cgt gtc ata ctg gga cgg aag cag tgg gct act 49 Gly Thr Gly Ile Val Arg Val Ile Leu Gly Arg Lys Gln Trp Ala Thr 1 5 10 15 caa ggt ggt cgc atc aaa atc gac tac gcg atg aac gcg ccg ttt att 97 Gln Gly Gly Arg Ile Lys Ile Asp Tyr Ala Met Asn Ala Pro Phe Ile 20 25 30 gct aat ttg aac ggg ttc cat cac atg tcg gct tgc cag gtt ccg agt 145 Ala Asn Leu Asn Gly Phe His His Met Ser Ala Cys Gln Val Pro Ser 35 40 45 gag agg gac ctc gga agt tgc aaa tac cct gct gtg gct cca tgc tgg 193 Glu Arg Asp Leu Gly Ser Cys Lys Tyr Pro Ala Val Ala Pro Cys Trp 50 55 60 gac agg cca tct gat cat tac ctt acc gcg aag cag aag acc gat ttc 241 Asp Arg Pro Ser Asp His Tyr Leu Thr Ala Lys Gln Lys Thr Asp Phe 65 70 75 80 gag tgg gcg aac aac aac ttc tgt atc tac gac tac tgc aag gac gac 289 Glu Trp Ala Asn Asn Asn Phe Cys Ile Tyr Asp Tyr Cys Lys Asp Asp 85 90 95 cag cga ttt gcc tcg acg gga aaa cca gca gaa tgc aac atc cca ctc 337 Gln Arg Phe Ala Ser Thr Gly Lys Pro Ala Glu Cys Asn Ile Pro Leu 100 105 110 tat tagatctcat actcttcttc gagcatctgt ctgggcccca gtggcattca 390 Tyr ttctaaataa gtagcatccc acttagacat cgctaattta attcattggt gttgctgtcc 450 ccctgcagtg gtccagcatt gcaagatggg gggttattga tcgagtcacg atgctcgggg 510 aactcgttgg gaaagggtgc tggagtggtc gcactgccgc ctcccattgc attagatgtc 570 tagcggcgtt cagcgaactg aaacatattt gtactagagt gcttaacaat tcctttctcc 630 cagtttttaa tactcgggat gacttattct tcaaaaaaaa 670 18 113 PRT Physcomitrella patens 18 Gly Thr Gly Ile Val Arg Val Ile Leu Gly Arg Lys Gln Trp Ala Thr 1 5 10 15 Gln Gly Gly Arg Ile Lys Ile Asp Tyr Ala Met Asn Ala Pro Phe Ile 20 25 30 Ala Asn Leu Asn Gly Phe His His Met Ser Ala Cys Gln Val Pro Ser 35 40 45 Glu Arg Asp Leu Gly Ser Cys Lys Tyr Pro Ala Val Ala Pro Cys Trp 50 55 60 Asp Arg Pro Ser Asp His Tyr Leu Thr Ala Lys Gln Lys Thr Asp Phe 65 70 75 80 Glu Trp Ala Asn Asn Asn Phe Cys Ile Tyr Asp Tyr Cys Lys Asp Asp 85 90 95 Gln Arg Phe Ala Ser Thr Gly Lys Pro Ala Glu Cys Asn Ile Pro Leu 100 105 110 Tyr 19 535 DNA Physcomitrella patens CDS (104)..(502) 48_ck10_h09fwd 19 ctggaactgt gttcgcattc tacacctctt cggatgggaa aatggatgac catgacgaaa 60 ttgatattga attcttggta acgaaacctc caagcacatc act atg cag acc aat 115 Met Gln Thr Asn 1 atc ttc atc aac ggt gtc ggt gat agg gaa atg cgc cac aac ctt gac 163 Ile Phe Ile Asn Gly Val Gly Asp Arg Glu Met Arg His Asn Leu Asp 5 10 15 20 tgg ttt gac cca tgc acc agc cat cat gac tac ttc atc aag tgg aat 211 Trp Phe Asp Pro Cys Thr Ser His His Asp Tyr Phe Ile Lys Trp Asn 25 30 35 tcc aac att gtc gta gtt gga gtt gat gat atc cct ctc cgc gtt cac 259 Ser Asn Ile Val Val Val Gly Val Asp Asp Ile Pro Leu Arg Val His 40 45 50 atg aac aat gag aag aac ggt ctc cca tat ttt aac aag gga cag gga 307 Met Asn Asn Glu Lys Asn Gly Leu Pro Tyr Phe Asn Lys Gly Gln Gly 55 60 65 ttg tac gtg tca tac tgg gac gga agc agc tgg gct act caa ggt ggt 355 Leu Tyr Val Ser Tyr Trp Asp Gly Ser Ser Trp Ala Thr Gln Gly Gly 70 75 80 cgc atc aaa atc gac tac gcg atg aac gcg ccg ttt att gct aat ttg 403 Arg Ile Lys Ile Asp Tyr Ala Met Asn Ala Pro Phe Ile Ala Asn Leu 85 90 95 100 aac ggg ttc cat cac atg tcg gct tgc cag gtt ccg agt gag agg gac 451 Asn Gly Phe His His Met Ser Ala Cys Gln Val Pro Ser Glu Arg Asp 105 110 115 ctc gga agt tgc aaa tac cct gct gtg ggc tcc atg ctg gga cag ggc 499 Leu Gly Ser Cys Lys Tyr Pro Ala Val Gly Ser Met Leu Gly Gln Gly 120 125 130 atc tgatcattac cttaccgcga agcagaagac cga 535 Ile 20 133 PRT Physcomitrella patens 20 Met Gln Thr Asn Ile Phe Ile Asn Gly Val Gly Asp Arg Glu Met Arg 1 5 10 15 His Asn Leu Asp Trp Phe Asp Pro Cys Thr Ser His His Asp Tyr Phe 20 25 30 Ile Lys Trp Asn Ser Asn Ile Val Val Val Gly Val Asp Asp Ile Pro 35 40 45 Leu Arg Val His Met Asn Asn Glu Lys Asn Gly Leu Pro Tyr Phe Asn 50 55 60 Lys Gly Gln Gly Leu Tyr Val Ser Tyr Trp Asp Gly Ser Ser Trp Ala 65 70 75 80 Thr Gln Gly Gly Arg Ile Lys Ile Asp Tyr Ala Met Asn Ala Pro Phe 85 90 95 Ile Ala Asn Leu Asn Gly Phe His His Met Ser Ala Cys Gln Val Pro 100 105 110 Ser Glu Arg Asp Leu Gly Ser Cys Lys Tyr Pro Ala Val Gly Ser Met 115 120 125 Leu Gly Gln Gly Ile 130 21 575 DNA Physcomitrella patens CDS (2)..(394) 18_ppprot1_055_c09 21 t gtt cct ggt gga cgg gcc gtc gtg cgg gtg ttc aag aac ctg gaa gga 49 Val Pro Gly Gly Arg Ala Val Val Arg Val Phe Lys Asn Leu Glu Gly 1 5 10 15 caa gtg ccg ggg ttc aag tac ctg aag gat cag gcg atg atg gtg tac 97 Gln Val Pro Gly Phe Lys Tyr Leu Lys Asp Gln Ala Met Met Val Tyr 20 25 30 gtg agc atc tgg gac ggc agc cag tgg gct act cag gga ggg agg gtg 145 Val Ser Ile Trp Asp Gly Ser Gln Trp Ala Thr Gln Gly Gly Arg Val 35 40 45 aag atc aac tat gac tcg gct ccc ttc gtg gcg cac tac gac tac ttc 193 Lys Ile Asn Tyr Asp Ser Ala Pro Phe Val Ala His Tyr Asp Tyr Phe 50 55 60 ggg ctg aat ggg tgc acg gtg gac ccg aat gat gga gcg aat gga gtg 241 Gly Leu Asn Gly Cys Thr Val Asp Pro Asn Asp Gly Ala Asn Gly Val 65 70 75 80 gca gcg tgc cag tac agt ccg tat gcg acg gga cag aac aat ggg aac 289 Ala Ala Cys Gln Tyr Ser Pro Tyr Ala Thr Gly Gln Asn Asn Gly Asn 85 90 95 agc aac cca cag ccc tcg aca acg acg acg atg ctg tac gac tac tgc 337 Ser Asn Pro Gln Pro Ser Thr Thr Thr Thr Met Leu Tyr Asp Tyr Cys 100 105 110 tat gac acg aac agg aac ccg acg ccg cca cca gaa tgc gcg tac aac 385 Tyr Asp Thr Asn Arg Asn Pro Thr Pro Pro Pro Glu Cys Ala Tyr Asn 115 120 125 aag gta gag tagagtagag gagtgcagat cagagcagcc catgtgggga 434 Lys Val Glu 130 ttggggattc ttcgatgagt gggcgtaggg gggcagcatt tgcagagtag ggcggaggag 494 ttgtaagtgt gtggaattgg ggagtgtatt gatacattgt tcttgaataa aagtggaacc 554 gttggggctg caaaaaaaaa a 575 22 131 PRT Physcomitrella patens 22 Val Pro Gly Gly Arg Ala Val Val Arg Val Phe Lys Asn Leu Glu Gly 1 5 10 15 Gln Val Pro Gly Phe Lys Tyr Leu Lys Asp Gln Ala Met Met Val Tyr 20 25 30 Val Ser Ile Trp Asp Gly Ser Gln Trp Ala Thr Gln Gly Gly Arg Val 35 40 45 Lys Ile Asn Tyr Asp Ser Ala Pro Phe Val Ala His Tyr Asp Tyr Phe 50 55 60 Gly Leu Asn Gly Cys Thr Val Asp Pro Asn Asp Gly Ala Asn Gly Val 65 70 75 80 Ala Ala Cys Gln Tyr Ser Pro Tyr Ala Thr Gly Gln Asn Asn Gly Asn 85 90 95 Ser Asn Pro Gln Pro Ser Thr Thr Thr Thr Met Leu Tyr Asp Tyr Cys 100 105 110 Tyr Asp Thr Asn Arg Asn Pro Thr Pro Pro Pro Glu Cys Ala Tyr Asn 115 120 125 Lys Val Glu 130 23 612 DNA Physcomitrella patens CDS (3)..(431) 90_ppprot1_056_g12 23 ac ttg tac acc ttc cgg tgg acc aag gac tcg gtg ctg ttc ctg gtg 47 Leu Tyr Thr Phe Arg Trp Thr Lys Asp Ser Val Leu Phe Leu Val 1 5 10 15 gac ggg gcc gtc gtg cgg gtg ttc aag aac ctg gaa gga caa gtg ccg 95 Asp Gly Ala Val Val Arg Val Phe Lys Asn Leu Glu Gly Gln Val Pro 20 25 30 ggg ttc aag tac ctg aag gat cag gcg atg atg gtg tac gtg agc atc 143 Gly Phe Lys Tyr Leu Lys Asp Gln Ala Met Met Val Tyr Val Ser Ile 35 40 45 tgg gac ggc agc cag tgg gct act cag gga ggg agg gtg aag atc aac 191 Trp Asp Gly Ser Gln Trp Ala Thr Gln Gly Gly Arg Val Lys Ile Asn 50 55 60 tat gac tcg gct ccc ttc gtg gcg cac tac gac tac ttc ggg ctg aat 239 Tyr Asp Ser Ala Pro Phe Val Ala His Tyr Asp Tyr Phe Gly Leu Asn 65 70 75 ggg tgc acg gtg gac ccg aat gat gca gcg aat gga gtg gca gcg tgc 287 Gly Cys Thr Val Asp Pro Asn Asp Ala Ala Asn Gly Val Ala Ala Cys 80 85 90 95 cag tac agt ccg tat gcg acg gga cag aac aat ggg aac agc aac cca 335 Gln Tyr Ser Pro Tyr Ala Thr Gly Gln Asn Asn Gly Asn Ser Asn Pro 100 105 110 cag ccc tcg aca acg acg acg atg ctg tac gac tac tgc tat gac acg 383 Gln Pro Ser Thr Thr Thr Thr Met Leu Tyr Asp Tyr Cys Tyr Asp Thr 115 120 125 aac agg aac ccg acg ccg cca cca gaa tgc gcg tac aac aag gta gag 431 Asn Arg Asn Pro Thr Pro Pro Pro Glu Cys Ala Tyr Asn Lys Val Glu 130 135 140 tagagtagag gagtgcagat cagagcagcc catgtgggga ttggggattc ttcgatgagt 491 gggcgtaggg gggcagcatt tgcagagtag ggcggaggag ttgtaagtgt gtggaattgg 551 ggagtgtatt gatacattgt tcttgaataa aagtggaacc gttggggctg caaaaaaaaa 611 a 612 24 143 PRT Physcomitrella patens 24 Leu Tyr Thr Phe Arg Trp Thr Lys Asp Ser Val Leu Phe Leu Val Asp 1 5 10 15 Gly Ala Val Val Arg Val Phe Lys Asn Leu Glu Gly Gln Val Pro Gly 20 25 30 Phe Lys Tyr Leu Lys Asp Gln Ala Met Met Val Tyr Val Ser Ile Trp 35 40 45 Asp Gly Ser Gln Trp Ala Thr Gln Gly Gly Arg Val Lys Ile Asn Tyr 50 55 60 Asp Ser Ala Pro Phe Val Ala His Tyr Asp Tyr Phe Gly Leu Asn Gly 65 70 75 80 Cys Thr Val Asp Pro Asn Asp Ala Ala Asn Gly Val Ala Ala Cys Gln 85 90 95 Tyr Ser Pro Tyr Ala Thr Gly Gln Asn Asn Gly Asn Ser Asn Pro Gln 100 105 110 Pro Ser Thr Thr Thr Thr Met Leu Tyr Asp Tyr Cys Tyr Asp Thr Asn 115 120 125 Arg Asn Pro Thr Pro Pro Pro Glu Cys Ala Tyr Asn Lys Val Glu 130 135 140 25 621 DNA Physcomitrella patens CDS (237)..(620) 37_ppprot1_051_g01 25 cagctttaga ttgcaagagc aggttccctc aggacttcga atctggatcg cgctcacaga 60 aagtccacat gttagttgcc tctcgtagtc gcgctgctta gtttcgacag gtttcaggct 120 cctggaagtc ttttgcaacc aggtttccgg gccagcttga acagcacttg ttcggtactg 180 tttagaagtt gaactttgaa gtgcgcaacg agatagtatt tcgagaagta tcgaca atg 239 Met 1 ggt tcc ttg gga aga caa gga tgt tta ttg gtc ggt gtc ttg ttt tac 287 Gly Ser Leu Gly Arg Gln Gly Cys Leu Leu Val Gly Val Leu Phe Tyr 5 10 15 ttg agc atg gct atc ggc gct caa gct cag agt tac cca gga ctt cag 335 Leu Ser Met Ala Ile Gly Ala Gln Ala Gln Ser Tyr Pro Gly Leu Gln 20 25 30 gct gca ttc aat tct tgg acg ccg aag cag att atc ccg gat aag aat 383 Ala Ala Phe Asn Ser Trp Thr Pro Lys Gln Ile Ile Pro Asp Lys Asn 35 40 45 gga agg aaa gtg caa ctc gtg ctt aac aat tca tct tcg gca tat act 431 Gly Arg Lys Val Gln Leu Val Leu Asn Asn Ser Ser Ser Ala Tyr Thr 50 55 60 65 ggc atg gga tct aag caa tcg tgg ctg ttt ggg ggt atc ggg gcc tgg 479 Gly Met Gly Ser Lys Gln Ser Trp Leu Phe Gly Gly Ile Gly Ala Trp 70 75 80 atc aag ctc ccc gct aac gat tcc gct gga act gtc acc aca ttc tac 527 Ile Lys Leu Pro Ala Asn Asp Ser Ala Gly Thr Val Thr Thr Phe Tyr 85 90 95 atg tca tct act ggg ccg aag cat tgc gag ttc gac ttc gag ttc cta 575 Met Ser Ser Thr Gly Pro Lys His Cys Glu Phe Asp Phe Glu Phe Leu 100 105 110 ggc aac tcc agc ggc caa cct tac ctt ctc cat acc aac atc ttc g 621 Gly Asn Ser Ser Gly Gln Pro Tyr Leu Leu His Thr Asn Ile Phe 115 120 125 26 128 PRT Physcomitrella patens 26 Met Gly Ser Leu Gly Arg Gln Gly Cys Leu Leu Val Gly Val Leu Phe 1 5 10 15 Tyr Leu Ser Met Ala Ile Gly Ala Gln Ala Gln Ser Tyr Pro Gly Leu 20 25 30 Gln Ala Ala Phe Asn Ser Trp Thr Pro Lys Gln Ile Ile Pro Asp Lys 35 40 45 Asn Gly Arg Lys Val Gln Leu Val Leu Asn Asn Ser Ser Ser Ala Tyr 50 55 60 Thr Gly Met Gly Ser Lys Gln Ser Trp Leu Phe Gly Gly Ile Gly Ala 65 70 75 80 Trp Ile Lys Leu Pro Ala Asn Asp Ser Ala Gly Thr Val Thr Thr Phe 85 90 95 Tyr Met Ser Ser Thr Gly Pro Lys His Cys Glu Phe Asp Phe Glu Phe 100 105 110 Leu Gly Asn Ser Ser Gly Gln Pro Tyr Leu Leu His Thr Asn Ile Phe 115 120 125 27 570 DNA Physcomitrella patens CDS (102)..(569) 35_mm14_f03rev 27 atttgatcgc aacgatttca cctagagcgg tggagtgatt ttcagctgct gcctgatagg 60 aaggattgtc taacgggatt gggggaacgt gcaatctagc a atg ggg tcg ctc ggg 116 Met Gly Ser Leu Gly 1 5 ggt tcg cgt agc acc ctg ctg att ttg ctg cta ctg tgt ttg agc ttg 164 Gly Ser Arg Ser Thr Leu Leu Ile Leu Leu Leu Leu Cys Leu Ser Leu 10 15 20 gct gtt ggc ggt cgc gcc caa acg ctt gct cag cag ttc act ccg tgg 212 Ala Val Gly Gly Arg Ala Gln Thr Leu Ala Gln Gln Phe Thr Pro Trp 25 30 35 act gaa aat gcg agg ttc act act gac act caa atg cag ctc acc ttg 260 Thr Glu Asn Ala Arg Phe Thr Thr Asp Thr Gln Met Gln Leu Thr Leu 40 45 50 gat caa cgc tat gca gct ggg gca gga tcc gtg aac gtt tgg acg tac 308 Asp Gln Arg Tyr Ala Ala Gly Ala Gly Ser Val Asn Val Trp Thr Tyr 55 60 65 gtc gac atc agc gcg tac ata aag atg ccg cca ttc gat tcc gct ggt 356 Val Asp Ile Ser Ala Tyr Ile Lys Met Pro Pro Phe Asp Ser Ala Gly 70 75 80 85 act gtg aca acg ttc tac atg tcg tct cag ggt gac cag cat tac gag 404 Thr Val Thr Thr Phe Tyr Met Ser Ser Gln Gly Asp Gln His Tyr Glu 90 95 100 ctg gac atg gag ttt ttg gga aac act agc gga cag ccc ttc ctg ctt 452 Leu Asp Met Glu Phe Leu Gly Asn Thr Ser Gly Gln Pro Phe Leu Leu 105 110 115 cac acg aat gtg ttc gtt gat ggg gtt ggg ggt cgc gag cag caa atg 500 His Thr Asn Val Phe Val Asp Gly Val Gly Gly Arg Glu Gln Gln Met 120 125 130 tac ctg gga ttc gac ccc tct gct gac ttc cac tac tac aga ttc cgg 548 Tyr Leu Gly Phe Asp Pro Ser Ala Asp Phe His Tyr Tyr Arg Phe Arg 135 140 145 tgg agt aag gat atg gtt gtt t 570 Trp Ser Lys Asp Met Val Val 150 155 28 156 PRT Physcomitrella patens 28 Met Gly Ser Leu Gly Gly Ser Arg Ser Thr Leu Leu Ile Leu Leu Leu 1 5 10 15 Leu Cys Leu Ser Leu Ala Val Gly Gly Arg Ala Gln Thr Leu Ala Gln 20 25 30 Gln Phe Thr Pro Trp Thr Glu Asn Ala Arg Phe Thr Thr Asp Thr Gln 35 40 45 Met Gln Leu Thr Leu Asp Gln Arg Tyr Ala Ala Gly Ala Gly Ser Val 50 55 60 Asn Val Trp Thr Tyr Val Asp Ile Ser Ala Tyr Ile Lys Met Pro Pro 65 70 75 80 Phe Asp Ser Ala Gly Thr Val Thr Thr Phe Tyr Met Ser Ser Gln Gly 85 90 95 Asp Gln His Tyr Glu Leu Asp Met Glu Phe Leu Gly Asn Thr Ser Gly 100 105 110 Gln Pro Phe Leu Leu His Thr Asn Val Phe Val Asp Gly Val Gly Gly 115 120 125 Arg Glu Gln Gln Met Tyr Leu Gly Phe Asp Pro Ser Ala Asp Phe His 130 135 140 Tyr Tyr Arg Phe Arg Trp Ser Lys Asp Met Val Val 145 150 155 29 597 DNA Physcomitrella patens CDS (1)..(432) 96_ppprot1_081_h12 29 tac tac aga ttc cgg tgg agt aag gat atg gtt gtt ttc tac gtc gat 48 Tyr Tyr Arg Phe Arg Trp Ser Lys Asp Met Val Val Phe Tyr Val Asp 1 5 10 15 aac aaa ccc gtc cga gtt ttc aag aat ctg gaa ggc acg gta ccg ggg 96 Asn Lys Pro Val Arg Val Phe Lys Asn Leu Glu Gly Thr Val Pro Gly 20 25 30 act aaa tac ctg aac cag caa gca atg ggg gtg tac ata agc atc tgg 144 Thr Lys Tyr Leu Asn Gln Gln Ala Met Gly Val Tyr Ile Ser Ile Trp 35 40 45 gac ggt agc agt tgg gcc acg caa gga ggg cgt gtg ccc atc aac tgg 192 Asp Gly Ser Ser Trp Ala Thr Gln Gly Gly Arg Val Pro Ile Asn Trp 50 55 60 gct tcc gct cca ttc act gcg acg tac cag gac ttc gca ctg aat ggg 240 Ala Ser Ala Pro Phe Thr Ala Thr Tyr Gln Asp Phe Ala Leu Asn Gly 65 70 75 80 tgc gtg gta gac ccc aac gat ccc aat gga gtt gca gca tgc cag aac 288 Cys Val Val Asp Pro Asn Asp Pro Asn Gly Val Ala Ala Cys Gln Asn 85 90 95 tct ccg tat gca acc gga gca gcc ttg agc aat cag gaa gtt tat gag 336 Ser Pro Tyr Ala Thr Gly Ala Ala Leu Ser Asn Gln Glu Val Tyr Glu 100 105 110 ttg ggg cag aac aaa gct tac atg atg aaa tac gac tac tgc gac gac 384 Leu Gly Gln Asn Lys Ala Tyr Met Met Lys Tyr Asp Tyr Cys Asp Asp 115 120 125 agg gtt cga tac cca gat gtg cca cct gaa tgt cct tac aac aac gtg 432 Arg Val Arg Tyr Pro Asp Val Pro Pro Glu Cys Pro Tyr Asn Asn Val 130 135 140 tagaatacgg aatgagtcgt gtacatgtta cgtgctagct atttggggcg tggttgccta 492 gtgaagatat agttgcgtag aggtcatctg attcttttgt atattaattg tacgcggatg 552 tcgattcttg aaaggaagat ttggttgtag ctcatattat taaaa 597 30 144 PRT Physcomitrella patens 30 Tyr Tyr Arg Phe Arg Trp Ser Lys Asp Met Val Val Phe Tyr Val Asp 1 5 10 15 Asn Lys Pro Val Arg Val Phe Lys Asn Leu Glu Gly Thr Val Pro Gly 20 25 30 Thr Lys Tyr Leu Asn Gln Gln Ala Met Gly Val Tyr Ile Ser Ile Trp 35 40 45 Asp Gly Ser Ser Trp Ala Thr Gln Gly Gly Arg Val Pro Ile Asn Trp 50 55 60 Ala Ser Ala Pro Phe Thr Ala Thr Tyr Gln Asp Phe Ala Leu Asn Gly 65 70 75 80 Cys Val Val Asp Pro Asn Asp Pro Asn Gly Val Ala Ala Cys Gln Asn 85 90 95 Ser Pro Tyr Ala Thr Gly Ala Ala Leu Ser Asn Gln Glu Val Tyr Glu 100 105 110 Leu Gly Gln Asn Lys Ala Tyr Met Met Lys Tyr Asp Tyr Cys Asp Asp 115 120 125 Arg Val Arg Tyr Pro Asp Val Pro Pro Glu Cys Pro Tyr Asn Asn Val 130 135 140 31 570 DNA Physcomitrella patens CDS (2)..(517) 96_ck7_h12fwd 31 g aag cgg tca atg aac aac tcc ggg acg ccg atg cgg cct ggc gtg gag 49 Lys Arg Ser Met Asn Asn Ser Gly Thr Pro Met Arg Pro Gly Val Glu 1 5 10 15 ttc gac gcc tac att gtg agc ctg tac gac gag aat ttg cgc ccg aca 97 Phe Asp Ala Tyr Ile Val Ser Leu Tyr Asp Glu Asn Leu Arg Pro Thr 20 25 30 ccg ccc gca tcg gcg cag cat tgg ggg cta ttc tac gtg aac ggg acg 145 Pro Pro Ala Ser Ala Gln His Trp Gly Leu Phe Tyr Val Asn Gly Thr 35 40 45 cac aag tac ggg ttt aac tat ttg aat ggg agt gat gtg cct ggc ggc 193 His Lys Tyr Gly Phe Asn Tyr Leu Asn Gly Ser Asp Val Pro Gly Gly 50 55 60 ggt ggt ggc gga ggc ggc ggt aat ggt tcc act cct gga tca cct cct 241 Gly Gly Gly Gly Gly Gly Gly Asn Gly Ser Thr Pro Gly Ser Pro Pro 65 70 75 80 gga agc ggt ggt ggc ggt gga gga ggt agc agt ggt ggc gca atc ccg 289 Gly Ser Gly Gly Gly Gly Gly Gly Gly Ser Ser Gly Gly Ala Ile Pro 85 90 95 ggc cag aaa gtg tgg tgc att gca aag tca agc gct tct aat acc agc 337 Gly Gln Lys Val Trp Cys Ile Ala Lys Ser Ser Ala Ser Asn Thr Ser 100 105 110 ttg ata cag gga att gac tgg gct tgt gga gcg ggg aag gcc aag tgc 385 Leu Ile Gln Gly Ile Asp Trp Ala Cys Gly Ala Gly Lys Ala Lys Cys 115 120 125 gac ccc att caa cgt ggc ggt gac tgt tac ttg ccc gac aca ccc tac 433 Asp Pro Ile Gln Arg Gly Gly Asp Cys Tyr Leu Pro Asp Thr Pro Tyr 130 135 140 tcg cac gcc tcc tat gcg ttt aac atc cac tac cac tgg ttc caa acg 481 Ser His Ala Ser Tyr Ala Phe Asn Ile His Tyr His Trp Phe Gln Thr 145 150 155 160 gat ccc cgg tcg tgt ata ttc ggc gga gac gca gac tgacttatgt 527 Asp Pro Arg Ser Cys Ile Phe Gly Gly Asp Ala Asp 165 170 cgatcccact atggaagctg ctactacgta ccgagtggtg cca 570 32 172 PRT Physcomitrella patens 32 Lys Arg Ser Met Asn Asn Ser Gly Thr Pro Met Arg Pro Gly Val Glu 1 5 10 15 Phe Asp Ala Tyr Ile Val Ser Leu Tyr Asp Glu Asn Leu Arg Pro Thr 20 25 30 Pro Pro Ala Ser Ala Gln His Trp Gly Leu Phe Tyr Val Asn Gly Thr 35 40 45 His Lys Tyr Gly Phe Asn Tyr Leu Asn Gly Ser Asp Val Pro Gly Gly 50 55 60 Gly Gly Gly Gly Gly Gly Gly Asn Gly Ser Thr Pro Gly Ser Pro Pro 65 70 75 80 Gly Ser Gly Gly Gly Gly Gly Gly Gly Ser Ser Gly Gly Ala Ile Pro 85 90 95 Gly Gln Lys Val Trp Cys Ile Ala Lys Ser Ser Ala Ser Asn Thr Ser 100 105 110 Leu Ile Gln Gly Ile Asp Trp Ala Cys Gly Ala Gly Lys Ala Lys Cys 115 120 125 Asp Pro Ile Gln Arg Gly Gly Asp Cys Tyr Leu Pro Asp Thr Pro Tyr 130 135 140 Ser His Ala Ser Tyr Ala Phe Asn Ile His Tyr His Trp Phe Gln Thr 145 150 155 160 Asp Pro Arg Ser Cys Ile Phe Gly Gly Asp Ala Asp 165 170 33 553 DNA Physcomitrella patens CDS (3)..(515) 37_mm21_g0lrev 33 gc gcc acc acc aag ggc acc acc atc ctg ggc ggc atc agg caa gtc 47 Ala Thr Thr Lys Gly Thr Thr Ile Leu Gly Gly Ile Arg Gln Val 1 5 10 15 ata ggt cgt aac tct gag gtt gta tac cag ccc aac ccc tct gcc gga 95 Ile Gly Arg Asn Ser Glu Val Val Tyr Gln Pro Asn Pro Ser Ala Gly 20 25 30 tat gct aag ggc aag ggc ttc gag tac gcc att gtc gtt gtt ggt gag 143 Tyr Ala Lys Gly Lys Gly Phe Glu Tyr Ala Ile Val Val Val Gly Glu 35 40 45 caa ccc tac gct gag gtg aac ggt gac aac ctc aac aat ctc aac atg 191 Gln Pro Tyr Ala Glu Val Asn Gly Asp Asn Leu Asn Asn Leu Asn Met 50 55 60 ccg gcg cca tac ccc gcc cta atc aag gat acc tgc tcc aat gtt gcg 239 Pro Ala Pro Tyr Pro Ala Leu Ile Lys Asp Thr Cys Ser Asn Val Ala 65 70 75 tgc gtg gta gtc atg atc tct ggc aga ccg ctt gtg gtt gag ccc tac 287 Cys Val Val Val Met Ile Ser Gly Arg Pro Leu Val Val Glu Pro Tyr 80 85 90 95 ctg ggc tac atg aac gcg ttt gtc gct gca tgg ctt cca gga tct gaa 335 Leu Gly Tyr Met Asn Ala Phe Val Ala Ala Trp Leu Pro Gly Ser Glu 100 105 110 gga cgt gga gtt gcc gaa gtg ctg ttc ggc aac tac gaa ttt tcc ggg 383 Gly Arg Gly Val Ala Glu Val Leu Phe Gly Asn Tyr Glu Phe Ser Gly 115 120 125 agg cta tca agg acg tgg ttc cgg cgc gtc gat cag ctg cct atg aac 431 Arg Leu Ser Arg Thr Trp Phe Arg Arg Val Asp Gln Leu Pro Met Asn 130 135 140 gtt ggc gat cga tac tac aac ccg ttg ttc ccc ttc gga tac ggg atg 479 Val Gly Asp Arg Tyr Tyr Asn Pro Leu Phe Pro Phe Gly Tyr Gly Met 145 150 155 aag atg ggc ctc aaa acg tgc cta gtt cct tcg agt tgaattatgt 525 Lys Met Gly Leu Lys Thr Cys Leu Val Pro Ser Ser 160 165 170 attccctgta gtgtgcaatt gatcgatg 553 34 171 PRT Physcomitrella patens 34 Ala Thr Thr Lys Gly Thr Thr Ile Leu Gly Gly Ile Arg Gln Val Ile 1 5 10 15 Gly Arg Asn Ser Glu Val Val Tyr Gln Pro Asn Pro Ser Ala Gly Tyr 20 25 30 Ala Lys Gly Lys Gly Phe Glu Tyr Ala Ile Val Val Val Gly Glu Gln 35 40 45 Pro Tyr Ala Glu Val Asn Gly Asp Asn Leu Asn Asn Leu Asn Met Pro 50 55 60 Ala Pro Tyr Pro Ala Leu Ile Lys Asp Thr Cys Ser Asn Val Ala Cys 65 70 75 80 Val Val Val Met Ile Ser Gly Arg Pro Leu Val Val Glu Pro Tyr Leu 85 90 95 Gly Tyr Met Asn Ala Phe Val Ala Ala Trp Leu Pro Gly Ser Glu Gly 100 105 110 Arg Gly Val Ala Glu Val Leu Phe Gly Asn Tyr Glu Phe Ser Gly Arg 115 120 125 Leu Ser Arg Thr Trp Phe Arg Arg Val Asp Gln Leu Pro Met Asn Val 130 135 140 Gly Asp Arg Tyr Tyr Asn Pro Leu Phe Pro Phe Gly Tyr Gly Met Lys 145 150 155 160 Met Gly Leu Lys Thr Cys Leu Val Pro Ser Ser 165 170 35 240 DNA Physcomitrella patens CDS (1)..(240) 10_ppprot1_085_b08 35 cgg aca gac tac ccc gtg att gaa aat ata tca att gag aat gtg gtg 48 Arg Thr Asp Tyr Pro Val Ile Glu Asn Ile Ser Ile Glu Asn Val Val 1 5 10 15 ggg gaa aac ata act cat gct ggc cta ttt ctg gga ctt cct gag tct 96 Gly Glu Asn Ile Thr His Ala Gly Leu Phe Leu Gly Leu Pro Glu Ser 20 25 30 ccc ttc cac aac att cac ctg gcc aac ata gct ctt gac gtc aag tct 144 Pro Phe His Asn Ile His Leu Ala Asn Ile Ala Leu Asp Val Lys Ser 35 40 45 gaa tcc gac gac tgg aac tgc tca tca gtc gct gga acc tac ttc ttc 192 Glu Ser Asp Asp Trp Asn Cys Ser Ser Val Ala Gly Thr Tyr Phe Phe 50 55 60 gtt tgg ccc cag cca tgc tca gac ttc act aag gag gag caa aag acc 240 Val Trp Pro Gln Pro Cys Ser Asp Phe Thr Lys Glu Glu Gln Lys Thr 65 70 75 80 36 80 PRT Physcomitrella patens 36 Arg Thr Asp Tyr Pro Val Ile Glu Asn Ile Ser Ile Glu Asn Val Val 1 5 10 15 Gly Glu Asn Ile Thr His Ala Gly Leu Phe Leu Gly Leu Pro Glu Ser 20 25 30 Pro Phe His Asn Ile His Leu Ala Asn Ile Ala Leu Asp Val Lys Ser 35 40 45 Glu Ser Asp Asp Trp Asn Cys Ser Ser Val Ala Gly Thr Tyr Phe Phe 50 55 60 Val Trp Pro Gln Pro Cys Ser Asp Phe Thr Lys Glu Glu Gln Lys Thr 65 70 75 80 37 496 DNA Physcomitrella patens CDS (2)..(496) 16_mm6 37 g gct gac ggg aca cac tgg cct gga aca tgg aat cag tct ggc aaa gag 49 Ala Asp Gly Thr His Trp Pro Gly Thr Trp Asn Gln Ser Gly Lys Glu 1 5 10 15 cat ggt aga gga gac cac gca ggc atc att cag gtg atg ctc gcg cct 97 His Gly Arg Gly Asp His Ala Gly Ile Ile Gln Val Met Leu Ala Pro 20 25 30 ccc act gcc gag cct ctg atg ggc agc agc gac gaa gag aac atc atc 145 Pro Thr Ala Glu Pro Leu Met Gly Ser Ser Asp Glu Glu Asn Ile Ile 35 40 45 gac acc acg gac gtc gat atc cgt ctg ccg atg ctt gtc tac atg tct 193 Asp Thr Thr Asp Val Asp Ile Arg Leu Pro Met Leu Val Tyr Met Ser 50 55 60 cgc gag aag cgc cgg gga tac gat cac aac aaa aag gcc gga gct atg 241 Arg Glu Lys Arg Arg Gly Tyr Asp His Asn Lys Lys Ala Gly Ala Met 65 70 75 80 aat gca ctt gtg cga acg agt gcc gta atg tct aac ggg ccc ttc att 289 Asn Ala Leu Val Arg Thr Ser Ala Val Met Ser Asn Gly Pro Phe Ile 85 90 95 ctc aat ctg gat tgt gat cac tac atc ttc aat tct ctc gct atc cga 337 Leu Asn Leu Asp Cys Asp His Tyr Ile Phe Asn Ser Leu Ala Ile Arg 100 105 110 gag gcc atg tgc ttc ttc atg gac aag ggc ggt gac cgc att gca tac 385 Glu Ala Met Cys Phe Phe Met Asp Lys Gly Gly Asp Arg Ile Ala Tyr 115 120 125 gtg cag ttc cct cag cgt ttt gag ggc gtg gat ccg aac gat cga tac 433 Val Gln Phe Pro Gln Arg Phe Glu Gly Val Asp Pro Asn Asp Arg Tyr 130 135 140 gcc aac cac aac acc gtc ttc ttc gac gtg aat atg agg gct ctg gat 481 Ala Asn His Asn Thr Val Phe Phe Asp Val Asn Met Arg Ala Leu Asp 145 150 155 160 gga ctg caa ggg cct 496 Gly Leu Gln Gly Pro 165 38 165 PRT Physcomitrella patens 38 Ala Asp Gly Thr His Trp Pro Gly Thr Trp Asn Gln Ser Gly Lys Glu 1 5 10 15 His Gly Arg Gly Asp His Ala Gly Ile Ile Gln Val Met Leu Ala Pro 20 25 30 Pro Thr Ala Glu Pro Leu Met Gly Ser Ser Asp Glu Glu Asn Ile Ile 35 40 45 Asp Thr Thr Asp Val Asp Ile Arg Leu Pro Met Leu Val Tyr Met Ser 50 55 60 Arg Glu Lys Arg Arg Gly Tyr Asp His Asn Lys Lys Ala Gly Ala Met 65 70 75 80 Asn Ala Leu Val Arg Thr Ser Ala Val Met Ser Asn Gly Pro Phe Ile 85 90 95 Leu Asn Leu Asp Cys Asp His Tyr Ile Phe Asn Ser Leu Ala Ile Arg 100 105 110 Glu Ala Met Cys Phe Phe Met Asp Lys Gly Gly Asp Arg Ile Ala Tyr 115 120 125 Val Gln Phe Pro Gln Arg Phe Glu Gly Val Asp Pro Asn Asp Arg Tyr 130 135 140 Ala Asn His Asn Thr Val Phe Phe Asp Val Asn Met Arg Ala Leu Asp 145 150 155 160 Gly Leu Gln Gly Pro 165 39 480 DNA Physcomitrella patens CDS (3)..(479) 83_mm10_f06rev 39 gc atc acg ctg gag gaa tgg tgg cga aat gag caa ttc tgg gtg atc 47 Ile Thr Leu Glu Glu Trp Trp Arg Asn Glu Gln Phe Trp Val Ile 1 5 10 15 ggt ggc acg agc gct cac tta gct gcc gtc ttt cag ggt ttc ctg aaa 95 Gly Gly Thr Ser Ala His Leu Ala Ala Val Phe Gln Gly Phe Leu Lys 20 25 30 gtc atc gcc ggg gtc gac atc tcc ttc acg ctt aca tcc aag gca act 143 Val Ile Ala Gly Val Asp Ile Ser Phe Thr Leu Thr Ser Lys Ala Thr 35 40 45 ggg gac gag ggg gat gac gag ttt gcc gat ctg tac gtg gtg aag tgg 191 Gly Asp Glu Gly Asp Asp Glu Phe Ala Asp Leu Tyr Val Val Lys Trp 50 55 60 agc gct ctc atg atc cct ccc atc acc atc atg atc acc aac gta gtg 239 Ser Ala Leu Met Ile Pro Pro Ile Thr Ile Met Ile Thr Asn Val Val 65 70 75 gct att gcg gtg ggc acc tcg cgc cag att tac agc acc atc ccg gag 287 Ala Ile Ala Val Gly Thr Ser Arg Gln Ile Tyr Ser Thr Ile Pro Glu 80 85 90 95 tgg agc aag ctc atc ggc ggc gtc ttc ttc tcc ttg tgg gtg ctc tct 335 Trp Ser Lys Leu Ile Gly Gly Val Phe Phe Ser Leu Trp Val Leu Ser 100 105 110 cat ctc tac ccc ttt gcc aag ggc ctc atg ggc cgc aag ggc aaa act 383 His Leu Tyr Pro Phe Ala Lys Gly Leu Met Gly Arg Lys Gly Lys Thr 115 120 125 ccg acc att atc tac gtg tgg tca ggt ttg ctc tcc gtc atc atc tcc 431 Pro Thr Ile Ile Tyr Val Trp Ser Gly Leu Leu Ser Val Ile Ile Ser 130 135 140 ctc atg tgg gtg tat ata aat ccg cct tca gga act tct gtc act ggg g 480 Leu Met Trp Val Tyr Ile Asn Pro Pro Ser Gly Thr Ser Val Thr Gly 145 150 155 40 159 PRT Physcomitrella patens 40 Ile Thr Leu Glu Glu Trp Trp Arg Asn Glu Gln Phe Trp Val Ile Gly 1 5 10 15 Gly Thr Ser Ala His Leu Ala Ala Val Phe Gln Gly Phe Leu Lys Val 20 25 30 Ile Ala Gly Val Asp Ile Ser Phe Thr Leu Thr Ser Lys Ala Thr Gly 35 40 45 Asp Glu Gly Asp Asp Glu Phe Ala Asp Leu Tyr Val Val Lys Trp Ser 50 55 60 Ala Leu Met Ile Pro Pro Ile Thr Ile Met Ile Thr Asn Val Val Ala 65 70 75 80 Ile Ala Val Gly Thr Ser Arg Gln Ile Tyr Ser Thr Ile Pro Glu Trp 85 90 95 Ser Lys Leu Ile Gly Gly Val Phe Phe Ser Leu Trp Val Leu Ser His 100 105 110 Leu Tyr Pro Phe Ala Lys Gly Leu Met Gly Arg Lys Gly Lys Thr Pro 115 120 125 Thr Ile Ile Tyr Val Trp Ser Gly Leu Leu Ser Val Ile Ile Ser Leu 130 135 140 Met Trp Val Tyr Ile Asn Pro Pro Ser Gly Thr Ser Val Thr Gly 145 150 155 41 410 DNA Physcomitrella patens CDS (1)..(345) 09_mm10_b02rev 41 atc tac gca gat ctt tac gta gtg aag tgg aca tct ctc atg att cct 48 Ile Tyr Ala Asp Leu Tyr Val Val Lys Trp Thr Ser Leu Met Ile Pro 1 5 10 15 ccc atc act atg ggt ctc acc aac atc atc gcc att gct gta ggc gtc 96 Pro Ile Thr Met Gly Leu Thr Asn Ile Ile Ala Ile Ala Val Gly Val 20 25 30 tcc cga acc atc tac agc gag atc ccc gag tgg agc aag ctc att gga 144 Ser Arg Thr Ile Tyr Ser Glu Ile Pro Glu Trp Ser Lys Leu Ile Gly 35 40 45 ggc gtg ttt ttc tct ctg tgg gtg ttg ttc cat ctc tac ccc ttc gcc 192 Gly Val Phe Phe Ser Leu Trp Val Leu Phe His Leu Tyr Pro Phe Ala 50 55 60 aag ggt ctc atg ggc aag ggg ggc aag acg ccc acc att att tac gtc 240 Lys Gly Leu Met Gly Lys Gly Gly Lys Thr Pro Thr Ile Ile Tyr Val 65 70 75 80 tgg gcc ggt ttg tta tcc gtc atc ata tcc cta ctc tgg ctc tac atc 288 Trp Ala Gly Leu Leu Ser Val Ile Ile Ser Leu Leu Trp Leu Tyr Ile 85 90 95 agt ccc tct gcg aac agg aca gca caa gct ggt gac ggc ggt ggc ttt 336 Ser Pro Ser Ala Asn Arg Thr Ala Gln Ala Gly Asp Gly Gly Gly Phe 100 105 110 cag ttc ccc tgaacactcc aaattggtgt tcatgttacg ccagcacatt 385 Gln Phe Pro 115 cccgatgtgc cgatcaattt tttgc 410 42 115 PRT Physcomitrella patens 42 Ile Tyr Ala Asp Leu Tyr Val Val Lys Trp Thr Ser Leu Met Ile Pro 1 5 10 15 Pro Ile Thr Met Gly Leu Thr Asn Ile Ile Ala Ile Ala Val Gly Val 20 25 30 Ser Arg Thr Ile Tyr Ser Glu Ile Pro Glu Trp Ser Lys Leu Ile Gly 35 40 45 Gly Val Phe Phe Ser Leu Trp Val Leu Phe His Leu Tyr Pro Phe Ala 50 55 60 Lys Gly Leu Met Gly Lys Gly Gly Lys Thr Pro Thr Ile Ile Tyr Val 65 70 75 80 Trp Ala Gly Leu Leu Ser Val Ile Ile Ser Leu Leu Trp Leu Tyr Ile 85 90 95 Ser Pro Ser Ala Asn Arg Thr Ala Gln Ala Gly Asp Gly Gly Gly Phe 100 105 110 Gln Phe Pro 115 43 642 DNA Physcomitrella patens CDS (3)..(521) 67_mm22_d04rev 43 ga cgg ggt gtc tat cca gat ggg ttg ttt aga atg ctg atg gag ttt 47 Arg Gly Val Tyr Pro Asp Gly Leu Phe Arg Met Leu Met Glu Phe 1 5 10 15 cat aaa cgc tat caa aag cac aat atg aaa ttt att att aca gag aac 95 His Lys Arg Tyr Gln Lys His Asn Met Lys Phe Ile Ile Thr Glu Asn 20 25 30 ggt gtg tca gac gcc acc gac tat att cgt cga cca tat ctt att gag 143 Gly Val Ser Asp Ala Thr Asp Tyr Ile Arg Arg Pro Tyr Leu Ile Glu 35 40 45 cat cta ctt gct gtc cga gca gca atg gac cag ggt gtg cgc gtt caa 191 His Leu Leu Ala Val Arg Ala Ala Met Asp Gln Gly Val Arg Val Gln 50 55 60 ggt tac tgc ttc tgg aca atc tca gac aac tgg gaa tgg gcc gat ggg 239 Gly Tyr Cys Phe Trp Thr Ile Ser Asp Asn Trp Glu Trp Ala Asp Gly 65 70 75 tac ggt cca aag ttc ggt ctc tgt gct gtg gat cga cac aag gac ctt 287 Tyr Gly Pro Lys Phe Gly Leu Cys Ala Val Asp Arg His Lys Asp Leu 80 85 90 95 gcg cgt cac ccc cgt cct tcc tat cat ctt tac tct gag gtg tca aaa 335 Ala Arg His Pro Arg Pro Ser Tyr His Leu Tyr Ser Glu Val Ser Lys 100 105 110 act ggg aaa ata acg aag aaa cag agg ctg gct gta tgg gaa gat ctt 383 Thr Gly Lys Ile Thr Lys Lys Gln Arg Leu Ala Val Trp Glu Asp Leu 115 120 125 cag gac caa gct agg cag agc aag atg aga cca ttt tgt cga gaa acc 431 Gln Asp Gln Ala Arg Gln Ser Lys Met Arg Pro Phe Cys Arg Glu Thr 130 135 140 aat gat cag ggc ctc atg ttt gca ggg ggt ctg gat gtg cca atg gat 479 Asn Asp Gln Gly Leu Met Phe Ala Gly Gly Leu Asp Val Pro Met Asp 145 150 155 cga cct tcg ctg ttc gag att ggc gct ttg gaa agt acg agg 521 Arg Pro Ser Leu Phe Glu Ile Gly Ala Leu Glu Ser Thr Arg 160 165 170 tagaaggtct tcaagatccg ttaagctctt ttgttcgtta cttccgtgga gcgaacccct 581 tcaggaagaa gacaaacagc agaagaagtc aatctcgaac ccagcactca ctgcagctta 641 g 642 44 173 PRT Physcomitrella patens 44 Arg Gly Val Tyr Pro Asp Gly Leu Phe Arg Met Leu Met Glu Phe His 1 5 10 15 Lys Arg Tyr Gln Lys His Asn Met Lys Phe Ile Ile Thr Glu Asn Gly 20 25 30 Val Ser Asp Ala Thr Asp Tyr Ile Arg Arg Pro Tyr Leu Ile Glu His 35 40 45 Leu Leu Ala Val Arg Ala Ala Met Asp Gln Gly Val Arg Val Gln Gly 50 55 60 Tyr Cys Phe Trp Thr Ile Ser Asp Asn Trp Glu Trp Ala Asp Gly Tyr 65 70 75 80 Gly Pro Lys Phe Gly Leu Cys Ala Val Asp Arg His Lys Asp Leu Ala 85 90 95 Arg His Pro Arg Pro Ser Tyr His Leu Tyr Ser Glu Val Ser Lys Thr 100 105 110 Gly Lys Ile Thr Lys Lys Gln Arg Leu Ala Val Trp Glu Asp Leu Gln 115 120 125 Asp Gln Ala Arg Gln Ser Lys Met Arg Pro Phe Cys Arg Glu Thr Asn 130 135 140 Asp Gln Gly Leu Met Phe Ala Gly Gly Leu Asp Val Pro Met Asp Arg 145 150 155 160 Pro Ser Leu Phe Glu Ile Gly Ala Leu Glu Ser Thr Arg 165 170 45 564 DNA Physcomitrella patens CDS (1)..(306) 73_ck12_e04fwd 45 att gaa tgg gat aag ggt aaa gct gtg gag ttt ctg ctt aag tct ctt 48 Ile Glu Trp Asp Lys Gly Lys Ala Val Glu Phe Leu Leu Lys Ser Leu 1 5 10 15 ggg ttt caa gat aca kat gat cta att cca cta tat ctt gga gat gat 96 Gly Phe Gln Asp Thr Xaa Asp Leu Ile Pro Leu Tyr Leu Gly Asp Asp 20 25 30 aag act gat gaa gat gca ttc aag gta gtc aat tcg aca aaa tac ggc 144 Lys Thr Asp Glu Asp Ala Phe Lys Val Val Asn Ser Thr Lys Tyr Gly 35 40 45 tgc agt att ttg gtg tct tct gta gcc aaa ccg act gaa gca aaa ttt 192 Cys Ser Ile Leu Val Ser Ser Val Ala Lys Pro Thr Glu Ala Lys Phe 50 55 60 tct ctc cga gat cca tct gag gtc atg ggg ttt tta tgc aag ctt gtg 240 Ser Leu Arg Asp Pro Ser Glu Val Met Gly Phe Leu Cys Lys Leu Val 65 70 75 80 cac tgg gaa aag tgc aga cag gat cct aac agc att tac atg gat cgt 288 His Trp Glu Lys Cys Arg Gln Asp Pro Asn Ser Ile Tyr Met Asp Arg 85 90 95 aac ttc tcc cag ata ccc taagattttt ctaatatctg ggtggttaag 336 Asn Phe Ser Gln Ile Pro 100 ctttgttcct aacctcccgt gtgtataact acctatcgca gttacaataa ccttcaaaca 396 ctcccaccat gtgaaagaag actacctgtc aaaccacctc atttcggtca gaccaaccct 456 tattctgctc attatttcta gtttgccctc tgctaaaaca gtcgattcag ttgacatttg 516 aactgaatcc tcagtaacct tgatggtatg taatcaagaa ggaaatag 564 46 102 PRT Physcomitrella patens VARIANT 22 Amino acid residue 22 may be Asp or Tyr. 46 Ile Glu Trp Asp Lys Gly Lys Ala Val Glu Phe Leu Leu Lys Ser Leu 1 5 10 15 Gly Phe Gln Asp Thr Xaa Asp Leu Ile Pro Leu Tyr Leu Gly Asp Asp 20 25 30 Lys Thr Asp Glu Asp Ala Phe Lys Val Val Asn Ser Thr Lys Tyr Gly 35 40 45 Cys Ser Ile Leu Val Ser Ser Val Ala Lys Pro Thr Glu Ala Lys Phe 50 55 60 Ser Leu Arg Asp Pro Ser Glu Val Met Gly Phe Leu Cys Lys Leu Val 65 70 75 80 His Trp Glu Lys Cys Arg Gln Asp Pro Asn Ser Ile Tyr Met Asp Arg 85 90 95 Asn Phe Ser Gln Ile Pro 100 47 520 DNA Physcomitrella patens CDS (1)..(519) 63_ck23_c05fwd 47 aga gat agt gtg caa ctc gta ttc gat tac ttc tgc gca aga acg cca 48 Arg Asp Ser Val Gln Leu Val Phe Asp Tyr Phe Cys Ala Arg Thr Pro 1 5 10 15 cga tct ttt gta gag aag cga gag aca tct ttg gtt tgg aat tat aaa 96 Arg Ser Phe Val Glu Lys Arg Glu Thr Ser Leu Val Trp Asn Tyr Lys 20 25 30 tat gct gat ttg gag ttt gga agg gtc caa gca cga aac atg ctt caa 144 Tyr Ala Asp Leu Glu Phe Gly Arg Val Gln Ala Arg Asn Met Leu Gln 35 40 45 cat cta tgg aca ggg ccc atc tcc aat gcg gct gtg gat gtc gtt caa 192 His Leu Trp Thr Gly Pro Ile Ser Asn Ala Ala Val Asp Val Val Gln 50 55 60 ggt caa aag tca gtg gag gtc cgt cct att ggt gtt tca aag ggt gca 240 Gly Gln Lys Ser Val Glu Val Arg Pro Ile Gly Val Ser Lys Gly Ala 65 70 75 80 gca atc gat cga att gta ttt gaa att ata cgc agc aag cat ccc agc 288 Ala Ile Asp Arg Ile Val Phe Glu Ile Ile Arg Ser Lys His Pro Ser 85 90 95 agt tca cag aca cca aat att cag ttc gac ttt gtc atg tgc ctg ggc 336 Ser Ser Gln Thr Pro Asn Ile Gln Phe Asp Phe Val Met Cys Leu Gly 100 105 110 cat ttt ttg agc aag gat gag gat gtg tat gct tat ttc gat ccg gat 384 His Phe Leu Ser Lys Asp Glu Asp Val Tyr Ala Tyr Phe Asp Pro Asp 115 120 125 aac gca ttt gat aga gat aat cgg tgc agt aat gga aag ctg gaa agg 432 Asn Ala Phe Asp Arg Asp Asn Arg Cys Ser Asn Gly Lys Leu Glu Arg 130 135 140 aac ctt gat cga cgg ttg tct gca aag tca tgt gat cgt gca tcg gta 480 Asn Leu Asp Arg Arg Leu Ser Ala Lys Ser Cys Asp Arg Ala Ser Val 145 150 155 160 aag aat aat aaa tcg agc gtg gtt cga acg aag act tac c 520 Lys Asn Asn Lys Ser Ser Val Val Arg Thr Lys Thr Tyr 165 170 48 173 PRT Physcomitrella patens 48 Arg Asp Ser Val Gln Leu Val Phe Asp Tyr Phe Cys Ala Arg Thr Pro 1 5 10 15 Arg Ser Phe Val Glu Lys Arg Glu Thr Ser Leu Val Trp Asn Tyr Lys 20 25 30 Tyr Ala Asp Leu Glu Phe Gly Arg Val Gln Ala Arg Asn Met Leu Gln 35 40 45 His Leu Trp Thr Gly Pro Ile Ser Asn Ala Ala Val Asp Val Val Gln 50 55 60 Gly Gln Lys Ser Val Glu Val Arg Pro Ile Gly Val Ser Lys Gly Ala 65 70 75 80 Ala Ile Asp Arg Ile Val Phe Glu Ile Ile Arg Ser Lys His Pro Ser 85 90 95 Ser Ser Gln Thr Pro Asn Ile Gln Phe Asp Phe Val Met Cys Leu Gly 100 105 110 His Phe Leu Ser Lys Asp Glu Asp Val Tyr Ala Tyr Phe Asp Pro Asp 115 120 125 Asn Ala Phe Asp Arg Asp Asn Arg Cys Ser Asn Gly Lys Leu Glu Arg 130 135 140 Asn Leu Asp Arg Arg Leu Ser Ala Lys Ser Cys Asp Arg Ala Ser Val 145 150 155 160 Lys Asn Asn Lys Ser Ser Val Val Arg Thr Lys Thr Tyr 165 170 49 541 DNA Physcomitrella patens CDS (3)..(539) 80_ck30_f10fwd 49 gg ttc gga tta ggt ttc cgg atc gta gct ctg gat ccg agc ttt aag 47 Phe Gly Leu Gly Phe Arg Ile Val Ala Leu Asp Pro Ser Phe Lys 1 5 10 15 aag ttg cgc acc gaa ctt att gtc gga gca tac ggg aag agt gcc acc 95 Lys Leu Arg Thr Glu Leu Ile Val Gly Ala Tyr Gly Lys Ser Ala Thr 20 25 30 aga gcc tta ctt ttg gat tat gat ggt aca gtg atg cct aca tca cac 143 Arg Ala Leu Leu Leu Asp Tyr Asp Gly Thr Val Met Pro Thr Ser His 35 40 45 gaa gag agt cct agt ccc gag gtt ttg gat ctt tta aat acg ctt tgc 191 Glu Glu Ser Pro Ser Pro Glu Val Leu Asp Leu Leu Asn Thr Leu Cys 50 55 60 aac gac cca aag aac aca ctt ttc atc gta agt ggg cgt cca cgg aat 239 Asn Asp Pro Lys Asn Thr Leu Phe Ile Val Ser Gly Arg Pro Arg Asn 65 70 75 aag ctt ggg gaa tgg ttt agt tcc tgc gag tta ctt ggt ctt gct gct 287 Lys Leu Gly Glu Trp Phe Ser Ser Cys Glu Leu Leu Gly Leu Ala Ala 80 85 90 95 gaa cat gga tac ttt tac agg tgg cga cgg gac tcg gat tgg gat act 335 Glu His Gly Tyr Phe Tyr Arg Trp Arg Arg Asp Ser Asp Trp Asp Thr 100 105 110 tgt aga cca caa agt gtt tca gag tgg gat cgg ttg agt gtt gtt gag 383 Cys Arg Pro Gln Ser Val Ser Glu Trp Asp Arg Leu Ser Val Val Glu 115 120 125 cgt gaa gcg ccg tcc acg agc ttt gat tgg aaa ctg att gca ggg cca 431 Arg Glu Ala Pro Ser Thr Ser Phe Asp Trp Lys Leu Ile Ala Gly Pro 130 135 140 gtc atg caa ctt tac acc gag tca aca gat ggc tcc tat att gag gcc 479 Val Met Gln Leu Tyr Thr Glu Ser Thr Asp Gly Ser Tyr Ile Glu Ala 145 150 155 aaa gaa agt gca ttg gtg tgg cat tat cga gat gca gac cat gac ttt 527 Lys Glu Ser Ala Leu Val Trp His Tyr Arg Asp Ala Asp His Asp Phe 160 165 170 175 gga gct tgg cag gc 541 Gly Ala Trp Gln 50 179 PRT Physcomitrella patens 50 Phe Gly Leu Gly Phe Arg Ile Val Ala Leu Asp Pro Ser Phe Lys Lys 1 5 10 15 Leu Arg Thr Glu Leu Ile Val Gly Ala Tyr Gly Lys Ser Ala Thr Arg 20 25 30 Ala Leu Leu Leu Asp Tyr Asp Gly Thr Val Met Pro Thr Ser His Glu 35 40 45 Glu Ser Pro Ser Pro Glu Val Leu Asp Leu Leu Asn Thr Leu Cys Asn 50 55 60 Asp Pro Lys Asn Thr Leu Phe Ile Val Ser Gly Arg Pro Arg Asn Lys 65 70 75 80 Leu Gly Glu Trp Phe Ser Ser Cys Glu Leu Leu Gly Leu Ala Ala Glu 85 90 95 His Gly Tyr Phe Tyr Arg Trp Arg Arg Asp Ser Asp Trp Asp Thr Cys 100 105 110 Arg Pro Gln Ser Val Ser Glu Trp Asp Arg Leu Ser Val Val Glu Arg 115 120 125 Glu Ala Pro Ser Thr Ser Phe Asp Trp Lys Leu Ile Ala Gly Pro Val 130 135 140 Met Gln Leu Tyr Thr Glu Ser Thr Asp Gly Ser Tyr Ile Glu Ala Lys 145 150 155 160 Glu Ser Ala Leu Val Trp His Tyr Arg Asp Ala Asp His Asp Phe Gly 165 170 175 Ala Trp Gln 51 473 DNA Physcomitrella patens CDS (187)..(471) 46_ck2_h08fwd 51 cagccatcga atgctcatcg gctctgctcg attcctttag agcttaatcg cggatcggcg 60 gcggcagcag cagcagcacc gagtgcagcg agcccatcca tctcgttgca acgcaggaac 120 tggagcactc cgagtcgtag cgatttcgag agcttcgttg cgcgcgagtg cttgtgttcg 180 ggagca atg gca ttg gct gcg tgc agg gct gcg cac tcc gtt gcg ggg 228 Met Ala Leu Ala Ala Cys Arg Ala Ala His Ser Val Ala Gly 1 5 10 gct tcg ccg tcg tct ctc gct gct gct gct gcc aaa ccc tct tcg tcg 276 Ala Ser Pro Ser Ser Leu Ala Ala Ala Ala Ala Lys Pro Ser Ser Ser 15 20 25 30 ctc gcg cgc ccc caa ttc gct gga ctg cgc cgt gct gat gtc gcc aac 324 Leu Ala Arg Pro Gln Phe Ala Gly Leu Arg Arg Ala Asp Val Ala Asn 35 40 45 gag tca tcg ttc ggg gca gtc ttg tct caa cgg ttg cag agt gcg ggt 372 Glu Ser Ser Phe Gly Ala Val Leu Ser Gln Arg Leu Gln Ser Ala Gly 50 55 60 aca ggg agc agg gga gtc gtc tcc atg gct gga act gga aag ttc ttc 420 Thr Gly Ser Arg Gly Val Val Ser Met Ala Gly Thr Gly Lys Phe Phe 65 70 75 gtc ggg ggc aac tgg aag tgc aat ggc acg act gag agc att aag aag 468 Val Gly Gly Asn Trp Lys Cys Asn Gly Thr Thr Glu Ser Ile Lys Lys 80 85 90 ctt gt 473 Leu 95 52 95 PRT Physcomitrella patens 52 Met Ala Leu Ala Ala Cys Arg Ala Ala His Ser Val Ala Gly Ala Ser 1 5 10 15 Pro Ser Ser Leu Ala Ala Ala Ala Ala Lys Pro Ser Ser Ser Leu Ala 20 25 30 Arg Pro Gln Phe Ala Gly Leu Arg Arg Ala Asp Val Ala Asn Glu Ser 35 40 45 Ser Phe Gly Ala Val Leu Ser Gln Arg Leu Gln Ser Ala Gly Thr Gly 50 55 60 Ser Arg Gly Val Val Ser Met Ala Gly Thr Gly Lys Phe Phe Val Gly 65 70 75 80 Gly Asn Trp Lys Cys Asn Gly Thr Thr Glu Ser Ile Lys Lys Leu 85 90 95 53 367 DNA Physcomitrella patens CDS (1)..(366) 83_bd06_f06rev 53 tgc cga ctc aga tca gct atc gct gct tct ttt tct gct ccc ctc gcg 48 Cys Arg Leu Arg Ser Ala Ile Ala Ala Ser Phe Ser Ala Pro Leu Ala 1 5 10 15 tct gcc cct gcc ttc tcc ggc ctc cgt cgc ctc cct ctt gct ccc gct 96 Ser Ala Pro Ala Phe Ser Gly Leu Arg Arg Leu Pro Leu Ala Pro Ala 20 25 30 tcg tct ccc gct ttc ggt gtc gtc ttc tct ttg agt gag ggg aag ggg 144 Ser Ser Pro Ala Phe Gly Val Val Phe Ser Leu Ser Glu Gly Lys Gly 35 40 45 cac aga ggt gtc gtc acc atg act ggg gcc ggg aag ttt ttc gtt ggc 192 His Arg Gly Val Val Thr Met Thr Gly Ala Gly Lys Phe Phe Val Gly 50 55 60 ggg aac tgg aag tgc aat ggc aca act gag tcg atc aag aag ctc gtg 240 Gly Asn Trp Lys Cys Asn Gly Thr Thr Glu Ser Ile Lys Lys Leu Val 65 70 75 80 gag gat ttg aac agt gcc caa att gag gac gac gtt gat gtc gtc gtc 288 Glu Asp Leu Asn Ser Ala Gln Ile Glu Asp Asp Val Asp Val Val Val 85 90 95 gct ccc ccg ttt ttg tat atc agc cag gtg gtc ggg tct ttg acg gac 336 Ala Pro Pro Phe Leu Tyr Ile Ser Gln Val Val Gly Ser Leu Thr Asp 100 105 110 cgc att gag gtc tcc gct cag aac tct tgg g 367 Arg Ile Glu Val Ser Ala Gln Asn Ser Trp 115 120 54 122 PRT Physcomitrella patens 54 Cys Arg Leu Arg Ser Ala Ile Ala Ala Ser Phe Ser Ala Pro Leu Ala 1 5 10 15 Ser Ala Pro Ala Phe Ser Gly Leu Arg Arg Leu Pro Leu Ala Pro Ala 20 25 30 Ser Ser Pro Ala Phe Gly Val Val Phe Ser Leu Ser Glu Gly Lys Gly 35 40 45 His Arg Gly Val Val Thr Met Thr Gly Ala Gly Lys Phe Phe Val Gly 50 55 60 Gly Asn Trp Lys Cys Asn Gly Thr Thr Glu Ser Ile Lys Lys Leu Val 65 70 75 80 Glu Asp Leu Asn Ser Ala Gln Ile Glu Asp Asp Val Asp Val Val Val 85 90 95 Ala Pro Pro Phe Leu Tyr Ile Ser Gln Val Val Gly Ser Leu Thr Asp 100 105 110 Arg Ile Glu Val Ser Ala Gln Asn Ser Trp 115 120 55 333 DNA Physcomitrella patens CDS (1)..(333) 19_ck1_d01fwd 55 ctt gca gct gtg ggc acc acc gat ttc ggt ggg ttc acg gtg gaa gta 48 Leu Ala Ala Val Gly Thr Thr Asp Phe Gly Gly Phe Thr Val Glu Val 1 5 10 15 att gac cct gtg gag gat tat cta gaa ttg ctg aag gaa gta ttc gac 96 Ile Asp Pro Val Glu Asp Tyr Leu Glu Leu Leu Lys Glu Val Phe Asp 20 25 30 ttt gac ttg atc cgc agt ctc ctt gcc agg ccg aac ttc agg ttt aag 144 Phe Asp Leu Ile Arg Ser Leu Leu Ala Arg Pro Asn Phe Arg Phe Lys 35 40 45 ttt gac gcc atg cac gct gtg act ggc gcc tac gcc aag act atc ttt 192 Phe Asp Ala Met His Ala Val Thr Gly Ala Tyr Ala Lys Thr Ile Phe 50 55 60 gtc gat acc ttg ggc gca tca gaa gac tcc att att aac ggc att ccc 240 Val Asp Thr Leu Gly Ala Ser Glu Asp Ser Ile Ile Asn Gly Ile Pro 65 70 75 80 aag gac gat ttc gga ggg ggc cac ccc gat ccc aac ctg acg tac gcc 288 Lys Asp Asp Phe Gly Gly Gly His Pro Asp Pro Asn Leu Thr Tyr Ala 85 90 95 cac gag ctc gtt gat atc atg tat ggc ccc gat gct cct ggt ttt 333 His Glu Leu Val Asp Ile Met Tyr Gly Pro Asp Ala Pro Gly Phe 100 105 110 56 111 PRT Physcomitrella patens 56 Leu Ala Ala Val Gly Thr Thr Asp Phe Gly Gly Phe Thr Val Glu Val 1 5 10 15 Ile Asp Pro Val Glu Asp Tyr Leu Glu Leu Leu Lys Glu Val Phe Asp 20 25 30 Phe Asp Leu Ile Arg Ser Leu Leu Ala Arg Pro Asn Phe Arg Phe Lys 35 40 45 Phe Asp Ala Met His Ala Val Thr Gly Ala Tyr Ala Lys Thr Ile Phe 50 55 60 Val Asp Thr Leu Gly Ala Ser Glu Asp Ser Ile Ile Asn Gly Ile Pro 65 70 75 80 Lys Asp Asp Phe Gly Gly Gly His Pro Asp Pro Asn Leu Thr Tyr Ala 85 90 95 His Glu Leu Val Asp Ile Met Tyr Gly Pro Asp Ala Pro Gly Phe 100 105 110 57 212 DNA Physcomitrella patens CDS (1)..(210) ll_ck_19_b03 57 ctt cat cct atg act gct aat cgc tcc aat cga gcg atc agg aaa ggt 48 Leu His Pro Met Thr Ala Asn Arg Ser Asn Arg Ala Ile Arg Lys Gly 1 5 10 15 gtc act tca cct agg ttg cat tgc acc act tgc caa gcc aga gat atg 96 Val Thr Ser Pro Arg Leu His Cys Thr Thr Cys Gln Ala Arg Asp Met 20 25 30 gac gac ttg gtg gta tgc ttt gga gag ctc ctg ata gat ttt gtg ccc 144 Asp Asp Leu Val Val Cys Phe Gly Glu Leu Leu Ile Asp Phe Val Pro 35 40 45 act gtg ggc ggt cta tcg ctt gct gaa gct ccc gca ttc aag aaa gcg 192 Thr Val Gly Gly Leu Ser Leu Ala Glu Ala Pro Ala Phe Lys Lys Ala 50 55 60 cct gga ggt gca cct gcc aa 212 Pro Gly Gly Ala Pro Ala 65 70 58 70 PRT Physcomitrella patens 58 Leu His Pro Met Thr Ala Asn Arg Ser Asn Arg Ala Ile Arg Lys Gly 1 5 10 15 Val Thr Ser Pro Arg Leu His Cys Thr Thr Cys Gln Ala Arg Asp Met 20 25 30 Asp Asp Leu Val Val Cys Phe Gly Glu Leu Leu Ile Asp Phe Val Pro 35 40 45 Thr Val Gly Gly Leu Ser Leu Ala Glu Ala Pro Ala Phe Lys Lys Ala 50 55 60 Pro Gly Gly Ala Pro Ala 65 70 59 677 DNA Physcomitrella patens CDS (2)..(394) 56_ppprot1_061_bl0 59 a aaa cac cac att gga att cga aag att gta gtg gag gtt tgc gat gtg 49 Lys His His Ile Gly Ile Arg Lys Ile Val Val Glu Val Cys Asp Val 1 5 10 15 gtg tgt aag aga ggt gct aga ctg gca ggt gcg gga att gta gga ata 97 Val Cys Lys Arg Gly Ala Arg Leu Ala Gly Ala Gly Ile Val Gly Ile 20 25 30 ttg aag aaa att gga agg gat gga agt gcg gcg aat ggg gtt atc aag 145 Leu Lys Lys Ile Gly Arg Asp Gly Ser Ala Ala Asn Gly Val Ile Lys 35 40 45 cgt aac ctg ttt gaa cag agt gac atg aat ggt tac cat gac gac gac 193 Arg Asn Leu Phe Glu Gln Ser Asp Met Asn Gly Tyr His Asp Asp Asp 50 55 60 cct atg caa tat aca tca gac gtg aaa acc gtt gtt gct ata gac ggt 241 Pro Met Gln Tyr Thr Ser Asp Val Lys Thr Val Val Ala Ile Asp Gly 65 70 75 80 ggt ttg tat gaa cac tac acc aag ttc cga gaa tac atg caa gat gct 289 Gly Leu Tyr Glu His Tyr Thr Lys Phe Arg Glu Tyr Met Gln Asp Ala 85 90 95 gtg ttt gaa ctt ctt gga gaa gca tca aag aat gtc tcc ata cag ctt 337 Val Phe Glu Leu Leu Gly Glu Ala Ser Lys Asn Val Ser Ile Gln Leu 100 105 110 tcc aaa gat gga tca ggc att gga gca gcc ctt ctt gct gca tcg cat 385 Ser Lys Asp Gly Ser Gly Ile Gly Ala Ala Leu Leu Ala Ala Ser His 115 120 125 gcc gag cat ctttcttctt gataacgatg aaaccaacta cagtcttgtg 434 Ala Glu His 130 aaatatgagt ctttgctgat tgaaacctct tagttctaat gttagaaatg tgtataccaa 494 tccgtcaagg gggtgcgagt tagcttcctt tggagccctt ggtttatcgg ctcgccattt 554 ctgtagaaag gttcgctttt tttaatcatt aatcacgcat ctcggcagct catgtttcca 614 agagtaactt gggacaacag atcccctggc tgcatacgta agcttatttg aaaaaaaaaa 674 aaa 677 60 131 PRT Physcomitrella patens 60 Lys His His Ile Gly Ile Arg Lys Ile Val Val Glu Val Cys Asp Val 1 5 10 15 Val Cys Lys Arg Gly Ala Arg Leu Ala Gly Ala Gly Ile Val Gly Ile 20 25 30 Leu Lys Lys Ile Gly Arg Asp Gly Ser Ala Ala Asn Gly Val Ile Lys 35 40 45 Arg Asn Leu Phe Glu Gln Ser Asp Met Asn Gly Tyr His Asp Asp Asp 50 55 60 Pro Met Gln Tyr Thr Ser Asp Val Lys Thr Val Val Ala Ile Asp Gly 65 70 75 80 Gly Leu Tyr Glu His Tyr Thr Lys Phe Arg Glu Tyr Met Gln Asp Ala 85 90 95 Val Phe Glu Leu Leu Gly Glu Ala Ser Lys Asn Val Ser Ile Gln Leu 100 105 110 Ser Lys Asp Gly Ser Gly Ile Gly Ala Ala Leu Leu Ala Ala Ser His 115 120 125 Ala Glu His 130 61 630 DNA Physcomitrella patens CDS (1)..(348) 18_ppprotl_064_c09 61 gac gtt ccg aga tct cgt ttc ctt ccc gtc aaa gct acc tca gat ttg 48 Asp Val Pro Arg Ser Arg Phe Leu Pro Val Lys Ala Thr Ser Asp Leu 1 5 10 15 ctg ttg gtt cag tcg gac ctc tac aca gtt caa gat ggt gca gtg gta 96 Leu Leu Val Gln Ser Asp Leu Tyr Thr Val Gln Asp Gly Ala Val Val 20 25 30 cgg aac cct gcc aga acc aac ccc gaa aac ccc tcc att gat ctc agt 144 Arg Asn Pro Ala Arg Thr Asn Pro Glu Asn Pro Ser Ile Asp Leu Ser 35 40 45 agc gaa ttc aaa aag gtg ggt gat ttc ttg aag cgt ttc aaa tca att 192 Ser Glu Phe Lys Lys Val Gly Asp Phe Leu Lys Arg Phe Lys Ser Ile 50 55 60 ccc agc atc ctt gaa ttg gag agc ttg aag gtt agc gga aac gta tgg 240 Pro Ser Ile Leu Glu Leu Glu Ser Leu Lys Val Ser Gly Asn Val Trp 65 70 75 80 ttc ggc aaa gac att gtc ctc aag ggt aaa gtg gtt gtt gaa gca gct 288 Phe Gly Lys Asp Ile Val Leu Lys Gly Lys Val Val Val Glu Ala Ala 85 90 95 aag gga gag aaa gtg gaa gtg cct gac gaa gct gtt ctt gat aac acg 336 Lys Gly Glu Lys Val Glu Val Pro Asp Glu Ala Val Leu Asp Asn Thr 100 105 110 gtc gtt aag aac tagattattt tatgaagtaa ctgttgctgt aacgtacacc 388 Val Val Lys Asn 115 gacttgtaag ccttccatct gatttaggag atgagctact ccgcaccgct tcagttagtg 448 tagccaagtt cattgtcatg gtggtatccc atccatcaga gattatctct gtttcaatgt 508 gttctgggca tatcatctgg tcaagttgcg atagtgatat gttagatcga catgacgaat 568 tattttgctg gatctgagac tttcttgttg cgctggtttc tattccagaa ataataactt 628 tg 630 62 116 PRT Physcomitrella patens 62 Asp Val Pro Arg Ser Arg Phe Leu Pro Val Lys Ala Thr Ser Asp Leu 1 5 10 15 Leu Leu Val Gln Ser Asp Leu Tyr Thr Val Gln Asp Gly Ala Val Val 20 25 30 Arg Asn Pro Ala Arg Thr Asn Pro Glu Asn Pro Ser Ile Asp Leu Ser 35 40 45 Ser Glu Phe Lys Lys Val Gly Asp Phe Leu Lys Arg Phe Lys Ser Ile 50 55 60 Pro Ser Ile Leu Glu Leu Glu Ser Leu Lys Val Ser Gly Asn Val Trp 65 70 75 80 Phe Gly Lys Asp Ile Val Leu Lys Gly Lys Val Val Val Glu Ala Ala 85 90 95 Lys Gly Glu Lys Val Glu Val Pro Asp Glu Ala Val Leu Asp Asn Thr 100 105 110 Val Val Lys Asn 115 63 496 DNA Physcomitrella patens CDS (2)..(496) 76_ck27_e11fwd 63 c ttt cca cgc atg acg agg ccg cag tct att ggg aat ggt gta caa ttt 49 Phe Pro Arg Met Thr Arg Pro Gln Ser Ile Gly Asn Gly Val Gln Phe 1 5 10 15 ctg aat cgg cac cta tct tcg agg ttg ttt cga gac gca gac agc atg 97 Leu Asn Arg His Leu Ser Ser Arg Leu Phe Arg Asp Ala Asp Ser Met 20 25 30 gaa cca ctt gtc gag ttt atg cgt gtt cat aaa tat aac gat cag act 145 Glu Pro Leu Val Glu Phe Met Arg Val His Lys Tyr Asn Asp Gln Thr 35 40 45 ttg ttg ctg aat gag agt att act aac gtc gtc agg ctt cga cca gct 193 Leu Leu Leu Asn Glu Ser Ile Thr Asn Val Val Arg Leu Arg Pro Ala 50 55 60 ctt ata aaa gcc gaa gaa tat ttg atc aag ctt ccg aac gac caa ccg 241 Leu Ile Lys Ala Glu Glu Tyr Leu Ile Lys Leu Pro Asn Asp Gln Pro 65 70 75 80 tta aag gat ttc tac tcc aag ttg caa gaa ctg ggg ctg gag aga ggc 289 Leu Lys Asp Phe Tyr Ser Lys Leu Gln Glu Leu Gly Leu Glu Arg Gly 85 90 95 tgg ggt gac aca gct gga cgc gtg ttg gaa atg atc cat ttg ctg cta 337 Trp Gly Asp Thr Ala Gly Arg Val Leu Glu Met Ile His Leu Leu Leu 100 105 110 gac ctt ttg caa gct cct gat ccc gac atc tta gag aag ttt ttg gct 385 Asp Leu Leu Gln Ala Pro Asp Pro Asp Ile Leu Glu Lys Phe Leu Ala 115 120 125 cgc ata ccg ata gta ttc agt gtg gcc att att tcg cct cac gga tac 433 Arg Ile Pro Ile Val Phe Ser Val Ala Ile Ile Ser Pro His Gly Tyr 130 135 140 ttc ggg cag tct aac gtt cta gga atg ccc gat acg gga gga caa gtt 481 Phe Gly Gln Ser Asn Val Leu Gly Met Pro Asp Thr Gly Gly Gln Val 145 150 155 160 gta tat ata ttg gac 496 Val Tyr Ile Leu Asp 165 64 165 PRT Physcomitrella patens 64 Phe Pro Arg Met Thr Arg Pro Gln Ser Ile Gly Asn Gly Val Gln Phe 1 5 10 15 Leu Asn Arg His Leu Ser Ser Arg Leu Phe Arg Asp Ala Asp Ser Met 20 25 30 Glu Pro Leu Val Glu Phe Met Arg Val His Lys Tyr Asn Asp Gln Thr 35 40 45 Leu Leu Leu Asn Glu Ser Ile Thr Asn Val Val Arg Leu Arg Pro Ala 50 55 60 Leu Ile Lys Ala Glu Glu Tyr Leu Ile Lys Leu Pro Asn Asp Gln Pro 65 70 75 80 Leu Lys Asp Phe Tyr Ser Lys Leu Gln Glu Leu Gly Leu Glu Arg Gly 85 90 95 Trp Gly Asp Thr Ala Gly Arg Val Leu Glu Met Ile His Leu Leu Leu 100 105 110 Asp Leu Leu Gln Ala Pro Asp Pro Asp Ile Leu Glu Lys Phe Leu Ala 115 120 125 Arg Ile Pro Ile Val Phe Ser Val Ala Ile Ile Ser Pro His Gly Tyr 130 135 140 Phe Gly Gln Ser Asn Val Leu Gly Met Pro Asp Thr Gly Gly Gln Val 145 150 155 160 Val Tyr Ile Leu Asp 165 65 548 DNA Physcomitrella patens CDS (1)..(375) 71_ck18_d06fwd 65 ggt gat ctc cag gag cgg acg tcc atc ttc ttc cat ttg ata cac gat 48 Gly Asp Leu Gln Glu Arg Thr Ser Ile Phe Phe His Leu Ile His Asp 1 5 10 15 ggc aag cac cag aac tgg aag acg ctc ttc tgc ggc gac cag agc caa 96 Gly Lys His Gln Asn Trp Lys Thr Leu Phe Cys Gly Asp Gln Ser Gln 20 25 30 tcc tcc ttg cag cag gac gtc gac aag acg gtg tat ggg tcc tac gtg 144 Ser Ser Leu Gln Gln Asp Val Asp Lys Thr Val Tyr Gly Ser Tyr Val 35 40 45 cgc gtg gat gac agc gac aag gtg ctg tcc gtg cgc att ctc gtc gac 192 Arg Val Asp Asp Ser Asp Lys Val Leu Ser Val Arg Ile Leu Val Asp 50 55 60 cac tcc atc gtg gag agc ttc gcc caa ggc ggc cgc acg gta atg aca 240 His Ser Ile Val Glu Ser Phe Ala Gln Gly Gly Arg Thr Val Met Thr 65 70 75 80 tcc aga gta tac ccg gag ctg gcg gtg aaa gac gcc gct cac gtg ttt 288 Ser Arg Val Tyr Pro Glu Leu Ala Val Lys Asp Ala Ala His Val Phe 85 90 95 ttg ttc aac aac ggt act gag ccc gtg aca gtg aaa tcg gta tcc acc 336 Leu Phe Asn Asn Gly Thr Glu Pro Val Thr Val Lys Ser Val Ser Thr 100 105 110 tgg gag atg aag agt gtc aac atc aag ttt tac aaa cct tgatttgcac 385 Trp Glu Met Lys Ser Val Asn Ile Lys Phe Tyr Lys Pro 115 120 125 gctctttccg cttaactccg gttgataact agccgaaatg ttgctttccc aatttagaat 445 tgtttggaca tcctcgaagc tcaagctgct gcatgcatac agagatattc aaaatcatgt 505 acacatctcc acttgtaata aaacataata aaccactctg ttt 548 66 125 PRT Physcomitrella patens 66 Gly Asp Leu Gln Glu Arg Thr Ser Ile Phe Phe His Leu Ile His Asp 1 5 10 15 Gly Lys His Gln Asn Trp Lys Thr Leu Phe Cys Gly Asp Gln Ser Gln 20 25 30 Ser Ser Leu Gln Gln Asp Val Asp Lys Thr Val Tyr Gly Ser Tyr Val 35 40 45 Arg Val Asp Asp Ser Asp Lys Val Leu Ser Val Arg Ile Leu Val Asp 50 55 60 His Ser Ile Val Glu Ser Phe Ala Gln Gly Gly Arg Thr Val Met Thr 65 70 75 80 Ser Arg Val Tyr Pro Glu Leu Ala Val Lys Asp Ala Ala His Val Phe 85 90 95 Leu Phe Asn Asn Gly Thr Glu Pro Val Thr Val Lys Ser Val Ser Thr 100 105 110 Trp Glu Met Lys Ser Val Asn Ile Lys Phe Tyr Lys Pro 115 120 125 67 496 DNA Physcomitrella patens CDS (1)..(297) 94_ck14_h11fwd 67 tgc ggc gac cag agc caa tcc tcc ttg cag cag gac gtc gac aag acg 48 Cys Gly Asp Gln Ser Gln Ser Ser Leu Gln Gln Asp Val Asp Lys Thr 1 5 10 15 gtg tat ggg tcc tac gtg cgc gtg gat gac agc gac aag gtg ctg tcc 96 Val Tyr Gly Ser Tyr Val Arg Val Asp Asp Ser Asp Lys Val Leu Ser 20 25 30 gtg cgc att ctc gtc gac cac tcc atc gtg gag agc ttc gcc caa ggc 144 Val Arg Ile Leu Val Asp His Ser Ile Val Glu Ser Phe Ala Gln Gly 35 40 45 ggc cgc acg gta atg aca tcc aga gta tac ccg gag ctg gcg gtg aaa 192 Gly Arg Thr Val Met Thr Ser Arg Val Tyr Pro Glu Leu Ala Val Lys 50 55 60 gac gcc gct cac gtg ttt ttg ttc aac aac ggt act gag ccc gtg aca 240 Asp Ala Ala His Val Phe Leu Phe Asn Asn Gly Thr Glu Pro Val Thr 65 70 75 80 gtg aaa tcg gta tcc acc tgg gag atg aag agt gtc aac atc aag ttt 288 Val Lys Ser Val Ser Thr Trp Glu Met Lys Ser Val Asn Ile Lys Phe 85 90 95 tac aaa cct tgatttgcac gctctttccg cttaactccg gttgataact 337 Tyr Lys Pro agccgaaatg ttgctttccc aatttagaat tgtttggaca tcctcgaagc tcaagctgct 397 gcatgcatac agagatattc aaaatcatgt acacatctcc acttgtaata aaacataata 457 aaccactctg ttttggcaaa aaaaaaaaaa aaaaaaaaa 496 68 99 PRT Physcomitrella patens 68 Cys Gly Asp Gln Ser Gln Ser Ser Leu Gln Gln Asp Val Asp Lys Thr 1 5 10 15 Val Tyr Gly Ser Tyr Val Arg Val Asp Asp Ser Asp Lys Val Leu Ser 20 25 30 Val Arg Ile Leu Val Asp His Ser Ile Val Glu Ser Phe Ala Gln Gly 35 40 45 Gly Arg Thr Val Met Thr Ser Arg Val Tyr Pro Glu Leu Ala Val Lys 50 55 60 Asp Ala Ala His Val Phe Leu Phe Asn Asn Gly Thr Glu Pro Val Thr 65 70 75 80 Val Lys Ser Val Ser Thr Trp Glu Met Lys Ser Val Asn Ile Lys Phe 85 90 95 Tyr Lys Pro 69 390 DNA Physcomitrella patens CDS (3)..(281) 25_bd07_e01rev 69 gt aac gtg att gtg ttt aga cct gat gga ggt tct gga ggt tgc tcg 47 Asn Val Ile Val Phe Arg Pro Asp Gly Gly Ser Gly Gly Cys Ser 1 5 10 15 ggt cat tgg tac ggg tac gtc act cct gat gat gtc cca gag ata atg 95 Gly His Trp Tyr Gly Tyr Val Thr Pro Asp Asp Val Pro Glu Ile Met 20 25 30 gag aag cac att gga ctt ggc gag gtg gtg ggt cgg ctt tgg agg ggt 143 Glu Lys His Ile Gly Leu Gly Glu Val Val Gly Arg Leu Trp Arg Gly 35 40 45 cag atg gga ttg act gag gat gag cag aag gaa gtt cag cag aaa agg 191 Gln Met Gly Leu Thr Glu Asp Glu Gln Lys Glu Val Gln Gln Lys Arg 50 55 60 aac ccc tcc agt aat cta act cag gag ggc act aaa cca gaa ggg aag 239 Asn Pro Ser Ser Asn Leu Thr Gln Glu Gly Thr Lys Pro Glu Gly Lys 65 70 75 gtg gat gca gct tca aca tct act gga ggc aac tgc tcc tat 281 Val Asp Ala Ala Ser Thr Ser Thr Gly Gly Asn Cys Ser Tyr 80 85 90 taggaaaaag cctcctcctc ctctacttcc acgcattggg tcacgcgacc tgcaccaaat 341 gtgtggggac gaacaggaag aagaaggtcc acttaaaccg tacgaggag 390 70 93 PRT Physcomitrella patens 70 Asn Val Ile Val Phe Arg Pro Asp Gly Gly Ser Gly Gly Cys Ser Gly 1 5 10 15 His Trp Tyr Gly Tyr Val Thr Pro Asp Asp Val Pro Glu Ile Met Glu 20 25 30 Lys His Ile Gly Leu Gly Glu Val Val Gly Arg Leu Trp Arg Gly Gln 35 40 45 Met Gly Leu Thr Glu Asp Glu Gln Lys Glu Val Gln Gln Lys Arg Asn 50 55 60 Pro Ser Ser Asn Leu Thr Gln Glu Gly Thr Lys Pro Glu Gly Lys Val 65 70 75 80 Asp Ala Ala Ser Thr Ser Thr Gly Gly Asn Cys Ser Tyr 85 90 71 415 DNA Physcomitrella patens CDS (1)..(414) 66_ppprotl_075_cl2 71 ctg acg aag tcg gag act gtt gcc atg ctg aac tct gcg ggg ctg tct 48 Leu Thr Lys Ser Glu Thr Val Ala Met Leu Asn Ser Ala Gly Leu Ser 1 5 10 15 cac atg gag ttc gac gct ctt att tgc agc agt gga agt gag gtg tac 96 His Met Glu Phe Asp Ala Leu Ile Cys Ser Ser Gly Ser Glu Val Tyr 20 25 30 tat cct gcc tca att caa gac gat agc gtc aca acg gac aac agc gac 144 Tyr Pro Ala Ser Ile Gln Asp Asp Ser Val Thr Thr Asp Asn Ser Asp 35 40 45 ttg cat gca gac gag gac tac aaa agc cac att gac tat cga tgg ggc 192 Leu His Ala Asp Glu Asp Tyr Lys Ser His Ile Asp Tyr Arg Trp Gly 50 55 60 tac gaa ggc ctc cgc aag acc atg gcg cgc ttg aac aca cct gac act 240 Tyr Glu Gly Leu Arg Lys Thr Met Ala Arg Leu Asn Thr Pro Asp Thr 65 70 75 80 gag agc ggt agc aac gac aag atc tgg acc gag gat aca gcg aac tgc 288 Glu Ser Gly Ser Asn Asp Lys Ile Trp Thr Glu Asp Thr Ala Asn Cys 85 90 95 aac tct cac tgc ctg gcc tac acg gtg acc aac tcg gac atc gcc cct 336 Asn Ser His Cys Leu Ala Tyr Thr Val Thr Asn Ser Asp Ile Ala Pro 100 105 110 act gtg gat cag ctg cga cag cgt ctg cgg atg cgg gga cta cga tgc 384 Thr Val Asp Gln Leu Arg Gln Arg Leu Arg Met Arg Gly Leu Arg Cys 115 120 125 cac gtg atg ttt tgc agg aat gct tca cgg t 415 His Val Met Phe Cys Arg Asn Ala Ser Arg 130 135 72 138 PRT Physcomitrella patens 72 Leu Thr Lys Ser Glu Thr Val Ala Met Leu Asn Ser Ala Gly Leu Ser 1 5 10 15 His Met Glu Phe Asp Ala Leu Ile Cys Ser Ser Gly Ser Glu Val Tyr 20 25 30 Tyr Pro Ala Ser Ile Gln Asp Asp Ser Val Thr Thr Asp Asn Ser Asp 35 40 45 Leu His Ala Asp Glu Asp Tyr Lys Ser His Ile Asp Tyr Arg Trp Gly 50 55 60 Tyr Glu Gly Leu Arg Lys Thr Met Ala Arg Leu Asn Thr Pro Asp Thr 65 70 75 80 Glu Ser Gly Ser Asn Asp Lys Ile Trp Thr Glu Asp Thr Ala Asn Cys 85 90 95 Asn Ser His Cys Leu Ala Tyr Thr Val Thr Asn Ser Asp Ile Ala Pro 100 105 110 Thr Val Asp Gln Leu Arg Gln Arg Leu Arg Met Arg Gly Leu Arg Cys 115 120 125 His Val Met Phe Cys Arg Asn Ala Ser Arg 130 135 73 576 DNA Physcomitrella patens CDS (1)..(576) 50_mm15_al0rev 73 ggc aaa ggc gtc gca atc gac ggc acg cgt tta cct ttc gaa gcg ggg 48 Gly Lys Gly Val Ala Ile Asp Gly Thr Arg Leu Pro Phe Glu Ala Gly 1 5 10 15 gag att gaa ttt ggg gag ccc ggc acg aac ggc cag cac agc ttc tac 96 Glu Ile Glu Phe Gly Glu Pro Gly Thr Asn Gly Gln His Ser Phe Tyr 20 25 30 cag ctg atc cac cag ggg cgc acc atc ccc tgc gac ttt att ggc tcc 144 Gln Leu Ile His Gln Gly Arg Thr Ile Pro Cys Asp Phe Ile Gly Ser 35 40 45 gtg aag agt cag aag cct atc tac atg atc ggg gag aag gtg agc aac 192 Val Lys Ser Gln Lys Pro Ile Tyr Met Ile Gly Glu Lys Val Ser Asn 50 55 60 cac gac gag ctc atg tca aat ttc ttc gct caa gca gat gct ctc gcc 240 His Asp Glu Leu Met Ser Asn Phe Phe Ala Gln Ala Asp Ala Leu Ala 65 70 75 80 tac ggc aag acg cgg gag gat ctg caa gcc gag aat gtg aag gag tct 288 Tyr Gly Lys Thr Arg Glu Asp Leu Gln Ala Glu Asn Val Lys Glu Ser 85 90 95 cta gtc cct cac aag gtt ttc act ggc aat cgc ccc tcc ttg agc att 336 Leu Val Pro His Lys Val Phe Thr Gly Asn Arg Pro Ser Leu Ser Ile 100 105 110 ctc ctc ccc gcg ctc aac gcc tac acc gtt ggc cag ctg cta tcc ctc 384 Leu Leu Pro Ala Leu Asn Ala Tyr Thr Val Gly Gln Leu Leu Ser Leu 115 120 125 tac gag aac cga atc gca gta cag gga ttc gtg tgg ggc att aac tca 432 Tyr Glu Asn Arg Ile Ala Val Gln Gly Phe Val Trp Gly Ile Asn Ser 130 135 140 ttc gac caa tgg ggc gtg gag ctc ggc aaa agc ttg gct acc aag gtg 480 Phe Asp Gln Trp Gly Val Glu Leu Gly Lys Ser Leu Ala Thr Lys Val 145 150 155 160 cgc tcg cag ctg aac gaa gca cgc acg aag gac gct ccc gtg caa gga 528 Arg Ser Gln Leu Asn Glu Ala Arg Thr Lys Asp Ala Pro Val Gln Gly 165 170 175 ttc aac tac agc acc acg tat ctc ttt gaa gca cta ctt aaa ggg gaa 576 Phe Asn Tyr Ser Thr Thr Tyr Leu Phe Glu Ala Leu Leu Lys Gly Glu 180 185 190 74 192 PRT Physcomitrella patens 74 Gly Lys Gly Val Ala Ile Asp Gly Thr Arg Leu Pro Phe Glu Ala Gly 1 5 10 15 Glu Ile Glu Phe Gly Glu Pro Gly Thr Asn Gly Gln His Ser Phe Tyr 20 25 30 Gln Leu Ile His Gln Gly Arg Thr Ile Pro Cys Asp Phe Ile Gly Ser 35 40 45 Val Lys Ser Gln Lys Pro Ile Tyr Met Ile Gly Glu Lys Val Ser Asn 50 55 60 His Asp Glu Leu Met Ser Asn Phe Phe Ala Gln Ala Asp Ala Leu Ala 65 70 75 80 Tyr Gly Lys Thr Arg Glu Asp Leu Gln Ala Glu Asn Val Lys Glu Ser 85 90 95 Leu Val Pro His Lys Val Phe Thr Gly Asn Arg Pro Ser Leu Ser Ile 100 105 110 Leu Leu Pro Ala Leu Asn Ala Tyr Thr Val Gly Gln Leu Leu Ser Leu 115 120 125 Tyr Glu Asn Arg Ile Ala Val Gln Gly Phe Val Trp Gly Ile Asn Ser 130 135 140 Phe Asp Gln Trp Gly Val Glu Leu Gly Lys Ser Leu Ala Thr Lys Val 145 150 155 160 Arg Ser Gln Leu Asn Glu Ala Arg Thr Lys Asp Ala Pro Val Gln Gly 165 170 175 Phe Asn Tyr Ser Thr Thr Tyr Leu Phe Glu Ala Leu Leu Lys Gly Glu 180 185 190 75 476 DNA Physcomitrella patens CDS (3)..(476) 70_mm10_d11rev 75 cc act ttt cgc cga atg tac aat cag tgg ccc ttt ttc cgt gtg act 47 Thr Phe Arg Arg Met Tyr Asn Gln Trp Pro Phe Phe Arg Val Thr 1 5 10 15 atc gac ttg gtg gag atg gtg ttt gcc aag ggt gat cca cgt att gcc 95 Ile Asp Leu Val Glu Met Val Phe Ala Lys Gly Asp Pro Arg Ile Ala 20 25 30 gct tta tat gat gac ttg ctt gtg tcg gac gag ctg aaa ccg ctt ggc 143 Ala Leu Tyr Asp Asp Leu Leu Val Ser Asp Glu Leu Lys Pro Leu Gly 35 40 45 gag gag ctg agg cag aag tac aac gag aca aga gat ctc ctt ctg aag 191 Glu Glu Leu Arg Gln Lys Tyr Asn Glu Thr Arg Asp Leu Leu Leu Lys 50 55 60 ata aca ttc cac gat gaa atc ttg caa ggg aac ccg tcg ctg aag caa 239 Ile Thr Phe His Asp Glu Ile Leu Gln Gly Asn Pro Ser Leu Lys Gln 65 70 75 cgg ctg cgg ctt cga gaa ccc tac atc acg gct ctc aac gtg cag cag 287 Arg Leu Arg Leu Arg Glu Pro Tyr Ile Thr Ala Leu Asn Val Gln Gln 80 85 90 95 gcg cta gtg ctg aag aag atg cgt gat cag ggc ttg cag ttc tgt gca 335 Ala Leu Val Leu Lys Lys Met Arg Asp Gln Gly Leu Gln Phe Cys Ala 100 105 110 tta caa aac agc agc aag gac caa tcc gac ata cca aca aca ccc aag 383 Leu Gln Asn Ser Ser Lys Asp Gln Ser Asp Ile Pro Thr Thr Pro Lys 115 120 125 cgt gct gca gag ctg gtt gaa ctg aac ccc aca act gag ttc cca ccc 431 Arg Ala Ala Glu Leu Val Glu Leu Asn Pro Thr Thr Glu Phe Pro Pro 130 135 140 gga ctg gag gat act ctc att ctc acc atg aag ggt atc gcg gcc 476 Gly Leu Glu Asp Thr Leu Ile Leu Thr Met Lys Gly Ile Ala Ala 145 150 155 76 158 PRT Physcomitrella patens 76 Thr Phe Arg Arg Met Tyr Asn Gln Trp Pro Phe Phe Arg Val Thr Ile 1 5 10 15 Asp Leu Val Glu Met Val Phe Ala Lys Gly Asp Pro Arg Ile Ala Ala 20 25 30 Leu Tyr Asp Asp Leu Leu Val Ser Asp Glu Leu Lys Pro Leu Gly Glu 35 40 45 Glu Leu Arg Gln Lys Tyr Asn Glu Thr Arg Asp Leu Leu Leu Lys Ile 50 55 60 Thr Phe His Asp Glu Ile Leu Gln Gly Asn Pro Ser Leu Lys Gln Arg 65 70 75 80 Leu Arg Leu Arg Glu Pro Tyr Ile Thr Ala Leu Asn Val Gln Gln Ala 85 90 95 Leu Val Leu Lys Lys Met Arg Asp Gln Gly Leu Gln Phe Cys Ala Leu 100 105 110 Gln Asn Ser Ser Lys Asp Gln Ser Asp Ile Pro Thr Thr Pro Lys Arg 115 120 125 Ala Ala Glu Leu Val Glu Leu Asn Pro Thr Thr Glu Phe Pro Pro Gly 130 135 140 Leu Glu Asp Thr Leu Ile Leu Thr Met Lys Gly Ile Ala Ala 145 150 155 77 559 DNA Physcomitrella patens CDS (3)..(443) 12_ck22_b09fwd 77 cg ctg ccg tcg cag tgg tgt tgt ttc aca ttg ctg gag gta gtt gcg 47 Leu Pro Ser Gln Trp Cys Cys Phe Thr Leu Leu Glu Val Val Ala 1 5 10 15 cat cgt gca ggg ttg agg tac ctg tca acc atg gtg gga gct ctc ggg 95 His Arg Ala Gly Leu Arg Tyr Leu Ser Thr Met Val Gly Ala Leu Gly 20 25 30 aag aat ttc gcg act ttc gcc tct cgt ttg aga gga ggc cat ggc tgt 143 Lys Asn Phe Ala Thr Phe Ala Ser Arg Leu Arg Gly Gly His Gly Cys 35 40 45 gac aca gct gct gcg gca gcg gtt tgg gcg gtg tct aag agg ttc atg 191 Asp Thr Ala Ala Ala Ala Ala Val Trp Ala Val Ser Lys Arg Phe Met 50 55 60 tcg tct tcg ggc gaa tcg att act gtc cga gag gct cta aac agt gcc 239 Ser Ser Ser Gly Glu Ser Ile Thr Val Arg Glu Ala Leu Asn Ser Ala 65 70 75 atc gac gag gag atg tca gct gat tcc aaa gtc ttt gtc atg ggc gaa 287 Ile Asp Glu Glu Met Ser Ala Asp Ser Lys Val Phe Val Met Gly Glu 80 85 90 95 gag gtt ggt gag tac caa ggt gcc tac aag gtc acg aag ggt ctc ttg 335 Glu Val Gly Glu Tyr Gln Gly Ala Tyr Lys Val Thr Lys Gly Leu Leu 100 105 110 cag aaa ttt gga cca gat cgt gtt tta gat acc cct att aca gag gct 383 Gln Lys Phe Gly Pro Asp Arg Val Leu Asp Thr Pro Ile Thr Glu Ala 115 120 125 gga ttc gca ggt ctt ggt gtt gga gca gca atg tat ggc ctg aac cta 431 Gly Phe Ala Gly Leu Gly Val Gly Ala Ala Met Tyr Gly Leu Asn Leu 130 135 140 ttg ttg agt tta tgacctttaa cttcccatgc agccattgat catctcatca 483 Leu Leu Ser Leu 145 attcgctgct aaaacaaact acatgtctgg cgggacaatt aatgttccta tagtattcag 543 gggtcctaat ggtgca 559 78 147 PRT Physcomitrella patens 78 Leu Pro Ser Gln Trp Cys Cys Phe Thr Leu Leu Glu Val Val Ala His 1 5 10 15 Arg Ala Gly Leu Arg Tyr Leu Ser Thr Met Val Gly Ala Leu Gly Lys 20 25 30 Asn Phe Ala Thr Phe Ala Ser Arg Leu Arg Gly Gly His Gly Cys Asp 35 40 45 Thr Ala Ala Ala Ala Ala Val Trp Ala Val Ser Lys Arg Phe Met Ser 50 55 60 Ser Ser Gly Glu Ser Ile Thr Val Arg Glu Ala Leu Asn Ser Ala Ile 65 70 75 80 Asp Glu Glu Met Ser Ala Asp Ser Lys Val Phe Val Met Gly Glu Glu 85 90 95 Val Gly Glu Tyr Gln Gly Ala Tyr Lys Val Thr Lys Gly Leu Leu Gln 100 105 110 Lys Phe Gly Pro Asp Arg Val Leu Asp Thr Pro Ile Thr Glu Ala Gly 115 120 125 Phe Ala Gly Leu Gly Val Gly Ala Ala Met Tyr Gly Leu Asn Leu Leu 130 135 140 Leu Ser Leu 145 79 491 DNA Physcomitrella patens CDS (88)..(489) 37_mm3_g01rev 79 cccaattctc acattccatg gaactgagca tcacagaact cggtgcattt gttttggaat 60 gttgttgtgg aaaacggttt ctgtgtt atg cca aaa gtt ccg gca acc ttc agt 114 Met Pro Lys Val Pro Ala Thr Phe Ser 1 5 ctt tac agc gta gtg ggc gtg cgg aga atg ttg ttg gag agt tct ggg 162 Leu Tyr Ser Val Val Gly Val Arg Arg Met Leu Leu Glu Ser Ser Gly 10 15 20 25 aga ccc aaa cta atg cga cag ggg act cgc tgg atg tca aaa aca gtg 210 Arg Pro Lys Leu Met Arg Gln Gly Thr Arg Trp Met Ser Lys Thr Val 30 35 40 gac atg aag gag aga ttg gct gaa tta atc ccg aaa gaa cag gac cgt 258 Asp Met Lys Glu Arg Leu Ala Glu Leu Ile Pro Lys Glu Gln Asp Arg 45 50 55 ttg aag aag att aag aaa gat tat ggc aag ata tct ctc gga gac acc 306 Leu Lys Lys Ile Lys Lys Asp Tyr Gly Lys Ile Ser Leu Gly Asp Thr 60 65 70 act gtc gac atg tgc att ggc ggc atg cgt ggc atc aaa ggc atg cta 354 Thr Val Asp Met Cys Ile Gly Gly Met Arg Gly Ile Lys Gly Met Leu 75 80 85 tgg gag aca tcc ttg ctc gac gct gat gag ggt att cgg ttc agg gga 402 Trp Glu Thr Ser Leu Leu Asp Ala Asp Glu Gly Ile Arg Phe Arg Gly 90 95 100 105 ctc tcc att cct gaa tgc cag aag aag ttg ccg gca gca att agt gga 450 Leu Ser Ile Pro Glu Cys Gln Lys Lys Leu Pro Ala Ala Ile Ser Gly 110 115 120 ggc gag cct ttg ccc gaa ggc tta ttg tgg ctt tta gtt ac 491 Gly Glu Pro Leu Pro Glu Gly Leu Leu Trp Leu Leu Val 125 130 80 134 PRT Physcomitrella patens 80 Met Pro Lys Val Pro Ala Thr Phe Ser Leu Tyr Ser Val Val Gly Val 1 5 10 15 Arg Arg Met Leu Leu Glu Ser Ser Gly Arg Pro Lys Leu Met Arg Gln 20 25 30 Gly Thr Arg Trp Met Ser Lys Thr Val Asp Met Lys Glu Arg Leu Ala 35 40 45 Glu Leu Ile Pro Lys Glu Gln Asp Arg Leu Lys Lys Ile Lys Lys Asp 50 55 60 Tyr Gly Lys Ile Ser Leu Gly Asp Thr Thr Val Asp Met Cys Ile Gly 65 70 75 80 Gly Met Arg Gly Ile Lys Gly Met Leu Trp Glu Thr Ser Leu Leu Asp 85 90 95 Ala Asp Glu Gly Ile Arg Phe Arg Gly Leu Ser Ile Pro Glu Cys Gln 100 105 110 Lys Lys Leu Pro Ala Ala Ile Ser Gly Gly Glu Pro Leu Pro Glu Gly 115 120 125 Leu Leu Trp Leu Leu Val 130 81 625 DNA Physcomitrella patens CDS (107)..(625) 70_ppprot1_069_d11 81 gcacgagggt ttttgtagcc gtagaaactc gtttagtaac tagagttatt ttgatttgtt 60 gggctacgtt gggttccgag gagattgtct tgtacctcga agagat atg acg atc 115 Met Thr Ile 1 ggc tcc cct ttg gtt gta gtt gga tcg gtg aat gcc gac att tat gtg 163 Gly Ser Pro Leu Val Val Val Gly Ser Val Asn Ala Asp Ile Tyr Val 5 10 15 gag gtt gag cgt cta ccg gcc gag ggt gaa acc ata gct gct aga agt 211 Glu Val Glu Arg Leu Pro Ala Glu Gly Glu Thr Ile Ala Ala Arg Ser 20 25 30 35 ggc cag act ctt cct ggt ggg aag gga gcc aat caa gct gct tgt gcc 259 Gly Gln Thr Leu Pro Gly Gly Lys Gly Ala Asn Gln Ala Ala Cys Ala 40 45 50 gct cgt ctt tcg tac cct acc ttc ttc tgt ggc cag gtc gga cag gac 307 Ala Arg Leu Ser Tyr Pro Thr Phe Phe Cys Gly Gln Val Gly Gln Asp 55 60 65 gcc cat gcc aac ctg gtt aga aat gca ctt gtt tct gca ggc gtt cat 355 Ala His Ala Asn Leu Val Arg Asn Ala Leu Val Ser Ala Gly Val His 70 75 80 tta gat cat gta aat act gtt gac gct cca act ggt cac gca gtt gtg 403 Leu Asp His Val Asn Thr Val Asp Ala Pro Thr Gly His Ala Val Val 85 90 95 ata tta cag cca gga ggc aaa aac tca att atc atc gtc gga gga gcc 451 Ile Leu Gln Pro Gly Gly Lys Asn Ser Ile Ile Ile Val Gly Gly Ala 100 105 110 115 aat gtc gca tgg ccg aag tta gaa gat gga ata agc agt cta acc acc 499 Asn Val Ala Trp Pro Lys Leu Glu Asp Gly Ile Ser Ser Leu Thr Thr 120 125 130 aac gcg cag gaa ttg att aaa cga gca ggt gca gtg ctt ctg caa cgt 547 Asn Ala Gln Glu Leu Ile Lys Arg Ala Gly Ala Val Leu Leu Gln Arg 135 140 145 gag att cca gac gca gtc aat ctt gaa gct gcg aag att gct aag agt 595 Glu Ile Pro Asp Ala Val Asn Leu Glu Ala Ala Lys Ile Ala Lys Ser 150 155 160 gcc ggt gtt cct gtg atc atg gat gct gga 625 Ala Gly Val Pro Val Ile Met Asp Ala Gly 165 170 82 173 PRT Physcomitrella patens 82 Met Thr Ile Gly Ser Pro Leu Val Val Val Gly Ser Val Asn Ala Asp 1 5 10 15 Ile Tyr Val Glu Val Glu Arg Leu Pro Ala Glu Gly Glu Thr Ile Ala 20 25 30 Ala Arg Ser Gly Gln Thr Leu Pro Gly Gly Lys Gly Ala Asn Gln Ala 35 40 45 Ala Cys Ala Ala Arg Leu Ser Tyr Pro Thr Phe Phe Cys Gly Gln Val 50 55 60 Gly Gln Asp Ala His Ala Asn Leu Val Arg Asn Ala Leu Val Ser Ala 65 70 75 80 Gly Val His Leu Asp His Val Asn Thr Val Asp Ala Pro Thr Gly His 85 90 95 Ala Val Val Ile Leu Gln Pro Gly Gly Lys Asn Ser Ile Ile Ile Val 100 105 110 Gly Gly Ala Asn Val Ala Trp Pro Lys Leu Glu Asp Gly Ile Ser Ser 115 120 125 Leu Thr Thr Asn Ala Gln Glu Leu Ile Lys Arg Ala Gly Ala Val Leu 130 135 140 Leu Gln Arg Glu Ile Pro Asp Ala Val Asn Leu Glu Ala Ala Lys Ile 145 150 155 160 Ala Lys Ser Ala Gly Val Pro Val Ile Met Asp Ala Gly 165 170 83 589 DNA Physcomitrella patens CDS (2)..(250) 96_ck20_h12fwd 83 g gag atc agc gag gat tct cct gcc aga cac agc ttg gtc tgt cgc ggc 49 Glu Ile Ser Glu Asp Ser Pro Ala Arg His Ser Leu Val Cys Arg Gly 1 5 10 15 ctc ctg tcg ctg ctc gtt gag ggg tcc gcc aag gcc acc gac tcg gaa 97 Leu Leu Ser Leu Leu Val Glu Gly Ser Ala Lys Ala Thr Asp Ser Glu 20 25 30 tcc acc gac gct atc ctc ggc gcg gct cta gat cac gcc ttg aag cgg 145 Ser Thr Asp Ala Ile Leu Gly Ala Ala Leu Asp His Ala Leu Lys Arg 35 40 45 aag ctg tgc att gtt gga gac tct gtt gtt gcg atc cac aga atc ggc 193 Lys Leu Cys Ile Val Gly Asp Ser Val Val Ala Ile His Arg Ile Gly 50 55 60 gcc gcg tct gtt atc aag atc gtc gag gtc aag gag aag gta gtc aag 241 Ala Ala Ser Val Ile Lys Ile Val Glu Val Lys Glu Lys Val Val Lys 65 70 75 80 gtg gcg gca tgaagacgag gggcgagtgc atcgtctcga ctgcacccaa 290 Val Ala Ala atccgtaatt agtttatacc aaggttgagc aattaataca ggaattattt tcgccgttta 350 tggcagcgta tggatgtatt atagctcgtt ttagtaaatt tcttctggaa catgcttcaa 410 cagcgggaac ttgtactttc tcctgctctt cgaggtagga tttgttgaag cgagtttcgg 470 agtattgagc gcgtccgaaa aatgttgaag atatgttcga tagcgtgcta acaatcgcca 530 cgatgatctt tcagaaggaa aagcaatcga gaaaagacca gttcttacaa ccaaaaaaa 589 84 83 PRT Physcomitrella patens 84 Glu Ile Ser Glu Asp Ser Pro Ala Arg His Ser Leu Val Cys Arg Gly 1 5 10 15 Leu Leu Ser Leu Leu Val Glu Gly Ser Ala Lys Ala Thr Asp Ser Glu 20 25 30 Ser Thr Asp Ala Ile Leu Gly Ala Ala Leu Asp His Ala Leu Lys Arg 35 40 45 Lys Leu Cys Ile Val Gly Asp Ser Val Val Ala Ile His Arg Ile Gly 50 55 60 Ala Ala Ser Val Ile Lys Ile Val Glu Val Lys Glu Lys Val Val Lys 65 70 75 80 Val Ala Ala 85 386 DNA Physcomitrella patens CDS (9)..(386) 88_mm13_g11rev 85 gcggtgca atg cag gga gcc tgg ggc gga gga gcc gcg ggg gcg ctg ctg 50 Met Gln Gly Ala Trp Gly Gly Gly Ala Ala Gly Ala Leu Leu 1 5 10 ccc tgc cag cgt ctg gag agg tcg cgt tgc ggc cgg atg gaa tgc cgc 98 Pro Cys Gln Arg Leu Glu Arg Ser Arg Cys Gly Arg Met Glu Cys Arg 15 20 25 30 tac tct ggt gta cgc tat ggc agg agc ggg aca ttg gaa cat gat cgt 146 Tyr Ser Gly Val Arg Tyr Gly Arg Ser Gly Thr Leu Glu His Asp Arg 35 40 45 tgt ggg gtc agg aag gca cat ttc gaa tcg aca ctg cag aac gta tca 194 Cys Gly Val Arg Lys Ala His Phe Glu Ser Thr Leu Gln Asn Val Ser 50 55 60 tgg gga caa gac cgc aag aag cct ttg atc gtg agg gct tcc tca gag 242 Trp Gly Gln Asp Arg Lys Lys Pro Leu Ile Val Arg Ala Ser Ser Glu 65 70 75 aaa gtc agt ttt cca gta tca gaa tcg cgt gca gcg aat ttg cgt agg 290 Lys Val Ser Phe Pro Val Ser Glu Ser Arg Ala Ala Asn Leu Arg Arg 80 85 90 tta tta gaa cag cca ggg att cgt caa gcg cca gcg tgt tat gat gct 338 Leu Leu Glu Gln Pro Gly Ile Arg Gln Ala Pro Ala Cys Tyr Asp Ala 95 100 105 110 ttg agt gcg agc ctt gtg gag aaa gct gga ttc gac atc act ttt atg 386 Leu Ser Ala Ser Leu Val Glu Lys Ala Gly Phe Asp Ile Thr Phe Met 115 120 125 86 126 PRT Physcomitrella patens 86 Met Gln Gly Ala Trp Gly Gly Gly Ala Ala Gly Ala Leu Leu Pro Cys 1 5 10 15 Gln Arg Leu Glu Arg Ser Arg Cys Gly Arg Met Glu Cys Arg Tyr Ser 20 25 30 Gly Val Arg Tyr Gly Arg Ser Gly Thr Leu Glu His Asp Arg Cys Gly 35 40 45 Val Arg Lys Ala His Phe Glu Ser Thr Leu Gln Asn Val Ser Trp Gly 50 55 60 Gln Asp Arg Lys Lys Pro Leu Ile Val Arg Ala Ser Ser Glu Lys Val 65 70 75 80 Ser Phe Pro Val Ser Glu Ser Arg Ala Ala Asn Leu Arg Arg Leu Leu 85 90 95 Glu Gln Pro Gly Ile Arg Gln Ala Pro Ala Cys Tyr Asp Ala Leu Ser 100 105 110 Ala Ser Leu Val Glu Lys Ala Gly Phe Asp Ile Thr Phe Met 115 120 125 87 433 DNA Physcomitrella patens CDS (3)..(431) 18_ck25_c09fwd 87 gg gcc gtg gtg gtt tgc aaa gct gct gat ggg cag act gtg gtc atc 47 Ala Val Val Val Cys Lys Ala Ala Asp Gly Gln Thr Val Val Ile 1 5 10 15 gga ctg gct gcg gac tct ggg tgc ggg aag tct acg ttc atg cgg agg 95 Gly Leu Ala Ala Asp Ser Gly Cys Gly Lys Ser Thr Phe Met Arg Arg 20 25 30 ctg acg tcc gtg ttc gga ggc gct gcg act ccc ccg aag ggt ggc aac 143 Leu Thr Ser Val Phe Gly Gly Ala Ala Thr Pro Pro Lys Gly Gly Asn 35 40 45 cct gac tcc aac acg ctg att agt gac acc acc acc gtg atc tgc ctg 191 Pro Asp Ser Asn Thr Leu Ile Ser Asp Thr Thr Thr Val Ile Cys Leu 50 55 60 gac gac tac cac tcc ctc gac agg tat ggt cgc aag gag aag gcc gtg 239 Asp Asp Tyr His Ser Leu Asp Arg Tyr Gly Arg Lys Glu Lys Ala Val 65 70 75 acc gcg ttg gac ccc agg gcg aac aac ttt gat ctc atg tac gag cag 287 Thr Ala Leu Asp Pro Arg Ala Asn Asn Phe Asp Leu Met Tyr Glu Gln 80 85 90 95 gtg aag gcc ttg aag gag ggc aag tct gtt gag aag ccg att tac aac 335 Val Lys Ala Leu Lys Glu Gly Lys Ser Val Glu Lys Pro Ile Tyr Asn 100 105 110 cac gtg acc ggt ttg ttg gat gcc ccc gaa acc att cac ccc cct aag 383 His Val Thr Gly Leu Leu Asp Ala Pro Glu Thr Ile His Pro Pro Lys 115 120 125 att ctc gtc atc gag ggt ctg cac cca atg tac gac gag cgt gtc cgg 431 Ile Leu Val Ile Glu Gly Leu His Pro Met Tyr Asp Glu Arg Val Arg 130 135 140 ga 433 88 143 PRT Physcomitrella patens 88 Ala Val Val Val Cys Lys Ala Ala Asp Gly Gln Thr Val Val Ile Gly 1 5 10 15 Leu Ala Ala Asp Ser Gly Cys Gly Lys Ser Thr Phe Met Arg Arg Leu 20 25 30 Thr Ser Val Phe Gly Gly Ala Ala Thr Pro Pro Lys Gly Gly Asn Pro 35 40 45 Asp Ser Asn Thr Leu Ile Ser Asp Thr Thr Thr Val Ile Cys Leu Asp 50 55 60 Asp Tyr His Ser Leu Asp Arg Tyr Gly Arg Lys Glu Lys Ala Val Thr 65 70 75 80 Ala Leu Asp Pro Arg Ala Asn Asn Phe Asp Leu Met Tyr Glu Gln Val 85 90 95 Lys Ala Leu Lys Glu Gly Lys Ser Val Glu Lys Pro Ile Tyr Asn His 100 105 110 Val Thr Gly Leu Leu Asp Ala Pro Glu Thr Ile His Pro Pro Lys Ile 115 120 125 Leu Val Ile Glu Gly Leu His Pro Met Tyr Asp Glu Arg Val Arg 130 135 140 89 522 DNA Physcomitrella patens CDS (2)..(520) 83_ck30_f06fwd 89 g gca ggt gac ctc gca gca act gct gtg aac gca ccc atg gta ccc gcg 49 Ala Gly Asp Leu Ala Ala Thr Ala Val Asn Ala Pro Met Val Pro Ala 1 5 10 15 gag gta atc gcc gag ctc acc ccg tat gtg gtt ttg gca gag aag ctg 97 Glu Val Ile Ala Glu Leu Thr Pro Tyr Val Val Leu Ala Glu Lys Leu 20 25 30 gga agg ctc act gtg cag ttg gta tcg ggt agt gcc gga gtg aag cag 145 Gly Arg Leu Thr Val Gln Leu Val Ser Gly Ser Ala Gly Val Lys Gln 35 40 45 gtg aag gtg gtg tac aaa tct tcc cgg gac gac ggc gat ttg gac acc 193 Val Lys Val Val Tyr Lys Ser Ser Arg Asp Asp Gly Asp Leu Asp Thr 50 55 60 agg cta ttg agg gcc agg atc tcg aag ggg ttg atc gag ccc gtg tcg 241 Arg Leu Leu Arg Ala Arg Ile Ser Lys Gly Leu Ile Glu Pro Val Ser 65 70 75 80 gac gca atc atc aat ttg gtg aat gca gat tat gtg gcc aag cag cgg 289 Asp Ala Ile Ile Asn Leu Val Asn Ala Asp Tyr Val Ala Lys Gln Arg 85 90 95 ggt ttg aag att agt gag gag cgg gag cca gct gat ggt gag agc gga 337 Gly Leu Lys Ile Ser Glu Glu Arg Glu Pro Ala Asp Gly Glu Ser Gly 100 105 110 gta cca ctg gag agt gtg tcc gtt aca att caa gat gta gag tca aaa 385 Val Pro Leu Glu Ser Val Ser Val Thr Ile Gln Asp Val Glu Ser Lys 115 120 125 ttc gcc agc gca aga ggg gat cac agc cgg agc atc acc ttg gag ggc 433 Phe Ala Ser Ala Arg Gly Asp His Ser Arg Ser Ile Thr Leu Glu Gly 130 135 140 aag gtg aag gac ggt gtg ccc cat ctt agc aag gtc gga aac ttc agt 481 Lys Val Lys Asp Gly Val Pro His Leu Ser Lys Val Gly Asn Phe Ser 145 150 155 160 gtc gac gtg agc ttg gac ggc aat gtc atc ttg tac ccg gc 522 Val Asp Val Ser Leu Asp Gly Asn Val Ile Leu Tyr Pro 165 170 90 173 PRT Physcomitrella patens 90 Ala Gly Asp Leu Ala Ala Thr Ala Val Asn Ala Pro Met Val Pro Ala 1 5 10 15 Glu Val Ile Ala Glu Leu Thr Pro Tyr Val Val Leu Ala Glu Lys Leu 20 25 30 Gly Arg Leu Thr Val Gln Leu Val Ser Gly Ser Ala Gly Val Lys Gln 35 40 45 Val Lys Val Val Tyr Lys Ser Ser Arg Asp Asp Gly Asp Leu Asp Thr 50 55 60 Arg Leu Leu Arg Ala Arg Ile Ser Lys Gly Leu Ile Glu Pro Val Ser 65 70 75 80 Asp Ala Ile Ile Asn Leu Val Asn Ala Asp Tyr Val Ala Lys Gln Arg 85 90 95 Gly Leu Lys Ile Ser Glu Glu Arg Glu Pro Ala Asp Gly Glu Ser Gly 100 105 110 Val Pro Leu Glu Ser Val Ser Val Thr Ile Gln Asp Val Glu Ser Lys 115 120 125 Phe Ala Ser Ala Arg Gly Asp His Ser Arg Ser Ile Thr Leu Glu Gly 130 135 140 Lys Val Lys Asp Gly Val Pro His Leu Ser Lys Val Gly Asn Phe Ser 145 150 155 160 Val Asp Val Ser Leu Asp Gly Asn Val Ile Leu Tyr Pro 165 170 91 596 DNA Physcomitrella patens CDS (2)..(388) 63_ck7_c05fwd 91 c gca agt gat aag ttc tct ccc gaa gcc aac act caa gtg tgc agc tcc 49 Ala Ser Asp Lys Phe Ser Pro Glu Ala Asn Thr Gln Val Cys Ser Ser 1 5 10 15 tca aac atc cct gcc ggc tgg atg gga cta gac att ggc ccg aag gca 97 Ser Asn Ile Pro Ala Gly Trp Met Gly Leu Asp Ile Gly Pro Lys Ala 20 25 30 atc gac caa ttc cag gat gcc ctg aag ggc gcc aag acg gtt ctg tgg 145 Ile Asp Gln Phe Gln Asp Ala Leu Lys Gly Ala Lys Thr Val Leu Trp 35 40 45 aac gga ccg atg gga gtg ttc gag ttc gag aag ttc gcg gac gga aca 193 Asn Gly Pro Met Gly Val Phe Glu Phe Glu Lys Phe Ala Asp Gly Thr 50 55 60 act gcc gtc gct aaa act ttg gca ggt ttg acc aag gag ggt gcc atc 241 Thr Ala Val Ala Lys Thr Leu Ala Gly Leu Thr Lys Glu Gly Ala Ile 65 70 75 80 acc atc att gga gga ggt gac tcc gtc gca gcc gtt gag aag gct gga 289 Thr Ile Ile Gly Gly Gly Asp Ser Val Ala Ala Val Glu Lys Ala Gly 85 90 95 ctc gcc gac cag atg agc cat gtg tcc acc gga gga ggg gcc agt ctc 337 Leu Ala Asp Gln Met Ser His Val Ser Thr Gly Gly Gly Ala Ser Leu 100 105 110 gag ttg ttg gaa ggc aag gta ttg cca gga gtt gct gct ctt gac aac 385 Glu Leu Leu Glu Gly Lys Val Leu Pro Gly Val Ala Ala Leu Asp Asn 115 120 125 gct taaatgcctc ttttgccgaa gaggtgaatt ccgtccacga actcgcagta 438 Ala gagtgacaat gtcactgagt gcacccccgg ctctggctgt ctaatcatat gattcatttt 498 tttggtagtt ttttttgtga tttgcctttg taccagtaaa cacagattat gaccagtaaa 558 gaactccagc tcgatttacc tggatgcttg gtattctc 596 92 129 PRT Physcomitrella patens 92 Ala Ser Asp Lys Phe Ser Pro Glu Ala Asn Thr Gln Val Cys Ser Ser 1 5 10 15 Ser Asn Ile Pro Ala Gly Trp Met Gly Leu Asp Ile Gly Pro Lys Ala 20 25 30 Ile Asp Gln Phe Gln Asp Ala Leu Lys Gly Ala Lys Thr Val Leu Trp 35 40 45 Asn Gly Pro Met Gly Val Phe Glu Phe Glu Lys Phe Ala Asp Gly Thr 50 55 60 Thr Ala Val Ala Lys Thr Leu Ala Gly Leu Thr Lys Glu Gly Ala Ile 65 70 75 80 Thr Ile Ile Gly Gly Gly Asp Ser Val Ala Ala Val Glu Lys Ala Gly 85 90 95 Leu Ala Asp Gln Met Ser His Val Ser Thr Gly Gly Gly Ala Ser Leu 100 105 110 Glu Leu Leu Glu Gly Lys Val Leu Pro Gly Val Ala Ala Leu Asp Asn 115 120 125 Ala 93 480 DNA Physcomitrella patens CDS (92)..(478) 18_ck24_c09fwd 93 ggaaacctcg atcatctccg cctgtgcagc agctgcagcc gttctgttgg agtgcttgtg 60 tggtgccgcg cgcggtcttt aagcttgaag g atg gag tcc ctc gcg ctg cga 112 Met Glu Ser Leu Ala Leu Arg 1 5 tct gcc gtg gtt gcc acc gga ttg acc tcc agt gtg gca tcc caa acc 160 Ser Ala Val Val Ala Thr Gly Leu Thr Ser Ser Val Ala Ser Gln Thr 10 15 20 tct gtg cag acc cgc gct acg gtt tcg tct gct ttc atc ggg aag agc 208 Ser Val Gln Thr Arg Ala Thr Val Ser Ser Ala Phe Ile Gly Lys Ser 25 30 35 ata cgt gtg aac act aaa ctc aac gcc tca gct gtg ccc gtc cag cag 256 Ile Arg Val Asn Thr Lys Leu Asn Ala Ser Ala Val Pro Val Gln Gln 40 45 50 55 aag ttc cgc tac gtg cgt gcc gac gct ggt gca cag act gcg cag gtt 304 Lys Phe Arg Tyr Val Arg Ala Asp Ala Gly Ala Gln Thr Ala Gln Val 60 65 70 gag acc gtt gag aag aag gct agc att aag gac gtt ccc gag tcg gaa 352 Glu Thr Val Glu Lys Lys Ala Ser Ile Lys Asp Val Pro Glu Ser Glu 75 80 85 ttc cag ggc aag gtt gtg ttc gtg cgt gct gat ctg aac gta cct ctc 400 Phe Gln Gly Lys Val Val Phe Val Arg Ala Asp Leu Asn Val Pro Leu 90 95 100 aat gat gca tgc gaa atc acc gat gac acc cga atc cgt gcc tcc ctc 448 Asn Asp Ala Cys Glu Ile Thr Asp Asp Thr Arg Ile Arg Ala Ser Leu 105 110 115 ccg acc atc cag cat ctt acg aag ccg gag cc 480 Pro Thr Ile Gln His Leu Thr Lys Pro Glu 120 125 94 129 PRT Physcomitrella patens 94 Met Glu Ser Leu Ala Leu Arg Ser Ala Val Val Ala Thr Gly Leu Thr 1 5 10 15 Ser Ser Val Ala Ser Gln Thr Ser Val Gln Thr Arg Ala Thr Val Ser 20 25 30 Ser Ala Phe Ile Gly Lys Ser Ile Arg Val Asn Thr Lys Leu Asn Ala 35 40 45 Ser Ala Val Pro Val Gln Gln Lys Phe Arg Tyr Val Arg Ala Asp Ala 50 55 60 Gly Ala Gln Thr Ala Gln Val Glu Thr Val Glu Lys Lys Ala Ser Ile 65 70 75 80 Lys Asp Val Pro Glu Ser Glu Phe Gln Gly Lys Val Val Phe Val Arg 85 90 95 Ala Asp Leu Asn Val Pro Leu Asn Asp Ala Cys Glu Ile Thr Asp Asp 100 105 110 Thr Arg Ile Arg Ala Ser Leu Pro Thr Ile Gln His Leu Thr Lys Pro 115 120 125 Glu 95 444 DNA Physcomitrella patens CDS (200)..(442) 18_ck26_c09fwd 95 cctccactca cttttttcgt tcctccacgc catcgttgag tgaataagca acagttggga 60 gtcggcagtt gagcagcagg agttgagagc tccttttgtc tgagcggcag ttgttgtccc 120 tggacacgcg atcgcagcga acgcatcgag atcgttgcgg ttttgtttgc atttagaaat 180 catggtcgct gctgtcggg atg tcg cag gtc tcc tcc tcc ggt att aaa tgg 232 Met Ser Gln Val Ser Ser Ser Gly Ile Lys Trp 1 5 10 agc ttc tgt ggg act tcg ctg gag agg aag gcc gct gcc gct tct aag 280 Ser Phe Cys Gly Thr Ser Leu Glu Arg Lys Ala Ala Ala Ala Ser Lys 15 20 25 gcg acg aat gta gcg ttc gct gtg cgt gcc gct ggt tat gac gag gag 328 Ala Thr Asn Val Ala Phe Ala Val Arg Ala Ala Gly Tyr Asp Glu Glu 30 35 40 ctc gtg aag acc gcg aaa acg atc gcg tca ccc ggg cgc ggg atc ttg 376 Leu Val Lys Thr Ala Lys Thr Ile Ala Ser Pro Gly Arg Gly Ile Leu 45 50 55 gcc atc gac gag tcg aat gct acg tgt ggc aag cgg ctg gcc tcg gtt 424 Ala Ile Asp Glu Ser Asn Ala Thr Cys Gly Lys Arg Leu Ala Ser Val 60 65 70 75 ggg ctg gaa gaa caa cga gg 444 Gly Leu Glu Glu Gln Arg 80 96 81 PRT Physcomitrella patens 96 Met Ser Gln Val Ser Ser Ser Gly Ile Lys Trp Ser Phe Cys Gly Thr 1 5 10 15 Ser Leu Glu Arg Lys Ala Ala Ala Ala Ser Lys Ala Thr Asn Val Ala 20 25 30 Phe Ala Val Arg Ala Ala Gly Tyr Asp Glu Glu Leu Val Lys Thr Ala 35 40 45 Lys Thr Ile Ala Ser Pro Gly Arg Gly Ile Leu Ala Ile Asp Glu Ser 50 55 60 Asn Ala Thr Cys Gly Lys Arg Leu Ala Ser Val Gly Leu Glu Glu Gln 65 70 75 80 Arg 97 403 DNA Physcomitrella patens CDS (74)..(403) 60_ppgam17_b12 97 cgggacgact cccttgttag tttgtgttct gcctcctgat tcatctctcc aggctgcaat 60 ggctgccgtc ggt atg acc atg tcg ctc agg agc agc acc acc ctc aag 109 Met Thr Met Ser Leu Arg Ser Ser Thr Thr Leu Lys 1 5 10 ggt gaa ttc tgt ggc gcg gct gtg agg cag agc gtc gcc gcc ccc aag 157 Gly Glu Phe Cys Gly Ala Ala Val Arg Gln Ser Val Ala Ala Pro Lys 15 20 25 gct gcc aat gtg gcg ttc gcc gtg cgc gct gga cag tat gac gat gag 205 Ala Ala Asn Val Ala Phe Ala Val Arg Ala Gly Gln Tyr Asp Asp Glu 30 35 40 ctt gtt aag acc gcg aac acc att gcc acc aag ggt aag ggt atc ttg 253 Leu Val Lys Thr Ala Asn Thr Ile Ala Thr Lys Gly Lys Gly Ile Leu 45 50 55 60 gcc atg gac gag tcc aat gcc acc tgc ggc aag cgt ctg gag tcg atc 301 Ala Met Asp Glu Ser Asn Ala Thr Cys Gly Lys Arg Leu Glu Ser Ile 65 70 75 ggt ttg gag aac acg gaa gcc aac cgt cag gcg tac agg caa ttg ttg 349 Gly Leu Glu Asn Thr Glu Ala Asn Arg Gln Ala Tyr Arg Gln Leu Leu 80 85 90 gtg acc acc ccc gat ctt ggt gac tac atc tct gga gcc atc ctc ttc 397 Val Thr Thr Pro Asp Leu Gly Asp Tyr Ile Ser Gly Ala Ile Leu Phe 95 100 105 gag gag 403 Glu Glu 110 98 110 PRT Physcomitrella patens 98 Met Thr Met Ser Leu Arg Ser Ser Thr Thr Leu Lys Gly Glu Phe Cys 1 5 10 15 Gly Ala Ala Val Arg Gln Ser Val Ala Ala Pro Lys Ala Ala Asn Val 20 25 30 Ala Phe Ala Val Arg Ala Gly Gln Tyr Asp Asp Glu Leu Val Lys Thr 35 40 45 Ala Asn Thr Ile Ala Thr Lys Gly Lys Gly Ile Leu Ala Met Asp Glu 50 55 60 Ser Asn Ala Thr Cys Gly Lys Arg Leu Glu Ser Ile Gly Leu Glu Asn 65 70 75 80 Thr Glu Ala Asn Arg Gln Ala Tyr Arg Gln Leu Leu Val Thr Thr Pro 85 90 95 Asp Leu Gly Asp Tyr Ile Ser Gly Ala Ile Leu Phe Glu Glu 100 105 110 99 228 DNA Physcomitrella patens CDS (2)..(169) 50_ck19_a10fwd 99 t gcc gga ggc tac agt agt gat ggc aag caa tct gtt ctg gac aag gtg 49 Ala Gly Gly Tyr Ser Ser Asp Gly Lys Gln Ser Val Leu Asp Lys Val 1 5 10 15 gtg gtg aac acc gac gac aga acc cag gtt gca tat ggg tct cgc gat 97 Val Val Asn Thr Asp Asp Arg Thr Gln Val Ala Tyr Gly Ser Arg Asp 20 25 30 gag atc atc cgc ttc gag gaa acg ttg tat ggc gac tcc agg ctc aag 145 Glu Ile Ile Arg Phe Glu Glu Thr Leu Tyr Gly Asp Ser Arg Leu Lys 35 40 45 gct gag ctc gcc gct gcc act gtg tagattgttt ttgtatctct ttttttgcac 199 Ala Glu Leu Ala Ala Ala Thr Val 50 55 tttttttaat ttttttttta ttatttttt 228 100 56 PRT Physcomitrella patens 100 Ala Gly Gly Tyr Ser Ser Asp Gly Lys Gln Ser Val Leu Asp Lys Val 1 5 10 15 Val Val Asn Thr Asp Asp Arg Thr Gln Val Ala Tyr Gly Ser Arg Asp 20 25 30 Glu Ile Ile Arg Phe Glu Glu Thr Leu Tyr Gly Asp Ser Arg Leu Lys 35 40 45 Ala Glu Leu Ala Ala Ala Thr Val 50 55 101 574 DNA Physcomitrella patens CDS (65)..(574) 35_ck11_f03fwd 101 gtgattgtgt attgagagtc gaattccttc ttgctttgtg cgttgtcgag gagctgaagc 60 agct atg gcg acc aca caa gcg att ctc tct gcc acc ctt gcc ata gcc 109 Met Ala Thr Thr Gln Ala Ile Leu Ser Ala Thr Leu Ala Ile Ala 1 5 10 15 ccg gct tcc agc tgc gag act tcg tca cgg agc ccg gcg tcc acc aaa 157 Pro Ala Ser Ser Cys Glu Thr Ser Ser Arg Ser Pro Ala Ser Thr Lys 20 25 30 act tgt ctc tca gtg gca gga tcg tcg ctg cat ggc tca gtg gcc gga 205 Thr Cys Leu Ser Val Ala Gly Ser Ser Leu His Gly Ser Val Ala Gly 35 40 45 ctc gga gct ggg aaa cag att gtg agc gtg cag agg aag agc gtt gcc 253 Leu Gly Ala Gly Lys Gln Ile Val Ser Val Gln Arg Lys Ser Val Ala 50 55 60 gtg agg gcc gcc gtt gca gct gag act gcc gct ccc aag cag cag gcg 301 Val Arg Ala Ala Val Ala Ala Glu Thr Ala Ala Pro Lys Gln Gln Ala 65 70 75 aag agc cag tat gac atc act acc ctg acg acg tgg ttg ctg aag aaa 349 Lys Ser Gln Tyr Asp Ile Thr Thr Leu Thr Thr Trp Leu Leu Lys Lys 80 85 90 95 gag cag gcg ggc gtc atc gat ggc gag ctc acc att gtg ctc tcc agc 397 Glu Gln Ala Gly Val Ile Asp Gly Glu Leu Thr Ile Val Leu Ser Ser 100 105 110 atc gcc ctg gct tgc aag caa att gcg tct ctg gtg cag agg gct ggc 445 Ile Ala Leu Ala Cys Lys Gln Ile Ala Ser Leu Val Gln Arg Ala Gly 115 120 125 atc tcc aac atg act ggg ttg caa gga gct gct aac att caa ggg gag 493 Ile Ser Asn Met Thr Gly Leu Gln Gly Ala Ala Asn Ile Gln Gly Glu 130 135 140 gac cag aag aag cta gac gtt att tcg aac gag gtg ttc tca agc tgt 541 Asp Gln Lys Lys Leu Asp Val Ile Ser Asn Glu Val Phe Ser Ser Cys 145 150 155 ctg cgc tca agc gga cgg aca ggc atc atc gct 574 Leu Arg Ser Ser Gly Arg Thr Gly Ile Ile Ala 160 165 170 102 170 PRT Physcomitrella patens 102 Met Ala Thr Thr Gln Ala Ile Leu Ser Ala Thr Leu Ala Ile Ala Pro 1 5 10 15 Ala Ser Ser Cys Glu Thr Ser Ser Arg Ser Pro Ala Ser Thr Lys Thr 20 25 30 Cys Leu Ser Val Ala Gly Ser Ser Leu His Gly Ser Val Ala Gly Leu 35 40 45 Gly Ala Gly Lys Gln Ile Val Ser Val Gln Arg Lys Ser Val Ala Val 50 55 60 Arg Ala Ala Val Ala Ala Glu Thr Ala Ala Pro Lys Gln Gln Ala Lys 65 70 75 80 Ser Gln Tyr Asp Ile Thr Thr Leu Thr Thr Trp Leu Leu Lys Lys Glu 85 90 95 Gln Ala Gly Val Ile Asp Gly Glu Leu Thr Ile Val Leu Ser Ser Ile 100 105 110 Ala Leu Ala Cys Lys Gln Ile Ala Ser Leu Val Gln Arg Ala Gly Ile 115 120 125 Ser Asn Met Thr Gly Leu Gln Gly Ala Ala Asn Ile Gln Gly Glu Asp 130 135 140 Gln Lys Lys Leu Asp Val Ile Ser Asn Glu Val Phe Ser Ser Cys Leu 145 150 155 160 Arg Ser Ser Gly Arg Thr Gly Ile Ile Ala 165 170 103 568 DNA Physcomitrella patens CDS (3)..(245) 20_ppprot1_083_d07 103 ca ata caa agg tta gag cca gtg att att gaa ctt gag aga cag cgt 47 Ile Gln Arg Leu Glu Pro Val Ile Ile Glu Leu Glu Arg Gln Arg 1 5 10 15 tcg cct gta gtt gtc att gcg cat caa gca att cta cgc tct cta tat 95 Ser Pro Val Val Val Ile Ala His Gln Ala Ile Leu Arg Ser Leu Tyr 20 25 30 gcg tac ttt gca gac aaa cct ctg aaa gag gta ccg cat att gag atg 143 Ala Tyr Phe Ala Asp Lys Pro Leu Lys Glu Val Pro His Ile Glu Met 35 40 45 cca ctg cat act att att aag att caa atg gga gtt act ggt gtt cag 191 Pro Leu His Thr Ile Ile Lys Ile Gln Met Gly Val Thr Gly Val Gln 50 55 60 gag aag cga tac aag ctc atg gag acc cag agc acc aaa tac ggt gaa 239 Glu Lys Arg Tyr Lys Leu Met Glu Thr Gln Ser Thr Lys Tyr Gly Glu 65 70 75 ttc cca tgagtatggc agtcctaagc agttttctct agcaatttac gactccaacg 295 Phe Pro 80 acgagctttc aaacaagcca tgtagttttg aggaccatag gaaatgcttg ataaacttaa 355 tgaaatcaca gcaacctgct attcgaattt tattttgtgc agtaattaca taggaaatca 415 tttcattact gaacttgatt ttacatcatg gctttctata ttctagtatt tactttgcgt 475 gcactccgca ctatttcgtg ggatagaatc agtattcttt tgtatcatta ttctagaaat 535 ttaagtaatg caaaacatgc gtttaaaaaa aaa 568 104 81 PRT Physcomitrella patens 104 Ile Gln Arg Leu Glu Pro Val Ile Ile Glu Leu Glu Arg Gln Arg Ser 1 5 10 15 Pro Val Val Val Ile Ala His Gln Ala Ile Leu Arg Ser Leu Tyr Ala 20 25 30 Tyr Phe Ala Asp Lys Pro Leu Lys Glu Val Pro His Ile Glu Met Pro 35 40 45 Leu His Thr Ile Ile Lys Ile Gln Met Gly Val Thr Gly Val Gln Glu 50 55 60 Lys Arg Tyr Lys Leu Met Glu Thr Gln Ser Thr Lys Tyr Gly Glu Phe 65 70 75 80 Pro 105 182 DNA Physcomitrella patens CDS (3)..(182) 14_ck4_c07fwd 105 ag tac cgg gag ctt gcg cat aga atc gac gag gct ttg ggc ttc atg 47 Tyr Arg Glu Leu Ala His Arg Ile Asp Glu Ala Leu Gly Phe Met 1 5 10 15 tcc gcg tgc ggg ctc acc ctg gat cac cca atc atg acc tcc act caa 95 Ser Ala Cys Gly Leu Thr Leu Asp His Pro Ile Met Thr Ser Thr Gln 20 25 30 ttc tgg acc tct cac gaa tgc ctg ctg ctc cca tac gag caa gcc ctc 143 Phe Trp Thr Ser His Glu Cys Leu Leu Leu Pro Tyr Glu Gln Ala Leu 35 40 45 acc cga gag gat tct acc tcg gga tta tgg tac gtc tgc 182 Thr Arg Glu Asp Ser Thr Ser Gly Leu Trp Tyr Val Cys 50 55 60 106 60 PRT Physcomitrella patens 106 Tyr Arg Glu Leu Ala His Arg Ile Asp Glu Ala Leu Gly Phe Met Ser 1 5 10 15 Ala Cys Gly Leu Thr Leu Asp His Pro Ile Met Thr Ser Thr Gln Phe 20 25 30 Trp Thr Ser His Glu Cys Leu Leu Leu Pro Tyr Glu Gln Ala Leu Thr 35 40 45 Arg Glu Asp Ser Thr Ser Gly Leu Trp Tyr Val Cys 50 55 60 107 548 DNA Physcomitrella patens CDS (2)..(424) 89_ck12_g06fwd 107 c aag gtt cgg ctc gca gga aac ccc aat gta atg gtg tgc gag aga ggc 49 Lys Val Arg Leu Ala Gly Asn Pro Asn Val Met Val Cys Glu Arg Gly 1 5 10 15 acc atg ttc ggc tac aat gac cta att gtg gat ccc cgg aac ttg gag 97 Thr Met Phe Gly Tyr Asn Asp Leu Ile Val Asp Pro Arg Asn Leu Glu 20 25 30 tgg atg cga gaa gcg ggt gct ccc gtt gtt gca gat atc act cat tct 145 Trp Met Arg Glu Ala Gly Ala Pro Val Val Ala Asp Ile Thr His Ser 35 40 45 cta caa cag ccg gct ggg caa cag ctg gag gga gga ggc gtt gcg agc 193 Leu Gln Gln Pro Ala Gly Gln Gln Leu Glu Gly Gly Gly Val Ala Ser 50 55 60 ggt ggc ctg cgc gag ctc atc ccc tgc att gcc cgg gct tgt gtg gcc 241 Gly Gly Leu Arg Glu Leu Ile Pro Cys Ile Ala Arg Ala Cys Val Ala 65 70 75 80 gta gga gta gac ggc atc ttc atg gag gtg cac gac aac ccc agg cag 289 Val Gly Val Asp Gly Ile Phe Met Glu Val His Asp Asn Pro Arg Gln 85 90 95 gcg ccc tgc gat ggc cct acg caa tgg ccc ttg cgt aac ctt aag aac 337 Ala Pro Cys Asp Gly Pro Thr Gln Trp Pro Leu Arg Asn Leu Lys Asn 100 105 110 ctg ctg gag gag ctc atc gct atc gcc aag gtt acc aag ggg aag gag 385 Leu Leu Glu Glu Leu Ile Ala Ile Ala Lys Val Thr Lys Gly Lys Glu 115 120 125 agg atg gcg att gac ctc act cct gtc gac gaa gac ttc tagcttctac 434 Arg Met Ala Ile Asp Leu Thr Pro Val Asp Glu Asp Phe 130 135 140 gaacccaatt gagttctcag ctttgcaatc acacttggag gtggcacttg caaggtttac 494 tccacatatg cattccactc gatttggagt cttgagtgca gccattgagc aaca 548 108 141 PRT Physcomitrella patens 108 Lys Val Arg Leu Ala Gly Asn Pro Asn Val Met Val Cys Glu Arg Gly 1 5 10 15 Thr Met Phe Gly Tyr Asn Asp Leu Ile Val Asp Pro Arg Asn Leu Glu 20 25 30 Trp Met Arg Glu Ala Gly Ala Pro Val Val Ala Asp Ile Thr His Ser 35 40 45 Leu Gln Gln Pro Ala Gly Gln Gln Leu Glu Gly Gly Gly Val Ala Ser 50 55 60 Gly Gly Leu Arg Glu Leu Ile Pro Cys Ile Ala Arg Ala Cys Val Ala 65 70 75 80 Val Gly Val Asp Gly Ile Phe Met Glu Val His Asp Asn Pro Arg Gln 85 90 95 Ala Pro Cys Asp Gly Pro Thr Gln Trp Pro Leu Arg Asn Leu Lys Asn 100 105 110 Leu Leu Glu Glu Leu Ile Ala Ile Ala Lys Val Thr Lys Gly Lys Glu 115 120 125 Arg Met Ala Ile Asp Leu Thr Pro Val Asp Glu Asp Phe 130 135 140 109 343 DNA Physcomitrella patens CDS (76)..(342) 55_bd01_b04rev 109 ccgccccagt atttagtgtg cgagcaaatt tgaattgcgg gggtcctgaa gtctgttgta 60 aagttgcaag gagcg atg gtg acg atg aca atg aca ggg gct gcc ttg gga 111 Met Val Thr Met Thr Met Thr Gly Ala Ala Leu Gly 1 5 10 ggg tgc acg gcg aaa att act gcg cag agc agc ttc tgg ggc gaa agg 159 Gly Cys Thr Ala Lys Ile Thr Ala Gln Ser Ser Phe Trp Gly Glu Arg 15 20 25 cag cgc tct gtc aag gtc tcc gcc acc acg agt gga agg gcg gcg atg 207 Gln Arg Ser Val Lys Val Ser Ala Thr Thr Ser Gly Arg Ala Ala Met 30 35 40 cca gca att gag gca act cac cgt gtt gat aag ttc tca aag aat gac 255 Pro Ala Ile Glu Ala Thr His Arg Val Asp Lys Phe Ser Lys Asn Asp 45 50 55 60 atc atc gtt tcg ccc tct atc cta tca gct aac ttc gcc aag ttg gga 303 Ile Ile Val Ser Pro Ser Ile Leu Ser Ala Asn Phe Ala Lys Leu Gly 65 70 75 gag cag atc aag gct gtg gaa aac gcc gga tgc gac tgg a 343 Glu Gln Ile Lys Ala Val Glu Asn Ala Gly Cys Asp Trp 80 85 110 89 PRT Physcomitrella patens 110 Met Val Thr Met Thr Met Thr Gly Ala Ala Leu Gly Gly Cys Thr Ala 1 5 10 15 Lys Ile Thr Ala Gln Ser Ser Phe Trp Gly Glu Arg Gln Arg Ser Val 20 25 30 Lys Val Ser Ala Thr Thr Ser Gly Arg Ala Ala Met Pro Ala Ile Glu 35 40 45 Ala Thr His Arg Val Asp Lys Phe Ser Lys Asn Asp Ile Ile Val Ser 50 55 60 Pro Ser Ile Leu Ser Ala Asn Phe Ala Lys Leu Gly Glu Gln Ile Lys 65 70 75 80 Ala Val Glu Asn Ala Gly Cys Asp Trp 85 111 576 DNA Physcomitrella patens CDS (1)..(576) 50_mm15_a10rev 111 ggc aaa ggc gtc gca atc gac ggc acg cgt tta cct ttc gaa gcg ggg 48 Gly Lys Gly Val Ala Ile Asp Gly Thr Arg Leu Pro Phe Glu Ala Gly 1 5 10 15 gag att gaa ttt ggg gag ccc ggc acg aac ggc cag cac agc ttc tac 96 Glu Ile Glu Phe Gly Glu Pro Gly Thr Asn Gly Gln His Ser Phe Tyr 20 25 30 cag ctg atc cac cag ggg cgc acc atc ccc tgc gac ttt att ggc tcc 144 Gln Leu Ile His Gln Gly Arg Thr Ile Pro Cys Asp Phe Ile Gly Ser 35 40 45 gtg aag agt cag aag cct atc tac atg atc ggg gag aag gtg agc aac 192 Val Lys Ser Gln Lys Pro Ile Tyr Met Ile Gly Glu Lys Val Ser Asn 50 55 60 cac gac gag ctc atg tca aat ttc ttc gct caa gca gat gct ctc gcc 240 His Asp Glu Leu Met Ser Asn Phe Phe Ala Gln Ala Asp Ala Leu Ala 65 70 75 80 tac ggc aag acg cgg gag gat ctg caa gcc gag aat gtg aag gag tct 288 Tyr Gly Lys Thr Arg Glu Asp Leu Gln Ala Glu Asn Val Lys Glu Ser 85 90 95 cta gtc cct cac aag gtt ttc act ggc aat cgc ccc tcc ttg agc att 336 Leu Val Pro His Lys Val Phe Thr Gly Asn Arg Pro Ser Leu Ser Ile 100 105 110 ctc ctc ccc gcg ctc aac gcc tac acc gtt ggc cag ctg cta tcc ctc 384 Leu Leu Pro Ala Leu Asn Ala Tyr Thr Val Gly Gln Leu Leu Ser Leu 115 120 125 tac gag aac cga atc gca gta cag gga ttc gtg tgg ggc att aac tca 432 Tyr Glu Asn Arg Ile Ala Val Gln Gly Phe Val Trp Gly Ile Asn Ser 130 135 140 ttc gac caa tgg ggc gtg gag ctc ggc aaa agc ttg gct acc aag gtg 480 Phe Asp Gln Trp Gly Val Glu Leu Gly Lys Ser Leu Ala Thr Lys Val 145 150 155 160 cgc tcg cag ctg aac gaa gca cgc acg aag gac gct ccc gtg caa gga 528 Arg Ser Gln Leu Asn Glu Ala Arg Thr Lys Asp Ala Pro Val Gln Gly 165 170 175 ttc aac tac agc acc acg tat ctc ttt gaa gca cta ctt aaa ggg gaa 576 Phe Asn Tyr Ser Thr Thr Tyr Leu Phe Glu Ala Leu Leu Lys Gly Glu 180 185 190 112 192 PRT Physcomitrella patens 112 Gly Lys Gly Val Ala Ile Asp Gly Thr Arg Leu Pro Phe Glu Ala Gly 1 5 10 15 Glu Ile Glu Phe Gly Glu Pro Gly Thr Asn Gly Gln His Ser Phe Tyr 20 25 30 Gln Leu Ile His Gln Gly Arg Thr Ile Pro Cys Asp Phe Ile Gly Ser 35 40 45 Val Lys Ser Gln Lys Pro Ile Tyr Met Ile Gly Glu Lys Val Ser Asn 50 55 60 His Asp Glu Leu Met Ser Asn Phe Phe Ala Gln Ala Asp Ala Leu Ala 65 70 75 80 Tyr Gly Lys Thr Arg Glu Asp Leu Gln Ala Glu Asn Val Lys Glu Ser 85 90 95 Leu Val Pro His Lys Val Phe Thr Gly Asn Arg Pro Ser Leu Ser Ile 100 105 110 Leu Leu Pro Ala Leu Asn Ala Tyr Thr Val Gly Gln Leu Leu Ser Leu 115 120 125 Tyr Glu Asn Arg Ile Ala Val Gln Gly Phe Val Trp Gly Ile Asn Ser 130 135 140 Phe Asp Gln Trp Gly Val Glu Leu Gly Lys Ser Leu Ala Thr Lys Val 145 150 155 160 Arg Ser Gln Leu Asn Glu Ala Arg Thr Lys Asp Ala Pro Val Gln Gly 165 170 175 Phe Asn Tyr Ser Thr Thr Tyr Leu Phe Glu Ala Leu Leu Lys Gly Glu 180 185 190 113 454 DNA Physcomitrella patens CDS (239)..(454) 86_ck23_g10fwd 113 attgcatagt gtccccgcag cagcagcagc tatggcgtcc accatgttgg agtctcatct 60 ggtctctagc gtcacattgc gggtagcagc agcacctcgc aattcggcag cctcggcctc 120 ggcctctgcc acagcgcagg ctgtgccttg caaggcactg ggagcgtcgt catctacgtt 180 gcttcgtggc gggcaactga ggacgggttt cgtggctgtg cacagaaggc cttgcacg 238 atg gcc ttc cgt ccc cgt gcg caa tcg caa ggt acc aag ctt aca cag 286 Met Ala Phe Arg Pro Arg Ala Gln Ser Gln Gly Thr Lys Leu Thr Gln 1 5 10 15 gat gaa ctc aag aag att gct gcc gag aag gct gtg gaa tat gtc aag 334 Asp Glu Leu Lys Lys Ile Ala Ala Glu Lys Ala Val Glu Tyr Val Lys 20 25 30 agt ggc atg gtc ttg ggt ttg ggc aca ggt tct aca gct gca ttt gca 382 Ser Gly Met Val Leu Gly Leu Gly Thr Gly Ser Thr Ala Ala Phe Ala 35 40 45 gtg gca aag att ggc gag ctt ttg aag gaa gga aag ctg acg gat att 430 Val Ala Lys Ile Gly Glu Leu Leu Lys Glu Gly Lys Leu Thr Asp Ile 50 55 60 gtt gga gtg cct acc tca aag aga 454 Val Gly Val Pro Thr Ser Lys Arg 65 70 114 72 PRT Physcomitrella patens 114 Met Ala Phe Arg Pro Arg Ala Gln Ser Gln Gly Thr Lys Leu Thr Gln 1 5 10 15 Asp Glu Leu Lys Lys Ile Ala Ala Glu Lys Ala Val Glu Tyr Val Lys 20 25 30 Ser Gly Met Val Leu Gly Leu Gly Thr Gly Ser Thr Ala Ala Phe Ala 35 40 45 Val Ala Lys Ile Gly Glu Leu Leu Lys Glu Gly Lys Leu Thr Asp Ile 50 55 60 Val Gly Val Pro Thr Ser Lys Arg 65 70 115 341 DNA Physcomitrella patens CDS (1)..(336) 22_ppgam15_d08 115 cag aaa ata aat cct tgg att tac cag atc att aga gtg tac aag aat 48 Gln Lys Ile Asn Pro Trp Ile Tyr Gln Ile Ile Arg Val Tyr Lys Asn 1 5 10 15 aag gaa cat gct gaa gtt gaa ttc act gtg ggt ccc ata cct att gaa 96 Lys Glu His Ala Glu Val Glu Phe Thr Val Gly Pro Ile Pro Ile Glu 20 25 30 gat gga gtt ggg aaa gag att gtc act cag atc tca acc acc ata aat 144 Asp Gly Val Gly Lys Glu Ile Val Thr Gln Ile Ser Thr Thr Ile Asn 35 40 45 agt aac aaa aga ttt tac tct gat tct aac ggc cga gac ttc att gaa 192 Ser Asn Lys Arg Phe Tyr Ser Asp Ser Asn Gly Arg Asp Phe Ile Glu 50 55 60 cgg att cga gac tac aga gct gac tgg gat ctt gaa gtg aat caa cca 240 Arg Ile Arg Asp Tyr Arg Ala Asp Trp Asp Leu Glu Val Asn Gln Pro 65 70 75 80 att gca gga aat tat tat cct ata aat ctt gga att tac ctg aaa gat 288 Ile Ala Gly Asn Tyr Tyr Pro Ile Asn Leu Gly Ile Tyr Leu Lys Asp 85 90 95 gat aac aat gag ttc tcg atc ttg gta cat aga tct gtt ggt gga tcc 336 Asp Asn Asn Glu Phe Ser Ile Leu Val His Arg Ser Val Gly Gly Ser 100 105 110 catgt 341 116 112 PRT Physcomitrella patens 116 Gln Lys Ile Asn Pro Trp Ile Tyr Gln Ile Ile Arg Val Tyr Lys Asn 1 5 10 15 Lys Glu His Ala Glu Val Glu Phe Thr Val Gly Pro Ile Pro Ile Glu 20 25 30 Asp Gly Val Gly Lys Glu Ile Val Thr Gln Ile Ser Thr Thr Ile Asn 35 40 45 Ser Asn Lys Arg Phe Tyr Ser Asp Ser Asn Gly Arg Asp Phe Ile Glu 50 55 60 Arg Ile Arg Asp Tyr Arg Ala Asp Trp Asp Leu Glu Val Asn Gln Pro 65 70 75 80 Ile Ala Gly Asn Tyr Tyr Pro Ile Asn Leu Gly Ile Tyr Leu Lys Asp 85 90 95 Asp Asn Asn Glu Phe Ser Ile Leu Val His Arg Ser Val Gly Gly Ser 100 105 110 117 467 DNA Physcomitrella patens CDS (2)..(466) 70_ck11_d11fwd 117 g ctg aag ttg gtt gag ccc tgc gcc gcg atg acg aag gac ctc tac ttc 49 Leu Lys Leu Val Glu Pro Cys Ala Ala Met Thr Lys Asp Leu Tyr Phe 1 5 10 15 agg tcc atc gtc ccc atc ggc ctc ctc ttc tcg ctc tct ctg tgg ttc 97 Arg Ser Ile Val Pro Ile Gly Leu Leu Phe Ser Leu Ser Leu Trp Phe 20 25 30 tcg aat tcg gct tac atc tac ctt agc gtc tcc ttc atc cag atg ctc 145 Ser Asn Ser Ala Tyr Ile Tyr Leu Ser Val Ser Phe Ile Gln Met Leu 35 40 45 aag gcg ctc atg ccg gtg gca gtc tac tct ctt ggg gta ctt ttc aag 193 Lys Ala Leu Met Pro Val Ala Val Tyr Ser Leu Gly Val Leu Phe Lys 50 55 60 aag gat gta ttc aac tct tcg acc atg gct aac atg gtc atg atc tcc 241 Lys Asp Val Phe Asn Ser Ser Thr Met Ala Asn Met Val Met Ile Ser 65 70 75 80 att ggt gtc gcc att gcg gcc tac ggg gag gcg cgg ttc aat gtc tgg 289 Ile Gly Val Ala Ile Ala Ala Tyr Gly Glu Ala Arg Phe Asn Val Trp 85 90 95 ggt gtc acg ctg cag ctt gcg gct gta tgc gtg gaa gcc ctc cgt ctt 337 Gly Val Thr Leu Gln Leu Ala Ala Val Cys Val Glu Ala Leu Arg Leu 100 105 110 gtc ttg atc caa att ctt ctc aac tcc cgg gga att tcc ctc aat ccc 385 Val Leu Ile Gln Ile Leu Leu Asn Ser Arg Gly Ile Ser Leu Asn Pro 115 120 125 att aca aca ctc tat tac gtc gcg ccc gcg tgt ttt gtc ttc ctc tct 433 Ile Thr Thr Leu Tyr Tyr Val Ala Pro Ala Cys Phe Val Phe Leu Ser 130 135 140 gtc cct tgg tat ctc atc gaa tgg ccg aag ctg c 467 Val Pro Trp Tyr Leu Ile Glu Trp Pro Lys Leu 145 150 155 118 155 PRT Physcomitrella patens 118 Leu Lys Leu Val Glu Pro Cys Ala Ala Met Thr Lys Asp Leu Tyr Phe 1 5 10 15 Arg Ser Ile Val Pro Ile Gly Leu Leu Phe Ser Leu Ser Leu Trp Phe 20 25 30 Ser Asn Ser Ala Tyr Ile Tyr Leu Ser Val Ser Phe Ile Gln Met Leu 35 40 45 Lys Ala Leu Met Pro Val Ala Val Tyr Ser Leu Gly Val Leu Phe Lys 50 55 60 Lys Asp Val Phe Asn Ser Ser Thr Met Ala Asn Met Val Met Ile Ser 65 70 75 80 Ile Gly Val Ala Ile Ala Ala Tyr Gly Glu Ala Arg Phe Asn Val Trp 85 90 95 Gly Val Thr Leu Gln Leu Ala Ala Val Cys Val Glu Ala Leu Arg Leu 100 105 110 Val Leu Ile Gln Ile Leu Leu Asn Ser Arg Gly Ile Ser Leu Asn Pro 115 120 125 Ile Thr Thr Leu Tyr Tyr Val Ala Pro Ala Cys Phe Val Phe Leu Ser 130 135 140 Val Pro Trp Tyr Leu Ile Glu Trp Pro Lys Leu 145 150 155 119 591 DNA Physcomitrella patens CDS (3)..(284) 29_ck12_e03fwd 119 tg gcg agt ttc ttg ttg gga tgg gga atc acg atc gga gcg ggt ctg 47 Ala Ser Phe Leu Leu Gly Trp Gly Ile Thr Ile Gly Ala Gly Leu 1 5 10 15 gcg tcg tac ccc atc gac acg gtt cgg cgt agg atg atg atg acc tcc 95 Ala Ser Tyr Pro Ile Asp Thr Val Arg Arg Arg Met Met Met Thr Ser 20 25 30 gga gag gca gtg aag tac aac ggg tcg atg gac gcg ttc aag cag att 143 Gly Glu Ala Val Lys Tyr Asn Gly Ser Met Asp Ala Phe Lys Gln Ile 35 40 45 ttg gcg aag gag gga gcg aag tcg ttg ttc aag ggc gct ggt gcg aac 191 Leu Ala Lys Glu Gly Ala Lys Ser Leu Phe Lys Gly Ala Gly Ala Asn 50 55 60 atc ctt cgt gcg gtg gct gga gcc gga gtg ttg tcg gga tac gat cag 239 Ile Leu Arg Ala Val Ala Gly Ala Gly Val Leu Ser Gly Tyr Asp Gln 65 70 75 ttg cag atc ttg ctt ctg ggc aag gcc tac tct gga ggc agc ggc 284 Leu Gln Ile Leu Leu Leu Gly Lys Ala Tyr Ser Gly Gly Ser Gly 80 85 90 tgagtgcttc gtagcggatt atgaagagaa ttttgttgcc ctggtcaatc tttaatttag 344 cactttcttt tttgtagtgt aactttttga gttctttcgc gttctgacta tcatagtgca 404 catgcgtata gtgcgctgag ctggttatcg tgttagtttt gtgtcttcga attaacttcg 464 agattactca acttaggcgc cataatgtgc ttatttacaa ctcttatgaa gcaagaattg 524 ctggcttctg gttcgtccat tgtgctctct ttttatcttc atttaatatc attctataca 584 cctcaac 591 120 94 PRT Physcomitrella patens 120 Ala Ser Phe Leu Leu Gly Trp Gly Ile Thr Ile Gly Ala Gly Leu Ala 1 5 10 15 Ser Tyr Pro Ile Asp Thr Val Arg Arg Arg Met Met Met Thr Ser Gly 20 25 30 Glu Ala Val Lys Tyr Asn Gly Ser Met Asp Ala Phe Lys Gln Ile Leu 35 40 45 Ala Lys Glu Gly Ala Lys Ser Leu Phe Lys Gly Ala Gly Ala Asn Ile 50 55 60 Leu Arg Ala Val Ala Gly Ala Gly Val Leu Ser Gly Tyr Asp Gln Leu 65 70 75 80 Gln Ile Leu Leu Leu Gly Lys Ala Tyr Ser Gly Gly Ser Gly 85 90 121 527 DNA Physcomitrella patens CDS (3)..(161) 07_ppprot1_057_b01 121 ct tgg gac gag ctc ttt ggc ggg ggc aac atg ccg gcc ttt ttg ttt 47 Trp Asp Glu Leu Phe Gly Gly Gly Asn Met Pro Ala Phe Leu Phe 1 5 10 15 gga gct gtg gct gct ttt atc ggg ggc atc gca gcc gtg ctt ctc cta 95 Gly Ala Val Ala Ala Phe Ile Gly Gly Ile Ala Ala Val Leu Leu Leu 20 25 30 cct cgc cct ccg ccc gat ttt acc acc agg aac cgg ctt cgc agg act 143 Pro Arg Pro Pro Pro Asp Phe Thr Thr Arg Asn Arg Leu Arg Arg Thr 35 40 45 cac agt tcc cct att cct tgaacttgta gagtttatcg ttcctttgaa 191 His Ser Ser Pro Ile Pro 50 ttgtagtgcc ttcgttttcg tgtagaaggt cataaattat ggcaggttgc agtgattttt 251 agacttcgaa ttttatgaat cagtctgtga taaggtcttc gatccgccag agtgttgatt 311 ggtatattgt gtatgataaa gtaggtgatg ttcacatgtg atatggtggt taagggagca 371 actaagtcgc agtgctgctg aaacccaaat cttagagttt tgttcgaagt ctatcggttc 431 aaattcaaat ggactaaata ccgtgctgca atcaatgcta ggtcggtttt ttttcgtatg 491 ctgaaaatag aattatcctg ttttaaaatt gttaac 527 122 53 PRT Physcomitrella patens 122 Trp Asp Glu Leu Phe Gly Gly Gly Asn Met Pro Ala Phe Leu Phe Gly 1 5 10 15 Ala Val Ala Ala Phe Ile Gly Gly Ile Ala Ala Val Leu Leu Leu Pro 20 25 30 Arg Pro Pro Pro Asp Phe Thr Thr Arg Asn Arg Leu Arg Arg Thr His 35 40 45 Ser Ser Pro Ile Pro 50 123 613 DNA Physcomitrella patens CDS (1)..(210) 25_ppprot1_057_e01 123 aac ctc gca gtc gtc gca ccc caa atg gtt gtg tcg gtg ggg agt ggg 48 Asn Leu Ala Val Val Ala Pro Gln Met Val Val Ser Val Gly Ser Gly 1 5 10 15 cct tgg gac gag ctc ttt ggc ggg ggc aac atg ccg gcc ttt ttg ttt 96 Pro Trp Asp Glu Leu Phe Gly Gly Gly Asn Met Pro Ala Phe Leu Phe 20 25 30 gga gct gtg gct gct ttt atc ggt ggc atc gca gcc gtg ctt ctc cta 144 Gly Ala Val Ala Ala Phe Ile Gly Gly Ile Ala Ala Val Leu Leu Leu 35 40 45 cct cgc cct ccg ccc gat ttt acc acc agg aac cgg ctt cgc agg act 192 Pro Arg Pro Pro Pro Asp Phe Thr Thr Arg Asn Arg Leu Arg Arg Thr 50 55 60 cac agt tcc cct att cct tgaacttgta gagtttatcg ttcctttgaa 240 His Ser Ser Pro Ile Pro 65 70 ttgtagtgcc ttcgttttcc tgtagaaggt cataaattat ggcaggttgc agtgattttt 300 agacttcgaa ttttatgaat cagtctgtga taaggtcttc gatccgccag agtgttgatt 360 ggtatattgt gtatgataaa gtaggtgatg ttcacatgtg atatggtggt taagggagca 420 actaagtcgc agtgctgctg aaacccaaat cttagagttt tgttcgaagt ctatcggttc 480 aaattcaaat ggactaaata ccgtgctgca atcaatgcta ggtcggtttt ttttcgtatg 540 ctgaaaatag aattatcctg ttttaaaatt gttaactact aactgacagt tcaatgaaaa 600 cgcccatttc cgc 613 124 70 PRT Physcomitrella patens 124 Asn Leu Ala Val Val Ala Pro Gln Met Val Val Ser Val Gly Ser Gly 1 5 10 15 Pro Trp Asp Glu Leu Phe Gly Gly Gly Asn Met Pro Ala Phe Leu Phe 20 25 30 Gly Ala Val Ala Ala Phe Ile Gly Gly Ile Ala Ala Val Leu Leu Leu 35 40 45 Pro Arg Pro Pro Pro Asp Phe Thr Thr Arg Asn Arg Leu Arg Arg Thr 50 55 60 His Ser Ser Pro Ile Pro 65 70 125 521 DNA Physcomitrella patens CDS (1)..(519) 48_ck24_h09fwd 125 cgc att cag aag cgg gct aca tct tcc gtg cgc gcc caa gct gct gat 48 Arg Ile Gln Lys Arg Ala Thr Ser Ser Val Arg Ala Gln Ala Ala Asp 1 5 10 15 gga gaa gcc tcg ggg gat gtt gcc act aga caa tct aat cct gct acc 96 Gly Glu Ala Ser Gly Asp Val Ala Thr Arg Gln Ser Asn Pro Ala Thr 20 25 30 act gga atg gtc ttg cct gca gtt ggt att gcc tgc ctt ggg gca atc 144 Thr Gly Met Val Leu Pro Ala Val Gly Ile Ala Cys Leu Gly Ala Ile 35 40 45 ttg ttt ggt tac cat ctc ggg gtg gtt aat ggt gca ttg gag tac att 192 Leu Phe Gly Tyr His Leu Gly Val Val Asn Gly Ala Leu Glu Tyr Ile 50 55 60 tct aag gat cta ggg ttt gcc acg gat gct gta aaa caa gga tgg gtg 240 Ser Lys Asp Leu Gly Phe Ala Thr Asp Ala Val Lys Gln Gly Trp Val 65 70 75 80 gta agc tca act cta gct ggt gcc act gtg ggt tcc ttt act gga ggc 288 Val Ser Ser Thr Leu Ala Gly Ala Thr Val Gly Ser Phe Thr Gly Gly 85 90 95 gcc ctt gct gac aac tta ggt cgc aag cgt aca ttc cag att aac gcc 336 Ala Leu Ala Asp Asn Leu Gly Arg Lys Arg Thr Phe Gln Ile Asn Ala 100 105 110 gtg cct ctt att gtg ggc act ctt ctc agt gca aaa gca acc agt ttc 384 Val Pro Leu Ile Val Gly Thr Leu Leu Ser Ala Lys Ala Thr Ser Phe 115 120 125 gag gct atg gtg att gga aga att ttg gtt ggt gtt ggg att gga gtt 432 Glu Ala Met Val Ile Gly Arg Ile Leu Val Gly Val Gly Ile Gly Val 130 135 140 tca tct ggt gtt gtg cct cta tac att tcg gag gtc tcg ccc aca gag 480 Ser Ser Gly Val Val Pro Leu Tyr Ile Ser Glu Val Ser Pro Thr Glu 145 150 155 160 att cga ggt acc atg ggg aca ttg aat cag ctc ttt att tg 521 Ile Arg Gly Thr Met Gly Thr Leu Asn Gln Leu Phe Ile 165 170 126 173 PRT Physcomitrella patens 126 Arg Ile Gln Lys Arg Ala Thr Ser Ser Val Arg Ala Gln Ala Ala Asp 1 5 10 15 Gly Glu Ala Ser Gly Asp Val Ala Thr Arg Gln Ser Asn Pro Ala Thr 20 25 30 Thr Gly Met Val Leu Pro Ala Val Gly Ile Ala Cys Leu Gly Ala Ile 35 40 45 Leu Phe Gly Tyr His Leu Gly Val Val Asn Gly Ala Leu Glu Tyr Ile 50 55 60 Ser Lys Asp Leu Gly Phe Ala Thr Asp Ala Val Lys Gln Gly Trp Val 65 70 75 80 Val Ser Ser Thr Leu Ala Gly Ala Thr Val Gly Ser Phe Thr Gly Gly 85 90 95 Ala Leu Ala Asp Asn Leu Gly Arg Lys Arg Thr Phe Gln Ile Asn Ala 100 105 110 Val Pro Leu Ile Val Gly Thr Leu Leu Ser Ala Lys Ala Thr Ser Phe 115 120 125 Glu Ala Met Val Ile Gly Arg Ile Leu Val Gly Val Gly Ile Gly Val 130 135 140 Ser Ser Gly Val Val Pro Leu Tyr Ile Ser Glu Val Ser Pro Thr Glu 145 150 155 160 Ile Arg Gly Thr Met Gly Thr Leu Asn Gln Leu Phe Ile 165 170 127 638 DNA Physcomitrella patens CDS (1)..(465) 41_ppprot1_105_g03 127 cct gtg tat cag cgt gca ggc acc atc att cca aag aag cta agg cat 48 Pro Val Tyr Gln Arg Ala Gly Thr Ile Ile Pro Lys Lys Leu Arg His 1 5 10 15 cgt cgc agc tcc act caa atg ctg aat gac cca tac act ttg gtt gtg 96 Arg Arg Ser Ser Thr Gln Met Leu Asn Asp Pro Tyr Thr Leu Val Val 20 25 30 gct ttg gac tcc aac tac gag gct gaa ggt gag ctc tac atc gac gac 144 Ala Leu Asp Ser Asn Tyr Glu Ala Glu Gly Glu Leu Tyr Ile Asp Asp 35 40 45 ggc aaa acc tat gag ttc gaa aag ggc gct ttc att cac aga cgt ttc 192 Gly Lys Thr Tyr Glu Phe Glu Lys Gly Ala Phe Ile His Arg Arg Phe 50 55 60 aag ttt gtc aag ggg aaa cta acc tcc act aac ttg gca ccc tcg aag 240 Lys Phe Val Lys Gly Lys Leu Thr Ser Thr Asn Leu Ala Pro Ser Lys 65 70 75 80 tcc aac ccg aag aag ttc acg tca cct tgc ctt gtt gag cgc att gtt 288 Ser Asn Pro Lys Lys Phe Thr Ser Pro Cys Leu Val Glu Arg Ile Val 85 90 95 atc atg gga gtt cga gcc agg gat ttg gtc act ggt aaa ggc gca gtc 336 Ile Met Gly Val Arg Ala Arg Asp Leu Val Thr Gly Lys Gly Ala Val 100 105 110 gtt gag ggt gaa agg tgg att cag acc gat att gga gct ccg tca ttg 384 Val Glu Gly Glu Arg Trp Ile Gln Thr Asp Ile Gly Ala Pro Ser Leu 115 120 125 ata cct ggt gcc cat tca agc gct ttg att ctc agg ctt cca aat gtg 432 Ile Pro Gly Ala His Ser Ser Ala Leu Ile Leu Arg Leu Pro Asn Val 130 135 140 cgc att gct gat gac tgg tct att aaa ctt ggt taaggatttg gtaggagatt 485 Arg Ile Ala Asp Asp Trp Ser Ile Lys Leu Gly 145 150 155 atccaaaata tagtggggtg catcaaccaa attcagtttt tagtgcatat agggtgatgg 545 aaattagaag catagtgcct actggattta gcatggaaca ggtcagactt gacgaagtga 605 ttgttgttta ttttctgaat ccattatcag ttg 638 128 155 PRT Physcomitrella patens 128 Pro Val Tyr Gln Arg Ala Gly Thr Ile Ile Pro Lys Lys Leu Arg His 1 5 10 15 Arg Arg Ser Ser Thr Gln Met Leu Asn Asp Pro Tyr Thr Leu Val Val 20 25 30 Ala Leu Asp Ser Asn Tyr Glu Ala Glu Gly Glu Leu Tyr Ile Asp Asp 35 40 45 Gly Lys Thr Tyr Glu Phe Glu Lys Gly Ala Phe Ile His Arg Arg Phe 50 55 60 Lys Phe Val Lys Gly Lys Leu Thr Ser Thr Asn Leu Ala Pro Ser Lys 65 70 75 80 Ser Asn Pro Lys Lys Phe Thr Ser Pro Cys Leu Val Glu Arg Ile Val 85 90 95 Ile Met Gly Val Arg Ala Arg Asp Leu Val Thr Gly Lys Gly Ala Val 100 105 110 Val Glu Gly Glu Arg Trp Ile Gln Thr Asp Ile Gly Ala Pro Ser Leu 115 120 125 Ile Pro Gly Ala His Ser Ser Ala Leu Ile Leu Arg Leu Pro Asn Val 130 135 140 Arg Ile Ala Asp Asp Trp Ser Ile Lys Leu Gly 145 150 155 129 599 DNA Physcomitrella patens CDS (1)..(597) 44_ppprotl_075_h07 129 caa cgt tgt gag att gat ttg agg aaa gaa gcg gtt atc agg att gca 48 Gln Arg Cys Glu Ile Asp Leu Arg Lys Glu Ala Val Ile Arg Ile Ala 1 5 10 15 gct gaa gcg cca tat ccc gtg ata aca ttc ggg ccg tat ccc aac ccg 96 Ala Glu Ala Pro Tyr Pro Val Ile Thr Phe Gly Pro Tyr Pro Asn Pro 20 25 30 gag gcg ttg tta gtt gcg ctt gcg agt gct att ggc acc atc caa atg 144 Glu Ala Leu Leu Val Ala Leu Ala Ser Ala Ile Gly Thr Ile Gln Met 35 40 45 cct ccg aag tgg gct ctt gga tac caa caa tgt aga tgg agt tac gaa 192 Pro Pro Lys Trp Ala Leu Gly Tyr Gln Gln Cys Arg Trp Ser Tyr Glu 50 55 60 acg gca gag aaa gta tct aag att gct aat act ttc cgg cag aag aac 240 Thr Ala Glu Lys Val Ser Lys Ile Ala Asn Thr Phe Arg Gln Lys Asn 65 70 75 80 ata cct tgt gat gtt gtc tgg atg gat atc gat tac atg cat ggg ttc 288 Ile Pro Cys Asp Val Val Trp Met Asp Ile Asp Tyr Met His Gly Phe 85 90 95 aag tgc ttt aca ttt gat gag aac ttc ttc cca gat ccg aag gct ctt 336 Lys Cys Phe Thr Phe Asp Glu Asn Phe Phe Pro Asp Pro Lys Ala Leu 100 105 110 tca gac gag ttg cat tcc att ggc ttt aag ggg atc tgg atg ctt gat 384 Ser Asp Glu Leu His Ser Ile Gly Phe Lys Gly Ile Trp Met Leu Asp 115 120 125 ccc ggg atc aag gca gag aaa ggt tgg gac gtt tat gac agt gga act 432 Pro Gly Ile Lys Ala Glu Lys Gly Trp Asp Val Tyr Asp Ser Gly Thr 130 135 140 gag gtg gac gct tgg att caa act tcg aat ggg aag gat ttt att ggt 480 Glu Val Asp Ala Trp Ile Gln Thr Ser Asn Gly Lys Asp Phe Ile Gly 145 150 155 160 gaa tgt tgg cct ggg tta gtc gtg ttc cca gat ttc aca aac aaa aac 528 Glu Cys Trp Pro Gly Leu Val Val Phe Pro Asp Phe Thr Asn Lys Asn 165 170 175 acc cgc aag tgg tgg tcc aaa ttg gtg gaa aag ttc gtt gct aat ggt 576 Thr Arg Lys Trp Trp Ser Lys Leu Val Glu Lys Phe Val Ala Asn Gly 180 185 190 gtg gat ggt att tgg aac gat at 599 Val Asp Gly Ile Trp Asn Asp 195 130 199 PRT Physcomitrella patens 130 Gln Arg Cys Glu Ile Asp Leu Arg Lys Glu Ala Val Ile Arg Ile Ala 1 5 10 15 Ala Glu Ala Pro Tyr Pro Val Ile Thr Phe Gly Pro Tyr Pro Asn Pro 20 25 30 Glu Ala Leu Leu Val Ala Leu Ala Ser Ala Ile Gly Thr Ile Gln Met 35 40 45 Pro Pro Lys Trp Ala Leu Gly Tyr Gln Gln Cys Arg Trp Ser Tyr Glu 50 55 60 Thr Ala Glu Lys Val Ser Lys Ile Ala Asn Thr Phe Arg Gln Lys Asn 65 70 75 80 Ile Pro Cys Asp Val Val Trp Met Asp Ile Asp Tyr Met His Gly Phe 85 90 95 Lys Cys Phe Thr Phe Asp Glu Asn Phe Phe Pro Asp Pro Lys Ala Leu 100 105 110 Ser Asp Glu Leu His Ser Ile Gly Phe Lys Gly Ile Trp Met Leu Asp 115 120 125 Pro Gly Ile Lys Ala Glu Lys Gly Trp Asp Val Tyr Asp Ser Gly Thr 130 135 140 Glu Val Asp Ala Trp Ile Gln Thr Ser Asn Gly Lys Asp Phe Ile Gly 145 150 155 160 Glu Cys Trp Pro Gly Leu Val Val Phe Pro Asp Phe Thr Asn Lys Asn 165 170 175 Thr Arg Lys Trp Trp Ser Lys Leu Val Glu Lys Phe Val Ala Asn Gly 180 185 190 Val Asp Gly Ile Trp Asn Asp 195 131 727 DNA Physcomitrella patens CDS (3)..(707) 63_ppprotl_60 131 tt tcg gag ttc tac aag gtg atg ccc ttt gac gga ctg tgg ctg gac 47 Ser Glu Phe Tyr Lys Val Met Pro Phe Asp Gly Leu Trp Leu Asp 1 5 10 15 atg aac gag cct tcc aat ttc tgt tct gga ccg aat tgc tac tat cct 95 Met Asn Glu Pro Ser Asn Phe Cys Ser Gly Pro Asn Cys Tyr Tyr Pro 20 25 30 ccc gac gtc gta tgc ccg gaa gcg ctc gac tgg tgc tgc atg gtt tgc 143 Pro Asp Val Val Cys Pro Glu Ala Leu Asp Trp Cys Cys Met Val Cys 35 40 45 gac aac acg aat gtc tcg cgg tgg gac agg ccg cca tac cgc atc acc 191 Asp Asn Thr Asn Val Ser Arg Trp Asp Arg Pro Pro Tyr Arg Ile Thr 50 55 60 aac aca tgg aac aag gag ctt tac gag aag acc gtc act atg act gca 239 Asn Thr Trp Asn Lys Glu Leu Tyr Glu Lys Thr Val Thr Met Thr Ala 65 70 75 cgc cac tac aac gac gtc aag cac tac gat gcg cac aac atc tac gga 287 Arg His Tyr Asn Asp Val Lys His Tyr Asp Ala His Asn Ile Tyr Gly 80 85 90 95 ttc agt cag acg gtc gcc act ttt aaa gct ctc aaa gag gta acc aag 335 Phe Ser Gln Thr Val Ala Thr Phe Lys Ala Leu Lys Glu Val Thr Lys 100 105 110 aag cgg cca ttt gtg atg tca cgc tcc ttg tat cct ggc tcg ggt gcc 383 Lys Arg Pro Phe Val Met Ser Arg Ser Leu Tyr Pro Gly Ser Gly Ala 115 120 125 tcc gct gcg cac tgg tcg ggt gac aac ggc gct tca tgg aac gat tta 431 Ser Ala Ala His Trp Ser Gly Asp Asn Gly Ala Ser Trp Asn Asp Leu 130 135 140 cga tac tcg atc gcc agt atc tta aat tca ggc ctg ttt ggc att cct 479 Arg Tyr Ser Ile Ala Ser Ile Leu Asn Ser Gly Leu Phe Gly Ile Pro 145 150 155 atg gta ggg gca gac atc tgc ggc ttc atc cca gcc act tgg gag gag 527 Met Val Gly Ala Asp Ile Cys Gly Phe Ile Pro Ala Thr Trp Glu Glu 160 165 170 175 ctt tgc aat cga tgg att cag gtg ggc gcc ttc tat ccc ttc gct cgc 575 Leu Cys Asn Arg Trp Ile Gln Val Gly Ala Phe Tyr Pro Phe Ala Arg 180 185 190 gac cac tct gac gtg cac ttc ggc ccc cag gag ctc tac ctc tgg aaa 623 Asp His Ser Asp Val His Phe Gly Pro Gln Glu Leu Tyr Leu Trp Lys 195 200 205 tcc gtc aca cat tcc gcg agg aaa gtc ttg cca ctg cgg tat aaa ctc 671 Ser Val Thr His Ser Ala Arg Lys Val Leu Pro Leu Arg Tyr Lys Leu 210 215 220 ctc ctt tca tgt ata cgc tac tcc acg aag ctc aca tgacgggcgc 717 Leu Leu Ser Cys Ile Arg Tyr Ser Thr Lys Leu Thr 225 230 235 tcccgttgca 727 132 235 PRT Physcomitrella patens 132 Ser Glu Phe Tyr Lys Val Met Pro Phe Asp Gly Leu Trp Leu Asp Met 1 5 10 15 Asn Glu Pro Ser Asn Phe Cys Ser Gly Pro Asn Cys Tyr Tyr Pro Pro 20 25 30 Asp Val Val Cys Pro Glu Ala Leu Asp Trp Cys Cys Met Val Cys Asp 35 40 45 Asn Thr Asn Val Ser Arg Trp Asp Arg Pro Pro Tyr Arg Ile Thr Asn 50 55 60 Thr Trp Asn Lys Glu Leu Tyr Glu Lys Thr Val Thr Met Thr Ala Arg 65 70 75 80 His Tyr Asn Asp Val Lys His Tyr Asp Ala His Asn Ile Tyr Gly Phe 85 90 95 Ser Gln Thr Val Ala Thr Phe Lys Ala Leu Lys Glu Val Thr Lys Lys 100 105 110 Arg Pro Phe Val Met Ser Arg Ser Leu Tyr Pro Gly Ser Gly Ala Ser 115 120 125 Ala Ala His Trp Ser Gly Asp Asn Gly Ala Ser Trp Asn Asp Leu Arg 130 135 140 Tyr Ser Ile Ala Ser Ile Leu Asn Ser Gly Leu Phe Gly Ile Pro Met 145 150 155 160 Val Gly Ala Asp Ile Cys Gly Phe Ile Pro Ala Thr Trp Glu Glu Leu 165 170 175 Cys Asn Arg Trp Ile Gln Val Gly Ala Phe Tyr Pro Phe Ala Arg Asp 180 185 190 His Ser Asp Val His Phe Gly Pro Gln Glu Leu Tyr Leu Trp Lys Ser 195 200 205 Val Thr His Ser Ala Arg Lys Val Leu Pro Leu Arg Tyr Lys Leu Leu 210 215 220 Leu Ser Cys Ile Arg Tyr Ser Thr Lys Leu Thr 225 230 235 133 599 DNA Physcomitrella patens CDS (2)..(565) 74_ck13_el0fwd 133 c aaa gac ttc act ctc gat ccc gtc aat tat ccc gtt gac aaa tta ctg 49 Lys Asp Phe Thr Leu Asp Pro Val Asn Tyr Pro Val Asp Lys Leu Leu 1 5 10 15 ccc ttt gtt cag aac ttg cac aag aac cat cag aag ttt atc atg att 97 Pro Phe Val Gln Asn Leu His Lys Asn His Gln Lys Phe Ile Met Ile 20 25 30 ctg gac cct ggg atc aag atc gat acc aac tac tcc acc tat gtt cgg 145 Leu Asp Pro Gly Ile Lys Ile Asp Thr Asn Tyr Ser Thr Tyr Val Arg 35 40 45 ggt gac aaa ctg gac ata ttc atg agg aat ggt acg agc cac cgc tac 193 Gly Asp Lys Leu Asp Ile Phe Met Arg Asn Gly Thr Ser His Arg Tyr 50 55 60 gtt gcc cag gta tgg cca ggc gcc aca aac ata ccc gac ttc ctc cat 241 Val Ala Gln Val Trp Pro Gly Ala Thr Asn Ile Pro Asp Phe Leu His 65 70 75 80 ccc aaa tcg cag gag ttt tgg tca aca gag gta gcc gaa ttt cat aaa 289 Pro Lys Ser Gln Glu Phe Trp Ser Thr Glu Val Ala Glu Phe His Lys 85 90 95 gtg att cca ttt gat ggc ttg tgg ctt gac atg aac gag cct gcc aac 337 Val Ile Pro Phe Asp Gly Leu Trp Leu Asp Met Asn Glu Pro Ala Asn 100 105 110 ttc tgc ggt ggt cct act tgt tat ttc ccc ccc gga att cag act tgt 385 Phe Cys Gly Gly Pro Thr Cys Tyr Phe Pro Pro Gly Ile Gln Thr Cys 115 120 125 cct cag atc gat gag tgt tgc atg ata tgt gat aac aca aat ctc aac 433 Pro Gln Ile Asp Glu Cys Cys Met Ile Cys Asp Asn Thr Asn Leu Asn 130 135 140 cgg tgg gat gat cct cca tac cac att aac tct ctt ggt atc cac cgg 481 Arg Trp Asp Asp Pro Pro Tyr His Ile Asn Ser Leu Gly Ile His Arg 145 150 155 160 cct ttg tac gcg cac aca atg ggc gat gaa ctg cga gca ttt caa tgg 529 Pro Leu Tyr Ala His Thr Met Gly Asp Glu Leu Arg Ala Phe Gln Trp 165 170 175 gta tcc ggg ctt acg ata ccc aca acg tct atg gaa tgagcgaggg 575 Val Ser Gly Leu Thr Ile Pro Thr Thr Ser Met Glu 180 185 acttgcgaca taccgacgct taag 599 134 188 PRT Physcomitrella patens 134 Lys Asp Phe Thr Leu Asp Pro Val Asn Tyr Pro Val Asp Lys Leu Leu 1 5 10 15 Pro Phe Val Gln Asn Leu His Lys Asn His Gln Lys Phe Ile Met Ile 20 25 30 Leu Asp Pro Gly Ile Lys Ile Asp Thr Asn Tyr Ser Thr Tyr Val Arg 35 40 45 Gly Asp Lys Leu Asp Ile Phe Met Arg Asn Gly Thr Ser His Arg Tyr 50 55 60 Val Ala Gln Val Trp Pro Gly Ala Thr Asn Ile Pro Asp Phe Leu His 65 70 75 80 Pro Lys Ser Gln Glu Phe Trp Ser Thr Glu Val Ala Glu Phe His Lys 85 90 95 Val Ile Pro Phe Asp Gly Leu Trp Leu Asp Met Asn Glu Pro Ala Asn 100 105 110 Phe Cys Gly Gly Pro Thr Cys Tyr Phe Pro Pro Gly Ile Gln Thr Cys 115 120 125 Pro Gln Ile Asp Glu Cys Cys Met Ile Cys Asp Asn Thr Asn Leu Asn 130 135 140 Arg Trp Asp Asp Pro Pro Tyr His Ile Asn Ser Leu Gly Ile His Arg 145 150 155 160 Pro Leu Tyr Ala His Thr Met Gly Asp Glu Leu Arg Ala Phe Gln Trp 165 170 175 Val Ser Gly Leu Thr Ile Pro Thr Thr Ser Met Glu 180 185 135 607 DNA Physcomitrella patens CDS (1)..(318) 03_ppprot1_056_a02 135 cag ggt tat gct tac atc ctc act cat cct ggt cag cct tgt gtg ttt 48 Gln Gly Tyr Ala Tyr Ile Leu Thr His Pro Gly Gln Pro Cys Val Phe 1 5 10 15 tac gat cat ttg tat gag tgg agc ggc gac ttg aag agg gtt att cta 96 Tyr Asp His Leu Tyr Glu Trp Ser Gly Asp Leu Lys Arg Val Ile Leu 20 25 30 gaa ttg att gat att cgc agg aaa ctt gag gtt cat agt cga tcg cac 144 Glu Leu Ile Asp Ile Arg Arg Lys Leu Glu Val His Ser Arg Ser His 35 40 45 atc acg ata ctt gaa gca gac acg aat ggt tat tca gcc gtt gtt gac 192 Ile Thr Ile Leu Glu Ala Asp Thr Asn Gly Tyr Ser Ala Val Val Asp 50 55 60 aac aag ctg tgc gtg cga tta ggc aac act gaa tgg acc cct ccc tct 240 Asn Lys Leu Cys Val Arg Leu Gly Asn Thr Glu Trp Thr Pro Pro Ser 65 70 75 80 gat agt ctc tgg gaa ctt act ctc tcg ggc agt ggc tat atg ata tgg 288 Asp Ser Leu Trp Glu Leu Thr Leu Ser Gly Ser Gly Tyr Met Ile Trp 85 90 95 agt aaa ccc cag ccg ctc tta acc tct caa tgagcgtctt gctcgtgaat 338 Ser Lys Pro Gln Pro Leu Leu Thr Ser Gln 100 105 ttcagacgca ttcagcattt atttattata catgaattgt ccattgtaaa gtggataagg 398 atcccgtagc gatctacatt aatttcttat gattggcttg cgaaacaatc actagttgcc 458 acagcagtca ccttgacttg tgtgatgaat tagtattttc aaacactttt acatatttga 518 atagtttcct gaagccactg cattgtggtc gggttatctg atagttggaa tttaacaatt 578 attgatttta taaaatacat atacgattt 607 136 106 PRT Physcomitrella patens 136 Gln Gly Tyr Ala Tyr Ile Leu Thr His Pro Gly Gln Pro Cys Val Phe 1 5 10 15 Tyr Asp His Leu Tyr Glu Trp Ser Gly Asp Leu Lys Arg Val Ile Leu 20 25 30 Glu Leu Ile Asp Ile Arg Arg Lys Leu Glu Val His Ser Arg Ser His 35 40 45 Ile Thr Ile Leu Glu Ala Asp Thr Asn Gly Tyr Ser Ala Val Val Asp 50 55 60 Asn Lys Leu Cys Val Arg Leu Gly Asn Thr Glu Trp Thr Pro Pro Ser 65 70 75 80 Asp Ser Leu Trp Glu Leu Thr Leu Ser Gly Ser Gly Tyr Met Ile Trp 85 90 95 Ser Lys Pro Gln Pro Leu Leu Thr Ser Gln 100 105 137 602 DNA Physcomitrella patens CDS (2)..(601) 50_ck1_a10fwd 137 g aag agc tcg tgc tgg tat gat gtc atg ggc gag act gcg gaa gat cta 49 Lys Ser Ser Cys Trp Tyr Asp Val Met Gly Glu Thr Ala Glu Asp Leu 1 5 10 15 gca gca gca ggc att act gat gtc tgg ttt cct cct tct agc cat tcc 97 Ala Ala Ala Gly Ile Thr Asp Val Trp Phe Pro Pro Ser Ser His Ser 20 25 30 gtg tcc ccc cag gga tac atg cca gga agg ctt tac gat ttg aac gac 145 Val Ser Pro Gln Gly Tyr Met Pro Gly Arg Leu Tyr Asp Leu Asn Asp 35 40 45 tgt aaa tat ggc aat gaa gag aag ctg agg gaa acc att gaa aag ttt 193 Cys Lys Tyr Gly Asn Glu Glu Lys Leu Arg Glu Thr Ile Glu Lys Phe 50 55 60 cac aga gtg gga gtt cgg tgc att gct gat att gtc gtg aat cat aga 241 His Arg Val Gly Val Arg Cys Ile Ala Asp Ile Val Val Asn His Arg 65 70 75 80 tgc ggt gaa gaa caa gac gag agg ggt gaa tgg gtt att ttt gaa gga 289 Cys Gly Glu Glu Gln Asp Glu Arg Gly Glu Trp Val Ile Phe Glu Gly 85 90 95 gga acg ccc gat gat gct ctc gac tgg ggt cct tgg gct ata gtc gga 337 Gly Thr Pro Asp Asp Ala Leu Asp Trp Gly Pro Trp Ala Ile Val Gly 100 105 110 gat gac tat ccc tat ggt aac gga aca ggt gct ccc gac acc gga gat 385 Asp Asp Tyr Pro Tyr Gly Asn Gly Thr Gly Ala Pro Asp Thr Gly Asp 115 120 125 gac ttt gag gct gca ccc gac att gat cac aca aac gat atc gtt caa 433 Asp Phe Glu Ala Ala Pro Asp Ile Asp His Thr Asn Asp Ile Val Gln 130 135 140 agc gac ctt atc gtc tgg atg aat tgg atg aag ttc aaa att ggg ttt 481 Ser Asp Leu Ile Val Trp Met Asn Trp Met Lys Phe Lys Ile Gly Phe 145 150 155 160 gat ggg tgg aga ttc gac ttt gcc aag ggt tac ggt gga tac ttc gtc 529 Asp Gly Trp Arg Phe Asp Phe Ala Lys Gly Tyr Gly Gly Tyr Phe Val 165 170 175 ggt cgc tac atc aga aaa act gaa cca cag ttt gca gtt ggg gag ttc 577 Gly Arg Tyr Ile Arg Lys Thr Glu Pro Gln Phe Ala Val Gly Glu Phe 180 185 190 tgg acg agc ttg aat tac gga cat g 602 Trp Thr Ser Leu Asn Tyr Gly His 195 200 138 200 PRT Physcomitrella patens 138 Lys Ser Ser Cys Trp Tyr Asp Val Met Gly Glu Thr Ala Glu Asp Leu 1 5 10 15 Ala Ala Ala Gly Ile Thr Asp Val Trp Phe Pro Pro Ser Ser His Ser 20 25 30 Val Ser Pro Gln Gly Tyr Met Pro Gly Arg Leu Tyr Asp Leu Asn Asp 35 40 45 Cys Lys Tyr Gly Asn Glu Glu Lys Leu Arg Glu Thr Ile Glu Lys Phe 50 55 60 His Arg Val Gly Val Arg Cys Ile Ala Asp Ile Val Val Asn His Arg 65 70 75 80 Cys Gly Glu Glu Gln Asp Glu Arg Gly Glu Trp Val Ile Phe Glu Gly 85 90 95 Gly Thr Pro Asp Asp Ala Leu Asp Trp Gly Pro Trp Ala Ile Val Gly 100 105 110 Asp Asp Tyr Pro Tyr Gly Asn Gly Thr Gly Ala Pro Asp Thr Gly Asp 115 120 125 Asp Phe Glu Ala Ala Pro Asp Ile Asp His Thr Asn Asp Ile Val Gln 130 135 140 Ser Asp Leu Ile Val Trp Met Asn Trp Met Lys Phe Lys Ile Gly Phe 145 150 155 160 Asp Gly Trp Arg Phe Asp Phe Ala Lys Gly Tyr Gly Gly Tyr Phe Val 165 170 175 Gly Arg Tyr Ile Arg Lys Thr Glu Pro Gln Phe Ala Val Gly Glu Phe 180 185 190 Trp Thr Ser Leu Asn Tyr Gly His 195 200 139 550 DNA Physcomitrella patens CDS (2)..(550) 25_ppprot1_104_e01 139 t ttg gac acc gta agc atg aat aac act ctg aac aga cgt cgc gcc ttg 49 Leu Asp Thr Val Ser Met Asn Asn Thr Leu Asn Arg Arg Arg Ala Leu 1 5 10 15 gac gca tct ttg ctg gct ctg aaa tcg gct ggt gtg gag ggg gtt atg 97 Asp Ala Ser Leu Leu Ala Leu Lys Ser Ala Gly Val Glu Gly Val Met 20 25 30 atg gat gtt tgg tgg gga atc gtc gag aaa gat ggc cct cag cag tac 145 Met Asp Val Trp Trp Gly Ile Val Glu Lys Asp Gly Pro Gln Gln Tyr 35 40 45 aat tgg tct gcg tat caa gag tta att gat atg gtg cgg aag cat ggt 193 Asn Trp Ser Ala Tyr Gln Glu Leu Ile Asp Met Val Arg Lys His Gly 50 55 60 ttg aag gtt cag gct gtg atg tcc ttt cac cag tgt ggt ggc aac gtt 241 Leu Lys Val Gln Ala Val Met Ser Phe His Gln Cys Gly Gly Asn Val 65 70 75 80 ggc gac agt tgc aat att cct ctg cct cca tgg gtg ttg gaa gag gta 289 Gly Asp Ser Cys Asn Ile Pro Leu Pro Pro Trp Val Leu Glu Glu Val 85 90 95 cga aag aat cca gac ttg gcc tac acc gat aag gct gga agg cgc aac 337 Arg Lys Asn Pro Asp Leu Ala Tyr Thr Asp Lys Ala Gly Arg Arg Asn 100 105 110 tca gaa tac atc tct ctt ggc gct gac aac gtg ccc gct ttg aag gga 385 Ser Glu Tyr Ile Ser Leu Gly Ala Asp Asn Val Pro Ala Leu Lys Gly 115 120 125 agg aca ccg gtt caa tgc tat gcg gat ttc atg agg agc ttc aga gac 433 Arg Thr Pro Val Gln Cys Tyr Ala Asp Phe Met Arg Ser Phe Arg Asp 130 135 140 aac ttc gac gat ttt ttg gga gat ttt att gtc gaa atc caa tgc gga 481 Asn Phe Asp Asp Phe Leu Gly Asp Phe Ile Val Glu Ile Gln Cys Gly 145 150 155 160 atg gga ccc gct ggt gaa ctt cgt tac cct tca tac cct gag agt gag 529 Met Gly Pro Ala Gly Glu Leu Arg Tyr Pro Ser Tyr Pro Glu Ser Glu 165 170 175 ggt agg tgg cgt ttt cca ggc 550 Gly Arg Trp Arg Phe Pro Gly 180 140 183 PRT Physcomitrella patens 140 Leu Asp Thr Val Ser Met Asn Asn Thr Leu Asn Arg Arg Arg Ala Leu 1 5 10 15 Asp Ala Ser Leu Leu Ala Leu Lys Ser Ala Gly Val Glu Gly Val Met 20 25 30 Met Asp Val Trp Trp Gly Ile Val Glu Lys Asp Gly Pro Gln Gln Tyr 35 40 45 Asn Trp Ser Ala Tyr Gln Glu Leu Ile Asp Met Val Arg Lys His Gly 50 55 60 Leu Lys Val Gln Ala Val Met Ser Phe His Gln Cys Gly Gly Asn Val 65 70 75 80 Gly Asp Ser Cys Asn Ile Pro Leu Pro Pro Trp Val Leu Glu Glu Val 85 90 95 Arg Lys Asn Pro Asp Leu Ala Tyr Thr Asp Lys Ala Gly Arg Arg Asn 100 105 110 Ser Glu Tyr Ile Ser Leu Gly Ala Asp Asn Val Pro Ala Leu Lys Gly 115 120 125 Arg Thr Pro Val Gln Cys Tyr Ala Asp Phe Met Arg Ser Phe Arg Asp 130 135 140 Asn Phe Asp Asp Phe Leu Gly Asp Phe Ile Val Glu Ile Gln Cys Gly 145 150 155 160 Met Gly Pro Ala Gly Glu Leu Arg Tyr Pro Ser Tyr Pro Glu Ser Glu 165 170 175 Gly Arg Trp Arg Phe Pro Gly 180 141 655 DNA Physcomitrella patens CDS (3)..(215) 53_ppprot1_074_a06 141 ct ttg ttg tcg gaa gga aag gta cct ttg ggc gtc ggc gag aac tca 47 Leu Leu Ser Glu Gly Lys Val Pro Leu Gly Val Gly Glu Asn Ser 1 5 10 15 aag ctg agg aat tgt att gtg gac aag aat gca aga att ggc aag gat 95 Lys Leu Arg Asn Cys Ile Val Asp Lys Asn Ala Arg Ile Gly Lys Asp 20 25 30 gtt gtc att gcg aac act gac aat gtc ttg gaa gcg gag aga caa agt 143 Val Val Ile Ala Asn Thr Asp Asn Val Leu Glu Ala Glu Arg Gln Ser 35 40 45 gaa ggt ttt tac atc cgt tcc gga att gta gta gta tac aag aac gcg 191 Glu Gly Phe Tyr Ile Arg Ser Gly Ile Val Val Val Tyr Lys Asn Ala 50 55 60 gtt atc aag cac gga act gta atc taaattacga atctttctcc atatcgtgaa 245 Val Ile Lys His Gly Thr Val Ile 65 70 aactgcttcc ttgcaacgcc ggtccctggt gagctgatcc ttggacctca tcatcgacgg 305 tgaaaaagat atcagtactt atccgagttg tgagattctc agctcgtgat tactgatcct 365 cttcctcttg ccaccctgaa gattgccgcg caggatctgg tttgtgtcgg tatatcagat 425 cagtagttct tacataagac tgaattgaaa tgtacaaaga gatcagatca tcgggagtgg 485 aaccgttcag aggaagaaac ctaccgtata gtcaagtgga cgaagattat ggtatcaatt 545 ttggagtgta aagtgtgagc gacttctact gtccttgtat cataccccat tgaagtaaag 605 aattgtgcaa agccttgaca gcgatgctgt tgatgtctga tgcttcactc 655 142 71 PRT Physcomitrella patens 142 Leu Leu Ser Glu Gly Lys Val Pro Leu Gly Val Gly Glu Asn Ser Lys 1 5 10 15 Leu Arg Asn Cys Ile Val Asp Lys Asn Ala Arg Ile Gly Lys Asp Val 20 25 30 Val Ile Ala Asn Thr Asp Asn Val Leu Glu Ala Glu Arg Gln Ser Glu 35 40 45 Gly Phe Tyr Ile Arg Ser Gly Ile Val Val Val Tyr Lys Asn Ala Val 50 55 60 Ile Lys His Gly Thr Val Ile 65 70 143 554 DNA Physcomitrella patens CDS (2)..(553) s_pp001047038r 143 g cac gag ggt ctg gaa aat cca cca gga gca cat tgt tgt ttg cct cac 49 His Glu Gly Leu Glu Asn Pro Pro Gly Ala His Cys Cys Leu Pro His 1 5 10 15 gta gaa aat ctg ctg gac gct cgt agt ccc atg gcc gcc caa gta ttt 97 Val Glu Asn Leu Leu Asp Ala Arg Ser Pro Met Ala Ala Gln Val Phe 20 25 30 ttc aat ggc agt ttg ctg gga ggc att agt tgc act tca aca ccc agt 145 Phe Asn Gly Ser Leu Leu Gly Gly Ile Ser Cys Thr Ser Thr Pro Ser 35 40 45 tca ctt tct gtg cct cga tct tcg ctg aca cta cct gtg cca act tcc 193 Ser Leu Ser Val Pro Arg Ser Ser Leu Thr Leu Pro Val Pro Thr Ser 50 55 60 ttg cgc aag agt ctt tac tct atg gta agc tgg aag gat ttg ctt tct 241 Leu Arg Lys Ser Leu Tyr Ser Met Val Ser Trp Lys Asp Leu Leu Ser 65 70 75 80 agg cac cgt tct ttt aag agg ggt atg agg tca agc gct tta gct gat 289 Arg His Arg Ser Phe Lys Arg Gly Met Arg Ser Ser Ala Leu Ala Asp 85 90 95 tca gac ttt tca gtg aag aaa gat gag atg caa acg caa agt atg ttt 337 Ser Asp Phe Ser Val Lys Lys Asp Glu Met Gln Thr Gln Ser Met Phe 100 105 110 cca gct gca aga cgt ggc aag gag aat gcg gtt tct acg acc act gtg 385 Pro Ala Ala Arg Arg Gly Lys Glu Asn Ala Val Ser Thr Thr Thr Val 115 120 125 aac gct aca agt gta ctt ccg gaa cgc aaa atc att cat gag aca gcg 433 Asn Ala Thr Ser Val Leu Pro Glu Arg Lys Ile Ile His Glu Thr Ala 130 135 140 gta gtt cat ccg gac gcc ttc ata ggt gag ggg gtt gtc atc agc gca 481 Val Val His Pro Asp Ala Phe Ile Gly Glu Gly Val Val Ile Ser Ala 145 150 155 160 ttt tgt aca gtg gga cct ggt gtt tca ata gga aat ggc tgc aag tta 529 Phe Cys Thr Val Gly Pro Gly Val Ser Ile Gly Asn Gly Cys Lys Leu 165 170 175 cat cct agt agt cac gtc tgt ggg a 554 His Pro Ser Ser His Val Cys Gly 180 144 184 PRT Physcomitrella patens 144 His Glu Gly Leu Glu Asn Pro Pro Gly Ala His Cys Cys Leu Pro His 1 5 10 15 Val Glu Asn Leu Leu Asp Ala Arg Ser Pro Met Ala Ala Gln Val Phe 20 25 30 Phe Asn Gly Ser Leu Leu Gly Gly Ile Ser Cys Thr Ser Thr Pro Ser 35 40 45 Ser Leu Ser Val Pro Arg Ser Ser Leu Thr Leu Pro Val Pro Thr Ser 50 55 60 Leu Arg Lys Ser Leu Tyr Ser Met Val Ser Trp Lys Asp Leu Leu Ser 65 70 75 80 Arg His Arg Ser Phe Lys Arg Gly Met Arg Ser Ser Ala Leu Ala Asp 85 90 95 Ser Asp Phe Ser Val Lys Lys Asp Glu Met Gln Thr Gln Ser Met Phe 100 105 110 Pro Ala Ala Arg Arg Gly Lys Glu Asn Ala Val Ser Thr Thr Thr Val 115 120 125 Asn Ala Thr Ser Val Leu Pro Glu Arg Lys Ile Ile His Glu Thr Ala 130 135 140 Val Val His Pro Asp Ala Phe Ile Gly Glu Gly Val Val Ile Ser Ala 145 150 155 160 Phe Cys Thr Val Gly Pro Gly Val Ser Ile Gly Asn Gly Cys Lys Leu 165 170 175 His Pro Ser Ser His Val Cys Gly 180 145 1660 DNA Physcomitrella patens CDS (224)..(1270) c_pp030002055r 145 ttggcgcgcc aggacaggca gaggacgaga caagggggat agcgttgcga cttcgtttgt 60 ttcccactct ggagcactgg aatcacgtcg tgtatctgag accgagattg gcagaggcga 120 tcgccagacg tttgtcaatc tcgactgctc tctctgctcg tggtttcagt tcgcgaggtg 180 acatcgtaag caaattgtgc ggtctcggag cagattgttt gca atg tct caa gag 235 Met Ser Gln Glu 1 gcg gcg gct tcg aag agg gcg ctc atc act ggt atc acc ggc caa gat 283 Ala Ala Ala Ser Lys Arg Ala Leu Ile Thr Gly Ile Thr Gly Gln Asp 5 10 15 20 ggc tcg tac ttg acc gaa ttc ttg ttg aac aag ggt tat gaa gtg cat 331 Gly Ser Tyr Leu Thr Glu Phe Leu Leu Asn Lys Gly Tyr Glu Val His 25 30 35 ggg atc atc aga aga tcc tcg aac ttc aac act cag cgt ttg gag cac 379 Gly Ile Ile Arg Arg Ser Ser Asn Phe Asn Thr Gln Arg Leu Glu His 40 45 50 atc tac atc gat ccg cac cag tcc agc gct cgc atg aaa ctg cac tac 427 Ile Tyr Ile Asp Pro His Gln Ser Ser Ala Arg Met Lys Leu His Tyr 55 60 65 gga gat ctg tca cac gcg tcg tca ttg cgg aaa tgg gtt gac tcg atc 475 Gly Asp Leu Ser His Ala Ser Ser Leu Arg Lys Trp Val Asp Ser Ile 70 75 80 cgc ccg gat gag gtt tac aat ctg ggg gcg cag tct cat gtg gga gtg 523 Arg Pro Asp Glu Val Tyr Asn Leu Gly Ala Gln Ser His Val Gly Val 85 90 95 100 tcg ttg gag aat ccg gat tat acc tcc gat gtg gta ggc acc gga acg 571 Ser Leu Glu Asn Pro Asp Tyr Thr Ser Asp Val Val Gly Thr Gly Thr 105 110 115 cta agg ctg ttg gaa gct att cga att cac atc caa gcc acc gga agg 619 Leu Arg Leu Leu Glu Ala Ile Arg Ile His Ile Gln Ala Thr Gly Arg 120 125 130 ctg gtg aag tac tac caa gct gga tct tct gag atg tac ggt gcc act 667 Leu Val Lys Tyr Tyr Gln Ala Gly Ser Ser Glu Met Tyr Gly Ala Thr 135 140 145 cct ccg cct caa gac gag acc acc gtg ttc cat cct cgc agc cct tac 715 Pro Pro Pro Gln Asp Glu Thr Thr Val Phe His Pro Arg Ser Pro Tyr 150 155 160 gcc gtc gcc aag gtg gca ggg cat ttc tac acc gtg aac tac cga gag 763 Ala Val Ala Lys Val Ala Gly His Phe Tyr Thr Val Asn Tyr Arg Glu 165 170 175 180 gca tac ggg atg ttt gca tgc aac ggc atc ctg ttc aac cac gag tct 811 Ala Tyr Gly Met Phe Ala Cys Asn Gly Ile Leu Phe Asn His Glu Ser 185 190 195 ccc cgc cga gga gag aac ttc gtg acg agg aag atc act aga gcc att 859 Pro Arg Arg Gly Glu Asn Phe Val Thr Arg Lys Ile Thr Arg Ala Ile 200 205 210 ggt cgc atc aag gtg ggc ctg cag aag aag ctg tat cta ggt aac ttg 907 Gly Arg Ile Lys Val Gly Leu Gln Lys Lys Leu Tyr Leu Gly Asn Leu 215 220 225 aag gcg tct cgt gat tgg gga ttt gcc gga gac tac gtg gag gga atg 955 Lys Ala Ser Arg Asp Trp Gly Phe Ala Gly Asp Tyr Val Glu Gly Met 230 235 240 tgg atg atg tta cag cag gag aag ccc gac gac tac gtg ctc gcg acg 1003 Trp Met Met Leu Gln Gln Glu Lys Pro Asp Asp Tyr Val Leu Ala Thr 245 250 255 260 gag gat tcc cac act gtg gag gag ttt ctg gaa gag gca ttc agc tat 1051 Glu Asp Ser His Thr Val Glu Glu Phe Leu Glu Glu Ala Phe Ser Tyr 265 270 275 gtt ggt ctg aac tgg aag gac cat gtc gag att gat ccc aga tat ttc 1099 Val Gly Leu Asn Trp Lys Asp His Val Glu Ile Asp Pro Arg Tyr Phe 280 285 290 cgt cct tcg gag gtg gac att ctg cga ggc agt gcg cag aaa gcg aag 1147 Arg Pro Ser Glu Val Asp Ile Leu Arg Gly Ser Ala Gln Lys Ala Lys 295 300 305 gag gtg ctg gga tgg cag cct aag gtg cag ttc aag cag ctg gtg gcg 1195 Glu Val Leu Gly Trp Gln Pro Lys Val Gln Phe Lys Gln Leu Val Ala 310 315 320 atg atg gtg gat ggt gat ttg gag aag gcg aag cga gag aag gtg ctt 1243 Met Met Val Asp Gly Asp Leu Glu Lys Ala Lys Arg Glu Lys Val Leu 325 330 335 340 gtg gat gct ggc ttc att gac tcg cac cagcagccct gaattttggg 1290 Val Asp Ala Gly Phe Ile Asp Ser His 345 caccgaatga atagtgttaa taattatatg aaacgaatgg atataatatg acaggccttg 1350 caatatatgg ttaatatatt gatacatagt gatatgtcaa cccgagagta cttcttcaat 1410 taggttatag ccttagcttt gccatgtaag gcttacaata tattcttcgc tgccgcagtg 1470 cttagcacac accaagtact agttccgagc aattttagtg ggttgtttat tcagcagaat 1530 gcactgacac cactcatcta gaatataagc ccgcattcgg gtgcaaatca atgctattct 1590 ctgatgagga cgattttgcc aacctgtgca ccctccttcg aaatgaatat tcaattctta 1650 aaactcgtgc 1660 146 349 PRT Physcomitrella patens 146 Met Ser Gln Glu Ala Ala Ala Ser Lys Arg Ala Leu Ile Thr Gly Ile 1 5 10 15 Thr Gly Gln Asp Gly Ser Tyr Leu Thr Glu Phe Leu Leu Asn Lys Gly 20 25 30 Tyr Glu Val His Gly Ile Ile Arg Arg Ser Ser Asn Phe Asn Thr Gln 35 40 45 Arg Leu Glu His Ile Tyr Ile Asp Pro His Gln Ser Ser Ala Arg Met 50 55 60 Lys Leu His Tyr Gly Asp Leu Ser His Ala Ser Ser Leu Arg Lys Trp 65 70 75 80 Val Asp Ser Ile Arg Pro Asp Glu Val Tyr Asn Leu Gly Ala Gln Ser 85 90 95 His Val Gly Val Ser Leu Glu Asn Pro Asp Tyr Thr Ser Asp Val Val 100 105 110 Gly Thr Gly Thr Leu Arg Leu Leu Glu Ala Ile Arg Ile His Ile Gln 115 120 125 Ala Thr Gly Arg Leu Val Lys Tyr Tyr Gln Ala Gly Ser Ser Glu Met 130 135 140 Tyr Gly Ala Thr Pro Pro Pro Gln Asp Glu Thr Thr Val Phe His Pro 145 150 155 160 Arg Ser Pro Tyr Ala Val Ala Lys Val Ala Gly His Phe Tyr Thr Val 165 170 175 Asn Tyr Arg Glu Ala Tyr Gly Met Phe Ala Cys Asn Gly Ile Leu Phe 180 185 190 Asn His Glu Ser Pro Arg Arg Gly Glu Asn Phe Val Thr Arg Lys Ile 195 200 205 Thr Arg Ala Ile Gly Arg Ile Lys Val Gly Leu Gln Lys Lys Leu Tyr 210 215 220 Leu Gly Asn Leu Lys Ala Ser Arg Asp Trp Gly Phe Ala Gly Asp Tyr 225 230 235 240 Val Glu Gly Met Trp Met Met Leu Gln Gln Glu Lys Pro Asp Asp Tyr 245 250 255 Val Leu Ala Thr Glu Asp Ser His Thr Val Glu Glu Phe Leu Glu Glu 260 265 270 Ala Phe Ser Tyr Val Gly Leu Asn Trp Lys Asp His Val Glu Ile Asp 275 280 285 Pro Arg Tyr Phe Arg Pro Ser Glu Val Asp Ile Leu Arg Gly Ser Ala 290 295 300 Gln Lys Ala Lys Glu Val Leu Gly Trp Gln Pro Lys Val Gln Phe Lys 305 310 315 320 Gln Leu Val Ala Met Met Val Asp Gly Asp Leu Glu Lys Ala Lys Arg 325 330 335 Glu Lys Val Leu Val Asp Ala Gly Phe Ile Asp Ser His 340 345 147 1490 DNA Physcomitrella patens CDS (347)..(1276) c_pp001064043r 147 aggacaggca gaggacgaga caagggggac cctcggtaag atttgacagg cagatctggc 60 tttgaaagaa gcgagtctgc attggagttt caggctgcga ttttgtcggc tggggattgt 120 tttgcgagat tgtgtgagtc gacatgtatt ggatctggtg gacagggttg agggttgtgg 180 tttctgcttg gtctattagc agtgggtttg ggagcctttg cattgccgtt tgtgagttgg 240 gttttggcgc attttcttca gatatgaatc tgtagtacaa atcaccaatc acacgttcaa 300 gaaaggtatt tggcgtgttt gcagcacatc tgtgcagatc gccagc atg ggt gtc 355 Met Gly Val 1 gac aag gac gcc aag atc ttt gtt gct gga cac cga ggt cta gta ggt 403 Asp Lys Asp Ala Lys Ile Phe Val Ala Gly His Arg Gly Leu Val Gly 5 10 15 gcg gct gtt gtt cgt gct ttg aag aag gat ggt tat aac aat ttg gtg 451 Ala Ala Val Val Arg Ala Leu Lys Lys Asp Gly Tyr Asn Asn Leu Val 20 25 30 35 atg aag act cat aaa gaa cta gat ctt acc cgt cag cac gag gaa ttt 499 Met Lys Thr His Lys Glu Leu Asp Leu Thr Arg Gln His Glu Glu Phe 40 45 50 ttc gac acg gag aaa cca gcg tac gtc atc cta gca gct gcg aag gtg 547 Phe Asp Thr Glu Lys Pro Ala Tyr Val Ile Leu Ala Ala Ala Lys Val 55 60 65 gga ggc att cac gca aac agt act tac cct gca gag ttc att gcc gtg 595 Gly Gly Ile His Ala Asn Ser Thr Tyr Pro Ala Glu Phe Ile Ala Val 70 75 80 aat ctg cag atc caa acg aat gtc atc gat gct gct tac aag tct ggg 643 Asn Leu Gln Ile Gln Thr Asn Val Ile Asp Ala Ala Tyr Lys Ser Gly 85 90 95 gtg aag aag ctc ttg ttt ctg ggc tct tcg tgt atc tac cca aag ttt 691 Val Lys Lys Leu Leu Phe Leu Gly Ser Ser Cys Ile Tyr Pro Lys Phe 100 105 110 115 gcc cag gta ccc atc gtt gag gag tcg ctc ctg aca ggg cct ttg gaa 739 Ala Gln Val Pro Ile Val Glu Glu Ser Leu Leu Thr Gly Pro Leu Glu 120 125 130 gct aca aac gag tgg tat gct gta gca aag att gca gga atc aaa atg 787 Ala Thr Asn Glu Trp Tyr Ala Val Ala Lys Ile Ala Gly Ile Lys Met 135 140 145 tgc cag gct tac agg ctg cag tat aat ttc gac gcc att tct gga atg 835 Cys Gln Ala Tyr Arg Leu Gln Tyr Asn Phe Asp Ala Ile Ser Gly Met 150 155 160 ccg aca aac ctc tac ggt ccc cac gac aat ttc cat ccc gag aac tcc 883 Pro Thr Asn Leu Tyr Gly Pro His Asp Asn Phe His Pro Glu Asn Ser 165 170 175 cac gtc ttg cca gcc ttg atc aga cgc ttt cac gag gct aag gtg aac 931 His Val Leu Pro Ala Leu Ile Arg Arg Phe His Glu Ala Lys Val Asn 180 185 190 195 ggc gct aag gaa gtg gtt gtg tgg gga tca ggt tcc cca ttc cgt gag 979 Gly Ala Lys Glu Val Val Val Trp Gly Ser Gly Ser Pro Phe Arg Glu 200 205 210 ttt ctt cac gtg gac gac ttg gca gag gca aca gta ttt ctg ctg cag 1027 Phe Leu His Val Asp Asp Leu Ala Glu Ala Thr Val Phe Leu Leu Gln 215 220 225 aat tac tcc gcg cat gag cat gtc aac atg ggc agt ggc tct gag gtc 1075 Asn Tyr Ser Ala His Glu His Val Asn Met Gly Ser Gly Ser Glu Val 230 235 240 tca atc aag gaa ctc gcc gaa atg gtg aag gaa gtg gtt gga ttt cag 1123 Ser Ile Lys Glu Leu Ala Glu Met Val Lys Glu Val Val Gly Phe Gln 245 250 255 ggg cag ctg aca tgg gat act tct aag cct gat gga act cca cga aag 1171 Gly Gln Leu Thr Trp Asp Thr Ser Lys Pro Asp Gly Thr Pro Arg Lys 260 265 270 275 ctc atc gat agc agc aaa ctt gcc aac atg ggg tgg caa gcg aga att 1219 Leu Ile Asp Ser Ser Lys Leu Ala Asn Met Gly Trp Gln Ala Arg Ile 280 285 290 ccc ctc aag gaa gga ttg gca gag act tac aaa tgg tac tgt gag aac 1267 Pro Leu Lys Glu Gly Leu Ala Glu Thr Tyr Lys Trp Tyr Cys Glu Asn 295 300 305 tac aat gtc taggctattt tattcggatc aaccttgaag cacctgtttt 1316 Tyr Asn Val 310 tgaattctta ctacgataga taaattcaag cggtggctat gtgaagcagt ggtagctttg 1376 caggatactg acctcgagga tatttatcac aattcattgc ctgtttagtg ggtactgcaa 1436 ccttgtattg tgaggctgtc atggcaattt tctttctagc atgctgactt taaa 1490 148 310 PRT Physcomitrella patens 148 Met Gly Val Asp Lys Asp Ala Lys Ile Phe Val Ala Gly His Arg Gly 1 5 10 15 Leu Val Gly Ala Ala Val Val Arg Ala Leu Lys Lys Asp Gly Tyr Asn 20 25 30 Asn Leu Val Met Lys Thr His Lys Glu Leu Asp Leu Thr Arg Gln His 35 40 45 Glu Glu Phe Phe Asp Thr Glu Lys Pro Ala Tyr Val Ile Leu Ala Ala 50 55 60 Ala Lys Val Gly Gly Ile His Ala Asn Ser Thr Tyr Pro Ala Glu Phe 65 70 75 80 Ile Ala Val Asn Leu Gln Ile Gln Thr Asn Val Ile Asp Ala Ala Tyr 85 90 95 Lys Ser Gly Val Lys Lys Leu Leu Phe Leu Gly Ser Ser Cys Ile Tyr 100 105 110 Pro Lys Phe Ala Gln Val Pro Ile Val Glu Glu Ser Leu Leu Thr Gly 115 120 125 Pro Leu Glu Ala Thr Asn Glu Trp Tyr Ala Val Ala Lys Ile Ala Gly 130 135 140 Ile Lys Met Cys Gln Ala Tyr Arg Leu Gln Tyr Asn Phe Asp Ala Ile 145 150 155 160 Ser Gly Met Pro Thr Asn Leu Tyr Gly Pro His Asp Asn Phe His Pro 165 170 175 Glu Asn Ser His Val Leu Pro Ala Leu Ile Arg Arg Phe His Glu Ala 180 185 190 Lys Val Asn Gly Ala Lys Glu Val Val Val Trp Gly Ser Gly Ser Pro 195 200 205 Phe Arg Glu Phe Leu His Val Asp Asp Leu Ala Glu Ala Thr Val Phe 210 215 220 Leu Leu Gln Asn Tyr Ser Ala His Glu His Val Asn Met Gly Ser Gly 225 230 235 240 Ser Glu Val Ser Ile Lys Glu Leu Ala Glu Met Val Lys Glu Val Val 245 250 255 Gly Phe Gln Gly Gln Leu Thr Trp Asp Thr Ser Lys Pro Asp Gly Thr 260 265 270 Pro Arg Lys Leu Ile Asp Ser Ser Lys Leu Ala Asn Met Gly Trp Gln 275 280 285 Ala Arg Ile Pro Leu Lys Glu Gly Leu Ala Glu Thr Tyr Lys Trp Tyr 290 295 300 Cys Glu Asn Tyr Asn Val 305 310 149 924 DNA Physcomitrella patens CDS (322)..(921) c_pp032009028r 149 attcatcagc cggtctgccg tagcttcggc gcgcaggaca ggcagaggac gagacaaggg 60 ggctgcaggc accaggctgc ttccgcagct ttagattgca agagcaggtt ccctcaggac 120 ttcgaatctg gatcgcgctc acagaaagtc cacatgttag ttgcctctcg tagtcgcgct 180 gcttagtttc gacaggtttc aggctcctgg aagtcttttg caaccaggtt tccgggccag 240 cttgaacagc acttgttcgg tactgtttag aagttgaact ttgaagtgcg caacgagata 300 gtatttcgag aagtatcgac a atg ggt tcc ttg gga aga caa gga tgt tta 351 Met Gly Ser Leu Gly Arg Gln Gly Cys Leu 1 5 10 ttg gtc ggt gtc ttg ttt tac ttg agc atg gct atc ggc gct caa gct 399 Leu Val Gly Val Leu Phe Tyr Leu Ser Met Ala Ile Gly Ala Gln Ala 15 20 25 cag agt tac cca gga ctt cag gct gca ttc aat tct tgg acg ccg aag 447 Gln Ser Tyr Pro Gly Leu Gln Ala Ala Phe Asn Ser Trp Thr Pro Lys 30 35 40 cag att atc ccg gat aag aat gga agg aaa gtg caa ctc gtg ctt aac 495 Gln Ile Ile Pro Asp Lys Asn Gly Arg Lys Val Gln Leu Val Leu Asn 45 50 55 aat tca tct tcg gca tat act ggc atg gga tct aag caa tcg tgg ctg 543 Asn Ser Ser Ser Ala Tyr Thr Gly Met Gly Ser Lys Gln Ser Trp Leu 60 65 70 ttt ggg ggt atc ggg gcc tgg atc aag ctc ccc gct aac gat tcc gct 591 Phe Gly Gly Ile Gly Ala Trp Ile Lys Leu Pro Ala Asn Asp Ser Ala 75 80 85 90 gga act gtc acc aca ttc tac atg tca tct act ggg ccg aag cat tgc 639 Gly Thr Val Thr Thr Phe Tyr Met Ser Ser Thr Gly Pro Lys His Cys 95 100 105 gag ttc gac ttc gag ttc cta ggc aac tcc agc ggc caa cct tac ctt 687 Glu Phe Asp Phe Glu Phe Leu Gly Asn Ser Ser Gly Gln Pro Tyr Leu 110 115 120 ctc cat acc aac atc ttc gtc gac ggc gtc gga ggc cgc gag cag cag 735 Leu His Thr Asn Ile Phe Val Asp Gly Val Gly Gly Arg Glu Gln Gln 125 130 135 atc cgc cta tgg ttt gac ccc act gca gca ttc cac tac tac aac ttc 783 Ile Arg Leu Trp Phe Asp Pro Thr Ala Ala Phe His Tyr Tyr Asn Phe 140 145 150 cag tgg aac aac gac gtg cta gtg ttc ttc att gac aac aca gcc atc 831 Gln Trp Asn Asn Asp Val Leu Val Phe Phe Ile Asp Asn Thr Ala Ile 155 160 165 170 gca tgt tca gaa cct aga agg cat cgt gcc atc atg tac ccc aaa gtg 879 Ala Cys Ser Glu Pro Arg Arg His Arg Ala Ile Met Tyr Pro Lys Val 175 180 185 tcc atg ggt gta act gag cat tgg gat gaa act ggc gat gcg ggt 924 Ser Met Gly Val Thr Glu His Trp Asp Glu Thr Gly Asp Ala 190 195 200 150 200 PRT Physcomitrella patens 150 Met Gly Ser Leu Gly Arg Gln Gly Cys Leu Leu Val Gly Val Leu Phe 1 5 10 15 Tyr Leu Ser Met Ala Ile Gly Ala Gln Ala Gln Ser Tyr Pro Gly Leu 20 25 30 Gln Ala Ala Phe Asn Ser Trp Thr Pro Lys Gln Ile Ile Pro Asp Lys 35 40 45 Asn Gly Arg Lys Val Gln Leu Val Leu Asn Asn Ser Ser Ser Ala Tyr 50 55 60 Thr Gly Met Gly Ser Lys Gln Ser Trp Leu Phe Gly Gly Ile Gly Ala 65 70 75 80 Trp Ile Lys Leu Pro Ala Asn Asp Ser Ala Gly Thr Val Thr Thr Phe 85 90 95 Tyr Met Ser Ser Thr Gly Pro Lys His Cys Glu Phe Asp Phe Glu Phe 100 105 110 Leu Gly Asn Ser Ser Gly Gln Pro Tyr Leu Leu His Thr Asn Ile Phe 115 120 125 Val Asp Gly Val Gly Gly Arg Glu Gln Gln Ile Arg Leu Trp Phe Asp 130 135 140 Pro Thr Ala Ala Phe His Tyr Tyr Asn Phe Gln Trp Asn Asn Asp Val 145 150 155 160 Leu Val Phe Phe Ile Asp Asn Thr Ala Ile Ala Cys Ser Glu Pro Arg 165 170 175 Arg His Arg Ala Ile Met Tyr Pro Lys Val Ser Met Gly Val Thr Glu 180 185 190 His Trp Asp Glu Thr Gly Asp Ala 195 200 151 1463 DNA Physcomitrella patens CDS (268)..(1128) c_pp004089354r 151 ggggcgtcta actagtggtc ccccgggctg aggcaccggc acagcgatgg tgcagcggat 60 tcaaccccac atcgatctgg aactttgtcg ttagtgctca cccagaagaa gagcttctgc 120 ggagtagtct tcacccctat agtgccgacc tagtggttat ctgagcattt gatcgcaacg 180 atttcaccta gagcggtgga gtgattttca gctgctgcct gataggaagg attgtctaac 240 gggattgggg gaacgtgcaa tctagca atg ggg tcg ctc ggg ggt tcg cgt agc 294 Met Gly Ser Leu Gly Gly Ser Arg Ser 1 5 acc ctg ctg att ttg ctg cta ctg tgt ttg agc ttg gct gtt ggc ggt 342 Thr Leu Leu Ile Leu Leu Leu Leu Cys Leu Ser Leu Ala Val Gly Gly 10 15 20 25 cgc gcc caa acg ctt gct cag cag ttc act ccg tgg act gaa aat gcg 390 Arg Ala Gln Thr Leu Ala Gln Gln Phe Thr Pro Trp Thr Glu Asn Ala 30 35 40 agg ttc act act gac act caa atg cag ctc acc ttg gat caa cgc tat 438 Arg Phe Thr Thr Asp Thr Gln Met Gln Leu Thr Leu Asp Gln Arg Tyr 45 50 55 gca gct ggg gca gga tcc gtg aac gtt tgg acg tac gtc gac atc agc 486 Ala Ala Gly Ala Gly Ser Val Asn Val Trp Thr Tyr Val Asp Ile Ser 60 65 70 gcg tac ata aag atg ccg cca ttc gat tcc gct ggt act gtg aca acg 534 Ala Tyr Ile Lys Met Pro Pro Phe Asp Ser Ala Gly Thr Val Thr Thr 75 80 85 ttc tac atg tcg tct cag ggt gac cag cat tac gag ctg gac atg gag 582 Phe Tyr Met Ser Ser Gln Gly Asp Gln His Tyr Glu Leu Asp Met Glu 90 95 100 105 ttt ttg gga aac act agc gga cag ccc ttc ctg ctt cac acg aat gtg 630 Phe Leu Gly Asn Thr Ser Gly Gln Pro Phe Leu Leu His Thr Asn Val 110 115 120 ttc gtt gat ggg gtt ggg ggt cgc gag cag caa atg tac ctg gga ttc 678 Phe Val Asp Gly Val Gly Gly Arg Glu Gln Gln Met Tyr Leu Gly Phe 125 130 135 gac ccc tct gct gac ttc cac tac tac aga ttc cgg tgg agt aag gat 726 Asp Pro Ser Ala Asp Phe His Tyr Tyr Arg Phe Arg Trp Ser Lys Asp 140 145 150 atg gtt gtt ttc tac gtc gat aac aaa ccc gtc cga gtt ttc aag aat 774 Met Val Val Phe Tyr Val Asp Asn Lys Pro Val Arg Val Phe Lys Asn 155 160 165 ctg gaa ggc acg gta ccg ggg act aaa tac ctg aac cag caa gca atg 822 Leu Glu Gly Thr Val Pro Gly Thr Lys Tyr Leu Asn Gln Gln Ala Met 170 175 180 185 ggg gtg tac ata agc atc tgg gac ggt agc agt tgg gcc acg caa gga 870 Gly Val Tyr Ile Ser Ile Trp Asp Gly Ser Ser Trp Ala Thr Gln Gly 190 195 200 ggg cgt gtg ccc atc aac tgg gct tcc gct cca ttc act gcg acg tac 918 Gly Arg Val Pro Ile Asn Trp Ala Ser Ala Pro Phe Thr Ala Thr Tyr 205 210 215 cag gac ttc gca ctg aat ggg tgc gtg gta gac ccc aac gat ccc aat 966 Gln Asp Phe Ala Leu Asn Gly Cys Val Val Asp Pro Asn Asp Pro Asn 220 225 230 gga gtt gca gca tgc cag aac tct ccg tat gca acc gga gca gcc ttg 1014 Gly Val Ala Ala Cys Gln Asn Ser Pro Tyr Ala Thr Gly Ala Ala Leu 235 240 245 agc aat cag gaa gtt tat gag ttg ggg cag aac aaa gct tac atg atg 1062 Ser Asn Gln Glu Val Tyr Glu Leu Gly Gln Asn Lys Ala Tyr Met Met 250 255 260 265 aaa tac gac tac tgc gac gac agg gtt cga tac cca gat gtg cca cct 1110 Lys Tyr Asp Tyr Cys Asp Asp Arg Val Arg Tyr Pro Asp Val Pro Pro 270 275 280 gaa tgt cct tac aac aac gtgttgaata cggaatgagt cgtgtacatg 1158 Glu Cys Pro Tyr Asn Asn 285 ttacgtgcta gctatttggg gcgtggttgc ctagtgaaga tatagttgcg tagaggtcat 1218 ctgattcttt tgtatattaa ttgtacgcgg aggtcgattc tttgacgact atggacagat 1278 gtggcccgtc agctcagagt agtaaaagac taggaatttt ctttagtgga aagaataacg 1338 atctctttcc acctgagttg gtacattcta tttgtaataa tgctgatgct catttggcag 1398 aagctatgaa ttctttgact tcaagtcatg tctctcaaaa aaaaaaaaaa aaaacctgca 1458 gcccg 1463 152 287 PRT Physcomitrella patens 152 Met Gly Ser Leu Gly Gly Ser Arg Ser Thr Leu Leu Ile Leu Leu Leu 1 5 10 15 Leu Cys Leu Ser Leu Ala Val Gly Gly Arg Ala Gln Thr Leu Ala Gln 20 25 30 Gln Phe Thr Pro Trp Thr Glu Asn Ala Arg Phe Thr Thr Asp Thr Gln 35 40 45 Met Gln Leu Thr Leu Asp Gln Arg Tyr Ala Ala Gly Ala Gly Ser Val 50 55 60 Asn Val Trp Thr Tyr Val Asp Ile Ser Ala Tyr Ile Lys Met Pro Pro 65 70 75 80 Phe Asp Ser Ala Gly Thr Val Thr Thr Phe Tyr Met Ser Ser Gln Gly 85 90 95 Asp Gln His Tyr Glu Leu Asp Met Glu Phe Leu Gly Asn Thr Ser Gly 100 105 110 Gln Pro Phe Leu Leu His Thr Asn Val Phe Val Asp Gly Val Gly Gly 115 120 125 Arg Glu Gln Gln Met Tyr Leu Gly Phe Asp Pro Ser Ala Asp Phe His 130 135 140 Tyr Tyr Arg Phe Arg Trp Ser Lys Asp Met Val Val Phe Tyr Val Asp 145 150 155 160 Asn Lys Pro Val Arg Val Phe Lys Asn Leu Glu Gly Thr Val Pro Gly 165 170 175 Thr Lys Tyr Leu Asn Gln Gln Ala Met Gly Val Tyr Ile Ser Ile Trp 180 185 190 Asp Gly Ser Ser Trp Ala Thr Gln Gly Gly Arg Val Pro Ile Asn Trp 195 200 205 Ala Ser Ala Pro Phe Thr Ala Thr Tyr Gln Asp Phe Ala Leu Asn Gly 210 215 220 Cys Val Val Asp Pro Asn Asp Pro Asn Gly Val Ala Ala Cys Gln Asn 225 230 235 240 Ser Pro Tyr Ala Thr Gly Ala Ala Leu Ser Asn Gln Glu Val Tyr Glu 245 250 255 Leu Gly Gln Asn Lys Ala Tyr Met Met Lys Tyr Asp Tyr Cys Asp Asp 260 265 270 Arg Val Arg Tyr Pro Asp Val Pro Pro Glu Cys Pro Tyr Asn Asn 275 280 285 153 1009 DNA Physcomitrella patens CDS (1)..(501) s_pp002010066r 153 ggc atc acg ctg gag gaa tgg tgg cga aat gag caa ttc tgg gtg atc 48 Gly Ile Thr Leu Glu Glu Trp Trp Arg Asn Glu Gln Phe Trp Val Ile 1 5 10 15 ggt ggc acg agc gct cac tta gct gcc gtc ttt cag ggt ttc ctg aaa 96 Gly Gly Thr Ser Ala His Leu Ala Ala Val Phe Gln Gly Phe Leu Lys 20 25 30 gtc atc gcc ggg gtc gac atc tcc ttc acg ctt aca tcc aag gca act 144 Val Ile Ala Gly Val Asp Ile Ser Phe Thr Leu Thr Ser Lys Ala Thr 35 40 45 ggg gac gag ggg gat gac gag ttt gcc gat ctg tac gtg gtg aag tgg 192 Gly Asp Glu Gly Asp Asp Glu Phe Ala Asp Leu Tyr Val Val Lys Trp 50 55 60 agc gct ctc atg atc cct ccc atc acc atc atg atc acc aac gta gtg 240 Ser Ala Leu Met Ile Pro Pro Ile Thr Ile Met Ile Thr Asn Val Val 65 70 75 80 gct att gcg gtg ggc acc tcg cgc cag att tac agc acc atc ccg gag 288 Ala Ile Ala Val Gly Thr Ser Arg Gln Ile Tyr Ser Thr Ile Pro Glu 85 90 95 tgg agc aag ctc atc ggc ggc gtc ttc ttc tcc ttg tgg gtg ctc tct 336 Trp Ser Lys Leu Ile Gly Gly Val Phe Phe Ser Leu Trp Val Leu Ser 100 105 110 cat ctc tac ccc ttt gcc aag ggc ctc atg ggc cgc aag ggc aaa act 384 His Leu Tyr Pro Phe Ala Lys Gly Leu Met Gly Arg Lys Gly Lys Thr 115 120 125 ccg acc att atc tac gtg tgg tca ggt ttg ctc tcc gtc atc atc tcc 432 Pro Thr Ile Ile Tyr Val Trp Ser Gly Leu Leu Ser Val Ile Ile Ser 130 135 140 ctc atg tgg gtg tat ata aat ccg cct tca gga act tct gtc act ggg 480 Leu Met Trp Val Tyr Ile Asn Pro Pro Ser Gly Thr Ser Val Thr Gly 145 150 155 160 ggc ggc ctc tcc ttt cct tga aaattcttta gcaaatttcc aacagaaatt 531 Gly Gly Leu Ser Phe Pro 165 tgcacagcat agctaccgct aacttgcccg acattggact agcatcggac cagctcactt 591 tcagcttatc acttccggtc ccttgcacgc acacatgcct tgaggattgc aaaactggac 651 tcggagagat ccagtgcggc tgtatcgaaa attgtgggaa ctgacccaga gtaaggaatt 711 ctggtgcaca tcatttttct gctgtgagcc gcaaagaagg atcttgagaa acgaaaaaca 771 agcggagcaa gcacgcggcg ttgagaactg caggtgccgg tcataaccac tgacgaatca 831 tcgcccctcg cagtgtagat tgctcattgc gaacggtgat taatgcgatc ctcatgcatc 891 gagttcggta agatgaacct taggcattca agtccatggg cctagcgcgt tgcatcttct 951 gtagagttga tcatttgttc aataaaaaat ttgacccagt tttgaaacct caaaaaaa 1009 154 166 PRT Physcomitrella patens 154 Gly Ile Thr Leu Glu Glu Trp Trp Arg Asn Glu Gln Phe Trp Val Ile 1 5 10 15 Gly Gly Thr Ser Ala His Leu Ala Ala Val Phe Gln Gly Phe Leu Lys 20 25 30 Val Ile Ala Gly Val Asp Ile Ser Phe Thr Leu Thr Ser Lys Ala Thr 35 40 45 Gly Asp Glu Gly Asp Asp Glu Phe Ala Asp Leu Tyr Val Val Lys Trp 50 55 60 Ser Ala Leu Met Ile Pro Pro Ile Thr Ile Met Ile Thr Asn Val Val 65 70 75 80 Ala Ile Ala Val Gly Thr Ser Arg Gln Ile Tyr Ser Thr Ile Pro Glu 85 90 95 Trp Ser Lys Leu Ile Gly Gly Val Phe Phe Ser Leu Trp Val Leu Ser 100 105 110 His Leu Tyr Pro Phe Ala Lys Gly Leu Met Gly Arg Lys Gly Lys Thr 115 120 125 Pro Thr Ile Ile Tyr Val Trp Ser Gly Leu Leu Ser Val Ile Ile Ser 130 135 140 Leu Met Trp Val Tyr Ile Asn Pro Pro Ser Gly Thr Ser Val Thr Gly 145 150 155 160 Gly Gly Leu Ser Phe Pro 165 155 1337 DNA Physcomitrella patens CDS (187)..(1167) c_pp001002092f 155 cagccatcga atgctcatcg gctctgctcg attcctttag agcttaatcg cggatcggcg 60 gcggcagcag cagcagcacc gagtgcagcg agcccatcca tctcgttgca acgcaggaac 120 tggagcactc cgagtcgtag cgatttcgag agcttcgttg cgcgcgagtg cttgtgttcg 180 ggagca atg gca ttg gct gcg tgc agg gct gcg cac tcc gtt gcg ggg 228 Met Ala Leu Ala Ala Cys Arg Ala Ala His Ser Val Ala Gly 1 5 10 gct tcg ccg tcg tct ctc gct gct gct gct gcc aaa ccc tct tcg tcg 276 Ala Ser Pro Ser Ser Leu Ala Ala Ala Ala Ala Lys Pro Ser Ser Ser 15 20 25 30 ctc gcg cgc ccc caa ttc gct gga ctg cgc cgt gct gat gtc gcc aac 324 Leu Ala Arg Pro Gln Phe Ala Gly Leu Arg Arg Ala Asp Val Ala Asn 35 40 45 gag tca tcg ttc ggg gca gtc ttg tct caa cgg ttg cag agt gcg ggt 372 Glu Ser Ser Phe Gly Ala Val Leu Ser Gln Arg Leu Gln Ser Ala Gly 50 55 60 aca ggg agc agg gga gtc gtc tcc atg gct gga act gga aag ttc ttc 420 Thr Gly Ser Arg Gly Val Val Ser Met Ala Gly Thr Gly Lys Phe Phe 65 70 75 gtc ggg ggc aac tgg aag tgc aat ggc acg act gag agc att aag aag 468 Val Gly Gly Asn Trp Lys Cys Asn Gly Thr Thr Glu Ser Ile Lys Lys 80 85 90 ctt gtg gat gag ctc aac agt gtc atg ctc gag gag ggt gtg gaa gtt 516 Leu Val Asp Glu Leu Asn Ser Val Met Leu Glu Glu Gly Val Glu Val 95 100 105 110 gtc gtg tcg cca cca tat ctg tac ata agc cag gtg ctg gga tcg ttg 564 Val Val Ser Pro Pro Tyr Leu Tyr Ile Ser Gln Val Leu Gly Ser Leu 115 120 125 tcc aat agg att gag gtc gcg gct cag aac tcg tgg gtt gga aag ggt 612 Ser Asn Arg Ile Glu Val Ala Ala Gln Asn Ser Trp Val Gly Lys Gly 130 135 140 gga gcg ttc acg ggg gag att agt gcg gag cag ttg gct gat gct ggc 660 Gly Ala Phe Thr Gly Glu Ile Ser Ala Glu Gln Leu Ala Asp Ala Gly 145 150 155 gtg aaa tgg gtg att caa ggg cat tct gag cga aga cat gtg atc ggc 708 Val Lys Trp Val Ile Gln Gly His Ser Glu Arg Arg His Val Ile Gly 160 165 170 gag acc gat gcc atg att ggg aag aag agc gcg tat gca ttg tcc caa 756 Glu Thr Asp Ala Met Ile Gly Lys Lys Ser Ala Tyr Ala Leu Ser Gln 175 180 185 190 ggc cta ggt gtg atc gcc tgt gtg ggg gag aag ctt gag gat cgt gaa 804 Gly Leu Gly Val Ile Ala Cys Val Gly Glu Lys Leu Glu Asp Arg Glu 195 200 205 gcg aat cgc acc acc gat gtt gtg ttc gag cag ttg caa gct tac gct 852 Ala Asn Arg Thr Thr Asp Val Val Phe Glu Gln Leu Gln Ala Tyr Ala 210 215 220 gat gct gtt gga tcg gac tgg tcg aac att gtg gta gcg tac gag ccc 900 Asp Ala Val Gly Ser Asp Trp Ser Asn Ile Val Val Ala Tyr Glu Pro 225 230 235 gtc tgg gct att gga act ggc aag gtg gcc agc cct cag caa gct caa 948 Val Trp Ala Ile Gly Thr Gly Lys Val Ala Ser Pro Gln Gln Ala Gln 240 245 250 gag gtg cac gct gcc atc cgt cag tgg ttg aag gag aaa gtt tct gat 996 Glu Val His Ala Ala Ile Arg Gln Trp Leu Lys Glu Lys Val Ser Asp 255 260 265 270 gat gtg tct tca aag acc cgc atc atc tat ggt ggc tca gtg aac ggt 1044 Asp Val Ser Ser Lys Thr Arg Ile Ile Tyr Gly Gly Ser Val Asn Gly 275 280 285 gcc aac agc gcc gag ctt gcc aca caa gag gac att gat gga ttc ctt 1092 Ala Asn Ser Ala Glu Leu Ala Thr Gln Glu Asp Ile Asp Gly Phe Leu 290 295 300 gtc gga gga gct tca ctg aag ggt gct gag ttt ggt gtt att tgc aac 1140 Val Gly Gly Ala Ser Leu Lys Gly Ala Glu Phe Gly Val Ile Cys Asn 305 310 315 gcg gtc act gca aag aaa gtt gct gca taagtcgatt gctggctctg 1187 Ala Val Thr Ala Lys Lys Val Ala Ala 320 325 cttaattttg tctgttgtag ccaaatcgct tgccttacac aacttgtttt tgttttaggt 1247 tagtgaacat gttgggcctt gcaaatccgt gtatggggta tttttggtga atgtccactg 1307 aggtgtctag tttgcgagct gagctaaaaa 1337 156 327 PRT Physcomitrella patens 156 Met Ala Leu Ala Ala Cys Arg Ala Ala His Ser Val Ala Gly Ala Ser 1 5 10 15 Pro Ser Ser Leu Ala Ala Ala Ala Ala Lys Pro Ser Ser Ser Leu Ala 20 25 30 Arg Pro Gln Phe Ala Gly Leu Arg Arg Ala Asp Val Ala Asn Glu Ser 35 40 45 Ser Phe Gly Ala Val Leu Ser Gln Arg Leu Gln Ser Ala Gly Thr Gly 50 55 60 Ser Arg Gly Val Val Ser Met Ala Gly Thr Gly Lys Phe Phe Val Gly 65 70 75 80 Gly Asn Trp Lys Cys Asn Gly Thr Thr Glu Ser Ile Lys Lys Leu Val 85 90 95 Asp Glu Leu Asn Ser Val Met Leu Glu Glu Gly Val Glu Val Val Val 100 105 110 Ser Pro Pro Tyr Leu Tyr Ile Ser Gln Val Leu Gly Ser Leu Ser Asn 115 120 125 Arg Ile Glu Val Ala Ala Gln Asn Ser Trp Val Gly Lys Gly Gly Ala 130 135 140 Phe Thr Gly Glu Ile Ser Ala Glu Gln Leu Ala Asp Ala Gly Val Lys 145 150 155 160 Trp Val Ile Gln Gly His Ser Glu Arg Arg His Val Ile Gly Glu Thr 165 170 175 Asp Ala Met Ile Gly Lys Lys Ser Ala Tyr Ala Leu Ser Gln Gly Leu 180 185 190 Gly Val Ile Ala Cys Val Gly Glu Lys Leu Glu Asp Arg Glu Ala Asn 195 200 205 Arg Thr Thr Asp Val Val Phe Glu Gln Leu Gln Ala Tyr Ala Asp Ala 210 215 220 Val Gly Ser Asp Trp Ser Asn Ile Val Val Ala Tyr Glu Pro Val Trp 225 230 235 240 Ala Ile Gly Thr Gly Lys Val Ala Ser Pro Gln Gln Ala Gln Glu Val 245 250 255 His Ala Ala Ile Arg Gln Trp Leu Lys Glu Lys Val Ser Asp Asp Val 260 265 270 Ser Ser Lys Thr Arg Ile Ile Tyr Gly Gly Ser Val Asn Gly Ala Asn 275 280 285 Ser Ala Glu Leu Ala Thr Gln Glu Asp Ile Asp Gly Phe Leu Val Gly 290 295 300 Gly Ala Ser Leu Lys Gly Ala Glu Phe Gly Val Ile Cys Asn Ala Val 305 310 315 320 Thr Ala Lys Lys Val Ala Ala 325 157 1060 DNA Physcomitrella patens CDS (3)..(917) s_pp013006066r 157 ca gct atc gct gct tct ttt tct gct ccc ctc gcg tct gcc cct gcc 47 Ala Ile Ala Ala Ser Phe Ser Ala Pro Leu Ala Ser Ala Pro Ala 1 5 10 15 ttc tcc ggc ctc cgt cgc ctc cct ctt gct ccc gct tcg tct ccc gct 95 Phe Ser Gly Leu Arg Arg Leu Pro Leu Ala Pro Ala Ser Ser Pro Ala 20 25 30 ttc ggt gtc gtc ttc tct ttg agt gag ggg aag ggg cac aga ggt gtc 143 Phe Gly Val Val Phe Ser Leu Ser Glu Gly Lys Gly His Arg Gly Val 35 40 45 gtc acc atg act ggg gcc ggg aag ttt ttc gtt ggc ggg aac tgg aag 191 Val Thr Met Thr Gly Ala Gly Lys Phe Phe Val Gly Gly Asn Trp Lys 50 55 60 tgc aat ggc aca act gag tcg atc aag aag ctc gtg gag gat ttg aac 239 Cys Asn Gly Thr Thr Glu Ser Ile Lys Lys Leu Val Glu Asp Leu Asn 65 70 75 agt gcc caa att gag gac gac gtt gat gtc gtc gtc gct ccc ccg ttt 287 Ser Ala Gln Ile Glu Asp Asp Val Asp Val Val Val Ala Pro Pro Phe 80 85 90 95 ttg tat atc agc cag gtg gtc ggg tct ttg acg gac cgc att gag gtc 335 Leu Tyr Ile Ser Gln Val Val Gly Ser Leu Thr Asp Arg Ile Glu Val 100 105 110 tcc gct cag aac tct tgg gtc ggc aag gga gga gcc ttc act ggt gag 383 Ser Ala Gln Asn Ser Trp Val Gly Lys Gly Gly Ala Phe Thr Gly Glu 115 120 125 att agc gcc gac cag ctg gtc gat gtc ggt gtg aag tgg gta att cag 431 Ile Ser Ala Asp Gln Leu Val Asp Val Gly Val Lys Trp Val Ile Gln 130 135 140 ggc cac tct gag cgc cga cac gtc att ggc gag tcg aat tca acc gtt 479 Gly His Ser Glu Arg Arg His Val Ile Gly Glu Ser Asn Ser Thr Val 145 150 155 ggg aag aag agc gcg tac gca ttg tcc aaa ggc ttg gga ttg att gct 527 Gly Lys Lys Ser Ala Tyr Ala Leu Ser Lys Gly Leu Gly Leu Ile Ala 160 165 170 175 tgc gtt gga gag ttg ctc gag gag cgc gaa gcc ggc cgt acc aca gat 575 Cys Val Gly Glu Leu Leu Glu Glu Arg Glu Ala Gly Arg Thr Thr Asp 180 185 190 gtt gtg ttt gag cag ctg caa gca tat gcc gat gag atc tca gat tgg 623 Val Val Phe Glu Gln Leu Gln Ala Tyr Ala Asp Glu Ile Ser Asp Trp 195 200 205 tcg aag gtg gtg att gcc tac gaa cca gtg tgg gcc att gga act ggc 671 Ser Lys Val Val Ile Ala Tyr Glu Pro Val Trp Ala Ile Gly Thr Gly 210 215 220 aaa gtt gcc tct cct cag caa gcg cag gag gtg cac agc gcc att cga 719 Lys Val Ala Ser Pro Gln Gln Ala Gln Glu Val His Ser Ala Ile Arg 225 230 235 tcg tgg ttg agt gac aag atc tcg cca gag gtg tcc tct gcg act cgc 767 Ser Trp Leu Ser Asp Lys Ile Ser Pro Glu Val Ser Ser Ala Thr Arg 240 245 250 255 att att tac ggt ggt tct gtg aac gga gct aac agt gcc gag ctt gcc 815 Ile Ile Tyr Gly Gly Ser Val Asn Gly Ala Asn Ser Ala Glu Leu Ala 260 265 270 aag caa gaa gat att gat ggt ttc ctt gtc ggt gga gcc tca ttg aaa 863 Lys Gln Glu Asp Ile Asp Gly Phe Leu Val Gly Gly Ala Ser Leu Lys 275 280 285 gga cct gag ttc gcc aca atc tgc aat gct gtc acc gca aag aaa gtt 911 Gly Pro Glu Phe Ala Thr Ile Cys Asn Ala Val Thr Ala Lys Lys Val 290 295 300 tct gca taatctcgta cattgaatgc gctggtttag ccgaatgact tagactaagc 967 Ser Ala 305 gcctcccttt gtaaatcgct ctcggacatg ctgtaatggt agcccatgtt tatggtaaaa 1027 aatcattgta attcttcaaa aaaaaaaaaa aaa 1060 158 305 PRT Physcomitrella patens 158 Ala Ile Ala Ala Ser Phe Ser Ala Pro Leu Ala Ser Ala Pro Ala Phe 1 5 10 15 Ser Gly Leu Arg Arg Leu Pro Leu Ala Pro Ala Ser Ser Pro Ala Phe 20 25 30 Gly Val Val Phe Ser Leu Ser Glu Gly Lys Gly His Arg Gly Val Val 35 40 45 Thr Met Thr Gly Ala Gly Lys Phe Phe Val Gly Gly Asn Trp Lys Cys 50 55 60 Asn Gly Thr Thr Glu Ser Ile Lys Lys Leu Val Glu Asp Leu Asn Ser 65 70 75 80 Ala Gln Ile Glu Asp Asp Val Asp Val Val Val Ala Pro Pro Phe Leu 85 90 95 Tyr Ile Ser Gln Val Val Gly Ser Leu Thr Asp Arg Ile Glu Val Ser 100 105 110 Ala Gln Asn Ser Trp Val Gly Lys Gly Gly Ala Phe Thr Gly Glu Ile 115 120 125 Ser Ala Asp Gln Leu Val Asp Val Gly Val Lys Trp Val Ile Gln Gly 130 135 140 His Ser Glu Arg Arg His Val Ile Gly Glu Ser Asn Ser Thr Val Gly 145 150 155 160 Lys Lys Ser Ala Tyr Ala Leu Ser Lys Gly Leu Gly Leu Ile Ala Cys 165 170 175 Val Gly Glu Leu Leu Glu Glu Arg Glu Ala Gly Arg Thr Thr Asp Val 180 185 190 Val Phe Glu Gln Leu Gln Ala Tyr Ala Asp Glu Ile Ser Asp Trp Ser 195 200 205 Lys Val Val Ile Ala Tyr Glu Pro Val Trp Ala Ile Gly Thr Gly Lys 210 215 220 Val Ala Ser Pro Gln Gln Ala Gln Glu Val His Ser Ala Ile Arg Ser 225 230 235 240 Trp Leu Ser Asp Lys Ile Ser Pro Glu Val Ser Ser Ala Thr Arg Ile 245 250 255 Ile Tyr Gly Gly Ser Val Asn Gly Ala Asn Ser Ala Glu Leu Ala Lys 260 265 270 Gln Glu Asp Ile Asp Gly Phe Leu Val Gly Gly Ala Ser Leu Lys Gly 275 280 285 Pro Glu Phe Ala Thr Ile Cys Asn Ala Val Thr Ala Lys Lys Val Ser 290 295 300 Ala 305 159 856 DNA Physcomitrella patens CDS (2)..(778) c_pp004048178r 159 g cac cag gca gga ttg tct ttc aat cca tgt aat gta cag cca tcg tcg 49 His Gln Ala Gly Leu Ser Phe Asn Pro Cys Asn Val Gln Pro Ser Ser 1 5 10 15 cgg cct gta tcg cag ccc gtt gtg acg gta tct aac tct gca tcg caa 97 Arg Pro Val Ser Gln Pro Val Val Thr Val Ser Asn Ser Ala Ser Gln 20 25 30 tcg tat gtg ttc tct tct agg ggg aga tca cca tct ctt ccc tcg ctt 145 Ser Tyr Val Phe Ser Ser Arg Gly Arg Ser Pro Ser Leu Pro Ser Leu 35 40 45 aag tca tca ttt ctt cat cct atg act gct aat cgc tcc aat cga gcg 193 Lys Ser Ser Phe Leu His Pro Met Thr Ala Asn Arg Ser Asn Arg Ala 50 55 60 atc agg aaa ggt gtc act tca cct agg ttg cat tgc acc act tcc caa 241 Ile Arg Lys Gly Val Thr Ser Pro Arg Leu His Cys Thr Thr Ser Gln 65 70 75 80 gcc aga gat atg gac gac ttg gtg gta tgc ttt gga gag ctc ctg ata 289 Ala Arg Asp Met Asp Asp Leu Val Val Cys Phe Gly Glu Leu Leu Ile 85 90 95 gat ttt gtg ccc act gtg ggc ggt cta tcg ctt gct gaa gct ccc gca 337 Asp Phe Val Pro Thr Val Gly Gly Leu Ser Leu Ala Glu Ala Pro Ala 100 105 110 ttc aag aaa gcg cct gga ggt gca cct gcc aat gtt gct tgt ggg ata 385 Phe Lys Lys Ala Pro Gly Gly Ala Pro Ala Asn Val Ala Cys Gly Ile 115 120 125 gct aag ctt ggc gga aac gct gct ttt gtc gga aaa gtt ggc gac gat 433 Ala Lys Leu Gly Gly Asn Ala Ala Phe Val Gly Lys Val Gly Asp Asp 130 135 140 gag ttt ggg tac atg ctt tgc gaa gtt ctc aag gat aac aaa gtg caa 481 Glu Phe Gly Tyr Met Leu Cys Glu Val Leu Lys Asp Asn Lys Val Gln 145 150 155 160 acc aag ggt gtc aga ttc gat gct caa gca aga aca gcc ctc gct ttt 529 Thr Lys Gly Val Arg Phe Asp Ala Gln Ala Arg Thr Ala Leu Ala Phe 165 170 175 gtt aca ttg cgc gac gac ggg gag cgg gaa ttt atg ttt tac cgc aat 577 Val Thr Leu Arg Asp Asp Gly Glu Arg Glu Phe Met Phe Tyr Arg Asn 180 185 190 cct agc gcc gac atg ctc ttc cag aca gat gag ttg gat att gag ttg 625 Pro Ser Ala Asp Met Leu Phe Gln Thr Asp Glu Leu Asp Ile Glu Leu 195 200 205 ttg aac caa gct tcc atc ttg cat tat ggc tcc atc agt ttg atc aca 673 Leu Asn Gln Ala Ser Ile Leu His Tyr Gly Ser Ile Ser Leu Ile Thr 210 215 220 gag cca tct cgc tcg acc cac ttg gag gct atg cgc att gcc aaa gag 721 Glu Pro Ser Arg Ser Thr His Leu Glu Ala Met Arg Ile Ala Lys Glu 225 230 235 240 gca ggc gca ctc ctg gtc cta cga tcc aaa cct tcg gct gcc ctt gtg 769 Ala Gly Ala Leu Leu Val Leu Arg Ser Lys Pro Ser Ala Ala Leu Val 245 250 255 gcc atc tgc tgacgccgca aaagagggga tatgtcgatt gggatccggg 818 Ala Ile Cys tgatttctca ggtcggacga ggggtctctt ctactgtg 856 160 259 PRT Physcomitrella patens 160 His Gln Ala Gly Leu Ser Phe Asn Pro Cys Asn Val Gln Pro Ser Ser 1 5 10 15 Arg Pro Val Ser Gln Pro Val Val Thr Val Ser Asn Ser Ala Ser Gln 20 25 30 Ser Tyr Val Phe Ser Ser Arg Gly Arg Ser Pro Ser Leu Pro Ser Leu 35 40 45 Lys Ser Ser Phe Leu His Pro Met Thr Ala Asn Arg Ser Asn Arg Ala 50 55 60 Ile Arg Lys Gly Val Thr Ser Pro Arg Leu His Cys Thr Thr Ser Gln 65 70 75 80 Ala Arg Asp Met Asp Asp Leu Val Val Cys Phe Gly Glu Leu Leu Ile 85 90 95 Asp Phe Val Pro Thr Val Gly Gly Leu Ser Leu Ala Glu Ala Pro Ala 100 105 110 Phe Lys Lys Ala Pro Gly Gly Ala Pro Ala Asn Val Ala Cys Gly Ile 115 120 125 Ala Lys Leu Gly Gly Asn Ala Ala Phe Val Gly Lys Val Gly Asp Asp 130 135 140 Glu Phe Gly Tyr Met Leu Cys Glu Val Leu Lys Asp Asn Lys Val Gln 145 150 155 160 Thr Lys Gly Val Arg Phe Asp Ala Gln Ala Arg Thr Ala Leu Ala Phe 165 170 175 Val Thr Leu Arg Asp Asp Gly Glu Arg Glu Phe Met Phe Tyr Arg Asn 180 185 190 Pro Ser Ala Asp Met Leu Phe Gln Thr Asp Glu Leu Asp Ile Glu Leu 195 200 205 Leu Asn Gln Ala Ser Ile Leu His Tyr Gly Ser Ile Ser Leu Ile Thr 210 215 220 Glu Pro Ser Arg Ser Thr His Leu Glu Ala Met Arg Ile Ala Lys Glu 225 230 235 240 Ala Gly Ala Leu Leu Val Leu Arg Ser Lys Pro Ser Ala Ala Leu Val 245 250 255 Ala Ile Cys 161 979 DNA Physcomitrella patens CDS (1)..(798) c_pp001074086r 161 cgg cgc gca gga cag gca gag gac gag aca agg gga aat gag tct agc 48 Arg Arg Ala Gly Gln Ala Glu Asp Glu Thr Arg Gly Asn Glu Ser Ser 1 5 10 15 agt gtg cag gat gat ata gag aag ggg tgg tct tcg gtg cag tgc ttg 96 Ser Val Gln Asp Asp Ile Glu Lys Gly Trp Ser Ser Val Gln Cys Leu 20 25 30 ccg agg cat atc tgg ttg gat gaa gaa tcg agt gcg aat ttg gtg cag 144 Pro Arg His Ile Trp Leu Asp Glu Glu Ser Ser Ala Asn Leu Val Gln 35 40 45 tgg ccg att gag gaa gtc gat aag ctt cgg cgg aat gaa atg acg gag 192 Trp Pro Ile Glu Glu Val Asp Lys Leu Arg Arg Asn Glu Met Thr Glu 50 55 60 aag aat gtg gag gtt ggg gtg ggt aag gtt gtg ccc gtc aag gcg gcg 240 Lys Asn Val Glu Val Gly Val Gly Lys Val Val Pro Val Lys Ala Ala 65 70 75 80 aag ggc gcg cag ctt gac att gtg gta gat ttc gcc ctg cct gag aag 288 Lys Gly Ala Gln Leu Asp Ile Val Val Asp Phe Ala Leu Pro Glu Lys 85 90 95 agc gag gga ttg gaa caa aac cca aac ctg ctg gcg gag atg gga cat 336 Ser Glu Gly Leu Glu Gln Asn Pro Asn Leu Leu Ala Glu Met Gly His 100 105 110 ttg aca tgc agc gat ttg gta ccc aag ggg tcg aat gca gct gga cca 384 Leu Thr Cys Ser Asp Leu Val Pro Lys Gly Ser Asn Ala Ala Gly Pro 115 120 125 cat agc ttc ggc ccg ttt ggt gtt cac gtg ctt gcg acc ggt gat ctc 432 His Ser Phe Gly Pro Phe Gly Val His Val Leu Ala Thr Gly Asp Leu 130 135 140 cag gag cgg acg tcc atc ttc ttc cat ttg ata cac gat ggc aag cac 480 Gln Glu Arg Thr Ser Ile Phe Phe His Leu Ile His Asp Gly Lys His 145 150 155 160 cag aac tgg aag acg ctc ttc tgc ggc gac cag agc caa tcc tcc ttg 528 Gln Asn Trp Lys Thr Leu Phe Cys Gly Asp Gln Ser Gln Ser Ser Leu 165 170 175 cag cag gac gtc gac aag acg gtg tat ggg tcc tac gtg cgc gtg gat 576 Gln Gln Asp Val Asp Lys Thr Val Tyr Gly Ser Tyr Val Arg Val Asp 180 185 190 gac agc gac aag gtg ctg tcc gtg cgc att ctc gtc gac cac tcc atc 624 Asp Ser Asp Lys Val Leu Ser Val Arg Ile Leu Val Asp His Ser Ile 195 200 205 gtg gag agc ttc gcc caa ggc ggc cgc acg gta atg aca tcc aga gta 672 Val Glu Ser Phe Ala Gln Gly Gly Arg Thr Val Met Thr Ser Arg Val 210 215 220 tac ccg gag ctg gcg gtg aaa gac gcc gct cac gtg ttt ttg ttc aac 720 Tyr Pro Glu Leu Ala Val Lys Asp Ala Ala His Val Phe Leu Phe Asn 225 230 235 240 aac ggt act gag ccc gtg aca gtg aaa tcg gta tcc acc tgg gag atg 768 Asn Gly Thr Glu Pro Val Thr Val Lys Ser Val Ser Thr Trp Glu Met 245 250 255 aag agt gtc aac atc aag ttt tac aaa cct tgatttgcac gctctttccg 818 Lys Ser Val Asn Ile Lys Phe Tyr Lys Pro 260 265 cttaactccg gttgataact agccgaaatg ttgctttccc aatttagaat tgtttggaca 878 tcctcgaagc tcaagctgct gcatgcatac agagatattc aaaatcatgt acacatctcc 938 acttgtaata aaacataata aaccactctg tttctcgtgc c 979 162 266 PRT Physcomitrella patens 162 Arg Arg Ala Gly Gln Ala Glu Asp Glu Thr Arg Gly Asn Glu Ser Ser 1 5 10 15 Ser Val Gln Asp Asp Ile Glu Lys Gly Trp Ser Ser Val Gln Cys Leu 20 25 30 Pro Arg His Ile Trp Leu Asp Glu Glu Ser Ser Ala Asn Leu Val Gln 35 40 45 Trp Pro Ile Glu Glu Val Asp Lys Leu Arg Arg Asn Glu Met Thr Glu 50 55 60 Lys Asn Val Glu Val Gly Val Gly Lys Val Val Pro Val Lys Ala Ala 65 70 75 80 Lys Gly Ala Gln Leu Asp Ile Val Val Asp Phe Ala Leu Pro Glu Lys 85 90 95 Ser Glu Gly Leu Glu Gln Asn Pro Asn Leu Leu Ala Glu Met Gly His 100 105 110 Leu Thr Cys Ser Asp Leu Val Pro Lys Gly Ser Asn Ala Ala Gly Pro 115 120 125 His Ser Phe Gly Pro Phe Gly Val His Val Leu Ala Thr Gly Asp Leu 130 135 140 Gln Glu Arg Thr Ser Ile Phe Phe His Leu Ile His Asp Gly Lys His 145 150 155 160 Gln Asn Trp Lys Thr Leu Phe Cys Gly Asp Gln Ser Gln Ser Ser Leu 165 170 175 Gln Gln Asp Val Asp Lys Thr Val Tyr Gly Ser Tyr Val Arg Val Asp 180 185 190 Asp Ser Asp Lys Val Leu Ser Val Arg Ile Leu Val Asp His Ser Ile 195 200 205 Val Glu Ser Phe Ala Gln Gly Gly Arg Thr Val Met Thr Ser Arg Val 210 215 220 Tyr Pro Glu Leu Ala Val Lys Asp Ala Ala His Val Phe Leu Phe Asn 225 230 235 240 Asn Gly Thr Glu Pro Val Thr Val Lys Ser Val Ser Thr Trp Glu Met 245 250 255 Lys Ser Val Asn Ile Lys Phe Tyr Lys Pro 260 265 163 1499 DNA Physcomitrella patens CDS (482)..(1390) c_pp004102322r 163 cggcaccagc gtgactccgt gtgtgagaag tatcgtttgt tggagtgcgc tgtcgatgcc 60 agtgtgtgtt gggcgcgtgt cggaattaag ctggtcgtga aggtgctggc actccttgac 120 tgggtcgacc ttggcgtgtg ggaggagact tttgagattt gggagtttcg tttttgttgc 180 gtgctgtggg ttgttctgca cgagaggctt tgcaggggag tgaattgggt tcgctctgtt 240 agtcgtcctg gctctctttt cgttcccgcg tgtggctaga tcgagcgccg aagcactctg 300 caaggcgttc tactgtcctg ttgcttcgag attagagccc ttgcaagccc ggtcgttgtt 360 cgtgtctccc atcgcttcgc atcctaattc ctcggtcgct tctgtatgtg gtgcttcctt 420 ctctctgaga tcaagcaccg ttttgcattt tagaggctct agaaaaggct tggtttcttg 480 c atg gca agc aat tct att gcc gga gag ctc atc cct gag agt gtt gag 529 Met Ala Ser Asn Ser Ile Ala Gly Glu Leu Ile Pro Glu Ser Val Glu 1 5 10 15 aag aag caa gtg gag atg ggc agc act gaa gag aat tta gat gca acg 577 Lys Lys Gln Val Glu Met Gly Ser Thr Glu Glu Asn Leu Asp Ala Thr 20 25 30 cat gga ttt acg cga cct gaa atg atg aag aag aaa ccg ctg gtt ggt 625 His Gly Phe Thr Arg Pro Glu Met Met Lys Lys Lys Pro Leu Val Gly 35 40 45 agc gtc gac ttg tat gat cgc cac gta ttt tta cgc tac aac cag cca 673 Ser Val Asp Leu Tyr Asp Arg His Val Phe Leu Arg Tyr Asn Gln Pro 50 55 60 agt agc tgg cca gcg aaa gta gaa gct gca gac tac cat cct ttg cca 721 Ser Ser Trp Pro Ala Lys Val Glu Ala Ala Asp Tyr His Pro Leu Pro 65 70 75 80 tct aaa ctg gtc agt acg ctg cgt agc aag aga aac gaa tta ccg aag 769 Ser Lys Leu Val Ser Thr Leu Arg Ser Lys Arg Asn Glu Leu Pro Lys 85 90 95 aag act cgc ttg act att gcc gat ggc caa gat gag cct gaa agg aca 817 Lys Thr Arg Leu Thr Ile Ala Asp Gly Gln Asp Glu Pro Glu Arg Thr 100 105 110 aac gga gat att ttg gtg ttt ccc gac atg gtg aag ggg aat ttc agg 865 Asn Gly Asp Ile Leu Val Phe Pro Asp Met Val Lys Gly Asn Phe Arg 115 120 125 aat cag atg ttg aat ctt tgt gtc gat gag gta ctg ttg aag ggg gac 913 Asn Gln Met Leu Asn Leu Cys Val Asp Glu Val Leu Leu Lys Gly Asp 130 135 140 aag tgg gcc tta ggg gaa tct gag cct ctt gtt gga acc cat gtg ttc 961 Lys Trp Ala Leu Gly Glu Ser Glu Pro Leu Val Gly Thr His Val Phe 145 150 155 160 atc tgt gca cat ggc agt cgt gac aag agg tgt ggt gta tgc gga cct 1009 Ile Cys Ala His Gly Ser Arg Asp Lys Arg Cys Gly Val Cys Gly Pro 165 170 175 cct tta aga gag cgt ttc aat cag gaa att gct ctg cgt ggg cta ggt 1057 Pro Leu Arg Glu Arg Phe Asn Gln Glu Ile Ala Leu Arg Gly Leu Gly 180 185 190 gaa caa gtg ttt gta act att tgc tct cac att gga ggc cat aag tat 1105 Glu Gln Val Phe Val Thr Ile Cys Ser His Ile Gly Gly His Lys Tyr 195 200 205 gcc ggt aac gtg att gtg ttt aga cct gat gga ggt tct gga ggt tgc 1153 Ala Gly Asn Val Ile Val Phe Arg Pro Asp Gly Gly Ser Gly Gly Cys 210 215 220 tcg ggt cat tgg tac ggg tac gtc act cct gat gat gtc cca gag ata 1201 Ser Gly His Trp Tyr Gly Tyr Val Thr Pro Asp Asp Val Pro Glu Ile 225 230 235 240 atg gag aag cac att gga ctt ggc gag gtg gtg ggt cgg ctt tgg agg 1249 Met Glu Lys His Ile Gly Leu Gly Glu Val Val Gly Arg Leu Trp Arg 245 250 255 ggt cag atg gga ttg act gag gat gag cag aag gaa gtt cag cag aaa 1297 Gly Gln Met Gly Leu Thr Glu Asp Glu Gln Lys Glu Val Gln Gln Lys 260 265 270 agg aac ccc tcc agt aat cta act cag gag ggc act aaa cca gaa ggg 1345 Arg Asn Pro Ser Ser Asn Leu Thr Gln Glu Gly Thr Lys Pro Glu Gly 275 280 285 aag gtg gat gca gct tca aca tct act gga ggc aac tgc tcc tat 1390 Lys Val Asp Ala Ala Ser Thr Ser Thr Gly Gly Asn Cys Ser Tyr 290 295 300 taggaaaaag cctcctcctc ctctacttcc acgcattggg tcacgcgacc tgcaccaaat 1450 gtgtggggac gaacaggaag aagaaggtcc acttaaaccg tacgaggag 1499 164 303 PRT Physcomitrella patens 164 Met Ala Ser Asn Ser Ile Ala Gly Glu Leu Ile Pro Glu Ser Val Glu 1 5 10 15 Lys Lys Gln Val Glu Met Gly Ser Thr Glu Glu Asn Leu Asp Ala Thr 20 25 30 His Gly Phe Thr Arg Pro Glu Met Met Lys Lys Lys Pro Leu Val Gly 35 40 45 Ser Val Asp Leu Tyr Asp Arg His Val Phe Leu Arg Tyr Asn Gln Pro 50 55 60 Ser Ser Trp Pro Ala Lys Val Glu Ala Ala Asp Tyr His Pro Leu Pro 65 70 75 80 Ser Lys Leu Val Ser Thr Leu Arg Ser Lys Arg Asn Glu Leu Pro Lys 85 90 95 Lys Thr Arg Leu Thr Ile Ala Asp Gly Gln Asp Glu Pro Glu Arg Thr 100 105 110 Asn Gly Asp Ile Leu Val Phe Pro Asp Met Val Lys Gly Asn Phe Arg 115 120 125 Asn Gln Met Leu Asn Leu Cys Val Asp Glu Val Leu Leu Lys Gly Asp 130 135 140 Lys Trp Ala Leu Gly Glu Ser Glu Pro Leu Val Gly Thr His Val Phe 145 150 155 160 Ile Cys Ala His Gly Ser Arg Asp Lys Arg Cys Gly Val Cys Gly Pro 165 170 175 Pro Leu Arg Glu Arg Phe Asn Gln Glu Ile Ala Leu Arg Gly Leu Gly 180 185 190 Glu Gln Val Phe Val Thr Ile Cys Ser His Ile Gly Gly His Lys Tyr 195 200 205 Ala Gly Asn Val Ile Val Phe Arg Pro Asp Gly Gly Ser Gly Gly Cys 210 215 220 Ser Gly His Trp Tyr Gly Tyr Val Thr Pro Asp Asp Val Pro Glu Ile 225 230 235 240 Met Glu Lys His Ile Gly Leu Gly Glu Val Val Gly Arg Leu Trp Arg 245 250 255 Gly Gln Met Gly Leu Thr Glu Asp Glu Gln Lys Glu Val Gln Gln Lys 260 265 270 Arg Asn Pro Ser Ser Asn Leu Thr Gln Glu Gly Thr Lys Pro Glu Gly 275 280 285 Lys Val Asp Ala Ala Ser Thr Ser Thr Gly Gly Asn Cys Ser Tyr 290 295 300 165 1777 DNA Physcomitrella patens CDS (135)..(1559) c_pp004089380r 165 gctaaaccta gtgatgcacg agccgttttg cccatcggca cgaggaaacc tcgatcatct 60 ccgcctgtgc agcagctgca gccgttctgt tggagtgctt gtgtggtgcc gcgcgcggtc 120 tttaagcttg aagg atg gag tcc ctc gcg ctg cga tct gcc gtg gtt gcc 170 Met Glu Ser Leu Ala Leu Arg Ser Ala Val Val Ala 1 5 10 acc gga ttg acc tcc agt gtg gca tcc caa acc tct gtg cag acc cgc 218 Thr Gly Leu Thr Ser Ser Val Ala Ser Gln Thr Ser Val Gln Thr Arg 15 20 25 gct acg gtt tcg tct gct ttc atc ggg aag agc ata cgt gtg aac act 266 Ala Thr Val Ser Ser Ala Phe Ile Gly Lys Ser Ile Arg Val Asn Thr 30 35 40 aaa ctc aac gcc tca gct gtg ccc gtc cag cag aag ttc cgc tac gtg 314 Lys Leu Asn Ala Ser Ala Val Pro Val Gln Gln Lys Phe Arg Tyr Val 45 50 55 60 cgt gcc gac gct ggt gca cag act gcg cag gtt gag acc gtt gag aag 362 Arg Ala Asp Ala Gly Ala Gln Thr Ala Gln Val Glu Thr Val Glu Lys 65 70 75 aag gct agc att aag gac gtt ccc gag tcg gaa ttc cag ggc aag gtt 410 Lys Ala Ser Ile Lys Asp Val Pro Glu Ser Glu Phe Gln Gly Lys Val 80 85 90 gtg ttc gtg cgt gct gat ctg aac gta cct ctc aat gat gca tgc gaa 458 Val Phe Val Arg Ala Asp Leu Asn Val Pro Leu Asn Asp Ala Cys Glu 95 100 105 atc acc gat gac acc cga atc cgt gcc tcc ctc ccg acc atc cag cat 506 Ile Thr Asp Asp Thr Arg Ile Arg Ala Ser Leu Pro Thr Ile Gln His 110 115 120 ctt acg aag gcc gga gcc aag gtg gtg ctc gct agc cat ttg ggt cgc 554 Leu Thr Lys Ala Gly Ala Lys Val Val Leu Ala Ser His Leu Gly Arg 125 130 135 140 ccc aag aag ggc cct gag gac aaa ttc agc ttg aag ccc gtt gca ggg 602 Pro Lys Lys Gly Pro Glu Asp Lys Phe Ser Leu Lys Pro Val Ala Gly 145 150 155 aga ctg acc gag ttg ctt ggc cag acc gtg gaa ttg gcc cct gat tgc 650 Arg Leu Thr Glu Leu Leu Gly Gln Thr Val Glu Leu Ala Pro Asp Cys 160 165 170 att ggt gct gaa gta gaa tct aag att gca gca ctg aag aat ggt gaa 698 Ile Gly Ala Glu Val Glu Ser Lys Ile Ala Ala Leu Lys Asn Gly Glu 175 180 185 gtt ctc ctt ctg gag aat gtt agg ttc tac aag gaa gag gag aag aac 746 Val Leu Leu Leu Glu Asn Val Arg Phe Tyr Lys Glu Glu Glu Lys Asn 190 195 200 gac agc gag ttc tcc caa aag ctt gcc aag ggt gtc gat atc ttc gtt 794 Asp Ser Glu Phe Ser Gln Lys Leu Ala Lys Gly Val Asp Ile Phe Val 205 210 215 220 aac gac gcc ttc ggc act gcc cac cgc gct cac tca tct act gca gga 842 Asn Asp Ala Phe Gly Thr Ala His Arg Ala His Ser Ser Thr Ala Gly 225 230 235 att gct gag tac gtt ggc aag act gtg gct ggg ttc ctc ttg gag aag 890 Ile Ala Glu Tyr Val Gly Lys Thr Val Ala Gly Phe Leu Leu Glu Lys 240 245 250 gag ttg gct tat ctc gct ggc gcc gtg aag gcc cca gcc agg cct ttc 938 Glu Leu Ala Tyr Leu Ala Gly Ala Val Lys Ala Pro Ala Arg Pro Phe 255 260 265 gtt gcc att gtt gga ggc agc aag gtc tca tcg aag att act gtg att 986 Val Ala Ile Val Gly Gly Ser Lys Val Ser Ser Lys Ile Thr Val Ile 270 275 280 gag tcc ttg atg aac gtg tgc gac aag gtc att ttg gga ggt ggc atg 1034 Glu Ser Leu Met Asn Val Cys Asp Lys Val Ile Leu Gly Gly Gly Met 285 290 295 300 atc ttt acc ttc ttc aag gca gac ggc aag gat gtt gga agt tcc cta 1082 Ile Phe Thr Phe Phe Lys Ala Asp Gly Lys Asp Val Gly Ser Ser Leu 305 310 315 gtg gag gat gac aag att gat ttg gcc aag gac ctc gtg gct cta gct 1130 Val Glu Asp Asp Lys Ile Asp Leu Ala Lys Asp Leu Val Ala Leu Ala 320 325 330 aag aag aag ggc gtt gag ctc att ctc ccc gtc gat gtc acc gca gct 1178 Lys Lys Lys Gly Val Glu Leu Ile Leu Pro Val Asp Val Thr Ala Ala 335 340 345 gat aag ttc tct ccc gaa gcc aac act caa gtg tgc agc tcc tcg aac 1226 Asp Lys Phe Ser Pro Glu Ala Asn Thr Gln Val Cys Ser Ser Ser Asn 350 355 360 atc cct gcc ggc tgg atg gga cta gac att ggc ccg aag gca atc gac 1274 Ile Pro Ala Gly Trp Met Gly Leu Asp Ile Gly Pro Lys Ala Ile Asp 365 370 375 380 caa ttc cag gat gcc ctg aag ggc gcc aag acg gtt ctg tgg aac gga 1322 Gln Phe Gln Asp Ala Leu Lys Gly Ala Lys Thr Val Leu Trp Asn Gly 385 390 395 ccg atg gga gtg ttc gag ttc gag aag ttc gcg gac gga aca act gcc 1370 Pro Met Gly Val Phe Glu Phe Glu Lys Phe Ala Asp Gly Thr Thr Ala 400 405 410 gtc gct aaa act ttg gca ggt ttg acc aag gag ggt gcc atc acc atc 1418 Val Ala Lys Thr Leu Ala Gly Leu Thr Lys Glu Gly Ala Ile Thr Ile 415 420 425 att gga gga ggt gac tcc gtc gca gcc gtt gag aag gct gga ctc gcc 1466 Ile Gly Gly Gly Asp Ser Val Ala Ala Val Glu Lys Ala Gly Leu Ala 430 435 440 gac cag atg agc cat gtg tcc acc gga gga ggg gcc agt ctc gag ttg 1514 Asp Gln Met Ser His Val Ser Thr Gly Gly Gly Ala Ser Leu Glu Leu 445 450 455 460 ttg gaa ggc aag gta ttg cca gga gtt gct gct ctt gac aac gct 1559 Leu Glu Gly Lys Val Leu Pro Gly Val Ala Ala Leu Asp Asn Ala 465 470 475 taaatgcctc ttttgccgaa gaggtgaatt ccgtccacga actcgcagta gagtgacaat 1619 gtcactgagt gcacccccgg ctctggctgt ctaatcatat gattcatttt tttggtagtt 1679 ttttttgtga tttgcctttg taccagtaaa cacagattat gaccagtaaa gaactccagc 1739 tcgatttacc tggatgcttg gtattctctt aaaaaaaa 1777 166 475 PRT Physcomitrella patens 166 Met Glu Ser Leu Ala Leu Arg Ser Ala Val Val Ala Thr Gly Leu Thr 1 5 10 15 Ser Ser Val Ala Ser Gln Thr Ser Val Gln Thr Arg Ala Thr Val Ser 20 25 30 Ser Ala Phe Ile Gly Lys Ser Ile Arg Val Asn Thr Lys Leu Asn Ala 35 40 45 Ser Ala Val Pro Val Gln Gln Lys Phe Arg Tyr Val Arg Ala Asp Ala 50 55 60 Gly Ala Gln Thr Ala Gln Val Glu Thr Val Glu Lys Lys Ala Ser Ile 65 70 75 80 Lys Asp Val Pro Glu Ser Glu Phe Gln Gly Lys Val Val Phe Val Arg 85 90 95 Ala Asp Leu Asn Val Pro Leu Asn Asp Ala Cys Glu Ile Thr Asp Asp 100 105 110 Thr Arg Ile Arg Ala Ser Leu Pro Thr Ile Gln His Leu Thr Lys Ala 115 120 125 Gly Ala Lys Val Val Leu Ala Ser His Leu Gly Arg Pro Lys Lys Gly 130 135 140 Pro Glu Asp Lys Phe Ser Leu Lys Pro Val Ala Gly Arg Leu Thr Glu 145 150 155 160 Leu Leu Gly Gln Thr Val Glu Leu Ala Pro Asp Cys Ile Gly Ala Glu 165 170 175 Val Glu Ser Lys Ile Ala Ala Leu Lys Asn Gly Glu Val Leu Leu Leu 180 185 190 Glu Asn Val Arg Phe Tyr Lys Glu Glu Glu Lys Asn Asp Ser Glu Phe 195 200 205 Ser Gln Lys Leu Ala Lys Gly Val Asp Ile Phe Val Asn Asp Ala Phe 210 215 220 Gly Thr Ala His Arg Ala His Ser Ser Thr Ala Gly Ile Ala Glu Tyr 225 230 235 240 Val Gly Lys Thr Val Ala Gly Phe Leu Leu Glu Lys Glu Leu Ala Tyr 245 250 255 Leu Ala Gly Ala Val Lys Ala Pro Ala Arg Pro Phe Val Ala Ile Val 260 265 270 Gly Gly Ser Lys Val Ser Ser Lys Ile Thr Val Ile Glu Ser Leu Met 275 280 285 Asn Val Cys Asp Lys Val Ile Leu Gly Gly Gly Met Ile Phe Thr Phe 290 295 300 Phe Lys Ala Asp Gly Lys Asp Val Gly Ser Ser Leu Val Glu Asp Asp 305 310 315 320 Lys Ile Asp Leu Ala Lys Asp Leu Val Ala Leu Ala Lys Lys Lys Gly 325 330 335 Val Glu Leu Ile Leu Pro Val Asp Val Thr Ala Ala Asp Lys Phe Ser 340 345 350 Pro Glu Ala Asn Thr Gln Val Cys Ser Ser Ser Asn Ile Pro Ala Gly 355 360 365 Trp Met Gly Leu Asp Ile Gly Pro Lys Ala Ile Asp Gln Phe Gln Asp 370 375 380 Ala Leu Lys Gly Ala Lys Thr Val Leu Trp Asn Gly Pro Met Gly Val 385 390 395 400 Phe Glu Phe Glu Lys Phe Ala Asp Gly Thr Thr Ala Val Ala Lys Thr 405 410 415 Leu Ala Gly Leu Thr Lys Glu Gly Ala Ile Thr Ile Ile Gly Gly Gly 420 425 430 Asp Ser Val Ala Ala Val Glu Lys Ala Gly Leu Ala Asp Gln Met Ser 435 440 445 His Val Ser Thr Gly Gly Gly Ala Ser Leu Glu Leu Leu Glu Gly Lys 450 455 460 Val Leu Pro Gly Val Ala Ala Leu Asp Asn Ala 465 470 475 167 1566 DNA Physcomitrella patens CDS (81)..(1160) c_pp004044298r 167 gttttctgag accttgtagc ggagctggtg agtaataaac cggccagccc tgactgtcgg 60 gattgaccca cagtctcgca atg gcg aag ggc ggg tcg agc gcc act gcc aac 113 Met Ala Lys Gly Gly Ser Ser Ala Thr Ala Asn 1 5 10 agc ggc gtg tta cag aga att gtc ttg agc tac acg tat gtc gca gta 161 Ser Gly Val Leu Gln Arg Ile Val Leu Ser Tyr Thr Tyr Val Ala Val 15 20 25 tgg atc ttt ctc agc ttc tcc gtg atc atc ttt aac aaa tat att ctt 209 Trp Ile Phe Leu Ser Phe Ser Val Ile Ile Phe Asn Lys Tyr Ile Leu 30 35 40 gac cgc gga atg tac aac tgg cca tac cca gtc tct ctg act atg att 257 Asp Arg Gly Met Tyr Asn Trp Pro Tyr Pro Val Ser Leu Thr Met Ile 45 50 55 cac atg gcg ttc tcc tcc ggg ctc gcc ttc ctc ctc gtg cgc ggg ctg 305 His Met Ala Phe Ser Ser Gly Leu Ala Phe Leu Leu Val Arg Gly Leu 60 65 70 75 aag ttg gtt gag ccc tgc gcc gcg atg acg aag gac ctc tac ttc agg 353 Lys Leu Val Glu Pro Cys Ala Ala Met Thr Lys Asp Leu Tyr Phe Arg 80 85 90 tcc atc gtc ccc atc ggc ctc ctc ttc tcg ctc tct ctg tgg ttc tcg 401 Ser Ile Val Pro Ile Gly Leu Leu Phe Ser Leu Ser Leu Trp Phe Ser 95 100 105 aat tcg gct tac atc tac ctt agc gtc tcc ttc atc cag atg ctc aag 449 Asn Ser Ala Tyr Ile Tyr Leu Ser Val Ser Phe Ile Gln Met Leu Lys 110 115 120 gcg ctc atg ccg gtg gca gtc tac tct ctt ggg gta ctt ttc aag aag 497 Ala Leu Met Pro Val Ala Val Tyr Ser Leu Gly Val Leu Phe Lys Lys 125 130 135 gat gta ttc aac tct tcg acc atg gct aac atg gtc atg atc tcc att 545 Asp Val Phe Asn Ser Ser Thr Met Ala Asn Met Val Met Ile Ser Ile 140 145 150 155 ggt gtc gcc att gcg gcc tac ggg gag gcg cgg ttc aat gtc tgg ggt 593 Gly Val Ala Ile Ala Ala Tyr Gly Glu Ala Arg Phe Asn Val Trp Gly 160 165 170 gtc acg ctg cag ctt gcg gct gta tgc gtg gaa gcc ctc cgt ctt gtc 641 Val Thr Leu Gln Leu Ala Ala Val Cys Val Glu Ala Leu Arg Leu Val 175 180 185 ttg atc caa att ctt ctc aac tcc cgg gga att tcc ctc aat ccc att 689 Leu Ile Gln Ile Leu Leu Asn Ser Arg Gly Ile Ser Leu Asn Pro Ile 190 195 200 aca aca ctc tat tac gtc gcg ccc gcg tgt ttt gtc ttc ctc tct gtc 737 Thr Thr Leu Tyr Tyr Val Ala Pro Ala Cys Phe Val Phe Leu Ser Val 205 210 215 cct tgg tat ctc atc gaa tgg ccg aag ctg ctg gta atg tcg tcc ttc 785 Pro Trp Tyr Leu Ile Glu Trp Pro Lys Leu Leu Val Met Ser Ser Phe 220 225 230 235 cac ttc gac ttc ttc acg ttc ggc ctc aac tct atg gtc gcg ttc ctg 833 His Phe Asp Phe Phe Thr Phe Gly Leu Asn Ser Met Val Ala Phe Leu 240 245 250 ctc aac atc gcc gtc ttt gtt ctg gtc ggg aaa aca tcc gcc ctc acc 881 Leu Asn Ile Ala Val Phe Val Leu Val Gly Lys Thr Ser Ala Leu Thr 255 260 265 atg aat gtg gcg ggc gtg gtg aag gac tgg ctc ctc atc gcc ttc tcc 929 Met Asn Val Ala Gly Val Val Lys Asp Trp Leu Leu Ile Ala Phe Ser 270 275 280 tgg tcc gtc atc ttg gac cga gtg act ttc atc aat ctc ttc ggc tac 977 Trp Ser Val Ile Leu Asp Arg Val Thr Phe Ile Asn Leu Phe Gly Tyr 285 290 295 ggc atc gct ttc gtc gcc gtc tgt tac tac aat tac gcc aaa ctg cag 1025 Gly Ile Ala Phe Val Ala Val Cys Tyr Tyr Asn Tyr Ala Lys Leu Gln 300 305 310 315 acc atg aag gcc aag gaa cag cag aaa tca cag aag gtc agc gag gac 1073 Thr Met Lys Ala Lys Glu Gln Gln Lys Ser Gln Lys Val Ser Glu Asp 320 325 330 gag gag aat ttg cgg ctg ctg gat tct aag ctg gag aga ctc gat gag 1121 Glu Glu Asn Leu Arg Leu Leu Asp Ser Lys Leu Glu Arg Leu Asp Glu 335 340 345 agt tca tct cct tct cac aag tcc gac gct caa acc cac taattttttt 1170 Ser Ser Ser Pro Ser His Lys Ser Asp Ala Gln Thr His 350 355 360 cttttatttt tcaccttttt tcttcccacc acttcaagcc gctgaagccc attcaacccc 1230 atgagaaagt cccatcagat gtcttctccc atttctgtgg catgatcact tggaagtgga 1290 tgtgttattg caaaaggcag cgattttcac atccgacact caaaccctag ctgtcgttac 1350 atggatgcga gctttaggac aggcaggcag atgcagatcc cggaggtgtg agtcttgggt 1410 acagttgtag cggcactggg tgtcggtgag agatctttgg taggattaag aagttggctg 1470 cggaggactc tcactccctc cctcgctcaa ttttctatta tgtctccgtt acccattttt 1530 taatttttaa cataagtttt gcagcgttta aaaaaa 1566 168 360 PRT Physcomitrella patens 168 Met Ala Lys Gly Gly Ser Ser Ala Thr Ala Asn Ser Gly Val Leu Gln 1 5 10 15 Arg Ile Val Leu Ser Tyr Thr Tyr Val Ala Val Trp Ile Phe Leu Ser 20 25 30 Phe Ser Val Ile Ile Phe Asn Lys Tyr Ile Leu Asp Arg Gly Met Tyr 35 40 45 Asn Trp Pro Tyr Pro Val Ser Leu Thr Met Ile His Met Ala Phe Ser 50 55 60 Ser Gly Leu Ala Phe Leu Leu Val Arg Gly Leu Lys Leu Val Glu Pro 65 70 75 80 Cys Ala Ala Met Thr Lys Asp Leu Tyr Phe Arg Ser Ile Val Pro Ile 85 90 95 Gly Leu Leu Phe Ser Leu Ser Leu Trp Phe Ser Asn Ser Ala Tyr Ile 100 105 110 Tyr Leu Ser Val Ser Phe Ile Gln Met Leu Lys Ala Leu Met Pro Val 115 120 125 Ala Val Tyr Ser Leu Gly Val Leu Phe Lys Lys Asp Val Phe Asn Ser 130 135 140 Ser Thr Met Ala Asn Met Val Met Ile Ser Ile Gly Val Ala Ile Ala 145 150 155 160 Ala Tyr Gly Glu Ala Arg Phe Asn Val Trp Gly Val Thr Leu Gln Leu 165 170 175 Ala Ala Val Cys Val Glu Ala Leu Arg Leu Val Leu Ile Gln Ile Leu 180 185 190 Leu Asn Ser Arg Gly Ile Ser Leu Asn Pro Ile Thr Thr Leu Tyr Tyr 195 200 205 Val Ala Pro Ala Cys Phe Val Phe Leu Ser Val Pro Trp Tyr Leu Ile 210 215 220 Glu Trp Pro Lys Leu Leu Val Met Ser Ser Phe His Phe Asp Phe Phe 225 230 235 240 Thr Phe Gly Leu Asn Ser Met Val Ala Phe Leu Leu Asn Ile Ala Val 245 250 255 Phe Val Leu Val Gly Lys Thr Ser Ala Leu Thr Met Asn Val Ala Gly 260 265 270 Val Val Lys Asp Trp Leu Leu Ile Ala Phe Ser Trp Ser Val Ile Leu 275 280 285 Asp Arg Val Thr Phe Ile Asn Leu Phe Gly Tyr Gly Ile Ala Phe Val 290 295 300 Ala Val Cys Tyr Tyr Asn Tyr Ala Lys Leu Gln Thr Met Lys Ala Lys 305 310 315 320 Glu Gln Gln Lys Ser Gln Lys Val Ser Glu Asp Glu Glu Asn Leu Arg 325 330 335 Leu Leu Asp Ser Lys Leu Glu Arg Leu Asp Glu Ser Ser Ser Pro Ser 340 345 350 His Lys Ser Asp Ala Gln Thr His 355 360 169 1536 DNA Physcomitrella patens CDS (82)..(1239) c_pp004075307r 169 gcagcaggca ccaccttcat cgccgccgcg ctccgtcttg ccctgtgtgt cagggttccc 60 ccggactgag catctacgac a atg gct gac cag cgt tgc ccc agc gta gtg 111 Met Ala Asp Gln Arg Cys Pro Ser Val Val 1 5 10 agc aag atg gga ggg acg tca tac ctg gga tcc agg ttg gca cct ggc 159 Ser Lys Met Gly Gly Thr Ser Tyr Leu Gly Ser Arg Leu Ala Pro Gly 15 20 25 cgc gcc atg tac ccc gcg tcg gag atg agc act ccg ttc gcg gcc gct 207 Arg Ala Met Tyr Pro Ala Ser Glu Met Ser Thr Pro Phe Ala Ala Ala 30 35 40 gcc aag ctg ggt gcg atg ccc agg cag acg ggg ctg agc tcc ctg tgc 255 Ala Lys Leu Gly Ala Met Pro Arg Gln Thr Gly Leu Ser Ser Leu Cys 45 50 55 ccc atc gac gtg acc ggc ggg agg aac atg tcg agc cag gtg ttc gtt 303 Pro Ile Asp Val Thr Gly Gly Arg Asn Met Ser Ser Gln Val Phe Val 60 65 70 ccg gcc gcg aac gag aag acg ttc gcg tcg ttc atg acc gac ttt ctg 351 Pro Ala Ala Asn Glu Lys Thr Phe Ala Ser Phe Met Thr Asp Phe Leu 75 80 85 90 atg ggc ggt gtg tcg gcc gcg gtg tcg aag acg gcc gct gcg ccc atc 399 Met Gly Gly Val Ser Ala Ala Val Ser Lys Thr Ala Ala Ala Pro Ile 95 100 105 gag cgc gtg aag ctg ctg atc cag aac cag gac gag atg ctg aag tcg 447 Glu Arg Val Lys Leu Leu Ile Gln Asn Gln Asp Glu Met Leu Lys Ser 110 115 120 ggg cgt ctg tcg cac ccg tac aag ggc atc ggc gag tgc ttc agc cga 495 Gly Arg Leu Ser His Pro Tyr Lys Gly Ile Gly Glu Cys Phe Ser Arg 125 130 135 acg gtg aag gac gag gga atg atg tcg ttg tgg cgt gga aac acg gcg 543 Thr Val Lys Asp Glu Gly Met Met Ser Leu Trp Arg Gly Asn Thr Ala 140 145 150 aat gtg atc aga tac ttt ccg acg cag gca ctg aac ttc gcg ttc aag 591 Asn Val Ile Arg Tyr Phe Pro Thr Gln Ala Leu Asn Phe Ala Phe Lys 155 160 165 170 gac tac ttc aag tcg ctg ttc ggg tac aag aag gac aag gac ggg tat 639 Asp Tyr Phe Lys Ser Leu Phe Gly Tyr Lys Lys Asp Lys Asp Gly Tyr 175 180 185 tgg aag tgg ttc gcg ggt aac ttg gcg tcg gga ggt gct gcg gga gcg 687 Trp Lys Trp Phe Ala Gly Asn Leu Ala Ser Gly Gly Ala Ala Gly Ala 190 195 200 tcg tct ctg ctg ttc gtg tac tct ctg gac tac gcg cgt acc cga ttg 735 Ser Ser Leu Leu Phe Val Tyr Ser Leu Asp Tyr Ala Arg Thr Arg Leu 205 210 215 gcg aac gac gcg aag tcg tcg aag aag gga gga ggc gag agg cag ttc 783 Ala Asn Asp Ala Lys Ser Ser Lys Lys Gly Gly Gly Glu Arg Gln Phe 220 225 230 aac ggg ctg gtg gac gtg tac aag aag acg ttg gcg acg gac gga atc 831 Asn Gly Leu Val Asp Val Tyr Lys Lys Thr Leu Ala Thr Asp Gly Ile 235 240 245 250 gcg ggg ctg tac aga ggg ttc gcg atc tct tgc gcg ggt atc atc gtg 879 Ala Gly Leu Tyr Arg Gly Phe Ala Ile Ser Cys Ala Gly Ile Ile Val 255 260 265 tac agg ggt ctg tac ttc gga att tac gac tcg ctg aag ccg gtg gtg 927 Tyr Arg Gly Leu Tyr Phe Gly Ile Tyr Asp Ser Leu Lys Pro Val Val 270 275 280 ttg gtg ggc aac ctg gag ggc aat ttc ttg gcg agt ttc ttg ttg gga 975 Leu Val Gly Asn Leu Glu Gly Asn Phe Leu Ala Ser Phe Leu Leu Gly 285 290 295 tgg gga atc acg atc gga gcg ggt ctg gcg tcg tac ccc atc gac acg 1023 Trp Gly Ile Thr Ile Gly Ala Gly Leu Ala Ser Tyr Pro Ile Asp Thr 300 305 310 gtt cgg cgt agg atg atg atg acc tcc gga gag gca gtg aag tac aac 1071 Val Arg Arg Arg Met Met Met Thr Ser Gly Glu Ala Val Lys Tyr Asn 315 320 325 330 ggg tcg atg gac gcg ttc aag cag att ttg gcg aag gag gga gcg aag 1119 Gly Ser Met Asp Ala Phe Lys Gln Ile Leu Ala Lys Glu Gly Ala Lys 335 340 345 tcg ttg ttc aag ggc gct ggt gcg aac atc ctt cgt gcg gtg gct gga 1167 Ser Leu Phe Lys Gly Ala Gly Ala Asn Ile Leu Arg Ala Val Ala Gly 350 355 360 gcc gga gtg ttg tcg gga tac gat cag ttg cag atc ttg ctt ctg ggc 1215 Ala Gly Val Leu Ser Gly Tyr Asp Gln Leu Gln Ile Leu Leu Leu Gly 365 370 375 aag gcc tac tct gga ggc agc ggc tgagtgcttc gtagcggatt atgaagagaa 1269 Lys Ala Tyr Ser Gly Gly Ser Gly 380 385 ttttgttgcc ctggtcaatc tttaatttag cactttcttt tttgtagtgt aactttttga 1329 gttctttcgc gttctgacta tcatagtgca catgcgtata gtgcgctgag ctggttatcg 1389 tgttagtttt gtgtcttcga attaacttcg agattactca acttaggcgc cataatgtgc 1449 ttatttacaa ctcttatgaa gcaagaattg ctggcttctg gttcgtccat tgtgctctct 1509 ttttatcttc atttaatatc attctat 1536 170 386 PRT Physcomitrella patens 170 Met Ala Asp Gln Arg Cys Pro Ser Val Val Ser Lys Met Gly Gly Thr 1 5 10 15 Ser Tyr Leu Gly Ser Arg Leu Ala Pro Gly Arg Ala Met Tyr Pro Ala 20 25 30 Ser Glu Met Ser Thr Pro Phe Ala Ala Ala Ala Lys Leu Gly Ala Met 35 40 45 Pro Arg Gln Thr Gly Leu Ser Ser Leu Cys Pro Ile Asp Val Thr Gly 50 55 60 Gly Arg Asn Met Ser Ser Gln Val Phe Val Pro Ala Ala Asn Glu Lys 65 70 75 80 Thr Phe Ala Ser Phe Met Thr Asp Phe Leu Met Gly Gly Val Ser Ala 85 90 95 Ala Val Ser Lys Thr Ala Ala Ala Pro Ile Glu Arg Val Lys Leu Leu 100 105 110 Ile Gln Asn Gln Asp Glu Met Leu Lys Ser Gly Arg Leu Ser His Pro 115 120 125 Tyr Lys Gly Ile Gly Glu Cys Phe Ser Arg Thr Val Lys Asp Glu Gly 130 135 140 Met Met Ser Leu Trp Arg Gly Asn Thr Ala Asn Val Ile Arg Tyr Phe 145 150 155 160 Pro Thr Gln Ala Leu Asn Phe Ala Phe Lys Asp Tyr Phe Lys Ser Leu 165 170 175 Phe Gly Tyr Lys Lys Asp Lys Asp Gly Tyr Trp Lys Trp Phe Ala Gly 180 185 190 Asn Leu Ala Ser Gly Gly Ala Ala Gly Ala Ser Ser Leu Leu Phe Val 195 200 205 Tyr Ser Leu Asp Tyr Ala Arg Thr Arg Leu Ala Asn Asp Ala Lys Ser 210 215 220 Ser Lys Lys Gly Gly Gly Glu Arg Gln Phe Asn Gly Leu Val Asp Val 225 230 235 240 Tyr Lys Lys Thr Leu Ala Thr Asp Gly Ile Ala Gly Leu Tyr Arg Gly 245 250 255 Phe Ala Ile Ser Cys Ala Gly Ile Ile Val Tyr Arg Gly Leu Tyr Phe 260 265 270 Gly Ile Tyr Asp Ser Leu Lys Pro Val Val Leu Val Gly Asn Leu Glu 275 280 285 Gly Asn Phe Leu Ala Ser Phe Leu Leu Gly Trp Gly Ile Thr Ile Gly 290 295 300 Ala Gly Leu Ala Ser Tyr Pro Ile Asp Thr Val Arg Arg Arg Met Met 305 310 315 320 Met Thr Ser Gly Glu Ala Val Lys Tyr Asn Gly Ser Met Asp Ala Phe 325 330 335 Lys Gln Ile Leu Ala Lys Glu Gly Ala Lys Ser Leu Phe Lys Gly Ala 340 345 350 Gly Ala Asn Ile Leu Arg Ala Val Ala Gly Ala Gly Val Leu Ser Gly 355 360 365 Tyr Asp Gln Leu Gln Ile Leu Leu Leu Gly Lys Ala Tyr Ser Gly Gly 370 375 380 Ser Gly 385 171 1905 DNA Physcomitrella patens CDS (1)..(1440) s_pp001024093f 171 cgc att cag aag cgg gct aca tct tcc gtg cgc gcc caa gct gct gat 48 Arg Ile Gln Lys Arg Ala Thr Ser Ser Val Arg Ala Gln Ala Ala Asp 1 5 10 15 gga gaa gcc tcg ggg gat gtt gcc act aga caa tct aat cct gct acc 96 Gly Glu Ala Ser Gly Asp Val Ala Thr Arg Gln Ser Asn Pro Ala Thr 20 25 30 act gga atg gtc ttg cct gca gtt ggt att gcc tgc ctt ggg gca atc 144 Thr Gly Met Val Leu Pro Ala Val Gly Ile Ala Cys Leu Gly Ala Ile 35 40 45 ttg ttt ggt tac cat ctc ggg gtg gtt aat ggt gca ttg gag tac att 192 Leu Phe Gly Tyr His Leu Gly Val Val Asn Gly Ala Leu Glu Tyr Ile 50 55 60 tct aag gat cta ggg ttt gcc acg gat gct gta aaa caa gga tgg gtg 240 Ser Lys Asp Leu Gly Phe Ala Thr Asp Ala Val Lys Gln Gly Trp Val 65 70 75 80 gta agc tca act cta gct ggt gcc act gtg ggt tcc ttt act gga ggc 288 Val Ser Ser Thr Leu Ala Gly Ala Thr Val Gly Ser Phe Thr Gly Gly 85 90 95 gcc ctt gct gac aac tta ggt cgc aag cgt aca ttc cag att aac gcc 336 Ala Leu Ala Asp Asn Leu Gly Arg Lys Arg Thr Phe Gln Ile Asn Ala 100 105 110 gtg cct ctt att gtg ggc act ctt ctc agt gca aaa gca acc agt ttc 384 Val Pro Leu Ile Val Gly Thr Leu Leu Ser Ala Lys Ala Thr Ser Phe 115 120 125 gag gct atg gtg att gga aga att ttg gtt ggt gtt ggg att gga gtt 432 Glu Ala Met Val Ile Gly Arg Ile Leu Val Gly Val Gly Ile Gly Val 130 135 140 tca tct ggt gtt gtg cct cta tac att tcg gag gtc tcg ccc aca gag 480 Ser Ser Gly Val Val Pro Leu Tyr Ile Ser Glu Val Ser Pro Thr Glu 145 150 155 160 att cga ggt acc atg ggg aca ttg aat cag ctc ttt att tgc gtg ggt 528 Ile Arg Gly Thr Met Gly Thr Leu Asn Gln Leu Phe Ile Cys Val Gly 165 170 175 atc ctg tta gct ctg att gct ggc ctt cct ttg ggc agt aac cct gtc 576 Ile Leu Leu Ala Leu Ile Ala Gly Leu Pro Leu Gly Ser Asn Pro Val 180 185 190 tgg tgg cgc acc atg ttt gcc tta gct aca gtt cct gcc gtt ttg ctg 624 Trp Trp Arg Thr Met Phe Ala Leu Ala Thr Val Pro Ala Val Leu Leu 195 200 205 ggt tta ggc atg gcg tac tgt ccg gag agt cca cgc tgg cta tac aag 672 Gly Leu Gly Met Ala Tyr Cys Pro Glu Ser Pro Arg Trp Leu Tyr Lys 210 215 220 aat ggt aag acc gca gag gcg gaa acc gca gta agg aga ctt tgg ggc 720 Asn Gly Lys Thr Ala Glu Ala Glu Thr Ala Val Arg Arg Leu Trp Gly 225 230 235 240 aag gca aag gtc gag agt tca atg gca gat ttg aag gct agc agc gtg 768 Lys Ala Lys Val Glu Ser Ser Met Ala Asp Leu Lys Ala Ser Ser Val 245 250 255 gaa aca gtg aaa ggt gac act caa gat gca agt tgg ggc gag cta ttt 816 Glu Thr Val Lys Gly Asp Thr Gln Asp Ala Ser Trp Gly Glu Leu Phe 260 265 270 ggc aaa aga tac cgt aaa gtt gtc acg gtt gga atg gcg ctc ttc ctt 864 Gly Lys Arg Tyr Arg Lys Val Val Thr Val Gly Met Ala Leu Phe Leu 275 280 285 ttc caa caa ttt gcc gga atc aat gct gtg gta tac ttc tct act cag 912 Phe Gln Gln Phe Ala Gly Ile Asn Ala Val Val Tyr Phe Ser Thr Gln 290 295 300 gtt ttc agg agt gct ggc atc acg aat gat gta gct gcc agt gct ctt 960 Val Phe Arg Ser Ala Gly Ile Thr Asn Asp Val Ala Ala Ser Ala Leu 305 310 315 320 gta ggt gct gca aat gtg gca ggt acc act gtg gcg tcc ggc atg atg 1008 Val Gly Ala Ala Asn Val Ala Gly Thr Thr Val Ala Ser Gly Met Met 325 330 335 gat aag caa ggg cgt aag agc ctg cta atg ggc agc ttc gct ggc atg 1056 Asp Lys Gln Gly Arg Lys Ser Leu Leu Met Gly Ser Phe Ala Gly Met 340 345 350 tca ctt tca atg ctt gtg ctt tcg ttg gcg ctt tca tgg agc ccc ctt 1104 Ser Leu Ser Met Leu Val Leu Ser Leu Ala Leu Ser Trp Ser Pro Leu 355 360 365 gca ccg tac tct ggc acg ctg gct gtc ctt gga aca gtt tca tac att 1152 Ala Pro Tyr Ser Gly Thr Leu Ala Val Leu Gly Thr Val Ser Tyr Ile 370 375 380 ttg tcc ttc tcc ctt ggt gct gga cca gtg cct ggc ctt ctg ttg ccc 1200 Leu Ser Phe Ser Leu Gly Ala Gly Pro Val Pro Gly Leu Leu Leu Pro 385 390 395 400 gag atc ttc ggt gct cgc atc cgt gct aag gcc gtt gct ctt tct ctc 1248 Glu Ile Phe Gly Ala Arg Ile Arg Ala Lys Ala Val Ala Leu Ser Leu 405 410 415 ggt gtc cac tgg att tgt aac ttc atg att gga cta ttt ttc ttg aac 1296 Gly Val His Trp Ile Cys Asn Phe Met Ile Gly Leu Phe Phe Leu Asn 420 425 430 gtc gtt cag aag ttc ggt gtt agc aca gta tat ctc ttc ttc tct gca 1344 Val Val Gln Lys Phe Gly Val Ser Thr Val Tyr Leu Phe Phe Ser Ala 435 440 445 gta tgc gcg gca gca att gcc tat gta ggc ggt aat gtg gta gaa aca 1392 Val Cys Ala Ala Ala Ile Ala Tyr Val Gly Gly Asn Val Val Glu Thr 450 455 460 aag ggg cgg tca ctg gag gac atc gaa cgc gag ctt agc cct gct gta 1440 Lys Gly Arg Ser Leu Glu Asp Ile Glu Arg Glu Leu Ser Pro Ala Val 465 470 475 480 tagtagcatc agtcgaaacc atcacttttt tctgaaagtg caatgcagtg gctgttggtg 1500 tggaaaagtc tctcccgaac gggtgtctga catgagctgc atgaatcgtt gacgactcgg 1560 tgtctagagt cggtctgcgc cttctacgca acgctgaagt gaattgaaga gaattactga 1620 ttgagtagtg tgtattatcc tcgaaggcca ggagtgtttt gcgcaacctt cggtgtcact 1680 gttgaggacg atgctgacac tcaacatggt taggtttgag cattatggtt gtaattaggt 1740 gacacattag acattagggt gatggatacg gtgttgcagt tagagtgtca gaagttcgat 1800 tcaggagcag gctttcgtgc atgtttggtt acttaaatgg ttgtgtaaat tactgcaaat 1860 cgctacgttg ccggatattt ctttgaagta aacggccgct ttttt 1905 172 480 PRT Physcomitrella patens 172 Arg Ile Gln Lys Arg Ala Thr Ser Ser Val Arg Ala Gln Ala Ala Asp 1 5 10 15 Gly Glu Ala Ser Gly Asp Val Ala Thr Arg Gln Ser Asn Pro Ala Thr 20 25 30 Thr Gly Met Val Leu Pro Ala Val Gly Ile Ala Cys Leu Gly Ala Ile 35 40 45 Leu Phe Gly Tyr His Leu Gly Val Val Asn Gly Ala Leu Glu Tyr Ile 50 55 60 Ser Lys Asp Leu Gly Phe Ala Thr Asp Ala Val Lys Gln Gly Trp Val 65 70 75 80 Val Ser Ser Thr Leu Ala Gly Ala Thr Val Gly Ser Phe Thr Gly Gly 85 90 95 Ala Leu Ala Asp Asn Leu Gly Arg Lys Arg Thr Phe Gln Ile Asn Ala 100 105 110 Val Pro Leu Ile Val Gly Thr Leu Leu Ser Ala Lys Ala Thr Ser Phe 115 120 125 Glu Ala Met Val Ile Gly Arg Ile Leu Val Gly Val Gly Ile Gly Val 130 135 140 Ser Ser Gly Val Val Pro Leu Tyr Ile Ser Glu Val Ser Pro Thr Glu 145 150 155 160 Ile Arg Gly Thr Met Gly Thr Leu Asn Gln Leu Phe Ile Cys Val Gly 165 170 175 Ile Leu Leu Ala Leu Ile Ala Gly Leu Pro Leu Gly Ser Asn Pro Val 180 185 190 Trp Trp Arg Thr Met Phe Ala Leu Ala Thr Val Pro Ala Val Leu Leu 195 200 205 Gly Leu Gly Met Ala Tyr Cys Pro Glu Ser Pro Arg Trp Leu Tyr Lys 210 215 220 Asn Gly Lys Thr Ala Glu Ala Glu Thr Ala Val Arg Arg Leu Trp Gly 225 230 235 240 Lys Ala Lys Val Glu Ser Ser Met Ala Asp Leu Lys Ala Ser Ser Val 245 250 255 Glu Thr Val Lys Gly Asp Thr Gln Asp Ala Ser Trp Gly Glu Leu Phe 260 265 270 Gly Lys Arg Tyr Arg Lys Val Val Thr Val Gly Met Ala Leu Phe Leu 275 280 285 Phe Gln Gln Phe Ala Gly Ile Asn Ala Val Val Tyr Phe Ser Thr Gln 290 295 300 Val Phe Arg Ser Ala Gly Ile Thr Asn Asp Val Ala Ala Ser Ala Leu 305 310 315 320 Val Gly Ala Ala Asn Val Ala Gly Thr Thr Val Ala Ser Gly Met Met 325 330 335 Asp Lys Gln Gly Arg Lys Ser Leu Leu Met Gly Ser Phe Ala Gly Met 340 345 350 Ser Leu Ser Met Leu Val Leu Ser Leu Ala Leu Ser Trp Ser Pro Leu 355 360 365 Ala Pro Tyr Ser Gly Thr Leu Ala Val Leu Gly Thr Val Ser Tyr Ile 370 375 380 Leu Ser Phe Ser Leu Gly Ala Gly Pro Val Pro Gly Leu Leu Leu Pro 385 390 395 400 Glu Ile Phe Gly Ala Arg Ile Arg Ala Lys Ala Val Ala Leu Ser Leu 405 410 415 Gly Val His Trp Ile Cys Asn Phe Met Ile Gly Leu Phe Phe Leu Asn 420 425 430 Val Val Gln Lys Phe Gly Val Ser Thr Val Tyr Leu Phe Phe Ser Ala 435 440 445 Val Cys Ala Ala Ala Ile Ala Tyr Val Gly Gly Asn Val Val Glu Thr 450 455 460 Lys Gly Arg Ser Leu Glu Asp Ile Glu Arg Glu Leu Ser Pro Ala Val 465 470 475 480 173 1668 DNA Physcomitrella patens CDS (1)..(1290) c_pp010010057r 173 atg ctg cta agc ccc agc tca agc gct ctc gga gcc agc acg agc aaa 48 Met Leu Leu Ser Pro Ser Ser Ser Ala Leu Gly Ala Ser Thr Ser Lys 1 5 10 15 gcc cga ggt ggc aac atc aag gca gat cct ctc aga gta atc atg ttt 96 Ala Arg Gly Gly Asn Ile Lys Ala Asp Pro Leu Arg Val Ile Met Phe 20 25 30 cag ggg ttc aac tgg gag tcg tgg aag agc tcg tgc tgg tat gat gtc 144 Gln Gly Phe Asn Trp Glu Ser Trp Lys Ser Ser Cys Trp Tyr Asp Val 35 40 45 atg ggc gag act gcg gaa gat cta gca gca gca ggc att act gat gtc 192 Met Gly Glu Thr Ala Glu Asp Leu Ala Ala Ala Gly Ile Thr Asp Val 50 55 60 tgg ttt cct cct tct agc cat tcc gtg tcc ccc cag gga tac atg cca 240 Trp Phe Pro Pro Ser Ser His Ser Val Ser Pro Gln Gly Tyr Met Pro 65 70 75 80 gga agg ctt tac gat ttg aac gac tgt aaa tat ggc aat gaa gag aag 288 Gly Arg Leu Tyr Asp Leu Asn Asp Cys Lys Tyr Gly Asn Glu Glu Lys 85 90 95 ctg agg gaa acc att gaa aag ttt cac aga gtg gga gtt cgg tgc att 336 Leu Arg Glu Thr Ile Glu Lys Phe His Arg Val Gly Val Arg Cys Ile 100 105 110 gct gat att gtc gtg aat cat aga tgc ggt gaa gaa caa gac gag agg 384 Ala Asp Ile Val Val Asn His Arg Cys Gly Glu Glu Gln Asp Glu Arg 115 120 125 ggt gaa tgg gtt att ttt gaa gga gga acg ccc gat gat gct ctc gac 432 Gly Glu Trp Val Ile Phe Glu Gly Gly Thr Pro Asp Asp Ala Leu Asp 130 135 140 tgg ggt cct tgg gct ata gtc gga gat gac tat ccc tat ggt aac gga 480 Trp Gly Pro Trp Ala Ile Val Gly Asp Asp Tyr Pro Tyr Gly Asn Gly 145 150 155 160 aca ggt gct ccc gac acc gga gat gac ttt gag gct gca ccc gac att 528 Thr Gly Ala Pro Asp Thr Gly Asp Asp Phe Glu Ala Ala Pro Asp Ile 165 170 175 gat cac aca aac gat atc gtt caa agc gac ctt atc gtc tgg atg aat 576 Asp His Thr Asn Asp Ile Val Gln Ser Asp Leu Ile Val Trp Met Asn 180 185 190 tgg atg aag ttc aaa att ggg ttt gat ggg tgg aga ttc gac ttt gcc 624 Trp Met Lys Phe Lys Ile Gly Phe Asp Gly Trp Arg Phe Asp Phe Ala 195 200 205 aag ggt tac ggt gga tac ttc gtc ggt cgc tac atc aga aaa act gaa 672 Lys Gly Tyr Gly Gly Tyr Phe Val Gly Arg Tyr Ile Arg Lys Thr Glu 210 215 220 cca cag ttt gca gtt ggg gag ttc tgg acg agc ttg aat tac gga cat 720 Pro Gln Phe Ala Val Gly Glu Phe Trp Thr Ser Leu Asn Tyr Gly His 225 230 235 240 gac ggt ctg gaa tac aac cag gat agt cac agg cag caa ctg gtt gat 768 Asp Gly Leu Glu Tyr Asn Gln Asp Ser His Arg Gln Gln Leu Val Asp 245 250 255 tgg atc cac gca acg aag gag agg tcc act gca ttc gat ttc acc acc 816 Trp Ile His Ala Thr Lys Glu Arg Ser Thr Ala Phe Asp Phe Thr Thr 260 265 270 aag ggt atc ttg caa gag gcc gtg aaa ggt cag ctg tgg cgg ctg cgg 864 Lys Gly Ile Leu Gln Glu Ala Val Lys Gly Gln Leu Trp Arg Leu Arg 275 280 285 gat ccg aac agc aag cca cca ggg ttg atc ggt tat tgg cct tca aaa 912 Asp Pro Asn Ser Lys Pro Pro Gly Leu Ile Gly Tyr Trp Pro Ser Lys 290 295 300 gca gta acg ttt ctc gac aac cat gac aca gga tct aca caa gga cac 960 Ala Val Thr Phe Leu Asp Asn His Asp Thr Gly Ser Thr Gln Gly His 305 310 315 320 tgg cct ttt cct ggt gaa cat atc atg caa ggc tat gct tac ata ctc 1008 Trp Pro Phe Pro Gly Glu His Ile Met Gln Gly Tyr Ala Tyr Ile Leu 325 330 335 act cat cct ggc aac cct tgt atc ttc tac gac cat ttc tat gat tgg 1056 Thr His Pro Gly Asn Pro Cys Ile Phe Tyr Asp His Phe Tyr Asp Trp 340 345 350 ggt ttg aaa gag gag atc aaa cgc tta ttg atc gtg cgc aag cgg aat 1104 Gly Leu Lys Glu Glu Ile Lys Arg Leu Leu Ile Val Arg Lys Arg Asn 355 360 365 gac atc aat gcg aag agc aaa gtg cac att tgt tgc gct gag cac gat 1152 Asp Ile Asn Ala Lys Ser Lys Val His Ile Cys Cys Ala Glu His Asp 370 375 380 ttg tac gtt gcg aag ata gat gat cgt gtc atc ctc aag atg ggg ccc 1200 Leu Tyr Val Ala Lys Ile Asp Asp Arg Val Ile Leu Lys Met Gly Pro 385 390 395 400 cga tat gac ata ggc gat cta gct cca act gcg acg aat ata aaa ttg 1248 Arg Tyr Asp Ile Gly Asp Leu Ala Pro Thr Ala Thr Asn Ile Lys Leu 405 410 415 cag ctg tgg gga aaa gac tac tgc gta tgg gag aag tgt aca 1290 Gln Leu Trp Gly Lys Asp Tyr Cys Val Trp Glu Lys Cys Thr 420 425 430 taatttctta cagagggttg catttatctt caagcggggc ctagccagcc gacgcgtgtg 1350 gaatgtagtt tcctaatccg tgtagctatt ttttcagtat caatgtattg tttttaattt 1410 tggagtgaag ctggtaacag atttgagacg tttgatgacg tatgtcacgt ttactacctg 1470 cttcagaagc gagcgtgaga cacttcatca atcttctgcc aatatcaatc ttcaggaaca 1530 attcgtgtac aggagaagta acttatttag agtagaatag tgcgccgtta ctattcctca 1590 gccatgttct gaggtaccac ttatgttaca actcgtttaa aatatatata tcgctctatt 1650 ggagtgtaac atagatgt 1668 174 430 PRT Physcomitrella patens 174 Met Leu Leu Ser Pro Ser Ser Ser Ala Leu Gly Ala Ser Thr Ser Lys 1 5 10 15 Ala Arg Gly Gly Asn Ile Lys Ala Asp Pro Leu Arg Val Ile Met Phe 20 25 30 Gln Gly Phe Asn Trp Glu Ser Trp Lys Ser Ser Cys Trp Tyr Asp Val 35 40 45 Met Gly Glu Thr Ala Glu Asp Leu Ala Ala Ala Gly Ile Thr Asp Val 50 55 60 Trp Phe Pro Pro Ser Ser His Ser Val Ser Pro Gln Gly Tyr Met Pro 65 70 75 80 Gly Arg Leu Tyr Asp Leu Asn Asp Cys Lys Tyr Gly Asn Glu Glu Lys 85 90 95 Leu Arg Glu Thr Ile Glu Lys Phe His Arg Val Gly Val Arg Cys Ile 100 105 110 Ala Asp Ile Val Val Asn His Arg Cys Gly Glu Glu Gln Asp Glu Arg 115 120 125 Gly Glu Trp Val Ile Phe Glu Gly Gly Thr Pro Asp Asp Ala Leu Asp 130 135 140 Trp Gly Pro Trp Ala Ile Val Gly Asp Asp Tyr Pro Tyr Gly Asn Gly 145 150 155 160 Thr Gly Ala Pro Asp Thr Gly Asp Asp Phe Glu Ala Ala Pro Asp Ile 165 170 175 Asp His Thr Asn Asp Ile Val Gln Ser Asp Leu Ile Val Trp Met Asn 180 185 190 Trp Met Lys Phe Lys Ile Gly Phe Asp Gly Trp Arg Phe Asp Phe Ala 195 200 205 Lys Gly Tyr Gly Gly Tyr Phe Val Gly Arg Tyr Ile Arg Lys Thr Glu 210 215 220 Pro Gln Phe Ala Val Gly Glu Phe Trp Thr Ser Leu Asn Tyr Gly His 225 230 235 240 Asp Gly Leu Glu Tyr Asn Gln Asp Ser His Arg Gln Gln Leu Val Asp 245 250 255 Trp Ile His Ala Thr Lys Glu Arg Ser Thr Ala Phe Asp Phe Thr Thr 260 265 270 Lys Gly Ile Leu Gln Glu Ala Val Lys Gly Gln Leu Trp Arg Leu Arg 275 280 285 Asp Pro Asn Ser Lys Pro Pro Gly Leu Ile Gly Tyr Trp Pro Ser Lys 290 295 300 Ala Val Thr Phe Leu Asp Asn His Asp Thr Gly Ser Thr Gln Gly His 305 310 315 320 Trp Pro Phe Pro Gly Glu His Ile Met Gln Gly Tyr Ala Tyr Ile Leu 325 330 335 Thr His Pro Gly Asn Pro Cys Ile Phe Tyr Asp His Phe Tyr Asp Trp 340 345 350 Gly Leu Lys Glu Glu Ile Lys Arg Leu Leu Ile Val Arg Lys Arg Asn 355 360 365 Asp Ile Asn Ala Lys Ser Lys Val His Ile Cys Cys Ala Glu His Asp 370 375 380 Leu Tyr Val Ala Lys Ile Asp Asp Arg Val Ile Leu Lys Met Gly Pro 385 390 395 400 Arg Tyr Asp Ile Gly Asp Leu Ala Pro Thr Ala Thr Asn Ile Lys Leu 405 410 415 Gln Leu Trp Gly Lys Asp Tyr Cys Val Trp Glu Lys Cys Thr 420 425 430 175 2068 DNA Physcomitrella patens CDS (168)..(1628) c_pp004072377r 175 cggcacccaa aggctcggag gaatggtgga ggaagcactc aagtactcct ggagactcta 60 tgtccgagcc caaagttggc catctttctc aaatgagtac tatgtttcca aagcacaaat 120 ctcttcttga ttgggagaat gcgggggagg agtggagtga atatttg atg cac gag 176 Met His Glu 1 acg gca aca agc aga ggt gtt cgt ggc ggc gtc cct gtg ttc gtg atg 224 Thr Ala Thr Ser Arg Gly Val Arg Gly Gly Val Pro Val Phe Val Met 5 10 15 ctc cct ttg gac acc gta agc atg aat aac act ctg aac aga cgt cgc 272 Leu Pro Leu Asp Thr Val Ser Met Asn Asn Thr Leu Asn Arg Arg Arg 20 25 30 35 gcc ttg gac gca tct ttg ctg gct ctg aaa tcg gct ggt gtg gag ggg 320 Ala Leu Asp Ala Ser Leu Leu Ala Leu Lys Ser Ala Gly Val Glu Gly 40 45 50 gtt atg atg gat gtt tgg tgg gga atc gtc gag aaa gat ggc cct cag 368 Val Met Met Asp Val Trp Trp Gly Ile Val Glu Lys Asp Gly Pro Gln 55 60 65 cag tac aat tgg tct gcg tat caa gag tta att gat atg gtg cgg aag 416 Gln Tyr Asn Trp Ser Ala Tyr Gln Glu Leu Ile Asp Met Val Arg Lys 70 75 80 cat ggt ttg aag gtt cag gct gtg atg tcc ttt cac cag tgt ggt ggc 464 His Gly Leu Lys Val Gln Ala Val Met Ser Phe His Gln Cys Gly Gly 85 90 95 aac gtt ggc gac agt tgc aat att cct ctg cct cca tgg gtg ttg gaa 512 Asn Val Gly Asp Ser Cys Asn Ile Pro Leu Pro Pro Trp Val Leu Glu 100 105 110 115 gag gta cga aag aat cca gac ttg gcc tac acc gat aag gct gga agg 560 Glu Val Arg Lys Asn Pro Asp Leu Ala Tyr Thr Asp Lys Ala Gly Arg 120 125 130 cgc aac tca gaa tac atc tct ctt ggc gct gac aac gtg ccc gct ttg 608 Arg Asn Ser Glu Tyr Ile Ser Leu Gly Ala Asp Asn Val Pro Ala Leu 135 140 145 aag gga agg aca ccg gtt caa tgc tat gcg gat ttc atg agg agc ttc 656 Lys Gly Arg Thr Pro Val Gln Cys Tyr Ala Asp Phe Met Arg Ser Phe 150 155 160 aga gac aac ttc gac gat ttt ttg gga gat ttt att gtc gaa atc caa 704 Arg Asp Asn Phe Asp Asp Phe Leu Gly Asp Phe Ile Val Glu Ile Gln 165 170 175 tgc gga atg gga ccc gct ggt gaa ctt cgt tac cct tca tac cct gag 752 Cys Gly Met Gly Pro Ala Gly Glu Leu Arg Tyr Pro Ser Tyr Pro Glu 180 185 190 195 agt gag ggt agg tgg cgt ttt cca ggc att ggt gag ttt cag tct tac 800 Ser Glu Gly Arg Trp Arg Phe Pro Gly Ile Gly Glu Phe Gln Ser Tyr 200 205 210 gac aaa tac atg att gcg agc ttg aaa gcc aat gct cag aag gtt gga 848 Asp Lys Tyr Met Ile Ala Ser Leu Lys Ala Asn Ala Gln Lys Val Gly 215 220 225 aag cct gca tgg ggt ttt agc ggt cct cac gat gct ggc agt tac aac 896 Lys Pro Ala Trp Gly Phe Ser Gly Pro His Asp Ala Gly Ser Tyr Asn 230 235 240 cag tgg ccc gag gaa gca gga ttc ttc aag aaa gat ggc acg tgg tct 944 Gln Trp Pro Glu Glu Ala Gly Phe Phe Lys Lys Asp Gly Thr Trp Ser 245 250 255 tca gaa tat ggg cag ttt ttc ttg gaa tgg tat tca gag atg ctt ctg 992 Ser Glu Tyr Gly Gln Phe Phe Leu Glu Trp Tyr Ser Glu Met Leu Leu 260 265 270 275 gcc cat ggt gaa cgc att ttg tca caa gct act ggc att ttc agg ggc 1040 Ala His Gly Glu Arg Ile Leu Ser Gln Ala Thr Gly Ile Phe Arg Gly 280 285 290 act gga gct atc att tca ggc aaa gtt gct ggt atc cat tgg cac tac 1088 Thr Gly Ala Ile Ile Ser Gly Lys Val Ala Gly Ile His Trp His Tyr 295 300 305 ggc acc aga agt cat gct gct gag ttg acg gcg tgg ata cta caa cac 1136 Gly Thr Arg Ser His Ala Ala Glu Leu Thr Ala Trp Ile Leu Gln His 310 315 320 tcg gac cag gga tgg aat att cgg cca ttg ccc aga tgt tcg cca agt 1184 Ser Asp Gln Gly Trp Asn Ile Arg Pro Leu Pro Arg Cys Ser Pro Ser 325 330 335 atg ggg gtt acc ctg aat ttc aca tgc atc gag atg cga gac ttc gaa 1232 Met Gly Val Thr Leu Asn Phe Thr Cys Ile Glu Met Arg Asp Phe Glu 340 345 350 355 caa cca tca cat gca ctg tgc agc ccc aga agg tct ggt gag aca gcg 1280 Gln Pro Ser His Ala Leu Cys Ser Pro Arg Arg Ser Gly Glu Thr Ala 360 365 370 tgg cat tgg gca aca cga aag gca cgg aat ttc caa atg gcc tgg gga 1328 Trp His Trp Ala Thr Arg Lys Ala Arg Asn Phe Gln Met Ala Trp Gly 375 380 385 aga aac gct ctt ccc agg ttc gac aat tca gcg cat gaa cca gat agt 1376 Arg Asn Ala Leu Pro Arg Phe Asp Asn Ser Ala His Glu Pro Asp Ser 390 395 400 tcg cga gtc gag att gca aat gaa cga gaa agg gga ttg tca gga gga 1424 Ser Arg Val Glu Ile Ala Asn Glu Arg Glu Arg Gly Leu Ser Gly Gly 405 410 415 tat gag ccg atg tct gct ttc acc ttc tta aga atg tgt gag agc ttg 1472 Tyr Glu Pro Met Ser Ala Phe Thr Phe Leu Arg Met Cys Glu Ser Leu 420 425 430 435 ttc cac agt gaa aac tgg aga ctg ttc gtt ccg ttt gtg cgc cac atg 1520 Phe His Ser Glu Asn Trp Arg Leu Phe Val Pro Phe Val Arg His Met 440 445 450 gag gaa gga cga acg ttt cag ccc tgg gag gaa gaa tca cac aga acg 1568 Glu Glu Gly Arg Thr Phe Gln Pro Trp Glu Glu Glu Ser His Arg Thr 455 460 465 cag aat cat atg cat gtg act cag ccc ttg ggc caa gaa gca gcc tcg 1616 Gln Asn His Met His Val Thr Gln Pro Leu Gly Gln Glu Ala Ala Ser 470 475 480 ttg atg tac cac tgatccgtaa gcgtgtcatg gattttagag gttggtgatt 1668 Leu Met Tyr His 485 gcctcccatt ttgcttgtta catacccata tacatatttg tagccagtac gatataccat 1728 acaaacatat acagacaaat acatgtattc tcgaactaga ggaaatcgcc ttccattaca 1788 ggcatgaaaa ctttttgttc tactcaacaa tgagagtaga tcaacagcgt aaaattattt 1848 catagtctga ctctctgttt cagtagattt ggaaatactg aacaagggca acagtctggc 1908 gtacggttgt attattatct aggacactag ttactactcc agtcagattg caaccttaga 1968 atcaccactg cgtatcactg gattttgtgg tagaaaagaa gtgggcagct gcttctgcag 2028 tcgttttgtg ctagtatcga atagggtgta acacgaaaaa 2068 176 487 PRT Physcomitrella patens 176 Met His Glu Thr Ala Thr Ser Arg Gly Val Arg Gly Gly Val Pro Val 1 5 10 15 Phe Val Met Leu Pro Leu Asp Thr Val Ser Met Asn Asn Thr Leu Asn 20 25 30 Arg Arg Arg Ala Leu Asp Ala Ser Leu Leu Ala Leu Lys Ser Ala Gly 35 40 45 Val Glu Gly Val Met Met Asp Val Trp Trp Gly Ile Val Glu Lys Asp 50 55 60 Gly Pro Gln Gln Tyr Asn Trp Ser Ala Tyr Gln Glu Leu Ile Asp Met 65 70 75 80 Val Arg Lys His Gly Leu Lys Val Gln Ala Val Met Ser Phe His Gln 85 90 95 Cys Gly Gly Asn Val Gly Asp Ser Cys Asn Ile Pro Leu Pro Pro Trp 100 105 110 Val Leu Glu Glu Val Arg Lys Asn Pro Asp Leu Ala Tyr Thr Asp Lys 115 120 125 Ala Gly Arg Arg Asn Ser Glu Tyr Ile Ser Leu Gly Ala Asp Asn Val 130 135 140 Pro Ala Leu Lys Gly Arg Thr Pro Val Gln Cys Tyr Ala Asp Phe Met 145 150 155 160 Arg Ser Phe Arg Asp Asn Phe Asp Asp Phe Leu Gly Asp Phe Ile Val 165 170 175 Glu Ile Gln Cys Gly Met Gly Pro Ala Gly Glu Leu Arg Tyr Pro Ser 180 185 190 Tyr Pro Glu Ser Glu Gly Arg Trp Arg Phe Pro Gly Ile Gly Glu Phe 195 200 205 Gln Ser Tyr Asp Lys Tyr Met Ile Ala Ser Leu Lys Ala Asn Ala Gln 210 215 220 Lys Val Gly Lys Pro Ala Trp Gly Phe Ser Gly Pro His Asp Ala Gly 225 230 235 240 Ser Tyr Asn Gln Trp Pro Glu Glu Ala Gly Phe Phe Lys Lys Asp Gly 245 250 255 Thr Trp Ser Ser Glu Tyr Gly Gln Phe Phe Leu Glu Trp Tyr Ser Glu 260 265 270 Met Leu Leu Ala His Gly Glu Arg Ile Leu Ser Gln Ala Thr Gly Ile 275 280 285 Phe Arg Gly Thr Gly Ala Ile Ile Ser Gly Lys Val Ala Gly Ile His 290 295 300 Trp His Tyr Gly Thr Arg Ser His Ala Ala Glu Leu Thr Ala Trp Ile 305 310 315 320 Leu Gln His Ser Asp Gln Gly Trp Asn Ile Arg Pro Leu Pro Arg Cys 325 330 335 Ser Pro Ser Met Gly Val Thr Leu Asn Phe Thr Cys Ile Glu Met Arg 340 345 350 Asp Phe Glu Gln Pro Ser His Ala Leu Cys Ser Pro Arg Arg Ser Gly 355 360 365 Glu Thr Ala Trp His Trp Ala Thr Arg Lys Ala Arg Asn Phe Gln Met 370 375 380 Ala Trp Gly Arg Asn Ala Leu Pro Arg Phe Asp Asn Ser Ala His Glu 385 390 395 400 Pro Asp Ser Ser Arg Val Glu Ile Ala Asn Glu Arg Glu Arg Gly Leu 405 410 415 Ser Gly Gly Tyr Glu Pro Met Ser Ala Phe Thr Phe Leu Arg Met Cys 420 425 430 Glu Ser Leu Phe His Ser Glu Asn Trp Arg Leu Phe Val Pro Phe Val 435 440 445 Arg His Met Glu Glu Gly Arg Thr Phe Gln Pro Trp Glu Glu Glu Ser 450 455 460 His Arg Thr Gln Asn His Met His Val Thr Gln Pro Leu Gly Gln Glu 465 470 475 480 Ala Ala Ser Leu Met Tyr His 485 177 2450 DNA Physcomitrella patens CDS (736)..(2055) c_pp001109095r 177 gcgcgccagg acaggcagag gacgagacaa gggggaccga ggtccagaga tcagctcgca 60 ggacctcgaa actgagctct agtagcgtag aattagcgca agggtggtgt aggtgaacag 120 agcgacgaga ccattctcgt catcgtagtt ataagacgca tacgagattc cgcagtgtcg 180 agagtcgggt accgagcccg cgcgagagtg aggatttgct acaggccttc cttttatttg 240 tcgacattat tgtccgagta ggttgtggct gaagttgcgg tggaacaggt tgtgtgtaga 300 actcgaagca gtcaagtttg cctgtcgaat ttctcaaact tactacagtt cttctcaaac 360 aagaagtttg ttagccgcga tggcagcaac agggactttc gcctccaccc gttacaccgc 420 actggcgagg ccagctcgct gcgaagcagt cggctacgat gccaccatgc ggtcgggctt 480 taagggggac ctcaagcctg catcttctgg gttcttggct ggtggcggtc gtctggctct 540 cgtcaccagc gttggtccca aacgcacagt tgccagagcc aagaccatcg gccttgaagt 600 ctccgctgtg ttggccgaac gcccaatggg ggctctgacc agacaagtaa cacgggagat 660 ggagaaagaa atggagaggg aaagggagaa ggagaaatcg agggagagca tgagctcgaa 720 ggagcaggtg actac atg acg aag gtg ttc tca atc atc ctg gga gga ggg 771 Met Thr Lys Val Phe Ser Ile Ile Leu Gly Gly Gly 1 5 10 gca ggc act cga ctc caa ccc ctc act ctt cgc cga gca aag cca gcg 819 Ala Gly Thr Arg Leu Gln Pro Leu Thr Leu Arg Arg Ala Lys Pro Ala 15 20 25 gtt cca ctt ggg ggt ggc tat cga ttg atc gat gtg ccc atg agc aac 867 Val Pro Leu Gly Gly Gly Tyr Arg Leu Ile Asp Val Pro Met Ser Asn 30 35 40 tgc att aac agc ggg att aac aag att tat gtt ctc act cag ttc aat 915 Cys Ile Asn Ser Gly Ile Asn Lys Ile Tyr Val Leu Thr Gln Phe Asn 45 50 55 60 tct acg tct tcg atc aac cgc cac ctt gcc aac act tac aat ttc ggc 963 Ser Thr Ser Ser Ile Asn Arg His Leu Ala Asn Thr Tyr Asn Phe Gly 65 70 75 aac ggt tgc aac ttc ggt gat ggt tac gtg gag gtc ctg gct gct gcc 1011 Asn Gly Cys Asn Phe Gly Asp Gly Tyr Val Glu Val Leu Ala Ala Ala 80 85 90 cag agg cct ggc ttc ggc ggt gac agg tgg ttc gaa ggt act gcg gac 1059 Gln Arg Pro Gly Phe Gly Gly Asp Arg Trp Phe Glu Gly Thr Ala Asp 95 100 105 gca gtg agg cag tac atg tgg ttg cac ttg gaa gat gcc aaa aac aaa 1107 Ala Val Arg Gln Tyr Met Trp Leu His Leu Glu Asp Ala Lys Asn Lys 110 115 120 gac gtc gaa gat gtg gtg atc ctg tcc ggg gat cac ctg tac cgc atg 1155 Asp Val Glu Asp Val Val Ile Leu Ser Gly Asp His Leu Tyr Arg Met 125 130 135 140 gat tac cga gat ttc gtc cag aaa cac aag gat tcc gga gct gat gtg 1203 Asp Tyr Arg Asp Phe Val Gln Lys His Lys Asp Ser Gly Ala Asp Val 145 150 155 act gtt tct tgc ata ccc atg gac gat agt cgt gct tct gat ttt ggc 1251 Thr Val Ser Cys Ile Pro Met Asp Asp Ser Arg Ala Ser Asp Phe Gly 160 165 170 ttg atg aag atc gac gga aag ggg cga atc aac cac ttt tct gaa aag 1299 Leu Met Lys Ile Asp Gly Lys Gly Arg Ile Asn His Phe Ser Glu Lys 175 180 185 ccg aaa gga aag gac ctg cag tcg atg caa gtg gac acc act gta ctc 1347 Pro Lys Gly Lys Asp Leu Gln Ser Met Gln Val Asp Thr Thr Val Leu 190 195 200 ggc ctg tcc gcg gag gag gct caa aag aag cca tac atc gct tcc atg 1395 Gly Leu Ser Ala Glu Glu Ala Gln Lys Lys Pro Tyr Ile Ala Ser Met 205 210 215 220 ggc att tac gtc ttc aag aag agc gtg ctc gcc aag ctg ctc agg tgg 1443 Gly Ile Tyr Val Phe Lys Lys Ser Val Leu Ala Lys Leu Leu Arg Trp 225 230 235 agg tat ccc ctc gcc aac gac ttt ggc tcc gag atc atc cct aag gct 1491 Arg Tyr Pro Leu Ala Asn Asp Phe Gly Ser Glu Ile Ile Pro Lys Ala 240 245 250 gcc aag gag ttc aat gtg aac gcc tac ctc ttt aac gat tac tgg gaa 1539 Ala Lys Glu Phe Asn Val Asn Ala Tyr Leu Phe Asn Asp Tyr Trp Glu 255 260 265 gac att gga acc atc aaa tcc ttc ttc gac gcg aac ttg gcg ctc cgc 1587 Asp Ile Gly Thr Ile Lys Ser Phe Phe Asp Ala Asn Leu Ala Leu Arg 270 275 280 agc cag aga atc ccc aac ttc agt ttc tac gac gct gaa aag ccc att 1635 Ser Gln Arg Ile Pro Asn Phe Ser Phe Tyr Asp Ala Glu Lys Pro Ile 285 290 295 300 tac aca tcc gcc cgc tac ttg ccc cca acc aag att gag aag tgt aga 1683 Tyr Thr Ser Ala Arg Tyr Leu Pro Pro Thr Lys Ile Glu Lys Cys Arg 305 310 315 gtg aag gat tca att gtc tcc cac gga tgc ttc ttg cgg gaa tgc agt 1731 Val Lys Asp Ser Ile Val Ser His Gly Cys Phe Leu Arg Glu Cys Ser 320 325 330 gta gag gat tcc gtc att gga atc cga tcc cgg ctc gag gct ggg tgc 1779 Val Glu Asp Ser Val Ile Gly Ile Arg Ser Arg Leu Glu Ala Gly Cys 335 340 345 gat gtc aag cgc gcc atg gtg atg gga gct gac tcc tat gaa acc gat 1827 Asp Val Lys Arg Ala Met Val Met Gly Ala Asp Ser Tyr Glu Thr Asp 350 355 360 ccc gaa gcg gct gct ttg ttg gcg gaa gga aag gta cct ttg ggc gtc 1875 Pro Glu Ala Ala Ala Leu Leu Ala Glu Gly Lys Val Pro Leu Gly Val 365 370 375 380 ggc gag aac tca aag ctg agg aat tgt att gtg gac aag aat gca aga 1923 Gly Glu Asn Ser Lys Leu Arg Asn Cys Ile Val Asp Lys Asn Ala Arg 385 390 395 att ggc aag gat gtt gtc att gcg aac act gac aat gtc ttg gaa gcg 1971 Ile Gly Lys Asp Val Val Ile Ala Asn Thr Asp Asn Val Leu Glu Ala 400 405 410 gag aga caa agt gaa ggt ttt tac atc cgt tcc gga att gta gta gta 2019 Glu Arg Gln Ser Glu Gly Phe Tyr Ile Arg Ser Gly Ile Val Val Val 415 420 425 tac aag aac gcg gtt atc aag cac gga act gta atc taaattacga 2065 Tyr Lys Asn Ala Val Ile Lys His Gly Thr Val Ile 430 435 440 atctttctcc atatcgtgaa aactgcttcc ttgcaacgcc ggtccctggt gagctgatcc 2125 ttggacctca tcatcgacgg tgaaaaagat atcagtactt atccgagttg tgagattctc 2185 agctcgtgat tactgatcct cttcctcttg ccaccctgaa gattgccgcg caggatctgg 2245 tttgtgtcgg tatatcagat cagtagttct tacataagac tgaattgaaa tgtacaaaga 2305 gatcagatca tcgggagtgg aaccgttcag aggaagaaac ctaccgtata gtcaagtgga 2365 cgaagattat ggtatcaatt ttggagtgta aagtgtgagc gacttctact gtccttgtat 2425 cataccccat tgaagtaaag aattg 2450 178 440 PRT Physcomitrella patens 178 Met Thr Lys Val Phe Ser Ile Ile Leu Gly Gly Gly Ala Gly Thr Arg 1 5 10 15 Leu Gln Pro Leu Thr Leu Arg Arg Ala Lys Pro Ala Val Pro Leu Gly 20 25 30 Gly Gly Tyr Arg Leu Ile Asp Val Pro Met Ser Asn Cys Ile Asn Ser 35 40 45 Gly Ile Asn Lys Ile Tyr Val Leu Thr Gln Phe Asn Ser Thr Ser Ser 50 55 60 Ile Asn Arg His Leu Ala Asn Thr Tyr Asn Phe Gly Asn Gly Cys Asn 65 70 75 80 Phe Gly Asp Gly Tyr Val Glu Val Leu Ala Ala Ala Gln Arg Pro Gly 85 90 95 Phe Gly Gly Asp Arg Trp Phe Glu Gly Thr Ala Asp Ala Val Arg Gln 100 105 110 Tyr Met Trp Leu His Leu Glu Asp Ala Lys Asn Lys Asp Val Glu Asp 115 120 125 Val Val Ile Leu Ser Gly Asp His Leu Tyr Arg Met Asp Tyr Arg Asp 130 135 140 Phe Val Gln Lys His Lys Asp Ser Gly Ala Asp Val Thr Val Ser Cys 145 150 155 160 Ile Pro Met Asp Asp Ser Arg Ala Ser Asp Phe Gly Leu Met Lys Ile 165 170 175 Asp Gly Lys Gly Arg Ile Asn His Phe Ser Glu Lys Pro Lys Gly Lys 180 185 190 Asp Leu Gln Ser Met Gln Val Asp Thr Thr Val Leu Gly Leu Ser Ala 195 200 205 Glu Glu Ala Gln Lys Lys Pro Tyr Ile Ala Ser Met Gly Ile Tyr Val 210 215 220 Phe Lys Lys Ser Val Leu Ala Lys Leu Leu Arg Trp Arg Tyr Pro Leu 225 230 235 240 Ala Asn Asp Phe Gly Ser Glu Ile Ile Pro Lys Ala Ala Lys Glu Phe 245 250 255 Asn Val Asn Ala Tyr Leu Phe Asn Asp Tyr Trp Glu Asp Ile Gly Thr 260 265 270 Ile Lys Ser Phe Phe Asp Ala Asn Leu Ala Leu Arg Ser Gln Arg Ile 275 280 285 Pro Asn Phe Ser Phe Tyr Asp Ala Glu Lys Pro Ile Tyr Thr Ser Ala 290 295 300 Arg Tyr Leu Pro Pro Thr Lys Ile Glu Lys Cys Arg Val Lys Asp Ser 305 310 315 320 Ile Val Ser His Gly Cys Phe Leu Arg Glu Cys Ser Val Glu Asp Ser 325 330 335 Val Ile Gly Ile Arg Ser Arg Leu Glu Ala Gly Cys Asp Val Lys Arg 340 345 350 Ala Met Val Met Gly Ala Asp Ser Tyr Glu Thr Asp Pro Glu Ala Ala 355 360 365 Ala Leu Leu Ala Glu Gly Lys Val Pro Leu Gly Val Gly Glu Asn Ser 370 375 380 Lys Leu Arg Asn Cys Ile Val Asp Lys Asn Ala Arg Ile Gly Lys Asp 385 390 395 400 Val Val Ile Ala Asn Thr Asp Asn Val Leu Glu Ala Glu Arg Gln Ser 405 410 415 Glu Gly Phe Tyr Ile Arg Ser Gly Ile Val Val Val Tyr Lys Asn Ala 420 425 430 Val Ile Lys His Gly Thr Val Ile 435 440 179 18 DNA Artificial Sequence Artificial sequence is a sequencing primer 179 caggaaacag ctatgacc 18 180 19 DNA Artificial Sequence Artificial sequence is a sequencing primer 180 ctaaagggaa caaaagctg 19 181 18 DNA Artificial Sequence Artificial sequence is a sequencing primer 181 tgtaaaacga cggccagt 18 

1. An isolated nucleic acid molecule from a moss encoding a Carbohydrate Metabolism Related Protein (CMRP), or a portion thereof.
 2. The isolated nucleic acid molecule of claim 1 wherein the moss is selected from Physcomitrella patens or Ceratodon purpureus.
 3. The isolated nucleic acid molecule of claim 1, wherein said nucleic acid molecule encodes a CMRP involved in the production of a fine chemical.
 4. The isolated nucleic acid molecule of claim 1, wherein said nucleic acid molecule encodes a CMRP involved in the production of carbohydrates.
 5. The isolated nucleic acid molecule of claim 1, wherein said nucleic acid molecule encodes an CMRP involved in the production of starch, cell wall polysaccharides and/or soluble sugars.
 6. The isolated nucleic acid molecule of claim 1, wherein said nucleic acid molecule encodes a CMRP polypeptide assisting in transmembrane transport.
 7. An isolated nucleic acid molecule from mosses selected from the group consisting of those sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), or a portion thereof.
 8. An isolated nucleic acid molecule which encodes a polypeptide sequence selected from the group consisting of those sequences set forth in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers).
 9. An isolated nucleic acid molecule which encodes a naturally occurring allelic variant of a polypeptide selected from the group of amino acid sequences consisting of those sequences set forth in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers).
 10. An isolated nucleic acid molecule comprising a nucleotide sequence which is at least 50% homologous to a nucleotide sequence selected from the group consisting of those sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers), or a portion thereof.
 11. An isolated nucleic acid molecule comprising a fragment of at least 15 nucleotides of a nucleic acid comprising a nucleotide sequence selected from the group consisting of those sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers).
 12. An isolated nucleic acid molecule which hybridizes to the nucleic acid molecule of any one of claims 1 or 7 to 11 under stringent conditions.
 13. An isolated nucleic acid molecule comprising the nucleic acid molecule of any one of claims 1 or 7 to 11 or a portion thereof and a nucleotide sequence encoding a heterologous polypeptide.
 14. A vector comprising the nucleic acid molecule of any one of claims 1 or 7 to 11, or a portion thereof, or the isolated nucleic acid molecule which hybridizes to a nucleic acid molecule of any one of claims 1 or 7 to 11 under stringent conditions, or a portion thereof, and, optionally, a nucleotide sequence encoding a heterologous polypeptide.
 15. The vector of claim 14, which is an expression vector.
 16. A host cell transformed with the expression vector of claim
 15. 17. The host cell of claim 16, wherein said cell is a microorganism.
 18. The host cell of claim 16, wherein said cell belongs to the genus mosses or algae.
 19. The host cell of claim 16, wherein said cell is a plant cell.
 20. The host cell of claim 16, wherein the expression of said nucleic acid molecule results in the modulation of the production of a fine chemical from said cell.
 21. The host cell of claim 16, wherein the expression of said nucleic acid molecule results in the modulation of the production of carbohydrates from said cell.
 22. The host cell of claim 16, wherein the expression of said nucleic acid molecule results in the modulation of the production of starch, cell wall polysaccharides and/or soluble sugars from said cell.
 23. Descendants, seeds or reproducable cell material derived from a host cell of claim
 16. 24. A method of producing a polypeptide comprising culturing the host cell of claim 16 in an appropriate culture medium to, thereby, produce the polypeptide.
 25. An isolated CMRP polypeptide from mosses or algae or a portion thereof.
 26. An isolated CMRP polypeptide from microorganisms or fungi or a portion thereof.
 27. An isolated CMRP polypeptide from plants or a portion thereof.
 28. The polypeptide of any one of claims 25 to 27, wherein said polypeptide is involved in the production of a fine chemical.
 29. The polypeptide of any one of claims 25 to 27, wherein said polypeptide is involved in assisting in transmembrane transport.
 30. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of those sequences set forth in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers).
 31. An isolated polypeptide comprising a naturally occurring allelic variant of a polypeptide comprising an amino acid sequence selected from the group consisting of those sequences set forth in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers), or a portion thereof.
 32. The isolated polypeptide of any of claims 25 to 27 or 30 to 31, further comprising heterologous amino acid sequences.
 33. An isolated polypeptide which is encoded by a nucleic acid molecule comprising a nucleotide sequence which is at least 50% homologous to a nucleic acid selected from the group consisting of those sequences set forth in Appendix A (SEQ ID NO:1 to SEQ ID NO:177, odd integers).
 34. An isolated polypeptide comprising an amino acid sequence which is at least 50% homologous to an amino acid sequence selected from the group consisting of those sequences set forth in Appendix B (SEQ ID NO:2 to SEQ ID NO:178, even integers).
 35. An antibody specifically binding to a CMRP polypeptide of any one of claims 25 to 27, 30 to 31 or 33 to 34 or a portion thereof.
 36. A test kit comprising a nucleic acid molecule of any one of claims 1 or 7 to 11, a portion and/or a complement thereof used as probe or primer for identifying and/or cloning further nucleic acid molecules involved in the production of carbohydrates or assisting in transmembrane transport in other cell types or organisms.
 37. A test kit comprising a CMRP polypeptide-antibody of claim 35 for identifying and/or purifying further CMRP polypeptide molecules or fragments thereof in other cell types or organisms.
 38. A method for producing a fine chemical, comprising culturing a cell containing a vector of claim 14 such that the fine chemical is produced.
 39. The method of claim 38, wherein said method further comprises the step of recovering the fine chemical from said culture.
 40. The method of claim 38, wherein said method further comprises the step of transforming said cell with the vector of claim 14 to result in a cell containing said vector.
 41. The method of claim 38, wherein said cell is a microorganism.
 42. The method of claim 38, wherein said cell belongs to the genus Corynebacterium or Brevibacterium.
 43. The method of claim 38, wherein said cell belongs to the genus mosses or algae.
 44. The method of claim 38, wherein said cell is a plant cell.
 45. The method of claim 38, wherein expression of the nucleic acid molecule from said vector results in modulation of the production of said fine chemical.
 46. The method of claim 38, wherein said fine chemical is selected from the group consisting of carbohydrates, cofactors and/or enzymes.
 47. The method of claim 46, wherein said fine chemical is selected from the group consisting of starch, cell wall polysaccharides and/or soluble sugars.
 48. A method for producing a fine chemical, comprising culturing a cell whose genomic DNA has been altered by the inclusion of a nucleic acid molecule of any one of claims 1 or 7 to
 11. 49. The method of claim 48, comprising culturing a cell whose membrane has been altered by the inclusion of a polypeptide of any one of claims 25 to 27, 30 to 31 or 33 to
 34. 50. A fine chemical produced by the method of claim 38 or
 48. 51. Use of a fine chemical of claim 50 or a polypeptide of any one of claims 25 to 27, 30, 31, 33 or 34 for the production of another fine chemical. 